data_2ain_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ain _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 16.9 tt0 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.174 0.512 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.89 133.65 32.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.65 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pt -148.08 147.23 17.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.172 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -111.91 124.86 53.28 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 m -101.19 135.9 35.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.431 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 m -103.16 97.54 7.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.571 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 mt -122.19 163.33 19.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.896 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -108.71 141.3 40.9 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.871 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -77.87 111.01 13.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.08 -42.61 17.22 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -168.41 37.42 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.08 174.51 18.65 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.09 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.411 ' SD ' HD11 ' A' ' 86' ' ' LEU . 28.7 mtm -103.69 -46.94 4.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.714 0.257 . . . . 0.0 111.341 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.24 81.62 0.12 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.809 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 pp -160.52 179.54 8.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.709 0.29 . . . . 0.0 110.868 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -132.81 146.59 51.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.718 0.294 . . . . 0.0 111.353 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.524 HD11 ' NE2' ' A' ' 70' ' ' GLN . 2.7 pp -142.34 153.43 18.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.819 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.1 t -135.84 136.4 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.425 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.69 130.74 34.48 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.073 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.36 142.6 45.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.425 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -122.0 -179.6 4.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.924 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.03 -141.34 3.1 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.85 143.32 33.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.659 0.266 . . . . 0.0 110.675 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.79 34.02 88.56 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.697 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.75 105.03 7.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.686 0.279 . . . . 0.0 110.817 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.11 19.96 6.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.355 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -138.48 -168.75 2.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.749 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tp -141.64 130.94 23.56 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.719 0.295 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.51 136.25 12.71 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.741 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.5 mm -90.62 83.76 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.69 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -74.14 162.18 29.23 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.359 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.41 134.86 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.264 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -105.53 -37.89 6.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.0 t -166.05 172.42 11.42 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.691 0.281 . . . . 0.0 110.957 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.0 t -130.89 126.71 60.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.763 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.3 145.17 10.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.009 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -68.14 150.22 48.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.323 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.34 20.23 73.2 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.917 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.11 157.58 23.41 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.388 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.77 62.03 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.25 -32.67 22.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.463 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.09 -44.85 59.89 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.296 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.8 t -66.4 -44.82 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.124 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.34 -37.67 66.02 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.867 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.42 82.61 0.57 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.653 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -133.16 -61.87 0.81 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.625 0.213 . . . . 0.0 111.35 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.29 156.02 16.92 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.336 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.28 173.47 11.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.484 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.71 140.41 53.52 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.264 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.37 38.95 8.04 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.491 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -121.32 178.59 4.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.498 0.19 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -125.04 139.98 53.31 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.414 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.3 tp -106.9 147.87 29.27 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.064 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.52 -59.31 1.3 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.385 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.54 144.06 50.73 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.963 0.411 . . . . 0.0 111.759 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.86 123.83 45.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.542 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.01 33.13 22.84 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 23.32 77.98 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.074 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -112.96 134.61 54.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 117.018 0.409 . . . . 0.0 110.268 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -83.01 86.42 7.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.47 54.75 3.01 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.126 0.489 . . . . 0.0 110.869 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.6 t -102.27 99.38 8.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.634 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.71 32.89 2.16 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.623 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.6 mt -117.66 161.75 19.15 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.4 152.87 24.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.299 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.524 ' NE2' HD11 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -47.07 -42.22 18.35 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.625 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -58.45 -49.99 75.33 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.039 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -69.76 -36.26 75.63 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.941 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.63 -58.23 5.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.633 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.96 -46.19 91.71 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.595 0.236 . . . . 0.0 111.276 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -55.42 -50.36 70.0 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.939 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.02 -40.65 96.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.393 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.9 mtp -58.48 -49.49 77.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.221 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.9 t -69.9 -27.88 65.16 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -82.96 43.93 0.89 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.801 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 p -101.37 171.26 7.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.274 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.9 m -85.27 -166.6 1.55 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.614 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -43.32 74.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.564 0.221 . . . . 0.0 110.928 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 t -93.19 140.2 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.647 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.2 t -130.36 134.51 62.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.275 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.48 89.74 3.17 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.411 HD11 ' SD ' ' A' ' 17' ' ' MET . 17.1 mt -94.54 120.3 34.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.75 101.92 13.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.323 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 p -105.23 150.2 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.353 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.3 148.02 28.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.575 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.593 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 27.8 p . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.765 0.317 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.744 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 2.6 tt0 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.153 0.501 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.0 mm -90.49 127.56 42.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.042 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pp -145.34 137.89 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.2 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.539 ' CG2' ' HG3' ' A' ' 87' ' ' GLU . 2.2 m -92.16 139.35 30.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.96 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.47 117.9 55.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.912 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -111.06 102.74 11.17 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.27 157.67 42.66 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -84.19 136.0 34.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.489 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.26 96.75 0.67 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.335 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -101.75 100.08 10.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.293 0.568 . . . . 0.0 110.428 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 55.04 35.2 24.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.921 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.53 -174.51 36.52 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.4 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.1 mtm -102.69 -36.95 8.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.418 0.151 . . . . 0.0 111.095 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.63 79.75 0.13 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.599 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 pp -160.71 179.81 8.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.669 0.271 . . . . 0.0 111.159 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -132.18 156.94 45.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.33 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' B' ' 101' ' ' SER . 2.8 pp -143.47 146.71 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 37' ' ' LYS . 40.1 t -133.85 134.83 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.261 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.43 122.14 34.58 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.678 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.91 149.41 48.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.44 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.61 -179.79 3.76 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.264 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.95 -140.13 2.8 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.23 146.05 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.723 0.296 . . . . 0.0 110.771 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.26 41.05 98.15 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.606 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 106.94 7.35 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.671 0.272 . . . . 0.0 110.999 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.36 19.7 5.83 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.256 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -146.97 -171.59 3.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.522 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.9 137.19 55.01 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.731 0.3 . . . . 0.0 110.886 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.83 125.31 8.5 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.627 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.434 HG13 ' CB ' ' A' ' 73' ' ' ALA . 19.3 mm -84.38 84.68 2.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.043 0.449 . . . . 0.0 110.737 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -77.66 168.83 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.512 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.0 t -104.23 129.06 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.403 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.51 ' HD3' ' HB3' ' B' ' 101' ' ' SER . 3.0 tttt -83.41 -45.41 13.72 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.603 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -170.4 176.93 4.26 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.058 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.13 127.94 75.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.759 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.92 125.69 40.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.185 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.68 143.86 56.93 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.011 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.74 -15.75 60.47 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.115 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.13 -152.23 3.17 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.803 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.25 -60.47 1.67 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.556 0.217 . . . . 0.0 111.576 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.414 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -61.62 -26.45 68.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.856 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.44 -47.74 46.6 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.2 t -73.38 -37.82 52.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.268 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.96 -44.92 45.65 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.094 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.02 65.69 0.99 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.477 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -141.02 30.79 1.8 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.565 0.221 . . . . 0.0 111.375 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.414 HD12 ' CB ' ' A' ' 45' ' ' ALA . 9.3 mt -154.43 171.07 19.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.889 0.376 . . . . 0.0 111.393 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.8 141.76 3.48 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 37' ' ' LYS . . . -61.38 117.09 5.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.6 31.41 3.71 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.617 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.24 -178.19 3.57 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.612 0.244 . . . . 0.0 110.999 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 6.0 tm0? -124.61 159.0 31.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.222 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.2 mt -124.05 107.38 11.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.962 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.1 -64.44 1.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.179 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 m -147.62 159.11 44.14 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.447 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.46 HG23 ' CG ' ' A' ' 77' ' ' MET . 38.9 t -127.87 125.42 64.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.822 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 55.79 33.85 22.29 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.22 36.61 85.4 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.061 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -119.41 152.75 36.3 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 111.083 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.2 m -79.05 118.2 20.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.204 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.2 mt -126.1 31.4 5.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.046 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.5 t -115.1 100.34 10.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.128 0.49 . . . . 0.0 110.925 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.55 -32.28 2.84 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.526 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.7 mt -66.5 172.04 4.46 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 110.984 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -84.03 160.03 21.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.078 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -51.93 -33.42 37.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.202 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -60.3 -54.87 40.56 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.022 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -60.32 -38.26 83.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.828 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' CB ' HG13 ' A' ' 34' ' ' ILE . . . -52.71 -62.44 1.65 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.237 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.84 -63.98 1.11 Allowed 'General case' 0 C--N 1.335 -0.055 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -36.07 -41.2 0.24 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.05 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 mt -66.31 -47.15 74.47 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.46 ' CG ' HG23 ' A' ' 60' ' ' VAL . 11.9 mtp -75.42 -30.45 60.07 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -32.05 69.1 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.635 0.255 . . . . 0.0 110.575 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -92.42 44.45 1.16 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.895 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.0 160.95 24.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.061 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.07 -164.66 1.1 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.038 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 82.5 p -50.27 -42.95 53.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.5 t -96.03 139.45 19.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.734 0.302 . . . . 0.0 110.807 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.88 96.22 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.02 90.3 4.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HG ' HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -115.81 128.8 56.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.955 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.539 ' HG3' ' CG2' ' A' ' 8' ' ' THR . 12.2 mt-10 -98.93 111.82 24.11 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.48 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.6 142.34 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.561 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . . . -105.14 108.76 20.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.636 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 8.1 mtmt . . . . . 0 N--CA 1.462 0.168 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.162 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.51 ' HB3' ' HD3' ' A' ' 37' ' ' LYS . 35.3 p . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.809 0.338 . . . . 0.0 111.876 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 39.2 p . . . . . 0 C--O 1.233 0.197 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.317 179.135 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 121.024 0.44 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -94.85 113.52 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.663 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 pt -127.12 150.66 33.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.321 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.402 ' HB ' ' CG ' ' A' ' 87' ' ' GLU . 7.9 t -109.38 131.92 54.61 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG11 HD12 ' A' ' 11' ' ' LEU . 14.3 p -106.3 122.79 60.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.004 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -96.27 103.59 15.5 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.599 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.445 HD12 HG11 ' A' ' 9' ' ' VAL . 7.1 mt -125.45 174.14 8.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.46 142.56 46.55 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.92 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.81 135.52 38.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.048 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -92.11 -60.75 1.77 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.307 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.86 36.38 0.26 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.725 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.16 144.79 6.88 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.024 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.0 mtm -73.03 -61.37 1.84 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.492 0.187 . . . . 0.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.4 81.25 0.2 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.569 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 pp -160.96 179.49 8.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.571 0.224 . . . . 0.0 110.807 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.8 m -136.88 149.18 47.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.227 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' B' ' 101' ' ' SER . 2.8 pp -136.74 157.32 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.603 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.438 ' CG2' ' HB2' ' A' ' 37' ' ' LYS . 14.8 t -127.82 145.43 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.55 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.85 142.0 33.84 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.823 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -142.5 142.43 32.27 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.71 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.89 -179.43 4.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.121 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.6 144.93 10.66 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.683 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.39 141.28 55.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.176 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.91 34.66 65.82 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.68 109.8 7.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.298 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -88.74 27.51 1.3 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.32 -172.81 3.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.712 0.292 . . . . 0.0 110.511 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.24 132.94 23.79 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.19 119.43 5.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.131 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.7 mm -88.41 105.22 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-O 120.899 0.38 . . . . 0.0 110.552 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 56' ' ' GLN . 70.7 m-85 -99.3 169.7 9.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.248 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.79 139.49 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 111.001 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . 2.3 tptt -100.79 -45.29 5.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.743 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -161.7 169.89 20.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.61 115.14 24.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.593 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.86 126.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.109 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -59.97 149.18 32.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.85 -24.01 33.98 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.998 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.68 -166.13 6.26 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.576 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.3 -52.85 4.72 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.705 -0.291 . . . . 0.0 111.617 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.66 -38.08 44.39 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.038 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.29 -55.71 9.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.629 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.79 -31.22 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.49 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.88 -56.83 9.77 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.38 57.68 1.84 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.763 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -119.72 -45.63 2.49 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.552 0.215 . . . . 0.0 110.952 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 pp -128.3 175.81 8.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.897 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.42 -173.91 4.54 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.297 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.01 127.57 33.36 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.212 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.9 27.41 6.65 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.617 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -118.61 138.14 52.78 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.4 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 35.5 tt0 -82.6 152.02 26.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.23 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.5 mp -119.26 144.04 46.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.013 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 mt -116.04 -60.6 1.84 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.193 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 m -123.05 156.73 34.28 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG21 ' CD1' ' A' ' 86' ' ' LEU . 19.5 t -142.1 120.71 9.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.111 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.82 35.59 26.5 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.205 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.63 21.17 79.69 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.945 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.3 mtm-85 -113.7 146.86 39.19 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.863 0.331 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.9 m -102.05 103.58 14.17 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 pp -109.11 42.22 1.48 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.2 t -87.7 99.57 8.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.189 0.519 . . . . 0.0 110.809 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.06 40.87 0.94 Allowed Glycine 0 CA--C 1.52 0.346 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.393 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 mt -127.97 157.63 40.08 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.712 0.291 . . . . 0.0 110.784 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.1 p -70.91 159.46 34.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.126 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -54.81 -40.15 69.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.946 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -56.91 -47.27 80.98 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.421 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -68.51 -38.68 81.14 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.596 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.85 -59.41 4.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.3 -67.02 0.42 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -35.2 -41.19 0.15 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.29 0.636 . . . . 0.0 112.173 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.58 -49.07 74.83 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.599 0.238 . . . . 0.0 111.454 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 7.2 mtm -70.78 -33.47 70.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.759 0.314 . . . . 0.0 110.704 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -29.2 70.58 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.31 42.67 1.11 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.721 0.296 . . . . 0.0 111.623 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 p -98.72 170.18 8.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.775 0.322 . . . . 0.0 111.183 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.6 p -99.9 -161.42 0.87 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.505 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.3 m -57.0 -39.71 75.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.518 0.199 . . . . 0.0 110.625 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.14 145.39 8.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.61 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.82 121.83 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.091 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.41 99.19 6.28 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.498 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.426 ' CD1' HG21 ' A' ' 60' ' ' VAL . 3.2 mm? -106.31 115.04 29.53 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.207 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.402 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 0.1 OUTLIER -81.36 89.48 6.1 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 110.143 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.423 ' CG2' ' HB3' ' A' ' 55' ' ' ASP . 14.2 p -93.19 150.65 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.472 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.49 143.86 31.67 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.484 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.484 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 34.0 t . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.615 0.245 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.195 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 33.1 tt0 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 121.193 0.521 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.1 mm -95.59 131.35 42.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.74 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.14 144.85 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.69 126.76 55.6 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 m -99.4 113.77 35.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.981 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.86 92.19 5.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.486 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt -116.03 173.87 6.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.17 162.24 13.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.022 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.08 113.78 25.51 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.513 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.85 -41.47 6.49 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.412 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -163.68 44.82 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.544 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.09 153.8 28.01 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.374 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.35 -48.54 80.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.606 0.203 . . . . 0.0 111.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.09 69.53 1.39 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.819 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.3 pp -160.72 177.48 10.42 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 122.202 0.201 . . . . 0.0 110.581 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -138.24 134.13 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.688 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.564 HD11 HG23 ' A' ' 34' ' ' ILE . 2.1 pp -120.87 165.73 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.407 HG22 ' CB ' ' B' ' 101' ' ' SER . 47.8 t -149.9 137.14 13.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.501 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.85 123.84 33.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.14 157.79 45.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.848 0.356 . . . . 0.0 111.645 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.87 179.69 4.55 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.006 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.24 -141.21 3.08 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.789 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.88 147.1 31.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.65 0.262 . . . . 0.0 110.787 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.27 37.15 92.57 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.784 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.89 106.29 8.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.65 0.262 . . . . 0.0 110.844 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.8 17.86 6.2 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HD2' ' CA ' ' A' ' 67' ' ' GLY . 19.4 mmtp -145.15 -171.06 3.57 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.632 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 tp -124.03 139.23 54.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.514 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.21 133.0 11.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.991 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.564 HG23 HD11 ' A' ' 21' ' ' ILE . 29.1 mm -92.12 71.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.149 0.5 . . . . 0.0 110.512 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -63.4 167.68 5.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.775 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.1 125.34 69.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.098 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.479 ' HD3' ' HB2' ' B' ' 101' ' ' SER . 2.3 pttt -87.01 -36.51 18.19 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.587 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -163.42 159.36 22.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.523 0.202 . . . . 0.0 111.039 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 19' ' ' LEU . 16.7 t -118.25 122.91 70.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.31 133.4 30.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.39 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 154.39 41.87 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.74 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.49 45.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.266 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.64 -163.7 4.94 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.59 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.42 -34.32 11.57 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.09 -47.13 38.49 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -59.55 -37.94 79.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.437 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.8 t -73.79 -32.79 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.248 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.43 -41.68 80.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.087 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.71 49.78 10.22 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.787 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -105.5 -36.16 7.23 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.576 0.227 . . . . 0.0 111.349 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.52 173.71 8.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 111.277 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.68 26.84 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.176 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.25 128.44 37.01 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.537 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.85 38.77 2.46 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.016 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -116.59 141.53 48.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.668 0.271 . . . . 0.0 110.77 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -85.97 143.51 28.12 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.068 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -99.81 143.72 29.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.324 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tt -122.41 -58.83 1.67 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.2 p -140.64 154.24 46.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.978 0.418 . . . . 0.0 111.795 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.4 t -135.03 112.83 15.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.438 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 56.83 34.5 24.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.232 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.37 -20.33 49.98 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.383 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -70.98 151.3 44.79 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 117.27 0.535 . . . . 0.0 111.065 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.1 p -107.14 119.47 39.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 mt -110.23 -9.19 14.68 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.736 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.88 83.62 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-O 121.692 0.758 . . . . 0.0 110.737 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.409 ' CA ' ' HD2' ' A' ' 31' ' ' LYS . . . 140.78 -23.49 2.63 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.658 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.4 mt -82.47 169.19 16.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.6 m -86.1 166.48 15.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.759 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -57.85 -28.73 64.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.416 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -64.74 -47.49 78.04 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-O 120.65 0.262 . . . . 0.0 110.765 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -53.78 39.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.27 -50.58 72.46 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.771 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.41 -63.27 1.25 Allowed 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.882 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -46.37 -48.05 18.58 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.445 0.466 . . . . 0.0 112.117 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.6 mt -68.16 -27.82 66.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.569 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.499 ' HE3' ' CD2' ' A' ' 86' ' ' LEU . 77.6 mtp -86.21 -19.99 29.18 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -43.42 63.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.799 0.333 . . . . 0.0 110.61 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -95.57 65.51 2.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.946 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -83.78 147.43 27.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.068 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.51 -167.54 1.83 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.765 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -56.55 -43.85 80.33 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.921 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.08 144.49 12.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.1 t -137.69 113.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.802 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.23 86.77 2.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.649 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.499 ' CD2' ' HE3' ' A' ' 77' ' ' MET . 1.3 mt -94.25 124.41 38.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.294 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -98.9 121.41 40.82 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.289 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.4 m -117.7 168.77 9.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.733 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.17 111.43 13.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.987 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 11.8 mmtt . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.521 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.479 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 97.8 p . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 120.747 0.308 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HB3' ' CG ' ' A' ' 90' ' ' LYS . 10.9 tt0 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 121.07 0.462 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.79 137.15 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.598 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.45 150.08 14.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.3 m -113.88 131.23 56.35 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.879 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.5 m -102.09 116.29 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.107 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 m -105.43 98.43 8.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.544 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mt -126.87 154.74 44.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 152.96 21.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -70.72 105.15 3.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.196 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.37 -38.72 10.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.087 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -161.58 42.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.01 0.433 . . . . 0.0 110.56 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.94 157.8 6.11 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.118 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.425 ' SD ' HD11 ' A' ' 86' ' ' LEU . 2.7 mtm -65.02 -56.05 15.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.696 0.248 . . . . 0.0 110.564 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.13 78.74 0.14 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.894 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 pp -160.81 177.72 10.14 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.11 153.17 43.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.952 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 pp -144.75 158.64 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 112.088 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.15 141.67 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.17 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.42 149.46 30.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.261 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -146.85 135.04 21.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.335 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -119.73 179.98 4.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.01 -137.85 2.28 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.12 142.78 41.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.665 0.269 . . . . 0.0 110.871 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.92 43.89 98.57 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.914 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.37 107.81 7.82 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.72 0.295 . . . . 0.0 111.025 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.96 22.34 3.71 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.435 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -144.13 -171.97 3.67 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.657 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 tp -136.11 136.88 40.49 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.906 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.88 161.88 19.38 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.767 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.0 mm -115.3 103.27 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 111.073 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -90.57 163.78 14.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.83 113.08 40.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.029 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -43.01 69.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 p -172.18 167.19 5.97 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.777 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.2 m -120.0 127.89 75.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.851 0.357 . . . . 0.0 110.816 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.43 121.7 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -64.17 154.18 35.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.19 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.48 -37.01 3.83 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.703 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.7 -177.8 5.88 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.773 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.1 -2.33 58.55 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.29 -38.32 11.57 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.04 -37.38 54.92 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.229 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.1 t -64.69 -33.27 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.636 0.255 . . . . 0.0 110.95 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.92 -45.18 64.73 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.098 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.74 29.23 43.77 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.784 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.64 -33.16 16.75 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.515 0.198 . . . . 0.0 111.167 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.46 171.2 11.24 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.031 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.94 -175.71 5.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.563 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.82 162.15 29.43 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.94 39.82 93.36 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.334 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.05 142.79 51.45 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.639 0.257 . . . . 0.0 111.055 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -89.79 160.3 16.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.8 mt -124.44 155.41 38.92 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 111.617 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.0 -55.95 1.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.072 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -136.09 142.06 44.27 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.695 0.284 . . . . 0.0 111.429 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 t -135.69 140.89 43.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.998 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 43.65 44.88 5.61 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.534 0.521 . . . . 0.0 111.841 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.5 32.52 81.95 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.663 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -138.69 161.94 35.91 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.855 0.328 . . . . 0.0 110.577 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 p -112.77 137.32 51.26 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.767 0.318 . . . . 0.0 111.11 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.7 mt -117.38 45.41 1.91 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.0 t -109.36 100.9 11.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.187 0.518 . . . . 0.0 110.896 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.77 -37.68 2.85 Favored Glycine 0 C--N 1.328 0.139 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.347 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.8 pp -73.48 147.26 44.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.777 0.322 . . . . 0.0 110.948 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -64.16 156.76 27.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.649 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -52.62 -39.11 61.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.631 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.59 -43.99 62.66 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -74.43 -40.79 61.74 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.2 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.18 -58.45 7.88 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.75 -64.38 0.95 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.06 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -38.04 -46.81 1.04 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.549 0.531 . . . . 0.0 111.764 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 mt -60.1 -43.52 95.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.007 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.1 mtp -76.71 -30.28 56.61 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.258 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -27.88 69.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.544 0.211 . . . . 0.0 110.816 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -96.47 32.82 1.92 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.208 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -60.21 146.34 43.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 111.412 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -85.93 -165.94 1.39 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.665 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -56.51 -31.35 64.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.038 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.45 141.58 19.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.965 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.48 114.65 43.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.619 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.52 88.54 2.92 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.425 HD11 ' SD ' ' A' ' 17' ' ' MET . 5.7 mt -101.77 133.31 46.7 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.317 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -115.72 127.33 55.05 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.926 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.58 170.64 13.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.326 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.35 133.19 51.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.903 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 48.6 mmtm . . . . . 0 N--CA 1.464 0.228 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.425 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 120.694 0.283 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.233 0.233 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.788 -179.911 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.029 0.442 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.3 mm -95.85 128.98 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.2 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.14 141.49 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.129 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.488 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 10.0 t -112.08 149.71 31.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.813 0.339 . . . . 0.0 111.019 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.22 118.37 58.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.211 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.0 m -94.28 101.13 13.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.463 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.9 mt -131.3 163.07 28.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -92.2 129.92 38.03 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.927 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HB2' ' CG2' ' A' ' 84' ' ' VAL . 8.4 ttpp -83.03 139.39 33.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.186 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -93.37 -57.78 2.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -158.99 38.11 0.21 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.723 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.43 -167.99 22.35 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.999 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 mtm -115.9 -42.73 3.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.69 0.245 . . . . 0.0 111.385 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.99 73.96 0.63 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.038 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 pp -160.8 177.94 9.92 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.646 0.26 . . . . 0.0 111.072 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.8 m -130.49 150.69 51.59 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.447 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 pp -142.61 152.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.807 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 37' ' ' LYS . 46.4 t -133.69 135.71 55.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.66 135.18 33.47 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.167 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.71 152.56 40.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.351 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -124.2 -179.54 4.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.938 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.78 -140.42 2.98 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.41 140.96 44.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.687 0.28 . . . . 0.0 110.728 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.32 45.79 95.74 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.597 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.4 107.9 7.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.707 0.289 . . . . 0.0 111.127 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -90.1 21.0 3.93 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -144.02 -168.89 2.98 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.678 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 tp -136.91 146.76 45.87 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.929 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.12 128.71 9.14 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.845 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.6 mm -87.14 87.25 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.994 0.426 . . . . 0.0 110.871 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 66.0 m-85 -79.17 168.07 20.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.603 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.8 t -99.11 135.73 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.606 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -100.58 -41.33 7.0 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.286 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -178.0 125.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.055 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.9 m -87.55 136.19 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.247 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.2 t -92.29 128.0 44.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -62.48 148.5 45.51 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.323 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.55 -30.35 10.42 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.579 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.97 152.49 51.88 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.428 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.75 -36.55 26.16 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.85 -44.26 64.14 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.651 0.263 . . . . 0.0 111.382 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -39.03 92.91 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.45 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.79 -39.37 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.144 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.27 -49.58 13.44 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.058 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.79 76.9 1.06 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.171 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -139.18 22.48 2.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.03 153.65 1.67 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.654 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.47 -179.99 6.61 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.487 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.71 139.44 58.38 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.034 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.73 22.06 32.13 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.862 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.87 175.68 5.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.64 0.22 . . . . 0.0 110.613 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.421 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 3.7 tt0 -125.17 142.36 51.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.053 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.94 164.17 12.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.338 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 mt -140.21 -55.52 0.54 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.362 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.7 m -127.08 154.62 44.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.689 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 77' ' ' MET . 22.6 t -141.91 107.76 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.048 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.71 50.71 10.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.97 0.414 . . . . 0.0 111.03 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.76 21.4 76.5 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.859 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -113.74 160.8 18.28 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.734 0.267 . . . . 0.0 110.37 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -114.41 110.94 20.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.032 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 mt -96.33 43.67 1.08 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.6 t -105.53 100.09 9.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.186 0.517 . . . . 0.0 110.572 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.87 30.48 5.15 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.553 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.02 158.06 30.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.2 p -79.9 162.11 25.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.738 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -54.28 -36.42 63.62 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.768 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.81 -59.69 4.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.091 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -59.71 -36.6 76.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.099 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.44 -62.02 1.77 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.493 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.07 79.06 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.412 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -56.3 -54.85 40.47 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.956 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.6 mt -53.69 -33.55 55.8 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.316 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.442 ' HA ' HG12 ' A' ' 60' ' ' VAL . 13.5 mtp -74.78 -51.38 14.27 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.6 t -63.2 -33.58 75.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.55 0.214 . . . . 0.0 111.161 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -84.2 47.48 1.34 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.878 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -98.2 179.54 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.868 0.366 . . . . 0.0 111.207 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -93.83 -165.63 1.36 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -55.81 -44.09 77.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 110.925 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.16 145.91 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.852 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 13' ' ' LYS . 22.5 t -128.39 126.76 66.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.532 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.67 83.5 2.14 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.765 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.3 mt -93.67 118.79 31.85 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.495 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.488 ' HG3' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -86.34 113.86 22.66 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.547 179.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.75 150.56 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.54 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.02 160.4 15.32 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.26 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt . . . . . 0 C--O 1.233 0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.763 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.887 0.375 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.681 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 34.8 tt0 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.252 0.548 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.33 136.68 24.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.844 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.5 153.17 13.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.448 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 5.0 m -111.27 141.16 45.16 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 m -120.7 133.54 67.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 m -109.68 95.17 5.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.709 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.0 mt -116.49 173.29 6.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -99.57 163.02 12.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.057 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -77.46 100.3 5.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.73 80.47 5.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.477 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.13 34.55 23.35 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.967 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.96 152.79 29.09 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.239 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -56.41 22.44 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.69 0.281 . . . . 0.0 110.666 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.26 72.75 0.84 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.661 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -160.61 178.12 9.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.732 0.301 . . . . 0.0 110.672 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 m -135.17 126.25 27.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.41 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.475 HG13 ' HB ' ' B' ' 102' ' ' THR . 2.1 pp -118.09 129.73 74.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.322 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -112.5 136.8 47.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.099 0.476 . . . . 0.0 111.138 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.27 120.03 34.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.199 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.85 148.65 52.3 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.946 0.403 . . . . 0.0 111.768 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.58 -179.86 4.67 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.667 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.8 -141.53 3.15 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.715 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.34 148.52 27.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.614 0.245 . . . . 0.0 110.66 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.78 33.22 82.05 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.744 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.25 103.46 6.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.684 0.278 . . . . 0.0 110.927 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.445 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 7.1 t0 -90.64 21.6 3.94 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.227 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -142.01 -168.15 2.63 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.5 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.7 tp -142.14 123.91 15.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.747 0.308 . . . . 0.0 110.889 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.78 116.94 5.61 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.411 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.449 HG23 HD11 ' A' ' 21' ' ' ILE . 31.3 mm -77.85 87.19 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.957 0.408 . . . . 0.0 110.413 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.94 162.32 28.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.648 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -104.33 108.01 23.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.835 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -62.52 -47.02 85.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.859 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 p -175.34 137.83 0.4 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.28 137.79 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.513 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -76.07 141.68 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 153.01 35.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.236 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.98 19.24 69.65 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.007 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.25 -158.03 33.72 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.442 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.17 -35.18 10.86 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.22 -33.59 20.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.377 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -40.93 94.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.539 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.96 -41.85 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.52 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.5 -55.1 34.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.361 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.9 49.85 1.72 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.438 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.8 mmt-85 -105.77 -58.16 1.94 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 110.643 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 pp -117.15 149.72 39.89 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.669 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.63 -175.22 3.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.183 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.2 131.1 42.31 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.008 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.35 27.6 10.58 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.739 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.18 171.36 7.53 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.589 0.194 . . . . 0.0 110.768 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -120.26 137.9 53.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.307 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.429 HD11 HG22 ' A' ' 21' ' ' ILE . 86.6 mt -101.35 162.19 13.08 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.178 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.48 -53.26 0.45 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.188 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.0 m -124.04 151.03 44.23 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.979 0.418 . . . . 0.0 111.712 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.34 133.23 38.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.765 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 53.65 38.0 27.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.37 26.98 72.32 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.337 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 mtp-105 -128.89 148.24 50.89 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.897 0.348 . . . . 0.0 110.723 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.5 m -89.66 135.23 33.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.982 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mp -130.0 50.02 2.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.974 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.14 99.62 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 110.876 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.54 35.35 3.09 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.64 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.7 mt -122.11 153.77 38.25 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.755 0.312 . . . . 0.0 110.768 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.8 m -75.33 158.2 33.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -57.25 -25.52 59.28 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.725 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.15 -49.58 76.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.692 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -51.89 52.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.47 81.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.584 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.79 -56.89 16.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.331 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -53.15 60.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.309 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.52 -32.28 71.31 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.982 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.411 ' HE2' HD13 ' A' ' 86' ' ' LEU . 30.5 mmm -69.58 -64.32 0.9 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.92 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.7 t -56.01 -36.23 67.71 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.684 0.278 . . . . 0.0 111.024 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -86.86 52.58 2.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.264 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -94.2 168.47 10.9 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.773 0.32 . . . . 0.0 110.746 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -97.62 -163.08 1.01 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.591 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -59.04 -26.78 64.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.165 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.82 149.21 5.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.952 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.01 87.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.1 m -91.88 80.68 5.2 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.411 HD13 ' HE2' ' A' ' 77' ' ' MET . 9.1 mt -103.94 133.97 48.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.44 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 27.2 tt0 -107.19 112.11 24.84 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.603 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.73 147.56 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.206 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.37 132.86 42.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.8 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.564 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.488 0.185 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.475 ' HB ' HG13 ' A' ' 21' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.013 0.435 . . . . 0.0 111.841 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.026 0.441 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mt -102.84 141.16 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.737 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 pt -146.26 151.84 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.371 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -112.88 140.0 48.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.955 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 m -123.19 127.92 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.183 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 15.6 m -108.65 112.38 24.68 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mt -138.97 162.27 35.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -98.08 176.6 5.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.877 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.51 150.42 26.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 111.408 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.98 -58.66 0.96 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.579 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -138.02 35.67 2.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.61 152.81 28.91 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.106 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 mtm -64.41 -48.87 73.74 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.629 0.214 . . . . 0.0 110.723 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.85 82.51 0.07 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.938 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -160.76 179.61 8.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.628 0.252 . . . . 0.0 110.781 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -129.45 144.78 51.39 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.27 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.467 HD11 ' NE2' ' A' ' 70' ' ' GLN . 2.7 pp -140.55 146.14 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.799 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.421 HG22 ' HB2' ' A' ' 37' ' ' LYS . 22.7 t -132.71 137.08 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.544 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.49 158.85 25.73 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.705 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -159.51 141.53 13.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 111.377 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.31 -179.67 4.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.82 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.37 -141.33 3.12 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.8 139.25 40.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.681 0.277 . . . . 0.0 110.597 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.43 35.47 91.75 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.707 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.05 103.76 7.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.672 0.272 . . . . 0.0 110.89 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -92.18 28.41 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.1 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -136.57 -170.16 2.62 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.449 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tp -151.96 124.47 8.34 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.672 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.22 150.5 20.2 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.025 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 14.7 mm -104.86 81.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 121.049 0.452 . . . . 0.0 110.786 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 56' ' ' GLN . 61.8 m-85 -71.57 166.37 21.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.316 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.3 t -106.43 128.99 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.107 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.421 ' HB2' HG22 ' A' ' 22' ' ' VAL . 8.5 ttpt -91.37 -42.6 10.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.3 172.84 15.9 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.726 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.05 121.97 30.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.558 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 t -72.13 124.96 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.721 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 124.12 21.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.79 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.11 -31.6 3.82 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.352 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.66 157.23 53.17 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.621 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.16 18.81 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.87 -49.67 71.83 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.683 0.277 . . . . 0.0 111.203 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.48 -41.16 96.64 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.163 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -61.02 -32.96 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.25 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -68.25 -55.88 10.63 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.238 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.44 51.43 2.92 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.85 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -128.24 -66.99 0.82 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.729 0.264 . . . . 0.0 110.805 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.4 161.59 30.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.98 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.93 -174.83 4.37 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.368 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.9 120.91 28.68 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.982 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.1 31.26 3.14 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.023 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -116.78 139.2 50.86 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.705 0.252 . . . . 0.0 110.955 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.9 tt0 -81.9 145.33 30.4 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -97.53 168.94 10.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.012 0.434 . . . . 0.0 111.321 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.18 -59.02 0.24 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.035 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.5 p -128.3 150.6 49.99 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.963 0.411 . . . . 0.0 111.713 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.402 HG23 ' CG ' ' A' ' 77' ' ' MET . 39.9 t -141.97 96.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.46 41.99 31.63 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.962 0.41 . . . . 0.0 111.0 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.36 25.86 49.66 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.952 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -120.64 129.78 53.86 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.19 111.14 21.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.967 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.5 mt -99.72 26.84 5.84 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.056 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.39 73.43 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.661 0.743 . . . . 0.0 110.638 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.66 -22.4 1.49 Allowed Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.199 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.4 mt -81.32 159.26 24.47 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.966 0.412 . . . . 0.0 111.188 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.5 m -74.73 147.17 41.6 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.024 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.467 ' NE2' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -42.45 -41.25 2.86 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.178 0.299 . . . . 0.0 111.412 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.94 -56.94 12.24 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.306 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -60.44 -40.83 92.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.404 ' CB ' HG13 ' A' ' 34' ' ' ILE . . . -58.73 -60.84 3.19 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.702 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.86 85.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.353 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 78' ' ' THR . 0.6 OUTLIER -69.08 -35.82 76.93 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.433 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.45 -44.18 58.7 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.402 ' CG ' HG23 ' A' ' 60' ' ' VAL . 11.1 mtp -59.53 -48.17 82.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.433 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 75' ' ' GLU . 7.8 t -64.51 -33.46 75.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.63 0.252 . . . . 0.0 110.611 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.72 50.19 1.92 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.892 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.0 p -103.79 172.72 6.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.646 0.26 . . . . 0.0 110.865 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 t -79.73 -169.93 2.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.49 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -53.4 -40.59 65.19 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.254 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.35 143.63 12.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.121 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' THR . 23.9 t -119.74 149.13 22.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.14 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.9 m -143.54 85.56 1.85 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 mt -98.27 140.45 32.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.365 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -121.78 110.07 15.46 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.735 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.84 169.19 2.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.204 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.17 137.67 53.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.17 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.548 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 21.5 t . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.975 0.417 . . . . 0.0 111.507 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.432 ' CG2' ' HG2' ' A' ' 70' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.235 0.292 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.155 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.875 0.369 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mt -100.49 139.14 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.318 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.02 139.19 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.145 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.415 ' HB ' ' CG ' ' A' ' 87' ' ' GLU . 7.3 t -109.41 159.25 17.17 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 110.98 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.61 132.7 31.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.326 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 m -90.99 97.0 10.92 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.471 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.21 169.12 8.94 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.357 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -113.54 153.84 28.11 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.752 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -82.61 102.8 11.68 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.212 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -100.46 78.55 2.03 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.279 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 57.74 36.97 27.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.905 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.73 148.04 16.22 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.091 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.4 mtm -65.64 -68.8 0.34 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.733 0.266 . . . . 0.0 111.007 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.53 70.09 1.09 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.045 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -160.65 176.82 11.12 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.401 0.143 . . . . 0.0 110.633 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -134.21 142.14 47.28 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.96 163.19 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.036 0.446 . . . . 0.0 112.069 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.06 131.83 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.974 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 70' ' ' GLN . . . -99.31 118.58 36.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -120.49 132.62 55.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.569 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HG3' ' CD1' ' A' ' 32' ' ' LEU . 4.6 tttt -114.51 -179.69 3.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.889 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.16 -140.52 3.01 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.69 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.46 152.63 23.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.56 0.219 . . . . 0.0 110.766 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.18 37.46 86.56 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.501 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.27 107.74 7.36 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.609 0.242 . . . . 0.0 110.801 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.476 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 7.8 p-10 -90.7 15.11 11.69 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 111.47 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -144.36 -171.38 3.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.383 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.432 ' CD1' ' HG3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -145.1 135.34 24.02 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 111.002 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.03 127.85 9.32 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.822 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.73 78.78 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 121.031 0.443 . . . . 0.0 110.513 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 73.0 m-85 -68.79 157.8 35.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.623 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.12 135.19 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.308 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -92.77 -47.77 6.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.622 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.17 130.57 0.17 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.03 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.13 132.22 31.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.667 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -81.74 139.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.19 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.72 145.17 55.4 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.206 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.57 -26.25 23.88 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.869 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.2 150.12 51.58 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.149 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.59 -36.69 67.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.93 95.84 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.689 0.281 . . . . 0.0 110.86 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -40.64 63.5 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.83 -36.38 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.397 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.28 -38.21 60.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.26 64.27 2.69 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.494 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -49.04 1.86 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.583 0.23 . . . . 0.0 111.383 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.84 165.72 10.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.261 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.8 177.77 7.95 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.519 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.77 140.31 42.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.047 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.61 27.94 28.27 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.871 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . 1.4 m-20 -110.67 155.22 22.73 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.635 0.218 . . . . 0.0 110.536 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.437 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 4.8 tt0 -96.67 144.56 26.58 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.091 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.96 169.24 8.62 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.65 -57.61 0.22 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.241 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 t -126.52 144.23 50.94 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.112 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.521 HG22 ' SD ' ' A' ' 77' ' ' MET . 23.4 t -135.47 112.22 13.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.576 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.09 39.04 23.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.333 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.48 4.64 84.88 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.321 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -98.96 142.33 30.6 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.42 0.61 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.05 108.78 21.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.828 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.8 mt -100.33 32.42 3.03 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.09 99.96 10.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.189 0.519 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 110.93 32.35 2.66 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.521 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 mt -129.18 161.5 29.97 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.695 0.284 . . . . 0.0 110.828 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.81 154.23 30.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.434 ' HB2' ' CB ' ' A' ' 23' ' ' ALA . 1.2 tm0? -52.29 -36.24 52.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -54.66 -53.1 59.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.715 0.293 . . . . 0.0 110.384 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -63.2 -41.33 99.16 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.738 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.4 -59.92 4.64 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.229 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.07 -33.96 65.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.626 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -45.08 57.82 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.602 0.239 . . . . 0.0 111.327 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.9 mt -67.69 -32.46 73.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.464 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.521 ' SD ' HG22 ' A' ' 60' ' ' VAL . 6.6 mtm -73.83 -48.2 32.98 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.491 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 t -64.1 -34.2 77.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.615 0.245 . . . . 0.0 110.793 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -83.8 49.04 1.53 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.669 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.7 -175.9 3.58 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.545 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 m -104.3 -164.59 1.07 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.3 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 13.7 p -56.77 -31.71 64.9 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.753 0.311 . . . . 0.0 110.714 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.48 148.34 13.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.629 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.41 139.46 21.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.28 95.2 4.45 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.73 104.69 17.25 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.078 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.415 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 1.8 mt-10 -80.23 83.14 6.14 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.227 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 55' ' ' ASP . 14.8 p -84.41 142.85 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.434 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.61 117.98 31.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 mttm . . . . . 0 N--CA 1.464 0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.936 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.531 0.226 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.284 179.351 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.222 0.534 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.6 mm -84.52 125.69 40.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.608 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -140.49 137.67 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.848 0.356 . . . . 0.0 111.119 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.08 113.03 26.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.887 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.51 151.91 5.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.166 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.22 119.69 25.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.771 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mt -132.97 162.54 31.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -110.03 138.06 46.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.727 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -64.85 121.47 14.68 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.216 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.34 -50.89 5.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -164.95 41.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.795 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.43 147.28 16.72 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.151 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.7 mmm -68.38 -68.06 0.42 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.453 0.168 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.96 78.57 0.53 Allowed Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.855 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 pp -160.46 179.47 8.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.52 0.2 . . . . 0.0 110.857 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.6 m -129.04 141.56 51.19 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.716 0.293 . . . . 0.0 111.665 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' B' ' 101' ' ' SER . 2.9 pp -137.68 154.77 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.806 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.57 135.13 26.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.989 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.71 146.62 23.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.777 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.63 158.03 43.8 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 111.935 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.31 179.16 4.19 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.856 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.89 -143.61 3.75 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.07 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.66 150.54 28.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.551 0.215 . . . . 0.0 110.878 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.83 28.57 63.41 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.502 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.55 106.93 4.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 110.565 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -97.44 39.27 1.21 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.936 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -137.29 -159.83 1.0 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.256 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tp -146.54 126.81 13.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.507 0.194 . . . . 0.0 110.747 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.15 142.69 15.64 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.822 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 mp -86.69 135.16 25.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.774 0.321 . . . . 0.0 110.502 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.406 ' CE1' ' HB2' ' A' ' 56' ' ' GLN . 96.8 m-85 -125.66 143.93 50.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.011 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -81.37 130.01 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.005 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -100.54 -40.74 7.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.327 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.48 128.13 0.09 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.633 0.254 . . . . 0.0 110.993 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 m -90.64 133.38 32.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.124 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.9 t -73.56 131.21 35.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -61.56 115.48 3.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.065 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.27 -30.03 3.38 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.786 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.58 151.19 50.85 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.689 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.66 65.07 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.72 -36.64 84.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -76.22 -45.91 30.73 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.243 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.26 -38.52 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.365 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.74 -41.57 62.31 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.145 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.24 33.09 18.37 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.984 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -83.83 -54.3 4.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.806 0.336 . . . . 0.0 110.689 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.19 152.64 32.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.818 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.99 175.12 10.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.138 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.01 122.81 15.87 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.315 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.4 38.77 2.2 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.926 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -135.24 142.31 45.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.517 0.199 . . . . 0.0 110.796 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.406 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 51.1 tt0 -93.55 152.97 18.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.933 0.397 . . . . 0.0 110.774 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.53 172.12 7.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.023 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.87 -54.25 0.16 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.329 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 t -133.87 140.73 47.04 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.66 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.5 t -129.1 120.24 51.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.594 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.59 34.92 25.27 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.184 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.74 35.65 39.64 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.106 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 175.22 8.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.655 0.264 . . . . 0.0 110.851 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -121.34 121.59 37.98 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.139 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.18 29.18 6.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.263 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.7 t -87.27 100.27 9.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.231 0.538 . . . . 0.0 110.878 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.97 27.58 5.07 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.593 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 mt -118.84 164.68 15.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -83.97 152.29 24.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.275 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -51.39 -30.89 20.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.337 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -65.37 -51.16 62.31 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.771 0.319 . . . . 0.0 110.498 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -62.97 -40.43 97.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.32 -60.31 3.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.45 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.3 -44.68 96.82 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.848 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -39.09 81.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.048 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.88 -34.89 76.18 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.027 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 11.3 mtp -76.31 -41.6 48.01 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.738 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.3 t -70.85 -37.36 73.13 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.648 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -89.95 56.08 3.35 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.444 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 p -110.52 178.84 4.25 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.877 0.37 . . . . 0.0 111.246 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -175.75 4.02 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.714 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 m -52.63 -39.29 61.59 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.137 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.4 t -97.84 147.84 6.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.925 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.41 134.18 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.64 85.0 2.35 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mt -92.23 139.08 30.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.258 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -124.86 98.9 5.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.3 m -105.07 172.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.803 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.43 107.15 17.57 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.942 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.665 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 80.6 p . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 120.559 0.219 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.534 0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.685 -179.884 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 121.239 0.542 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -96.43 128.08 47.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.666 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 pt -142.66 155.98 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.025 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.5 t -118.6 128.83 54.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.199 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 t -87.85 91.62 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.634 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.4 m -81.51 105.16 12.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.934 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.8 mt -139.4 177.58 7.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.27 153.06 20.8 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.684 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 100.75 0.21 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.879 0.371 . . . . 0.0 111.12 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.38 80.35 2.4 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.406 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m120 56.55 35.62 26.32 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.079 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.05 160.72 28.48 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.614 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 42.1 mtm -77.62 -38.91 46.96 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.497 0.189 . . . . 0.0 110.997 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.85 70.4 1.06 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.903 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 pp -160.62 176.76 11.21 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.793 0.33 . . . . 0.0 111.009 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.89 129.23 34.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.668 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.83 153.43 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.891 0.377 . . . . 0.0 111.535 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' B' ' 101' ' ' SER . 43.2 t -142.33 146.92 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.231 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.08 147.32 30.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.196 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.74 155.09 39.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.64 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -120.1 179.47 4.27 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.772 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.13 -143.31 3.65 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.908 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.91 146.08 31.44 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.8 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.12 27.89 63.22 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.693 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.57 105.6 3.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.673 0.273 . . . . 0.0 110.486 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -96.3 28.16 3.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.412 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.524 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -120.19 -165.53 1.2 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.358 179.423 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 tp -145.03 124.5 13.13 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.628 0.252 . . . . 0.0 110.828 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.23 119.48 5.47 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.478 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 18.6 mm -80.09 74.62 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.938 0.399 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -71.2 168.19 17.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.426 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.52 108.7 25.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.057 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -64.33 -45.94 85.66 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.903 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.4 p -176.62 155.85 1.39 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.49 131.79 51.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.881 0.372 . . . . 0.0 110.797 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 t -79.61 132.32 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.974 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 127.98 34.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.008 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.59 -21.43 30.37 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.877 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.57 157.19 45.17 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.962 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.08 -38.37 76.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.25 -35.65 58.85 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.536 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.47 -45.11 88.78 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.141 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.77 -34.75 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.5 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.06 -53.95 21.87 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.687 0.28 . . . . 0.0 111.442 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.73 30.58 23.48 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.923 -0.655 . . . . 0.0 113.085 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -44.14 16.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.863 0.363 . . . . 0.0 110.724 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.82 178.77 4.16 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.95 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.22 175.99 11.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.366 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.68 132.76 46.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.676 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.77 28.89 8.5 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.5 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.33 174.57 5.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.459 0.171 . . . . 0.0 110.687 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -118.3 144.78 45.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.35 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 34' ' ' ILE . 6.6 tt -113.28 140.84 47.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.192 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.47 -58.74 1.83 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.98 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.0 m -136.63 156.77 48.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.935 0.398 . . . . 0.0 111.459 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 86' ' ' LEU . 40.4 t -128.9 122.88 57.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.516 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 t70 67.35 11.68 8.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.445 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.3 18.74 30.11 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.557 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.46 142.63 51.4 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.376 0.588 . . . . 0.0 111.164 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.3 m -74.58 128.67 36.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.391 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.66 31.57 3.96 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.16 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 p -104.35 83.54 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.596 0.713 . . . . 0.0 110.467 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 157.62 -28.92 0.49 Allowed Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.523 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.9 167.91 12.84 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.856 0.36 . . . . 0.0 110.84 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -71.07 158.77 35.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.145 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -54.83 -28.73 51.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.301 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -60.53 -36.48 78.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.348 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.22 -42.39 31.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.645 0.259 . . . . 0.0 110.883 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.47 -51.76 18.78 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.617 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.47 -46.35 89.05 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.415 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -57.37 -45.26 84.62 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.685 0.278 . . . . 0.0 110.569 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.71 -33.49 75.75 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.32 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.69 -57.14 13.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.138 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -62.38 -39.3 92.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 110.391 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 51.92 2.19 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.779 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.37 176.8 5.57 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 111.048 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.43 -173.46 4.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.233 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 t -54.91 -33.4 62.04 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.626 0.25 . . . . 0.0 111.135 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.5 144.35 15.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.063 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.9 t -112.64 145.97 17.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.75 81.14 1.68 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -94.92 113.16 24.85 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.172 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.08 91.81 6.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.615 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.64 136.13 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.245 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.88 145.56 26.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.423 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.195 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.4 ' HA ' HG23 ' A' ' 22' ' ' VAL . 40.2 t . . . . . 0 N--CA 1.462 0.146 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.733 -179.756 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 19.4 tt0 . . . . . 0 C--O 1.233 0.213 0 CA-C-O 121.064 0.459 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.14 135.97 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.655 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.55 145.9 22.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.634 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -106.62 126.61 52.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.839 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.01 163.77 15.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.176 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -126.44 113.19 16.52 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.597 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.83 143.33 50.88 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -95.1 155.35 16.77 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.04 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -80.11 126.96 31.74 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.043 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -95.12 -52.85 4.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.503 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -164.62 44.24 0.09 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.532 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.97 151.01 17.69 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.226 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.1 mmm -74.28 -70.89 0.37 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.481 0.181 . . . . 0.0 110.683 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.31 77.09 0.58 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.82 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 pp -161.21 177.68 9.99 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.671 0.272 . . . . 0.0 110.992 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 m -130.17 155.76 45.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.477 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.403 ' HB ' HG22 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -144.12 164.33 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.778 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 37' ' ' LYS . 64.8 t -140.79 138.75 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.701 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.26 94.97 10.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.804 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.57 146.04 24.09 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.041 0.448 . . . . 0.0 112.109 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -132.65 -179.89 5.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.67 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -177.3 -142.63 4.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.775 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.83 149.34 25.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.615 0.245 . . . . 0.0 110.718 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.92 31.32 75.81 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.779 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.13 103.9 7.24 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.627 0.251 . . . . 0.0 110.731 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -91.1 23.06 3.41 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.222 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -140.77 -164.11 1.67 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.541 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.55 116.62 10.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.477 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.26 133.25 11.8 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.471 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.413 HG12 ' CB ' ' A' ' 73' ' ' ALA . 1.8 mp -92.45 88.74 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 121.054 0.454 . . . . 0.0 110.498 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 56' ' ' GLN . 47.0 m-85 -82.28 173.03 12.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.918 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.16 136.34 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 111.356 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.403 ' HB2' HG23 ' A' ' 22' ' ' VAL . 11.6 tttp -98.37 -43.99 6.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.815 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.97 107.9 0.07 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.012 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 p -81.65 137.41 21.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.1 132.44 32.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.051 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 151.51 47.39 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.94 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.05 -28.79 12.96 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.679 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.85 157.65 53.23 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.27 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.33 -40.32 34.85 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.82 -36.82 70.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.398 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -86.09 -39.99 16.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.247 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.36 -37.68 79.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.87 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -68.7 -43.55 75.8 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.511 0.196 . . . . 0.0 111.202 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.06 75.5 1.09 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.762 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.19 -50.88 0.76 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.538 0.209 . . . . 0.0 110.819 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -123.78 177.57 5.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.099 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.54 -174.31 4.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.413 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.1 152.07 44.75 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.392 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.57 26.16 63.79 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.365 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.03 169.12 8.74 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.629 0.252 . . . . 0.0 110.766 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 1.3 tt0 -100.25 166.55 10.93 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.59 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.05 130.8 9.07 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.99 -44.65 1.04 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.877 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.48 ' HB3' ' CB ' ' A' ' 87' ' ' GLU . 22.8 t -95.65 143.34 27.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.583 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -144.47 121.75 5.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.805 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.12 35.09 25.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.268 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.5 24.04 68.9 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.873 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.4 mtp85 -125.13 -176.55 3.6 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.3 p -123.65 116.24 22.76 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.689 0.28 . . . . 0.0 110.979 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.4 mt -110.68 31.29 6.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.004 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -89.87 101.21 11.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.123 0.487 . . . . 0.0 110.415 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.93 42.85 0.55 Allowed Glycine 0 CA--C 1.518 0.233 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.444 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.82 -178.81 3.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.773 0.321 . . . . 0.0 110.764 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.21 19.45 10.61 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.844 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 78.49 -54.87 0.48 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.098 0.559 . . . . 0.0 111.581 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -53.37 -43.69 68.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.621 0.248 . . . . 0.0 110.773 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -33.31 75.5 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.413 ' CB ' HG12 ' A' ' 34' ' ' ILE . . . -66.92 -62.8 1.25 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.288 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.1 77.88 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.867 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -60.72 -33.1 72.38 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.122 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 mt -77.82 -46.2 22.21 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.61 0.243 . . . . 0.0 110.898 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.6 mtp -57.58 -41.24 80.74 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.187 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.9 t -73.42 -32.33 64.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.574 0.226 . . . . 0.0 110.563 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.38 49.63 1.85 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.34 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.9 p -115.13 170.32 8.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.656 0.265 . . . . 0.0 111.081 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t -81.58 -170.88 3.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.685 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.51 -48.68 68.79 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 p -85.47 127.81 39.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.979 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.43 141.72 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 m -119.93 106.4 12.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.095 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.69 133.14 53.47 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.121 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.48 ' CB ' ' HB3' ' A' ' 59' ' ' SER . 45.8 tt0 -115.39 106.02 13.52 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.756 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -105.24 174.27 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.595 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -123.2 143.39 50.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.895 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.276 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.345 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 94.2 p . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.218 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.49 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 19.9 tt0 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.98 0.419 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.7 mt -103.81 116.78 48.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 pt -142.88 149.55 18.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 111.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -111.3 120.34 41.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.055 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 85' ' ' THR . 12.6 m -96.03 169.56 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.154 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.96 114.44 8.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.801 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.16 164.09 28.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.248 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -96.16 144.12 26.67 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -87.86 105.33 17.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.083 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -58.56 3.89 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.588 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.86 36.55 0.4 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.774 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.65 147.37 8.0 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.352 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -52.27 64.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.603 0.239 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.93 64.33 2.35 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.718 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.413 ' HB2' HG12 ' A' ' 39' ' ' VAL . 4.0 pp -160.54 179.33 8.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.46 0.171 . . . . 0.0 110.727 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.3 m -138.36 151.69 47.75 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.439 0.162 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.56 HD11 HG21 ' A' ' 34' ' ' ILE . 2.2 pp -133.72 156.53 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.5 t -137.78 133.85 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.119 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.91 128.5 35.06 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.887 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.4 143.69 46.14 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.79 0.328 . . . . 0.0 111.471 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -120.33 -179.71 4.04 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.12 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.92 -139.82 2.74 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.734 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.32 150.95 27.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.67 0.271 . . . . 0.0 110.789 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.37 38.23 93.11 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.63 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 107.5 8.1 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.711 0.291 . . . . 0.0 110.855 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -90.29 19.0 5.43 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.545 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -144.77 -169.73 3.24 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.486 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 tp -129.19 142.81 50.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.66 0.267 . . . . 0.0 110.962 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.17 128.28 8.93 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.754 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 21' ' ' ILE . 1.9 mp -92.15 91.63 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-O 121.155 0.503 . . . . 0.0 110.274 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -80.16 167.81 19.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.593 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -94.93 127.48 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 111.094 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -80.36 -49.11 11.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.691 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.3 p -178.96 111.08 0.05 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.114 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' A' ' 19' ' ' LEU . 9.2 m -73.58 129.34 36.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.793 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.54 141.46 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.202 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 151.82 42.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.066 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -37.68 3.38 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.742 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.43 151.81 45.58 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.428 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.29 -36.69 43.6 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.87 84.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.738 0.304 . . . . 0.0 111.137 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.0 -39.77 41.21 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.501 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.88 -34.03 51.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.576 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -68.53 -55.84 10.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.15 32.09 11.08 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.708 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -88.23 -43.38 11.64 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.687 0.279 . . . . 0.0 110.896 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.86 -178.77 3.51 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.886 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.89 -177.33 6.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.377 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.9 156.98 38.31 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.97 27.11 71.07 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.751 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -109.53 172.75 6.67 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.631 0.215 . . . . 0.0 110.579 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -110.05 147.42 33.6 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.6 0.238 . . . . 0.0 110.814 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 tp -115.84 142.17 47.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.873 0.368 . . . . 0.0 111.314 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.6 -56.27 2.21 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.4 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.4 t -147.28 156.35 42.85 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.055 0.455 . . . . 0.0 111.96 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.0 121.35 43.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.524 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 60.09 35.23 21.28 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.287 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.3 26.29 73.8 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.263 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.0 mtt-85 -96.91 -178.31 4.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.988 0.394 . . . . 0.0 110.799 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -120.67 103.47 9.15 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.9 mt -108.39 29.57 7.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.175 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.8 t -111.35 100.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.207 0.527 . . . . 0.0 110.875 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.35 30.7 3.5 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.642 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.6 mt -133.47 179.43 6.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.77 0.319 . . . . 0.0 110.307 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.07 168.5 10.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.524 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -61.43 -21.58 64.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.837 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -77.75 -38.09 47.68 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.756 0.312 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -56.66 8.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.32 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.413 ' CB ' HG12 ' A' ' 34' ' ' ILE . . . -61.49 -45.58 93.63 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.616 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.55 -55.15 37.47 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.395 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.53 -36.19 64.0 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.045 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.7 mt -72.01 -39.91 68.85 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.254 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 81.9 mtp -64.61 -55.35 20.85 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.093 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -57.38 -36.28 71.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.851 0.357 . . . . 0.0 110.429 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -83.35 52.04 2.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.656 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.08 168.75 9.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.686 0.279 . . . . 0.0 111.109 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.98 -164.64 1.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.624 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.4 m -57.19 -34.99 69.05 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.3 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -95.99 150.66 4.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.61 120.58 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.268 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 5.4 m -123.58 95.99 4.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.01 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.74 141.89 40.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.409 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -107.35 106.93 17.6 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.535 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.9 t -96.61 149.1 4.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.675 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.25 104.36 9.68 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.835 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 7.0 mttm . . . . . 0 C--O 1.233 0.205 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 2.4 p . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.523 0.202 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.763 -179.774 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.937 0.399 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.3 mt -115.86 125.33 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.767 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.63 138.04 46.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.34 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -94.49 145.77 24.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.823 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 50' ' ' ARG . 28.1 m -124.08 125.56 70.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.75 111.71 23.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.76 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.1 mt -131.9 154.49 49.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -91.4 130.48 37.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.764 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.42 122.46 21.28 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.227 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.64 -40.16 5.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.83 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -160.12 43.42 0.2 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 111.214 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.42 -165.22 49.95 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.122 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.0 mtm -127.13 90.73 3.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.768 0.284 . . . . 0.0 110.684 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.77 84.32 0.02 OUTLIER Glycine 0 C--O 1.225 -0.43 0 C-N-CA 121.394 -0.431 . . . . 0.0 113.104 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -160.84 178.57 9.29 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.748 0.309 . . . . 0.0 110.942 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 p -131.84 153.87 49.73 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.229 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 34' ' ' ILE . 2.9 pp -132.75 157.67 43.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.985 0.422 . . . . 0.0 112.122 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.67 138.26 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.227 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.6 158.01 22.07 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.24 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.88 141.97 20.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -131.1 179.57 5.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.044 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.62 -139.83 2.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.864 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.96 142.71 36.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.587 0.232 . . . . 0.0 110.612 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.96 36.32 92.02 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.691 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -121.91 101.16 7.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 111.013 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.26 19.29 5.21 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.248 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.26 -171.51 3.13 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.4 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.12 143.55 44.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.108 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.33 117.95 4.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.454 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.471 HG22 HD11 ' A' ' 21' ' ' ILE . 2.0 mp -93.45 87.69 2.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.177 0.513 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -80.61 172.53 13.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.626 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.4 t -103.39 148.15 8.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.644 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.0 -37.23 2.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.709 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 m -153.24 130.93 11.55 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.771 0.32 . . . . 0.0 111.205 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.4 106.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.201 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 t -68.32 135.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.374 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.14 147.56 49.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.966 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.58 -14.61 63.02 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.226 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.27 -155.07 3.08 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.677 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.56 -41.82 10.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.668 0.27 . . . . 0.0 111.487 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.26 -33.41 69.77 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.065 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -71.31 -38.45 71.73 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.0 t -66.31 -54.19 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 111.566 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -63.66 -50.6 68.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.136 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.7 68.43 1.23 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.212 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.42 ' HB3' HG11 ' A' ' 9' ' ' VAL . 21.6 mmt85 -145.06 33.68 1.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.821 0.343 . . . . 0.0 110.648 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mt -152.48 176.08 12.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.213 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.32 142.56 4.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.096 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.96 124.0 19.97 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.942 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.82 29.33 6.22 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.405 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -115.81 159.81 20.98 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.521 0.201 . . . . 0.0 110.805 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -96.47 154.8 17.07 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.047 0.451 . . . . 0.0 112.046 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.11 100.23 6.47 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.355 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.45 -59.73 2.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.247 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -139.44 159.04 43.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.433 HG22 ' HG2' ' A' ' 77' ' ' MET . 38.9 t -132.89 124.55 50.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.988 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.1 t70 56.42 31.36 18.65 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.031 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.96 35.44 58.96 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.804 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -101.99 14.2 32.63 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.74 87.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.38 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 5.5 mt -111.82 61.87 0.62 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.302 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -130.22 98.52 3.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.109 0.48 . . . . 0.0 110.977 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.79 -25.71 4.39 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.747 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.44 174.76 2.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.15 0.5 . . . . 0.0 111.334 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.0 m -88.73 162.72 16.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.989 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -52.66 -28.48 21.77 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.555 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -77.66 -54.52 6.28 Favored 'General case' 0 C--N 1.335 -0.054 0 CA-C-O 120.575 0.226 . . . . 0.0 111.057 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -56.94 -34.68 68.24 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.29 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 34' ' ' ILE . . . -70.89 -59.62 2.69 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.366 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.57 -48.34 77.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.26 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -57.08 -44.72 83.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.87 -37.62 82.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.621 0.248 . . . . 0.0 111.033 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.433 ' HG2' HG22 ' A' ' 60' ' ' VAL . 56.6 mtp -61.95 -56.52 18.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.437 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t -61.12 -38.13 85.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.769 0.319 . . . . 0.0 110.506 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -85.5 53.07 2.63 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.454 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.51 179.5 4.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.735 0.302 . . . . 0.0 111.1 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.53 -165.59 1.34 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.749 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.3 m -55.75 -47.51 76.85 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.28 143.74 10.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.881 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.1 t -136.65 111.05 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.054 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.57 83.76 1.91 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.541 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.62 137.48 32.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.426 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 8.4 mt-10 -103.13 140.33 37.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.677 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.8 p -128.7 138.16 55.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.366 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.53 116.65 32.18 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.711 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.216 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.136 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.755 0.312 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 C--O 1.233 0.206 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.495 179.586 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.06 0.457 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.2 135.38 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.814 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 1.5 pp -142.27 138.26 29.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.259 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -104.08 98.54 8.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.17 169.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.44 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -125.18 109.22 12.6 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.755 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 mt -109.52 155.26 21.59 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.768 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -107.52 118.82 37.74 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.725 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -62.45 100.73 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.86 87.48 3.31 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.727 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.12 39.58 28.93 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.208 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.93 153.87 30.53 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.171 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.5 mtm -80.28 -79.92 0.14 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.648 0.224 . . . . 0.0 111.038 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.75 -0.74 27.45 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.149 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.86 173.8 12.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 117.071 0.436 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' B' ' 102' ' ' THR . 57.9 m -127.12 151.62 48.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.74 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.422 HD12 ' CG2' ' A' ' 34' ' ' ILE . 2.2 pp -139.75 150.83 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.554 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 37' ' ' LYS . 85.7 t -126.15 145.67 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.274 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.2 119.9 40.66 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.748 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.9 151.47 44.29 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.414 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.71 -179.74 3.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.63 -139.68 2.73 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.35 143.89 38.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.628 0.251 . . . . 0.0 110.801 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.37 41.59 99.56 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.652 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 107.26 7.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.719 0.295 . . . . 0.0 110.973 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.438 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 24.5 t0 -91.93 20.51 5.68 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.316 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -141.19 -167.87 2.49 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.307 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 tp -136.61 126.2 25.32 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 110.801 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.36 130.39 10.1 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.946 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.422 ' CG2' HD12 ' A' ' 21' ' ' ILE . 21.3 mm -95.19 71.13 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.073 0.463 . . . . 0.0 110.835 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.429 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 94.4 m-85 -62.16 160.51 12.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -96.25 121.22 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.731 0.3 . . . . 0.0 111.277 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.462 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . 6.3 tttp -80.19 -43.66 21.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.042 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.8 p -156.41 178.23 10.55 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.94 123.05 12.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.673 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -50.4 132.03 10.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.66 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.84 92.78 8.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.01 -21.64 2.64 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.148 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.64 -167.83 7.26 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.066 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.52 -1.32 53.45 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.45 -43.14 8.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.749 0.309 . . . . 0.0 111.013 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -72.69 -44.97 61.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.524 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.4 t -64.86 -39.53 85.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.541 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.46 -47.92 62.43 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.927 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.22 44.52 6.22 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.665 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -102.56 -38.63 7.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.547 0.213 . . . . 0.0 110.965 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.79 158.85 35.49 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.894 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.29 -174.95 4.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.193 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.54 138.94 43.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 39.42 9.98 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.875 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -116.16 138.19 51.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.514 0.197 . . . . 0.0 110.742 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.429 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -81.11 147.75 29.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.059 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 2.1 tp -101.02 154.36 18.77 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 111.563 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.54 -57.53 0.53 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.032 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.53 156.72 48.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.254 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.3 t -141.49 123.43 13.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.827 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.57 33.05 22.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.313 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.44 27.93 71.94 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.042 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -115.07 165.38 12.96 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.827 0.314 . . . . 0.0 110.825 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.43 106.99 17.66 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.99 33.22 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.89 98.86 4.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.24 0.543 . . . . 0.0 110.695 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.34 28.81 3.92 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.64 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.0 mt -110.42 158.44 18.47 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.764 0.316 . . . . 0.0 110.737 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.67 153.01 42.88 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.391 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -52.01 -34.55 43.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.76 -48.53 71.52 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.313 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -63.51 -44.31 94.65 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.609 0.242 . . . . 0.0 111.335 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.417 ' CB ' HG13 ' A' ' 34' ' ' ILE . . . -59.67 -56.24 24.4 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.71 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.93 -45.97 89.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.075 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -57.79 -26.3 61.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.547 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.3 mt -74.63 -47.87 29.63 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.6 mtp -60.43 -48.06 83.38 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.355 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -61.12 -36.12 78.87 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.83 0.348 . . . . 0.0 110.304 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.98 52.57 2.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.843 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.9 p -118.01 176.48 5.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 111.072 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -92.54 -163.86 1.1 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.517 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.03 -34.03 58.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.945 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.59 140.8 22.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.904 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 t -136.76 118.2 18.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.137 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.63 100.54 12.1 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 mp -100.77 116.99 33.95 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.204 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 28.8 tt0 -101.4 101.52 12.16 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.547 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.02 171.32 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.625 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.31 135.94 53.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.096 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt . . . . . 0 C--O 1.232 0.156 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.457 179.885 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 120.814 0.34 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 20' ' ' SER . 19.7 m . . . . . 0 N--CA 1.465 0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.593 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.256 0.551 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 58' ' ' LEU . 4.6 mp -80.03 122.33 35.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.176 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.14 138.76 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.337 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -100.37 126.58 46.75 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.38 131.22 67.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 m -105.31 123.39 47.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.917 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mt -140.72 160.18 40.6 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.118 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 mtmm -101.23 163.76 12.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -90.96 98.42 11.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -74.86 -53.14 9.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.2 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -166.46 45.28 0.06 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.347 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.75 150.38 14.31 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.226 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -60.08 3.31 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.688 0.244 . . . . 0.0 110.479 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.93 72.23 1.03 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.324 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 pp -161.14 178.02 9.7 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.446 0.165 . . . . 0.0 110.698 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -127.54 141.48 51.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.669 0.271 . . . . 0.0 111.615 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.406 HG23 ' HE3' ' A' ' 77' ' ' MET . 2.3 pp -132.59 159.91 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.409 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.44 HG23 ' HA ' ' B' ' 101' ' ' SER . 61.8 t -146.64 148.05 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.356 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.35 147.88 27.02 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.056 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.77 149.8 30.21 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.83 0.347 . . . . 0.0 111.762 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -121.79 -179.9 4.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.81 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.2 -144.01 3.82 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.978 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.14 145.15 37.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.603 0.24 . . . . 0.0 110.748 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.81 30.6 63.14 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.587 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.74 108.83 4.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.682 0.277 . . . . 0.0 110.67 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -93.96 27.56 2.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.384 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.471 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -116.04 -165.48 1.05 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.421 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 tp -144.57 136.87 26.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.632 0.253 . . . . 0.0 111.119 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.35 116.68 5.62 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.625 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.428 HG12 ' CB ' ' A' ' 73' ' ' ALA . 2.1 mp -85.48 81.54 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.368 0.604 . . . . 0.0 110.496 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 56' ' ' GLN . 93.4 m-85 -79.8 145.59 32.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.106 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.9 t -83.47 123.3 38.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.901 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.425 ' HB2' HG22 ' A' ' 22' ' ' VAL . 10.3 tptt -82.38 -43.21 17.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.846 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 t -169.01 -179.92 3.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.2 t -132.78 129.94 58.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.706 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.36 129.75 36.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.016 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.8 136.8 58.11 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.62 -26.67 17.27 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.7 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.74 158.73 46.69 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.784 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.3 -39.3 72.5 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.02 -39.62 63.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.196 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -60.35 -38.96 85.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 36.7 t -73.35 -38.76 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.335 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.46 -43.26 93.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.319 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.78 36.48 57.9 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.946 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.3 mtt-85 -98.93 -45.9 5.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.781 0.29 . . . . 0.0 110.889 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 pp -101.84 171.46 7.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.783 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.75 -173.13 3.8 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.281 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.42 157.75 23.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.47 30.46 71.17 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.696 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.67 -177.02 3.25 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.562 0.22 . . . . 0.0 110.792 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 65.8 tt0 -125.85 152.74 45.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.945 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -112.16 142.84 44.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.126 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.422 ' CD1' HG12 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -115.17 -54.65 2.54 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.351 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.3 p -140.12 154.36 46.98 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.086 0.47 . . . . 0.0 111.95 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.409 HG21 ' CG ' ' A' ' 77' ' ' MET . 59.6 t -132.09 112.84 20.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.518 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.09 35.48 26.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.997 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.07 31.98 45.86 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.041 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -128.9 149.3 50.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.815 0.307 . . . . 0.0 110.655 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t -92.27 132.62 36.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.169 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.83 -28.9 9.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.494 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.07 99.24 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.188 0.518 . . . . 0.0 111.017 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 142.87 -35.39 1.7 Allowed Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.882 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.41 HD11 ' CB ' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -88.11 166.49 14.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.1 t -72.5 161.07 31.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.757 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -53.46 -44.2 68.72 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.067 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -61.4 -39.61 91.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.704 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.37 -35.86 73.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.866 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.428 ' CB ' HG12 ' A' ' 34' ' ' ILE . . . -72.04 -61.01 1.94 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.383 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.23 -39.76 67.06 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.313 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.55 -50.11 72.62 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.843 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.83 -32.17 65.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.217 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.409 ' CG ' HG21 ' A' ' 60' ' ' VAL . 22.4 mtp -71.22 -58.83 3.17 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.565 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.8 t -59.36 -33.98 71.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.811 0.338 . . . . 0.0 110.709 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -86.43 51.98 2.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.516 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 p -110.09 -178.99 3.66 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.678 0.275 . . . . 0.0 110.95 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.16 -174.03 4.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.83 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.5 p -52.33 -44.11 64.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.22 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.73 140.38 16.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.844 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.28 121.27 65.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.072 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.23 80.87 1.41 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.785 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.31 121.8 32.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 24.9 tt0 -104.19 103.8 13.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.5 m -102.32 170.86 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.116 0.484 . . . . 0.0 111.64 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.8 98.11 6.65 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.993 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.44 ' HA ' HG23 ' A' ' 22' ' ' VAL . 27.2 t . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 120.802 0.334 . . . . 0.0 111.791 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 31.6 m . . . . . 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.351 178.994 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 8.6 tt0 . . . . . 0 C--O 1.233 0.2 0 CA-C-O 121.091 0.472 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.76 125.84 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.629 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pt -141.65 142.79 28.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.262 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -99.77 116.62 32.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.887 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.2 146.54 16.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 m -119.95 127.7 52.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mt -133.38 166.1 23.3 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.407 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -109.83 176.7 4.97 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 mtpt -106.28 92.25 4.05 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.846 0.355 . . . . 0.0 111.361 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -45.41 38.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.439 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -167.05 45.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.209 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.92 145.34 15.32 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.152 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -41.3 98.56 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.643 0.222 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.77 68.3 1.74 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.051 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 36' ' ' VAL . 2.3 pp -160.75 168.38 24.91 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.553 0.216 . . . . 0.0 111.017 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 m -116.16 153.36 31.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.122 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.17 165.52 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.707 0.289 . . . . 0.0 111.682 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 37' ' ' LYS . 25.7 t -151.42 140.81 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.465 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.84 158.59 18.69 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.22 132.83 11.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.927 0.394 . . . . 0.0 111.64 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -128.9 179.85 5.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.761 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.72 -140.04 3.02 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.73 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.07 147.79 28.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.629 0.252 . . . . 0.0 110.634 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.25 36.54 92.59 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.693 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.53 106.37 7.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.64 0.257 . . . . 0.0 110.776 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -90.16 20.79 4.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.516 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -144.33 -169.16 3.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.822 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -138.39 131.06 29.32 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.782 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.69 151.05 21.53 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.924 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.402 HG13 ' HB1' ' A' ' 73' ' ' ALA . 23.8 mm -106.39 110.3 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.726 0.298 . . . . 0.0 111.215 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 56' ' ' GLN . 6.4 m-85 -103.5 174.1 6.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.207 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.46 HG12 HD13 ' A' ' 19' ' ' LEU . 47.0 t -111.85 112.11 39.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.008 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.487 ' HB2' HG22 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -60.29 -49.64 76.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.592 179.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.4 p -176.61 131.4 0.2 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.0 t -82.74 127.29 39.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.427 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -80.06 127.6 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.09 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 128.45 36.38 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.74 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.56 -19.86 11.3 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.967 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.12 -162.27 5.79 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.667 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.06 -34.6 14.33 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.49 -33.8 54.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -67.96 -47.62 68.12 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.61 -42.18 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.558 0.218 . . . . 0.0 111.336 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.21 -35.67 79.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.148 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.38 45.09 88.55 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.902 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.76 -34.2 10.99 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.577 0.227 . . . . 0.0 110.954 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.7 147.61 50.13 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.006 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.57 -168.59 1.35 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.36 146.81 44.9 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.351 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.45 47.13 23.15 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.245 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.49 129.99 56.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.478 0.18 . . . . 0.0 110.782 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 35' ' ' TYR . 2.1 tm0? -80.62 145.53 31.65 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.02 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 mt -117.04 120.92 39.85 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.765 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.41 -58.33 2.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.9 p -130.76 163.92 26.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.44 HG21 ' CG ' ' A' ' 77' ' ' MET . 24.9 t -139.73 114.99 7.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.12 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.34 24.28 12.81 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.508 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.18 28.96 26.58 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.77 160.5 27.17 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 110.636 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -101.96 114.54 28.73 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.3 mt -114.63 31.91 6.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.015 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.2 t -114.26 100.85 11.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.143 0.497 . . . . 0.0 110.667 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.08 -35.45 1.47 Allowed Glycine 0 CA--C 1.517 0.207 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.627 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.9 168.64 13.22 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 110.459 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 t -64.71 157.57 27.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.181 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -52.24 -31.08 30.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.928 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.26 -52.23 65.25 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.954 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -43.19 94.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.045 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -67.45 -61.47 1.89 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.679 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -55.74 -36.12 66.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.631 0.253 . . . . 0.0 111.378 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.72 -34.6 62.61 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.411 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 mt -68.9 -44.15 73.77 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.482 0.182 . . . . 0.0 110.968 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.44 ' CG ' HG21 ' A' ' 60' ' ' VAL . 36.2 mtp -59.75 -52.46 65.39 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.563 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.6 t -62.35 -36.75 83.21 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.665 0.269 . . . . 0.0 110.764 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -87.73 53.94 2.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.632 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.2 p -108.76 176.2 5.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 111.005 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.59 -174.55 1.75 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.429 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 m -52.27 -34.26 45.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.628 0.252 . . . . 0.0 111.125 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.71 151.4 9.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.92 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.8 t -137.65 118.37 16.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.0 m -104.58 94.34 5.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.843 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mp -98.95 138.42 36.09 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.411 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 48.5 tt0 -114.89 99.74 7.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.714 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.1 m -101.98 173.83 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.041 0.448 . . . . 0.0 111.746 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.87 123.34 39.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.126 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 1.7 mptm? . . . . . 0 C--O 1.233 0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.607 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.804 0.335 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.53 0.204 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.907 -179.63 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 121.052 0.453 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mt -84.06 113.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.85 141.01 45.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 27.5 m -104.87 141.33 36.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -119.59 127.93 75.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.283 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 m -99.42 103.54 15.33 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.671 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -143.9 149.01 36.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.359 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.18 167.78 14.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.208 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.66 124.89 28.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.62 85.48 2.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.38 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 m120 58.38 34.56 24.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.946 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.11 158.0 31.0 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.669 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.49 -48.57 16.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.534 0.207 . . . . 0.0 110.634 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.48 74.96 0.55 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.555 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 pp -160.74 173.82 14.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.556 0.217 . . . . 0.0 110.776 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -124.35 149.58 46.46 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.804 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.423 HD13 ' NE2' ' A' ' 70' ' ' GLN . 8.6 pt -137.71 154.48 29.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.8 t -147.12 134.97 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.251 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.96 144.43 26.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.952 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.41 159.44 35.76 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.837 0.351 . . . . 0.0 111.783 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.45 179.31 4.63 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.052 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.88 -144.06 3.85 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.888 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.07 150.31 28.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.645 0.26 . . . . 0.0 110.865 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.79 28.82 60.84 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.586 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.78 107.98 4.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.651 0.262 . . . . 0.0 110.455 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -97.57 37.42 1.37 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -133.52 -164.62 1.51 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.477 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tp -147.53 125.76 12.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.68 0.276 . . . . 0.0 110.772 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.76 137.57 13.34 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.607 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 18.8 mm -86.6 72.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.107 0.48 . . . . 0.0 110.736 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -60.23 160.18 8.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.348 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 t -100.96 115.09 41.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.964 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.4 -46.78 78.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.791 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.94 124.87 0.09 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.902 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.5 m -72.67 142.51 15.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.089 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.91 137.67 21.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.38 153.25 27.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.213 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.05 14.94 76.32 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.884 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 159.39 25.3 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.296 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.23 69.42 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.3 -34.41 25.72 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.291 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.11 -47.09 69.12 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.309 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.2 t -63.81 -46.53 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.4 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -43.95 97.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.168 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.47 64.96 1.77 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.839 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -136.78 23.47 3.1 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.632 0.253 . . . . 0.0 111.374 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -179.83 177.97 0.65 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.755 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.77 -170.05 2.07 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.187 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.44 160.23 32.67 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.914 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.91 31.24 80.26 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.244 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.8 124.69 45.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.59 0.234 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.413 ' HB3' ' CB ' ' A' ' 89' ' ' ALA . 8.7 tm0? -79.47 117.57 20.55 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.057 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -88.75 136.09 33.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.198 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.54 -63.01 1.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.837 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.8 m -127.91 145.49 50.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.196 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.2 t -120.87 118.19 55.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.667 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 60.56 32.01 20.34 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.105 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.73 -6.28 70.66 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.273 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -80.53 154.62 27.41 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 117.186 0.493 . . . . 0.0 111.057 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.35 101.09 12.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.42 44.2 1.28 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.688 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.3 t -101.8 99.97 9.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.719 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.83 -29.25 5.66 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.759 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.7 mt -65.36 168.59 6.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 111.241 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.0 t -87.22 168.16 13.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.449 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.423 ' NE2' HD13 ' A' ' 21' ' ' ILE . 5.9 tp60 -58.24 -29.44 65.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.003 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.47 -56.01 27.39 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.786 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -63.21 -45.99 89.11 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.693 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.07 -58.39 8.87 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.972 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.07 -48.56 44.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.712 0.291 . . . . 0.0 111.387 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -61.76 2.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.739 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.8 mt -56.22 -30.53 62.44 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.3 mmm -66.01 -64.15 0.92 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.8 -0.182 . . . . 0.0 111.175 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.4 t -62.4 -35.82 80.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.775 0.322 . . . . 0.0 110.729 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -85.33 49.4 1.75 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.333 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.89 169.56 10.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.717 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.14 -169.34 0.93 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.822 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.63 -54.55 21.98 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.697 0.284 . . . . 0.0 110.86 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.73 147.16 5.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.692 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.3 t -121.78 111.63 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.987 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.14 105.85 14.7 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.781 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.2 131.13 57.03 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 2.3 mt-10 -102.16 95.55 6.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.3 m -89.66 172.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.256 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.413 ' CB ' ' HB3' ' A' ' 56' ' ' GLN . . . -130.48 118.77 21.62 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.52 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.228 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.643 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 53.9 p . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 120.716 0.294 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.416 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.73 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.984 0.421 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.63 131.14 43.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.881 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.0 pt -150.74 154.89 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.198 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 m -122.49 132.25 54.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.882 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.6 t -115.78 136.8 51.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.183 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -101.68 112.14 24.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.656 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 mt -134.74 168.67 18.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.236 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.1 157.28 19.53 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -86.33 69.75 10.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -43.79 -41.27 4.88 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.701 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -172.77 44.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.294 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.46 152.23 25.17 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.178 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.4 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -74.91 -51.42 13.84 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.571 0.224 . . . . 0.0 110.821 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.06 80.77 0.12 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.083 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -160.92 -179.76 7.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.619 0.247 . . . . 0.0 110.88 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m -125.28 141.69 51.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.067 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.419 HD12 ' NE2' ' A' ' 70' ' ' GLN . 2.4 pp -136.26 157.47 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.832 0.348 . . . . 0.0 111.796 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -145.32 148.59 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.235 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.09 131.97 46.76 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.235 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.86 146.89 38.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.493 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -122.83 -179.73 4.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.957 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.39 -140.57 2.91 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.751 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.3 147.27 32.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.586 0.231 . . . . 0.0 110.779 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.78 40.89 97.25 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.614 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.53 106.24 7.33 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.715 0.293 . . . . 0.0 110.907 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -90.68 24.43 2.69 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.003 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -144.35 -165.83 2.23 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.647 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tp -138.67 135.1 34.48 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.798 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.36 127.42 8.78 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.709 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.9 mp -95.91 94.72 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 121.129 0.49 . . . . 0.0 110.562 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -78.59 168.56 19.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.375 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -101.48 133.9 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.134 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -97.53 -40.61 8.56 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.9 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.2 m -160.4 174.29 14.35 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.93 123.47 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.795 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.8 t -79.87 153.19 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.261 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -72.01 153.37 41.81 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.154 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.89 8.92 87.54 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.366 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 17' ' ' MET . . . -96.16 156.48 21.3 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.377 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.59 -43.35 68.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.622 0.249 . . . . 0.0 111.5 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.38 -34.66 74.87 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.242 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.65 -46.1 48.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.339 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.11 -49.34 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.164 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.69 -44.82 89.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.163 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.95 28.55 66.53 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.081 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.84 -47.52 16.46 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.805 0.303 . . . . 0.0 110.894 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -109.73 170.42 8.08 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.96 177.76 7.58 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.169 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.92 141.72 53.05 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.43 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.48 43.57 4.86 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.675 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -128.22 146.03 50.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.686 0.279 . . . . 0.0 110.887 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -83.5 152.55 24.86 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.676 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 7.0 mp -115.0 148.51 38.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.942 0.401 . . . . 0.0 111.72 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.78 -55.17 2.01 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.782 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.7 p -137.58 152.13 49.09 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.9 0.381 . . . . 0.0 111.778 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.4 t -143.38 107.52 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.962 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t0 61.14 41.86 13.07 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.161 0.505 . . . . 0.0 110.823 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.99 37.5 38.14 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.058 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.47 162.0 21.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.766 0.283 . . . . 0.0 110.689 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.22 83.66 1.87 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.591 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.7 mt -60.8 -22.68 64.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.298 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.1 t -78.21 97.83 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.186 0.517 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.71 32.95 1.04 Allowed Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.288 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.435 HD12 ' HB1' ' A' ' 73' ' ' ALA . 1.2 pp -150.16 165.34 33.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 110.57 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.0 p -79.63 161.79 25.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.946 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.419 ' NE2' HD12 ' A' ' 21' ' ' ILE . 2.8 tt0 -56.55 -32.3 65.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.325 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.84 -34.48 64.56 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.491 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -76.23 -33.22 59.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.978 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' A' ' 68' ' ' LEU . . . -76.28 -58.64 3.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.334 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.55 -42.88 79.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.537 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.77 -39.85 93.1 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-O 120.698 0.285 . . . . 0.0 110.812 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.18 -32.2 68.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.291 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.1 mtp -72.24 -53.56 12.18 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.608 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 t -60.7 -38.7 85.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.751 0.31 . . . . 0.0 110.795 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.6 mtp85 -87.87 55.94 3.68 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.644 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.4 p -106.52 178.5 4.54 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.895 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.1 p -88.1 -169.69 2.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.697 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.14 -54.77 43.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.631 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 84' ' ' VAL . 35.7 t -84.58 139.27 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' THR . 16.8 t -129.7 151.62 36.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.465 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.11 83.27 2.01 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.781 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.71 122.18 32.57 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.098 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.07 97.46 7.43 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.675 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.3 m -93.07 173.96 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.87 101.98 6.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.018 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.233 0.221 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.75 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 67.1 p . . . . . 0 CA--C 1.531 0.221 0 CA-C-O 120.762 0.315 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.418 ' HB ' ' CD1' ' A' ' 21' ' ' ILE . 51.8 m . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.601 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.065 0.459 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.13 127.33 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.814 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -144.34 148.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.3 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -115.22 120.65 40.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.85 153.34 3.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.144 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.04 106.99 10.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.6 mt -138.37 169.08 18.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.141 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -104.77 175.75 5.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -87.15 135.25 33.37 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.17 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.37 84.96 2.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.327 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.45 36.75 28.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.729 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.98 144.23 16.33 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.107 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.9 mtm -64.84 -46.84 80.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.553 0.216 . . . . 0.0 110.69 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.53 83.66 0.07 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.944 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 pp -160.52 -179.4 7.62 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.65 0.262 . . . . 0.0 110.725 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' B' ' 102' ' ' THR . 46.4 m -131.58 142.63 49.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.309 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' B' ' 101' ' ' SER . 2.7 pp -137.68 139.83 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.405 HG22 ' HB2' ' A' ' 37' ' ' LYS . 29.7 t -129.71 132.68 65.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.13 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.09 127.5 43.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.844 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.2 147.05 52.4 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.351 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -119.76 -179.76 4.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.037 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.89 -139.85 2.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.14 143.67 38.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.588 0.233 . . . . 0.0 110.741 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.33 44.75 97.21 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.568 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 108.15 6.91 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.639 0.257 . . . . 0.0 110.916 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -92.61 20.02 6.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.363 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -140.28 -166.09 2.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.458 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 tp -136.43 152.02 50.14 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.672 0.272 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.13 111.37 2.83 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.703 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -81.43 73.0 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.215 0.531 . . . . 0.0 110.503 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -67.5 155.28 39.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.339 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.62 121.55 44.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.259 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.405 ' HB2' HG22 ' A' ' 22' ' ' VAL . 10.2 tptt -85.28 -36.15 21.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.971 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 t -170.24 175.32 4.96 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 111.23 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.6 t -138.45 118.15 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.2 t -68.55 125.88 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.019 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 153.16 37.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.472 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.01 -29.92 11.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.773 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.25 154.8 48.22 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.57 58.54 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.11 -51.36 70.03 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.26 -34.31 55.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.317 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.1 t -62.85 -34.22 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.706 0.289 . . . . 0.0 110.698 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -71.56 -43.35 66.49 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.048 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.68 40.8 5.55 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.811 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.05 31.93 4.37 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.677 0.275 . . . . 0.0 110.997 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mt -150.63 160.3 43.91 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.295 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.02 143.4 3.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.097 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.83 132.86 53.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.836 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.81 29.45 6.18 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.483 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.08 -177.48 3.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.46 0.172 . . . . 0.0 110.714 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -127.57 150.77 49.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.823 0.344 . . . . 0.0 111.375 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.21 150.07 29.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.959 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.84 -57.58 1.43 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.093 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 p -139.12 153.44 47.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.461 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.2 t -137.94 129.04 38.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.624 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 57.56 34.25 24.32 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.789 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.76 21.91 76.67 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.95 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.38 157.08 18.25 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 111.06 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -101.36 98.88 9.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.614 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.95 28.84 7.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.788 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.2 t -87.36 100.95 10.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.217 0.532 . . . . 0.0 110.462 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.46 31.74 2.3 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.536 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 mt -119.93 155.57 32.49 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.723 0.297 . . . . 0.0 110.726 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 87.2 p -68.01 157.39 35.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.162 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -52.08 -40.31 61.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.049 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -58.45 -53.72 55.18 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.858 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -61.24 -39.07 88.93 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.894 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.07 -62.86 1.38 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.38 -61.25 2.72 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.56 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -40.85 -44.9 2.38 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.511 0.507 . . . . 0.0 111.881 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 mt -58.07 -42.19 84.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.779 0.323 . . . . 0.0 110.797 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 mtp -80.8 -28.67 36.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.384 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -31.54 72.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.66 0.267 . . . . 0.0 110.699 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -101.18 42.82 1.09 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.315 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 p -85.38 168.49 14.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.835 0.35 . . . . 0.0 111.196 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.0 p -91.91 -165.73 1.41 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.732 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 p -51.59 -52.34 48.21 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.083 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.45 141.86 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.219 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -128.63 110.97 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.858 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.22 97.58 8.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.919 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.18 136.36 44.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.403 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 33.5 tt0 -106.63 107.32 18.27 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.385 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 p -107.64 151.83 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.615 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.88 98.74 9.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.194 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.45 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 85.6 p . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.771 0.319 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 20' ' ' SER . 23.7 p . . . . . 0 N--CA 1.463 0.179 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.344 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ptt? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.833 0.349 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.49 41.43 0.21 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.047 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 62.18 98.97 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.274 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.58 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.31 -173.77 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.755 2.304 . . . . 0.0 112.962 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 16.9 tt0 -116.5 93.31 4.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.174 0.512 . . . . 0.0 110.986 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.89 133.65 32.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.65 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pt -148.08 147.23 17.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.172 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -111.91 124.86 53.28 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 m -101.19 135.9 35.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.431 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 m -103.16 97.54 7.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.571 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 mt -122.19 163.33 19.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.896 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -108.71 141.3 40.9 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.871 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -77.87 111.01 13.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.08 -42.61 17.22 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -168.41 37.42 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.08 174.51 18.65 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.09 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.411 ' SD ' HD11 ' A' ' 86' ' ' LEU . 28.7 mtm -103.69 -46.94 4.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.714 0.257 . . . . 0.0 111.341 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.24 81.62 0.12 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.809 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 pp -160.52 179.54 8.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.709 0.29 . . . . 0.0 110.868 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -132.81 146.59 51.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.718 0.294 . . . . 0.0 111.353 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.524 HD11 ' NE2' ' A' ' 70' ' ' GLN . 2.7 pp -142.34 153.43 18.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.819 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 42.1 t -135.84 136.4 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.425 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -85.69 130.74 34.48 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.073 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.36 142.6 45.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.425 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -122.0 -179.6 4.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.924 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.03 -141.34 3.1 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.85 143.32 33.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.659 0.266 . . . . 0.0 110.675 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.79 34.02 88.56 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.697 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.75 105.03 7.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.686 0.279 . . . . 0.0 110.817 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.11 19.96 6.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.355 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -138.48 -168.75 2.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.749 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tp -141.64 130.94 23.56 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.719 0.295 . . . . 0.0 110.927 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.51 136.25 12.71 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.741 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.5 mm -90.62 83.76 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.69 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -74.14 162.18 29.23 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.359 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.41 134.86 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.264 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -105.53 -37.89 6.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.0 t -166.05 172.42 11.42 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.691 0.281 . . . . 0.0 110.957 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.0 t -130.89 126.71 60.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.763 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.3 145.17 10.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.009 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -68.14 150.22 48.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.323 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.34 20.23 73.2 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.917 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.11 157.58 23.41 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.388 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.77 62.03 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.25 -32.67 22.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.463 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.09 -44.85 59.89 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.296 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.8 t -66.4 -44.82 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.124 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.34 -37.67 66.02 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.867 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.42 82.61 0.57 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.653 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -133.16 -61.87 0.81 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.625 0.213 . . . . 0.0 111.35 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.29 156.02 16.92 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.336 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.28 173.47 11.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.484 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.71 140.41 53.52 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.264 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.37 38.95 8.04 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.491 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -121.32 178.59 4.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.498 0.19 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -125.04 139.98 53.31 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.414 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.3 tp -106.9 147.87 29.27 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.064 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.52 -59.31 1.3 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.385 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.54 144.06 50.73 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.963 0.411 . . . . 0.0 111.759 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.86 123.83 45.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.542 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.01 33.13 22.84 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 23.32 77.98 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.074 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -112.96 134.61 54.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 117.018 0.409 . . . . 0.0 110.268 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -83.01 86.42 7.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.47 54.75 3.01 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.126 0.489 . . . . 0.0 110.869 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.6 t -102.27 99.38 8.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.634 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.71 32.89 2.16 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.623 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.6 mt -117.66 161.75 19.15 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.4 152.87 24.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.299 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.524 ' NE2' HD11 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -47.07 -42.22 18.35 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.625 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -58.45 -49.99 75.33 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.039 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -69.76 -36.26 75.63 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.941 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.63 -58.23 5.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.633 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.96 -46.19 91.71 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.595 0.236 . . . . 0.0 111.276 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -55.42 -50.36 70.0 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.939 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.02 -40.65 96.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.393 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 37.9 mtp -58.48 -49.49 77.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.221 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' B' ' 104' ' ' VAL . 8.9 t -69.9 -27.88 65.16 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -82.96 43.93 0.89 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.801 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 p -101.37 171.26 7.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.274 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.9 m -85.27 -166.6 1.55 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.614 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -43.32 74.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.564 0.221 . . . . 0.0 110.928 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 t -93.19 140.2 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.647 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.2 t -130.36 134.51 62.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.275 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.48 89.74 3.17 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.411 HD11 ' SD ' ' A' ' 17' ' ' MET . 17.1 mt -94.54 120.3 34.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.75 101.92 13.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.323 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 p -105.23 150.2 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.353 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.3 148.02 28.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.575 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -101.11 116.13 32.11 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.593 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -165.47 -173.98 2.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.26 139.61 2.79 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.631 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.193 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.04 172.96 6.61 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.481 0.181 . . . . 0.0 110.574 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 27.8 p -124.21 99.28 6.15 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.765 0.317 . . . . 0.0 111.293 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -92.2 -172.59 3.17 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.744 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -141.53 118.34 11.11 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.755 0.312 . . . . 0.0 110.408 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 78' ' ' THR . 12.6 p . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.706 -0.664 . . . . 0.0 111.401 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.604 0.24 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt 62.55 -174.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.037 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.59 131.01 31.73 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.66 -164.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.771 2.314 . . . . 0.0 112.692 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 2.6 tt0 -132.44 101.68 5.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.153 0.501 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 34.0 mm -90.49 127.56 42.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.042 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pp -145.34 137.89 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.2 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.539 ' CG2' ' HG3' ' A' ' 87' ' ' GLU . 2.2 m -92.16 139.35 30.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.96 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -119.47 117.9 55.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.912 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 m -111.06 102.74 11.17 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.27 157.67 42.66 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -84.19 136.0 34.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.489 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.26 96.75 0.67 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.335 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -101.75 100.08 10.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.293 0.568 . . . . 0.0 110.428 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 55.04 35.2 24.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.921 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.53 -174.51 36.52 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.4 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.1 mtm -102.69 -36.95 8.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.418 0.151 . . . . 0.0 111.095 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.63 79.75 0.13 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.599 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.404 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 3.4 pp -160.71 179.81 8.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.669 0.271 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.7 m -132.18 156.94 45.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.33 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' B' ' 101' ' ' SER . 2.8 pp -143.47 146.71 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 37' ' ' LYS . 40.1 t -133.85 134.83 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.261 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.43 122.14 34.58 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.678 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.91 149.41 48.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.44 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.61 -179.79 3.76 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.264 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.95 -140.13 2.8 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.23 146.05 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.723 0.296 . . . . 0.0 110.771 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.26 41.05 98.15 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.606 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 106.94 7.35 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.671 0.272 . . . . 0.0 110.999 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.36 19.7 5.83 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.256 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -146.97 -171.59 3.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.522 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.9 137.19 55.01 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.731 0.3 . . . . 0.0 110.886 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.83 125.31 8.5 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.627 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.434 HG13 ' CB ' ' A' ' 73' ' ' ALA . 19.3 mm -84.38 84.68 2.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.043 0.449 . . . . 0.0 110.737 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -77.66 168.83 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.512 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.0 t -104.23 129.06 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.403 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.51 ' HD3' ' HB3' ' B' ' 101' ' ' SER . 3.0 tttt -83.41 -45.41 13.72 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.603 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -170.4 176.93 4.26 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.058 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.13 127.94 75.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.759 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.92 125.69 40.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.185 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.68 143.86 56.93 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.011 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.74 -15.75 60.47 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.115 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.13 -152.23 3.17 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.803 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.25 -60.47 1.67 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.556 0.217 . . . . 0.0 111.576 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -61.62 -26.45 68.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.856 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.44 -47.74 46.6 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.2 t -73.38 -37.82 52.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.268 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.96 -44.92 45.65 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.094 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.02 65.69 0.99 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.477 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -141.02 30.79 1.8 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.565 0.221 . . . . 0.0 111.375 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.414 HD12 ' CB ' ' A' ' 45' ' ' ALA . 9.3 mt -154.43 171.07 19.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.889 0.376 . . . . 0.0 111.393 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.8 141.76 3.48 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 37' ' ' LYS . . . -61.38 117.09 5.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.844 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.6 31.41 3.71 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.617 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.24 -178.19 3.57 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.612 0.244 . . . . 0.0 110.999 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 89' ' ' ALA . 6.0 tm0? -124.61 159.0 31.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.222 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 64.2 mt -124.05 107.38 11.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.962 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.1 -64.44 1.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.179 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 m -147.62 159.11 44.14 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.447 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.46 HG23 ' CG ' ' A' ' 77' ' ' MET . 38.9 t -127.87 125.42 64.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.822 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 55.79 33.85 22.29 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.22 36.61 85.4 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.061 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -119.41 152.75 36.3 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 111.083 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.2 m -79.05 118.2 20.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.204 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.2 mt -126.1 31.4 5.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.046 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.5 t -115.1 100.34 10.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.128 0.49 . . . . 0.0 110.925 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.55 -32.28 2.84 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.526 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 54.7 mt -66.5 172.04 4.46 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 110.984 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -84.03 160.03 21.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.078 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -51.93 -33.42 37.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.202 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -60.3 -54.87 40.56 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.022 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -60.32 -38.26 83.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.828 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' CB ' HG13 ' A' ' 34' ' ' ILE . . . -52.71 -62.44 1.65 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.237 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.84 -63.98 1.11 Allowed 'General case' 0 C--N 1.335 -0.055 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -36.07 -41.2 0.24 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.05 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.0 mt -66.31 -47.15 74.47 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.46 ' CG ' HG23 ' A' ' 60' ' ' VAL . 11.9 mtp -75.42 -30.45 60.07 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -32.05 69.1 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.635 0.255 . . . . 0.0 110.575 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -92.42 44.45 1.16 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.895 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.0 160.95 24.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.061 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.07 -164.66 1.1 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.038 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 82.5 p -50.27 -42.95 53.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.5 t -96.03 139.45 19.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.734 0.302 . . . . 0.0 110.807 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.88 96.22 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.02 90.3 4.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.407 ' HG ' HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -115.81 128.8 56.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.955 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.539 ' HG3' ' CG2' ' A' ' 8' ' ' THR . 12.2 mt-10 -98.93 111.82 24.11 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.48 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.6 142.34 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.561 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . . . -105.14 108.76 20.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.636 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 8.1 mtmt -71.01 133.68 46.53 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.162 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -94.08 174.7 7.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.22 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -97.38 1.45 60.42 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.812 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.222 179.654 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 mt . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.921 0.391 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.75 -174.96 2.99 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.31 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.51 ' HB3' ' HD3' ' A' ' 37' ' ' LYS . 35.3 p -138.7 102.85 4.69 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.809 0.338 . . . . 0.0 111.876 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 39.2 p -94.57 -173.12 2.94 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.317 179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.6 pt-20 -141.26 101.6 4.05 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.803 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . . . . . . . . . 10.2 p . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.421 -179.843 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.715 0.293 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 33.83 4.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.918 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -133.51 97.97 15.5 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -58.36 -178.53 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.071 2.514 . . . . 0.0 112.821 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -116.2 93.12 4.1 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.13 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 mt -94.85 113.52 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.663 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 pt -127.12 150.66 33.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.321 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.402 ' HB ' ' CG ' ' A' ' 87' ' ' GLU . 7.9 t -109.38 131.92 54.61 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG11 HD12 ' A' ' 11' ' ' LEU . 14.3 p -106.3 122.79 60.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.004 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -96.27 103.59 15.5 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.599 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.445 HD12 HG11 ' A' ' 9' ' ' VAL . 7.1 mt -125.45 174.14 8.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.46 142.56 46.55 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.92 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.81 135.52 38.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.048 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -92.11 -60.75 1.77 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.307 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.86 36.38 0.26 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.725 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.16 144.79 6.88 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.024 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.0 mtm -73.03 -61.37 1.84 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.492 0.187 . . . . 0.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.4 81.25 0.2 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.569 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 pp -160.96 179.49 8.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.571 0.224 . . . . 0.0 110.807 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.8 m -136.88 149.18 47.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.227 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' B' ' 101' ' ' SER . 2.8 pp -136.74 157.32 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.603 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.438 ' CG2' ' HB2' ' A' ' 37' ' ' LYS . 14.8 t -127.82 145.43 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.55 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.85 142.0 33.84 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.823 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -142.5 142.43 32.27 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.71 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.89 -179.43 4.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.121 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.6 144.93 10.66 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.683 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.39 141.28 55.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.176 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.91 34.66 65.82 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.68 109.8 7.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.298 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -88.74 27.51 1.3 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.32 -172.81 3.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.712 0.292 . . . . 0.0 110.511 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.24 132.94 23.79 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.19 119.43 5.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.131 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.7 mm -88.41 105.22 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-O 120.899 0.38 . . . . 0.0 110.552 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 56' ' ' GLN . 70.7 m-85 -99.3 169.7 9.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.248 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.79 139.49 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 111.001 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.438 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . 2.3 tptt -100.79 -45.29 5.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.743 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -161.7 169.89 20.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.61 115.14 24.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.593 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.86 126.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.109 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -59.97 149.18 32.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.85 -24.01 33.98 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.998 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.68 -166.13 6.26 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.576 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.3 -52.85 4.72 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.705 -0.291 . . . . 0.0 111.617 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.66 -38.08 44.39 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.038 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.29 -55.71 9.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.629 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.79 -31.22 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.49 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.88 -56.83 9.77 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.38 57.68 1.84 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.763 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -119.72 -45.63 2.49 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.552 0.215 . . . . 0.0 110.952 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 pp -128.3 175.81 8.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.897 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.42 -173.91 4.54 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.297 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.01 127.57 33.36 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.212 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.9 27.41 6.65 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.617 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -118.61 138.14 52.78 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.4 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 35.5 tt0 -82.6 152.02 26.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.23 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.5 mp -119.26 144.04 46.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.013 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 mt -116.04 -60.6 1.84 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.193 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 m -123.05 156.73 34.28 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG21 ' CD1' ' A' ' 86' ' ' LEU . 19.5 t -142.1 120.71 9.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.111 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.82 35.59 26.5 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.205 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.63 21.17 79.69 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.945 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.3 mtm-85 -113.7 146.86 39.19 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.863 0.331 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.9 m -102.05 103.58 14.17 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 pp -109.11 42.22 1.48 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.2 t -87.7 99.57 8.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.189 0.519 . . . . 0.0 110.809 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.06 40.87 0.94 Allowed Glycine 0 CA--C 1.52 0.346 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.393 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 mt -127.97 157.63 40.08 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.712 0.291 . . . . 0.0 110.784 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.1 p -70.91 159.46 34.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.126 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -54.81 -40.15 69.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.946 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -56.91 -47.27 80.98 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.421 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -68.51 -38.68 81.14 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.596 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.85 -59.41 4.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.3 -67.02 0.42 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -35.2 -41.19 0.15 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.29 0.636 . . . . 0.0 112.173 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.58 -49.07 74.83 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.599 0.238 . . . . 0.0 111.454 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.422 ' HB2' HG21 ' B' ' 104' ' ' VAL . 7.2 mtm -70.78 -33.47 70.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.759 0.314 . . . . 0.0 110.704 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -29.2 70.58 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.31 42.67 1.11 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.721 0.296 . . . . 0.0 111.623 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.2 p -98.72 170.18 8.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.775 0.322 . . . . 0.0 111.183 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.6 p -99.9 -161.42 0.87 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.505 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.3 m -57.0 -39.71 75.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.518 0.199 . . . . 0.0 110.625 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.14 145.39 8.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.61 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.82 121.83 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.091 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.41 99.19 6.28 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.498 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.426 ' CD1' HG21 ' A' ' 60' ' ' VAL . 3.2 mm? -106.31 115.04 29.53 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.207 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.402 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 0.1 OUTLIER -81.36 89.48 6.1 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 110.143 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.423 ' CG2' ' HB3' ' A' ' 55' ' ' ASP . 14.2 p -93.19 150.65 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.472 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.49 143.86 31.67 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.484 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.77 77.11 8.65 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.484 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -125.7 177.53 6.21 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.986 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.32 -141.88 10.21 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.414 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.187 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 17.1 mt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -60.92 173.12 0.82 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.671 0.272 . . . . 0.0 111.284 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 34.0 t 179.53 100.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.406 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 4.0 p -98.37 -163.67 1.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -150.13 111.36 4.4 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 111.113 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 77' ' ' MET . 9.1 p . . . . . 0 C--O 1.253 1.287 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.213 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttm . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.545 0.212 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 tttm 63.54 82.5 0.18 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.805 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.25 89.27 46.48 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.992 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.5 -171.47 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.9 2.4 . . . . 0.0 112.802 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 33.1 tt0 -112.83 92.26 3.95 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.193 0.521 . . . . 0.0 110.674 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.1 mm -95.59 131.35 42.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.74 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.14 144.85 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.69 126.76 55.6 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 m -99.4 113.77 35.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.981 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.86 92.19 5.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.486 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt -116.03 173.87 6.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.17 162.24 13.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.022 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.08 113.78 25.51 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.513 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.85 -41.47 6.49 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.412 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -163.68 44.82 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.544 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.09 153.8 28.01 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.374 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.35 -48.54 80.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.606 0.203 . . . . 0.0 111.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.09 69.53 1.39 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.819 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 3.3 pp -160.72 177.48 10.42 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 122.202 0.201 . . . . 0.0 110.581 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -138.24 134.13 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.688 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.564 HD11 HG23 ' A' ' 34' ' ' ILE . 2.1 pp -120.87 165.73 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.407 HG22 ' CB ' ' B' ' 101' ' ' SER . 47.8 t -149.9 137.14 13.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.501 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.85 123.84 33.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.14 157.79 45.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.848 0.356 . . . . 0.0 111.645 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.87 179.69 4.55 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.006 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.24 -141.21 3.08 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.789 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.88 147.1 31.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.65 0.262 . . . . 0.0 110.787 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.27 37.15 92.57 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.784 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.89 106.29 8.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.65 0.262 . . . . 0.0 110.844 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.8 17.86 6.2 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HD2' ' CA ' ' A' ' 67' ' ' GLY . 19.4 mmtp -145.15 -171.06 3.57 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.632 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 tp -124.03 139.23 54.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.514 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.21 133.0 11.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.991 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.564 HG23 HD11 ' A' ' 21' ' ' ILE . 29.1 mm -92.12 71.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.149 0.5 . . . . 0.0 110.512 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -63.4 167.68 5.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.775 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.9 t -112.1 125.34 69.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.098 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.479 ' HD3' ' HB2' ' B' ' 101' ' ' SER . 2.3 pttt -87.01 -36.51 18.19 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.587 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -163.42 159.36 22.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.523 0.202 . . . . 0.0 111.039 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 19' ' ' LEU . 16.7 t -118.25 122.91 70.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.31 133.4 30.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.39 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 154.39 41.87 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.74 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.49 45.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.266 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.64 -163.7 4.94 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.59 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.42 -34.32 11.57 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.09 -47.13 38.49 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -59.55 -37.94 79.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.437 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.8 t -73.79 -32.79 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.248 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.43 -41.68 80.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.087 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.71 49.78 10.22 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.787 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -105.5 -36.16 7.23 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.576 0.227 . . . . 0.0 111.349 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.52 173.71 8.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 111.277 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.68 26.84 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.176 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.25 128.44 37.01 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.537 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.85 38.77 2.46 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.016 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -116.59 141.53 48.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.668 0.271 . . . . 0.0 110.77 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -85.97 143.51 28.12 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.068 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -99.81 143.72 29.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.324 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tt -122.41 -58.83 1.67 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.2 p -140.64 154.24 46.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.978 0.418 . . . . 0.0 111.795 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.4 t -135.03 112.83 15.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.438 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 56.83 34.5 24.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.232 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.37 -20.33 49.98 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.383 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -70.98 151.3 44.79 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 117.27 0.535 . . . . 0.0 111.065 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.1 p -107.14 119.47 39.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 mt -110.23 -9.19 14.68 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.736 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.88 83.62 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-O 121.692 0.758 . . . . 0.0 110.737 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.409 ' CA ' ' HD2' ' A' ' 31' ' ' LYS . . . 140.78 -23.49 2.63 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.658 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.4 mt -82.47 169.19 16.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.6 m -86.1 166.48 15.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.759 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -57.85 -28.73 64.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.416 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -64.74 -47.49 78.04 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-O 120.65 0.262 . . . . 0.0 110.765 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -53.78 39.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.27 -50.58 72.46 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.771 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.41 -63.27 1.25 Allowed 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.882 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -46.37 -48.05 18.58 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.445 0.466 . . . . 0.0 112.117 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.6 mt -68.16 -27.82 66.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.569 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.499 ' HE3' ' CD2' ' A' ' 86' ' ' LEU . 77.6 mtp -86.21 -19.99 29.18 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -43.42 63.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.799 0.333 . . . . 0.0 110.61 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -95.57 65.51 2.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.946 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -83.78 147.43 27.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.068 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.51 -167.54 1.83 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.765 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -56.55 -43.85 80.33 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.921 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.08 144.49 12.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.1 t -137.69 113.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.802 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.23 86.77 2.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.649 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.499 ' CD2' ' HE3' ' A' ' 77' ' ' MET . 1.3 mt -94.25 124.41 38.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.294 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -98.9 121.41 40.82 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.289 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.4 m -117.7 168.77 9.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.733 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.17 111.43 13.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.987 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 11.8 mmtt -65.18 110.12 2.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.521 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.47 -177.62 6.34 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.171 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.76 137.26 2.18 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.478 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.142 -0.933 . . . . 0.0 111.108 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.022 0.439 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -121.19 176.24 5.71 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.477 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.479 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 97.8 p -118.67 133.36 55.91 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.747 0.308 . . . . 0.0 111.793 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -98.96 -151.89 0.4 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -174.11 44.89 0.01 OUTLIER 'General case' 0 C--N 1.341 0.22 0 CA-C-O 121.665 0.745 . . . . 0.0 109.404 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.248 1.026 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.035 -179.109 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 ptt? . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.38 114.34 1.78 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.611 0.243 . . . . 0.0 110.974 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -106.04 92.12 6.18 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.723 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.72 -170.81 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.432 2.088 . . . . 0.0 112.589 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HB3' ' CG ' ' A' ' 90' ' ' LYS . 10.9 tt0 -129.42 103.86 7.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.07 0.462 . . . . 0.0 110.79 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.79 137.15 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.598 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.45 150.08 14.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 8.3 m -113.88 131.23 56.35 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.879 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.5 m -102.09 116.29 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.107 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 m -105.43 98.43 8.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.544 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mt -126.87 154.74 44.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 152.96 21.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -70.72 105.15 3.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.196 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.37 -38.72 10.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.087 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -161.58 42.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.01 0.433 . . . . 0.0 110.56 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.94 157.8 6.11 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.118 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.425 ' SD ' HD11 ' A' ' 86' ' ' LEU . 2.7 mtm -65.02 -56.05 15.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.696 0.248 . . . . 0.0 110.564 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.13 78.74 0.14 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.894 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 4.0 pp -160.81 177.72 10.14 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.11 153.17 43.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.952 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 pp -144.75 158.64 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 112.088 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.15 141.67 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.17 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.42 149.46 30.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.261 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -146.85 135.04 21.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.335 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -119.73 179.98 4.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.01 -137.85 2.28 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.12 142.78 41.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.665 0.269 . . . . 0.0 110.871 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.92 43.89 98.57 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.914 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.37 107.81 7.82 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.72 0.295 . . . . 0.0 111.025 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.96 22.34 3.71 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.435 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -144.13 -171.97 3.67 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.657 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 tp -136.11 136.88 40.49 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.906 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.88 161.88 19.38 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.767 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.0 mm -115.3 103.27 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 111.073 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -90.57 163.78 14.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.83 113.08 40.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.029 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -43.01 69.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 p -172.18 167.19 5.97 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.777 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.2 m -120.0 127.89 75.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.851 0.357 . . . . 0.0 110.816 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.43 121.7 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -64.17 154.18 35.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.19 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.48 -37.01 3.83 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.703 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.7 -177.8 5.88 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.773 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.1 -2.33 58.55 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.29 -38.32 11.57 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.04 -37.38 54.92 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.229 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.1 t -64.69 -33.27 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.636 0.255 . . . . 0.0 110.95 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.92 -45.18 64.73 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.098 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.74 29.23 43.77 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.784 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.64 -33.16 16.75 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.515 0.198 . . . . 0.0 111.167 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.46 171.2 11.24 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.031 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.94 -175.71 5.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.563 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.82 162.15 29.43 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.94 39.82 93.36 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.334 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.05 142.79 51.45 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.639 0.257 . . . . 0.0 111.055 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -89.79 160.3 16.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.8 mt -124.44 155.41 38.92 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 111.617 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.0 -55.95 1.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.072 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -136.09 142.06 44.27 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.695 0.284 . . . . 0.0 111.429 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.3 t -135.69 140.89 43.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.998 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 43.65 44.88 5.61 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.534 0.521 . . . . 0.0 111.841 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.5 32.52 81.95 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.663 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -138.69 161.94 35.91 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.855 0.328 . . . . 0.0 110.577 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 p -112.77 137.32 51.26 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.767 0.318 . . . . 0.0 111.11 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.7 mt -117.38 45.41 1.91 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.0 t -109.36 100.9 11.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.187 0.518 . . . . 0.0 110.896 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.77 -37.68 2.85 Favored Glycine 0 C--N 1.328 0.139 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.347 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.8 pp -73.48 147.26 44.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.777 0.322 . . . . 0.0 110.948 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -64.16 156.76 27.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.649 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -52.62 -39.11 61.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.631 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.59 -43.99 62.66 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -74.43 -40.79 61.74 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.2 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.18 -58.45 7.88 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.75 -64.38 0.95 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.06 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -38.04 -46.81 1.04 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.549 0.531 . . . . 0.0 111.764 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 mt -60.1 -43.52 95.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.007 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.1 mtp -76.71 -30.28 56.61 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.258 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -27.88 69.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.544 0.211 . . . . 0.0 110.816 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -96.47 32.82 1.92 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.208 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -60.21 146.34 43.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 111.412 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -85.93 -165.94 1.39 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.665 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -56.51 -31.35 64.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.038 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.45 141.58 19.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.965 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.48 114.65 43.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.619 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.52 88.54 2.92 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.425 HD11 ' SD ' ' A' ' 17' ' ' MET . 5.7 mt -101.77 133.31 46.7 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.317 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -115.72 127.33 55.05 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.926 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.58 170.64 13.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.326 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.35 133.19 51.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.903 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 48.6 mmtm -70.1 93.02 0.78 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.425 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.28 174.35 15.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.918 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.19 0.33 65.68 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.682 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.369 179.823 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 120.622 0.249 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -170.54 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.689 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 4.6 p 168.98 43.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.694 0.283 . . . . 0.0 110.812 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 1.6 t -84.7 -174.74 5.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.788 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.2 mp0 -130.36 80.11 1.93 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.649 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.555 -179.7 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.679 0.276 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.28 127.06 29.82 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.087 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -133.97 111.38 12.15 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.73 -170.89 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.726 2.284 . . . . 0.0 112.605 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -121.69 98.41 5.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.029 0.442 . . . . 0.0 110.674 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.3 mm -95.85 128.98 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.2 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.14 141.49 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.129 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.488 ' HB ' ' HG3' ' A' ' 87' ' ' GLU . 10.0 t -112.08 149.71 31.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.813 0.339 . . . . 0.0 111.019 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.22 118.37 58.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.211 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.0 m -94.28 101.13 13.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.463 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.9 mt -131.3 163.07 28.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -92.2 129.92 38.03 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.927 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HB2' ' CG2' ' A' ' 84' ' ' VAL . 8.4 ttpp -83.03 139.39 33.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.186 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -93.37 -57.78 2.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -158.99 38.11 0.21 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.723 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.43 -167.99 22.35 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.999 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.7 mtm -115.9 -42.73 3.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.69 0.245 . . . . 0.0 111.385 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.99 73.96 0.63 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.038 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.428 ' HG ' HG12 ' B' ' 104' ' ' VAL . 4.0 pp -160.8 177.94 9.92 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.646 0.26 . . . . 0.0 111.072 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.8 m -130.49 150.69 51.59 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.447 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 pp -142.61 152.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.807 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 37' ' ' LYS . 46.4 t -133.69 135.71 55.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.66 135.18 33.47 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.167 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.71 152.56 40.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.351 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.7 tttt -124.2 -179.54 4.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.938 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.78 -140.42 2.98 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.41 140.96 44.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.687 0.28 . . . . 0.0 110.728 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.32 45.79 95.74 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.597 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.4 107.9 7.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.707 0.289 . . . . 0.0 111.127 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -90.1 21.0 3.93 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -144.02 -168.89 2.98 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.678 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 tp -136.91 146.76 45.87 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.929 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.12 128.71 9.14 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.845 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.6 mm -87.14 87.25 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.994 0.426 . . . . 0.0 110.871 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 66.0 m-85 -79.17 168.07 20.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.603 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.8 t -99.11 135.73 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.606 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.424 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -100.58 -41.33 7.0 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.286 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -178.0 125.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.055 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.9 m -87.55 136.19 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.247 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.2 t -92.29 128.0 44.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -62.48 148.5 45.51 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.323 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.55 -30.35 10.42 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.579 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.97 152.49 51.88 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.428 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.75 -36.55 26.16 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.85 -44.26 64.14 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.651 0.263 . . . . 0.0 111.382 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -39.03 92.91 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.45 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.0 t -57.79 -39.37 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.144 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.27 -49.58 13.44 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.058 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.79 76.9 1.06 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.171 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.9 mmm-85 -139.18 22.48 2.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.03 153.65 1.67 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.654 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.47 -179.99 6.61 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.487 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.71 139.44 58.38 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.034 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.73 22.06 32.13 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.862 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.87 175.68 5.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.64 0.22 . . . . 0.0 110.613 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.421 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 3.7 tt0 -125.17 142.36 51.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.053 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.94 164.17 12.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.338 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 mt -140.21 -55.52 0.54 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.362 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.7 m -127.08 154.62 44.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.689 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 77' ' ' MET . 22.6 t -141.91 107.76 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.048 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.71 50.71 10.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.97 0.414 . . . . 0.0 111.03 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.76 21.4 76.5 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.859 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -113.74 160.8 18.28 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.734 0.267 . . . . 0.0 110.37 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -114.41 110.94 20.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.032 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.1 mt -96.33 43.67 1.08 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.6 t -105.53 100.09 9.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.186 0.517 . . . . 0.0 110.572 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.87 30.48 5.15 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.553 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.02 158.06 30.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.2 p -79.9 162.11 25.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.738 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -54.28 -36.42 63.62 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.768 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.81 -59.69 4.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.091 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -59.71 -36.6 76.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.099 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.44 -62.02 1.77 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.493 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.19 -47.07 79.06 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.412 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -56.3 -54.85 40.47 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.956 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.6 mt -53.69 -33.55 55.8 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.316 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.442 ' HA ' HG12 ' A' ' 60' ' ' VAL . 13.5 mtp -74.78 -51.38 14.27 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.487 ' HB ' HG21 ' B' ' 104' ' ' VAL . 8.6 t -63.2 -33.58 75.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.55 0.214 . . . . 0.0 111.161 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -84.2 47.48 1.34 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.878 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -98.2 179.54 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.868 0.366 . . . . 0.0 111.207 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -93.83 -165.63 1.36 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -55.81 -44.09 77.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 110.925 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.16 145.91 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.852 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 13' ' ' LYS . 22.5 t -128.39 126.76 66.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.532 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.67 83.5 2.14 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.765 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.3 mt -93.67 118.79 31.85 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.495 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.488 ' HG3' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -86.34 113.86 22.66 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.547 179.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.75 150.56 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.54 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.02 160.4 15.32 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.26 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -114.36 103.84 11.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.763 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.19 177.75 8.41 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.244 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.69 -0.77 71.86 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.853 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.464 179.697 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -132.89 169.92 16.07 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -120.93 90.99 3.43 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.887 0.375 . . . . 0.0 110.774 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.49 175.44 10.66 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.681 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.54 129.34 45.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.804 0.335 . . . . 0.0 110.835 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.487 HG21 ' HB ' ' A' ' 78' ' ' THR . 8.4 p . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.194 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.677 0.275 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.84 36.61 1.91 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.923 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -82.6 123.88 78.1 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.862 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.71 -166.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.861 2.374 . . . . 0.0 112.822 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 34.8 tt0 -108.52 90.75 3.39 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.252 0.548 . . . . 0.0 110.952 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.33 136.68 24.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.844 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.5 153.17 13.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.448 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 5.0 m -111.27 141.16 45.16 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 m -120.7 133.54 67.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 m -109.68 95.17 5.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.709 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.0 mt -116.49 173.29 6.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -99.57 163.02 12.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.057 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -77.46 100.3 5.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.73 80.47 5.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.477 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.13 34.55 23.35 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.967 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.96 152.79 29.09 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.239 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -56.41 22.44 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.69 0.281 . . . . 0.0 110.666 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.26 72.75 0.84 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.661 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 3.6 pp -160.61 178.12 9.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.732 0.301 . . . . 0.0 110.672 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 m -135.17 126.25 27.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.41 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.475 HG13 ' HB ' ' B' ' 102' ' ' THR . 2.1 pp -118.09 129.73 74.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.322 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 93.7 t -112.5 136.8 47.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.099 0.476 . . . . 0.0 111.138 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.27 120.03 34.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.199 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.85 148.65 52.3 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.946 0.403 . . . . 0.0 111.768 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.58 -179.86 4.67 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.667 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.8 -141.53 3.15 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.715 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.34 148.52 27.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.614 0.245 . . . . 0.0 110.66 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.78 33.22 82.05 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.744 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.25 103.46 6.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.684 0.278 . . . . 0.0 110.927 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.445 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 7.1 t0 -90.64 21.6 3.94 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.227 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -142.01 -168.15 2.63 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.5 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.7 tp -142.14 123.91 15.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.747 0.308 . . . . 0.0 110.889 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.78 116.94 5.61 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.411 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.449 HG23 HD11 ' A' ' 21' ' ' ILE . 31.3 mm -77.85 87.19 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.957 0.408 . . . . 0.0 110.413 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.94 162.32 28.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.648 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -104.33 108.01 23.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.835 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -62.52 -47.02 85.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.859 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 p -175.34 137.83 0.4 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.28 137.79 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.513 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -76.07 141.68 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 153.01 35.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.236 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.98 19.24 69.65 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.007 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.25 -158.03 33.72 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.442 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.17 -35.18 10.86 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.22 -33.59 20.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.377 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -40.93 94.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.539 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.96 -41.85 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.52 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.5 -55.1 34.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.361 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.9 49.85 1.72 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.438 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 72.8 mmt-85 -105.77 -58.16 1.94 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 110.643 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 pp -117.15 149.72 39.89 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.669 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.63 -175.22 3.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.183 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.2 131.1 42.31 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.008 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.35 27.6 10.58 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.739 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.18 171.36 7.53 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.589 0.194 . . . . 0.0 110.768 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -120.26 137.9 53.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.307 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.429 HD11 HG22 ' A' ' 21' ' ' ILE . 86.6 mt -101.35 162.19 13.08 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.178 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.48 -53.26 0.45 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.188 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.0 m -124.04 151.03 44.23 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.979 0.418 . . . . 0.0 111.712 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.7 t -139.34 133.23 38.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.765 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 53.65 38.0 27.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.37 26.98 72.32 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.337 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 mtp-105 -128.89 148.24 50.89 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.897 0.348 . . . . 0.0 110.723 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.5 m -89.66 135.23 33.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.982 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mp -130.0 50.02 2.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.974 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -94.14 99.62 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 110.876 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 105.54 35.35 3.09 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.64 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.7 mt -122.11 153.77 38.25 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.755 0.312 . . . . 0.0 110.768 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.8 m -75.33 158.2 33.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -57.25 -25.52 59.28 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.725 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.15 -49.58 76.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.692 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -51.89 52.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.47 81.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.584 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.79 -56.89 16.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.331 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -53.15 60.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.309 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.52 -32.28 71.31 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.982 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.411 ' HE2' HD13 ' A' ' 86' ' ' LEU . 30.5 mmm -69.58 -64.32 0.9 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.92 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.7 t -56.01 -36.23 67.71 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.684 0.278 . . . . 0.0 111.024 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -86.86 52.58 2.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.264 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -94.2 168.47 10.9 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.773 0.32 . . . . 0.0 110.746 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -97.62 -163.08 1.01 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.591 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -59.04 -26.78 64.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.165 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.82 149.21 5.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.952 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.01 87.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.1 m -91.88 80.68 5.2 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.411 HD13 ' HE2' ' A' ' 77' ' ' MET . 9.1 mt -103.94 133.97 48.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.44 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 27.2 tt0 -107.19 112.11 24.84 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.603 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.73 147.56 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.206 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.37 132.86 42.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.8 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.414 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -69.02 91.37 0.48 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.564 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.43 -177.82 4.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.912 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.06 140.43 3.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.567 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.518 179.829 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 70.05 94.03 0.08 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 110.712 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 8.2 t -154.23 -50.9 0.09 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.475 ' HB ' HG13 ' A' ' 21' ' ' ILE . 0.8 OUTLIER 53.65 -172.74 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.013 0.435 . . . . 0.0 111.841 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER 179.35 51.94 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.404 HG12 HG23 ' B' ' 102' ' ' THR . 30.8 m . . . . . 0 C--O 1.251 1.153 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.811 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 tpp . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.35 115.22 2.58 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.673 0.273 . . . . 0.0 110.92 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.75 102.39 22.66 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.98 -172.18 0.57 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.828 2.352 . . . . 0.0 112.679 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -128.21 104.32 7.68 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.026 0.441 . . . . 0.0 111.117 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mt -102.84 141.16 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.737 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 pt -146.26 151.84 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.371 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -112.88 140.0 48.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.955 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 m -123.19 127.92 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.183 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 15.6 m -108.65 112.38 24.68 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mt -138.97 162.27 35.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mptt -98.08 176.6 5.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.877 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.51 150.42 26.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 111.408 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.98 -58.66 0.96 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.579 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -138.02 35.67 2.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.61 152.81 28.91 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.106 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 mtm -64.41 -48.87 73.74 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.629 0.214 . . . . 0.0 110.723 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.85 82.51 0.07 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.938 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -160.76 179.61 8.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.628 0.252 . . . . 0.0 110.781 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -129.45 144.78 51.39 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.27 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.467 HD11 ' NE2' ' A' ' 70' ' ' GLN . 2.7 pp -140.55 146.14 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.799 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.421 HG22 ' HB2' ' A' ' 37' ' ' LYS . 22.7 t -132.71 137.08 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.544 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.49 158.85 25.73 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.705 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -159.51 141.53 13.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 111.377 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.31 -179.67 4.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.82 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.37 -141.33 3.12 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.8 139.25 40.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.681 0.277 . . . . 0.0 110.597 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.43 35.47 91.75 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.707 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.05 103.76 7.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.672 0.272 . . . . 0.0 110.89 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -92.18 28.41 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.1 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -136.57 -170.16 2.62 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.449 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.9 tp -151.96 124.47 8.34 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.672 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.22 150.5 20.2 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.025 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.432 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 14.7 mm -104.86 81.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 121.049 0.452 . . . . 0.0 110.786 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.425 ' CE2' ' HG3' ' A' ' 56' ' ' GLN . 61.8 m-85 -71.57 166.37 21.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.316 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.3 t -106.43 128.99 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.107 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.421 ' HB2' HG22 ' A' ' 22' ' ' VAL . 8.5 ttpt -91.37 -42.6 10.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.3 172.84 15.9 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.726 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.05 121.97 30.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.558 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 t -72.13 124.96 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.721 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 124.12 21.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.79 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.11 -31.6 3.82 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.352 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.66 157.23 53.17 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.621 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.16 18.81 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.87 -49.67 71.83 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.683 0.277 . . . . 0.0 111.203 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.48 -41.16 96.64 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.163 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.9 t -61.02 -32.96 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.25 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -68.25 -55.88 10.63 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.238 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.44 51.43 2.92 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.85 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -128.24 -66.99 0.82 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.729 0.264 . . . . 0.0 110.805 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.4 161.59 30.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.98 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.93 -174.83 4.37 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.368 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.9 120.91 28.68 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.982 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.1 31.26 3.14 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.023 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -116.78 139.2 50.86 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.705 0.252 . . . . 0.0 110.955 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.9 tt0 -81.9 145.33 30.4 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -97.53 168.94 10.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.012 0.434 . . . . 0.0 111.321 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.18 -59.02 0.24 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.035 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.5 p -128.3 150.6 49.99 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.963 0.411 . . . . 0.0 111.713 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.402 HG23 ' CG ' ' A' ' 77' ' ' MET . 39.9 t -141.97 96.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.46 41.99 31.63 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.962 0.41 . . . . 0.0 111.0 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.36 25.86 49.66 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.952 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -120.64 129.78 53.86 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.19 111.14 21.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.967 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.5 mt -99.72 26.84 5.84 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.056 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.2 p -107.39 73.43 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.661 0.743 . . . . 0.0 110.638 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.66 -22.4 1.49 Allowed Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.199 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.4 mt -81.32 159.26 24.47 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.966 0.412 . . . . 0.0 111.188 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.5 m -74.73 147.17 41.6 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.024 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.467 ' NE2' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -42.45 -41.25 2.86 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.178 0.299 . . . . 0.0 111.412 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.94 -56.94 12.24 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.306 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -60.44 -40.83 92.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.404 ' CB ' HG13 ' A' ' 34' ' ' ILE . . . -58.73 -60.84 3.19 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.702 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.44 ' O ' HG22 ' B' ' 104' ' ' VAL . . . -63.49 -36.86 85.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.353 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 78' ' ' THR . 0.6 OUTLIER -69.08 -35.82 76.93 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.433 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.45 -44.18 58.7 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.402 ' CG ' HG23 ' A' ' 60' ' ' VAL . 11.1 mtp -59.53 -48.17 82.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.433 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 75' ' ' GLU . 7.8 t -64.51 -33.46 75.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.63 0.252 . . . . 0.0 110.611 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.72 50.19 1.92 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.892 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.0 p -103.79 172.72 6.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.646 0.26 . . . . 0.0 110.865 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 t -79.73 -169.93 2.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.49 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -53.4 -40.59 65.19 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.254 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.1 t -97.35 143.63 12.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.121 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 10' ' ' THR . 23.9 t -119.74 149.13 22.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.14 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.9 m -143.54 85.56 1.85 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.8 mt -98.27 140.45 32.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.365 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -121.78 110.07 15.46 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.735 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.84 169.19 2.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.204 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.17 137.67 53.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.17 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.62 121.44 36.18 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.548 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -159.46 -171.83 3.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.871 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.5 138.99 2.53 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.489 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.244 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.479 0.181 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 73.65 144.25 0.07 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.991 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 21.5 t -121.75 134.92 54.94 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.975 0.417 . . . . 0.0 111.507 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.432 ' CG2' ' HG2' ' A' ' 70' ' ' GLN . 0.9 OUTLIER -120.55 -176.23 3.19 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.155 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -135.94 116.86 14.2 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 110.783 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 74' ' ' ALA . 14.2 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.157 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttp . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.664 0.269 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -174.45 116.54 0.2 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.695 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 66.57 108.35 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.541 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.85 -174.84 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.592 2.195 . . . . 0.0 112.64 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.5 100.95 5.97 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.875 0.369 . . . . 0.0 111.025 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mt -100.49 139.14 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.318 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.02 139.19 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.145 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.415 ' HB ' ' CG ' ' A' ' 87' ' ' GLU . 7.3 t -109.41 159.25 17.17 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 110.98 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.61 132.7 31.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.326 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 m -90.99 97.0 10.92 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.471 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.21 169.12 8.94 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.357 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -113.54 153.84 28.11 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.752 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -82.61 102.8 11.68 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.212 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -100.46 78.55 2.03 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.279 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 57.74 36.97 27.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.905 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.73 148.04 16.22 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.091 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.4 mtm -65.64 -68.8 0.34 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.733 0.266 . . . . 0.0 111.007 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.53 70.09 1.09 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.045 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 pp -160.65 176.82 11.12 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.401 0.143 . . . . 0.0 110.633 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -134.21 142.14 47.28 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.96 163.19 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.036 0.446 . . . . 0.0 112.069 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 ' CG1' ' HB2' ' B' ' 100' ' ' PHE . 21.2 t -142.06 131.83 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.434 ' CB ' ' HB2' ' A' ' 70' ' ' GLN . . . -99.31 118.58 36.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -120.49 132.62 55.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.569 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HG3' ' CD1' ' A' ' 32' ' ' LEU . 4.6 tttt -114.51 -179.69 3.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.889 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.16 -140.52 3.01 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.69 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.46 152.63 23.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.56 0.219 . . . . 0.0 110.766 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.18 37.46 86.56 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.501 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.27 107.74 7.36 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.609 0.242 . . . . 0.0 110.801 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.476 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 7.8 p-10 -90.7 15.11 11.69 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 111.47 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -144.36 -171.38 3.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.383 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.432 ' CD1' ' HG3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -145.1 135.34 24.02 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 111.002 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.03 127.85 9.32 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.822 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.73 78.78 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 121.031 0.443 . . . . 0.0 110.513 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.437 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 73.0 m-85 -68.79 157.8 35.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.623 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.12 135.19 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.308 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -92.77 -47.77 6.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.622 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.17 130.57 0.17 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.03 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.13 132.22 31.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.667 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -81.74 139.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.19 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.72 145.17 55.4 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.206 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.57 -26.25 23.88 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.869 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.2 150.12 51.58 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.149 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.59 -36.69 67.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.93 95.84 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.689 0.281 . . . . 0.0 110.86 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -40.64 63.5 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.83 -36.38 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.397 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.28 -38.21 60.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.26 64.27 2.69 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.494 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -49.04 1.86 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.583 0.23 . . . . 0.0 111.383 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.84 165.72 10.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.261 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.8 177.77 7.95 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.519 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.77 140.31 42.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.047 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.61 27.94 28.27 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.871 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . 1.4 m-20 -110.67 155.22 22.73 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.635 0.218 . . . . 0.0 110.536 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.437 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 4.8 tt0 -96.67 144.56 26.58 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.091 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.96 169.24 8.62 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.65 -57.61 0.22 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.241 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 t -126.52 144.23 50.94 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.112 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.521 HG22 ' SD ' ' A' ' 77' ' ' MET . 23.4 t -135.47 112.22 13.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.576 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.09 39.04 23.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.333 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.48 4.64 84.88 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.321 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -98.96 142.33 30.6 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.42 0.61 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.05 108.78 21.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.828 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.8 mt -100.33 32.42 3.03 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 62.5 t -90.09 99.96 10.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.189 0.519 . . . . 0.0 110.826 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 110.93 32.35 2.66 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.521 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.3 mt -129.18 161.5 29.97 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.695 0.284 . . . . 0.0 110.828 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.81 154.23 30.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.434 ' HB2' ' CB ' ' A' ' 23' ' ' ALA . 1.2 tm0? -52.29 -36.24 52.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -54.66 -53.1 59.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.715 0.293 . . . . 0.0 110.384 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -63.2 -41.33 99.16 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.738 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.4 -59.92 4.64 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.229 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.498 ' O ' HG21 ' B' ' 104' ' ' VAL . . . -56.07 -33.96 65.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.626 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -45.08 57.82 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.602 0.239 . . . . 0.0 111.327 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.9 mt -67.69 -32.46 73.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.464 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.521 ' SD ' HG22 ' A' ' 60' ' ' VAL . 6.6 mtm -73.83 -48.2 32.98 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.491 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 t -64.1 -34.2 77.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.615 0.245 . . . . 0.0 110.793 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -83.8 49.04 1.53 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.669 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.7 -175.9 3.58 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.545 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 m -104.3 -164.59 1.07 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.3 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 13.7 p -56.77 -31.71 64.9 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.753 0.311 . . . . 0.0 110.714 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.48 148.34 13.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.629 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.41 139.46 21.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.28 95.2 4.45 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.73 104.69 17.25 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.078 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.415 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 1.8 mt-10 -80.23 83.14 6.14 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.227 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.4 ' CG2' ' HB3' ' A' ' 55' ' ' ASP . 14.8 p -84.41 142.85 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.434 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.61 117.98 31.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -71.21 148.29 47.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -139.13 169.02 18.54 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.859 0.361 . . . . 0.0 111.572 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.22 -4.25 62.92 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.544 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.989 179.812 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.423 ' HB2' ' CG1' ' A' ' 22' ' ' VAL . 55.6 p90 -62.85 170.73 2.48 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.734 0.302 . . . . 0.0 111.645 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 59.8 p 53.84 70.17 0.63 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.582 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -111.34 -164.59 0.93 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.284 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -131.32 127.52 37.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 74' ' ' ALA . 10.8 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.66 0.267 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -102.67 25.66 8.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.209 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -153.3 88.7 3.7 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.026 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.71 -171.57 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.982 2.454 . . . . 0.0 112.834 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.41 87.26 2.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.222 0.534 . . . . 0.0 111.119 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.6 mm -84.52 125.69 40.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.608 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pp -140.49 137.67 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.848 0.356 . . . . 0.0 111.119 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -105.08 113.03 26.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.887 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.9 m -100.51 151.91 5.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.166 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.22 119.69 25.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.771 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mt -132.97 162.54 31.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.6 mtmt -110.03 138.06 46.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.727 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -64.85 121.47 14.68 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.216 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.34 -50.89 5.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -164.95 41.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.795 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.43 147.28 16.72 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.151 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.7 mmm -68.38 -68.06 0.42 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.453 0.168 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.96 78.57 0.53 Allowed Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.855 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 pp -160.46 179.47 8.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.52 0.2 . . . . 0.0 110.857 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.6 m -129.04 141.56 51.19 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.716 0.293 . . . . 0.0 111.665 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' B' ' 101' ' ' SER . 2.9 pp -137.68 154.77 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.806 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.57 135.13 26.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.989 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.71 146.62 23.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.777 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.63 158.03 43.8 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 111.935 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.31 179.16 4.19 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.856 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.89 -143.61 3.75 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.07 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.66 150.54 28.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.551 0.215 . . . . 0.0 110.878 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.83 28.57 63.41 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.502 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.55 106.93 4.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 110.565 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -97.44 39.27 1.21 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.936 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -137.29 -159.83 1.0 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.256 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tp -146.54 126.81 13.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.507 0.194 . . . . 0.0 110.747 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.15 142.69 15.64 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.822 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 mp -86.69 135.16 25.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.774 0.321 . . . . 0.0 110.502 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.406 ' CE1' ' HB2' ' A' ' 56' ' ' GLN . 96.8 m-85 -125.66 143.93 50.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.011 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 39.3 t -81.37 130.01 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.005 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -100.54 -40.74 7.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.327 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.48 128.13 0.09 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.633 0.254 . . . . 0.0 110.993 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 m -90.64 133.38 32.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.124 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.9 t -73.56 131.21 35.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -61.56 115.48 3.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.065 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.27 -30.03 3.38 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.786 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.58 151.19 50.85 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.689 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.66 65.07 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.72 -36.64 84.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -76.22 -45.91 30.73 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.243 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.3 t -60.26 -38.52 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.365 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.74 -41.57 62.31 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.145 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.24 33.09 18.37 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.984 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -83.83 -54.3 4.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.806 0.336 . . . . 0.0 110.689 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.19 152.64 32.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.818 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.99 175.12 10.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.138 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.01 122.81 15.87 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.315 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.4 38.77 2.2 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.926 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -135.24 142.31 45.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.517 0.199 . . . . 0.0 110.796 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.406 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 51.1 tt0 -93.55 152.97 18.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.933 0.397 . . . . 0.0 110.774 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.53 172.12 7.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.023 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.87 -54.25 0.16 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.329 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 t -133.87 140.73 47.04 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.66 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.5 t -129.1 120.24 51.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.594 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.59 34.92 25.27 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.184 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.74 35.65 39.64 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.106 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 175.22 8.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.655 0.264 . . . . 0.0 110.851 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -121.34 121.59 37.98 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.139 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.18 29.18 6.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.263 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.7 t -87.27 100.27 9.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.231 0.538 . . . . 0.0 110.878 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.97 27.58 5.07 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.593 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 mt -118.84 164.68 15.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -83.97 152.29 24.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.275 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -51.39 -30.89 20.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.337 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -65.37 -51.16 62.31 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.771 0.319 . . . . 0.0 110.498 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -62.97 -40.43 97.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.32 -60.31 3.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.45 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.3 -44.68 96.82 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.848 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -39.09 81.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.048 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.88 -34.89 76.18 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.027 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 11.3 mtp -76.31 -41.6 48.01 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.738 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.3 t -70.85 -37.36 73.13 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.648 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -89.95 56.08 3.35 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.444 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 p -110.52 178.84 4.25 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.877 0.37 . . . . 0.0 111.246 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -175.75 4.02 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.714 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 m -52.63 -39.29 61.59 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.137 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.4 t -97.84 147.84 6.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.925 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.41 134.18 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.64 85.0 2.35 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.1 mt -92.23 139.08 30.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.258 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -124.86 98.9 5.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.3 m -105.07 172.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.803 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.43 107.15 17.57 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.942 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 mmtt -63.97 104.15 0.67 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -135.84 158.68 43.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.317 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.83 1.16 56.59 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.715 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.593 -0.718 . . . . 0.0 111.471 179.773 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.91 160.38 39.86 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.602 0.239 . . . . 0.0 110.859 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 80.6 p -128.99 118.62 22.9 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.698 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 1.7 t -111.58 -164.25 0.9 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.685 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.06 114.03 7.68 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.85 0.357 . . . . 0.0 110.748 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.083 -0.961 . . . . 0.0 111.032 -179.97 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtm . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.684 0.278 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 62.91 89.11 0.09 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.126 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -69.59 117.19 50.69 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.987 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -64.09 -163.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.939 2.426 . . . . 0.0 112.634 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -100.43 86.44 3.17 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.239 0.542 . . . . 0.0 111.019 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -96.43 128.08 47.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.666 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 pt -142.66 155.98 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.025 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 14.5 t -118.6 128.83 54.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.199 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 t -87.85 91.62 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.634 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.4 m -81.51 105.16 12.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.934 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.8 mt -139.4 177.58 7.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.27 153.06 20.8 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.684 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 100.75 0.21 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.879 0.371 . . . . 0.0 111.12 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.38 80.35 2.4 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.406 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m120 56.55 35.62 26.32 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.079 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.05 160.72 28.48 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.614 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 42.1 mtm -77.62 -38.91 46.96 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.497 0.189 . . . . 0.0 110.997 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.85 70.4 1.06 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.903 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 3.4 pp -160.62 176.76 11.21 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.793 0.33 . . . . 0.0 111.009 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.89 129.23 34.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.668 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.8 pp -121.83 153.43 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.891 0.377 . . . . 0.0 111.535 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.4 HG23 ' HA ' ' B' ' 101' ' ' SER . 43.2 t -142.33 146.92 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.231 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.08 147.32 30.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.196 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.74 155.09 39.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.64 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -120.1 179.47 4.27 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.772 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.13 -143.31 3.65 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.908 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.91 146.08 31.44 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.8 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.12 27.89 63.22 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.693 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.57 105.6 3.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.673 0.273 . . . . 0.0 110.486 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -96.3 28.16 3.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.412 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.524 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -120.19 -165.53 1.2 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.358 179.423 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 tp -145.03 124.5 13.13 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.628 0.252 . . . . 0.0 110.828 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.23 119.48 5.47 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.478 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 18.6 mm -80.09 74.62 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.938 0.399 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -71.2 168.19 17.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.426 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.52 108.7 25.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.057 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -64.33 -45.94 85.66 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.903 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.4 p -176.62 155.85 1.39 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 t -103.49 131.79 51.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.881 0.372 . . . . 0.0 110.797 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 t -79.61 132.32 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.974 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 127.98 34.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.008 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.59 -21.43 30.37 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.877 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.57 157.19 45.17 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.962 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.08 -38.37 76.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.25 -35.65 58.85 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.536 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -64.47 -45.11 88.78 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.141 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.77 -34.75 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.5 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.06 -53.95 21.87 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.687 0.28 . . . . 0.0 111.442 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.73 30.58 23.48 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.923 -0.655 . . . . 0.0 113.085 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -44.14 16.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.863 0.363 . . . . 0.0 110.724 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.82 178.77 4.16 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.95 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.22 175.99 11.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.366 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.68 132.76 46.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.676 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.77 28.89 8.5 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.5 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.33 174.57 5.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.459 0.171 . . . . 0.0 110.687 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -118.3 144.78 45.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.35 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 34' ' ' ILE . 6.6 tt -113.28 140.84 47.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.192 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.47 -58.74 1.83 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.98 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.0 m -136.63 156.77 48.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.935 0.398 . . . . 0.0 111.459 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.412 HG21 HD21 ' A' ' 86' ' ' LEU . 40.4 t -128.9 122.88 57.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.516 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 t70 67.35 11.68 8.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.445 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.3 18.74 30.11 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.557 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.46 142.63 51.4 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.376 0.588 . . . . 0.0 111.164 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.3 m -74.58 128.67 36.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.391 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.66 31.57 3.96 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.16 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.0 p -104.35 83.54 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.596 0.713 . . . . 0.0 110.467 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 157.62 -28.92 0.49 Allowed Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.523 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.9 167.91 12.84 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.856 0.36 . . . . 0.0 110.84 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -71.07 158.77 35.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.145 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -54.83 -28.73 51.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.301 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -60.53 -36.48 78.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.348 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.22 -42.39 31.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.645 0.259 . . . . 0.0 110.883 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.47 -51.76 18.78 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.617 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.47 -46.35 89.05 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.415 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -57.37 -45.26 84.62 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.685 0.278 . . . . 0.0 110.569 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.71 -33.49 75.75 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.32 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -60.69 -57.14 13.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.138 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -62.38 -39.3 92.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 110.391 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 51.92 2.19 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.779 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.37 176.8 5.57 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 111.048 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.43 -173.46 4.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.233 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 t -54.91 -33.4 62.04 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.626 0.25 . . . . 0.0 111.135 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.5 144.35 15.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.063 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.9 t -112.64 145.97 17.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.75 81.14 1.68 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -94.92 113.16 24.85 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.172 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.08 91.81 6.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.615 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.64 136.13 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.245 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.88 145.56 26.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.423 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.07 122.62 41.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -163.76 -174.9 3.86 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.53 139.8 2.77 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.625 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.409 179.68 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.997 0.427 . . . . 0.0 111.301 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.59 177.7 7.75 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.4 ' HA ' HG23 ' A' ' 22' ' ' VAL . 40.2 t -103.03 104.51 14.69 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 18.7 p -85.18 -149.8 0.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.733 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 14.1 pt-20 -170.78 48.13 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.905 0.86 . . . . 0.0 109.297 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . . . . . . . . . 20.1 m . . . . . 0 C--O 1.248 1.004 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.135 -178.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.9 ttm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.874 0.369 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 129.04 34.96 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.65 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -125.27 150.0 65.86 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.27 172.03 11.8 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.739 2.293 . . . . 0.0 112.596 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 19.4 tt0 -132.84 100.62 4.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.731 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.14 135.97 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.655 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.55 145.9 22.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.634 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -106.62 126.61 52.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.839 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.01 163.77 15.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.176 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -126.44 113.19 16.52 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.597 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.83 143.33 50.88 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -95.1 155.35 16.77 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.04 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -80.11 126.96 31.74 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.043 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -95.12 -52.85 4.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.503 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -164.62 44.24 0.09 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.532 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.97 151.01 17.69 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.226 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.1 mmm -74.28 -70.89 0.37 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.481 0.181 . . . . 0.0 110.683 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.31 77.09 0.58 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.82 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 pp -161.21 177.68 9.99 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.671 0.272 . . . . 0.0 110.992 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 m -130.17 155.76 45.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.477 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.403 ' HB ' HG22 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -144.12 164.33 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.778 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 37' ' ' LYS . 64.8 t -140.79 138.75 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.701 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.26 94.97 10.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.804 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.57 146.04 24.09 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.041 0.448 . . . . 0.0 112.109 -178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -132.65 -179.89 5.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.67 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -177.3 -142.63 4.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.775 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.83 149.34 25.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.615 0.245 . . . . 0.0 110.718 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.92 31.32 75.81 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.779 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.13 103.9 7.24 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.627 0.251 . . . . 0.0 110.731 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -91.1 23.06 3.41 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.222 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -140.77 -164.11 1.67 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.541 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.0 tp -140.55 116.62 10.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.477 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.26 133.25 11.8 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.471 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.413 HG12 ' CB ' ' A' ' 73' ' ' ALA . 1.8 mp -92.45 88.74 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 121.054 0.454 . . . . 0.0 110.498 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 56' ' ' GLN . 47.0 m-85 -82.28 173.03 12.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.918 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.16 136.34 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 111.356 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.403 ' HB2' HG23 ' A' ' 22' ' ' VAL . 11.6 tttp -98.37 -43.99 6.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.815 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.97 107.9 0.07 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.012 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.8 p -81.65 137.41 21.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.1 132.44 32.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.051 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 151.51 47.39 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.94 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.05 -28.79 12.96 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.679 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.85 157.65 53.23 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.27 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.33 -40.32 34.85 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.82 -36.82 70.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.398 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -86.09 -39.99 16.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.247 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.36 -37.68 79.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.87 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -68.7 -43.55 75.8 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.511 0.196 . . . . 0.0 111.202 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.06 75.5 1.09 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.762 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.19 -50.88 0.76 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.538 0.209 . . . . 0.0 110.819 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -123.78 177.57 5.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.099 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.54 -174.31 4.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.413 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.1 152.07 44.75 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.392 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.57 26.16 63.79 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.365 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.439 ' HA ' ' NE2' ' A' ' 91' ' ' GLN . 0.8 OUTLIER -107.03 169.12 8.74 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.629 0.252 . . . . 0.0 110.766 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 1.3 tt0 -100.25 166.55 10.93 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.59 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.05 130.8 9.07 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.99 -44.65 1.04 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.877 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.48 ' HB3' ' CB ' ' A' ' 87' ' ' GLU . 22.8 t -95.65 143.34 27.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.583 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.4 t -144.47 121.75 5.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.805 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.12 35.09 25.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.268 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.5 24.04 68.9 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.873 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.4 mtp85 -125.13 -176.55 3.6 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.3 p -123.65 116.24 22.76 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.689 0.28 . . . . 0.0 110.979 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.4 mt -110.68 31.29 6.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.004 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -89.87 101.21 11.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.123 0.487 . . . . 0.0 110.415 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.93 42.85 0.55 Allowed Glycine 0 CA--C 1.518 0.233 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.444 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.82 -178.81 3.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.773 0.321 . . . . 0.0 110.764 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.21 19.45 10.61 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.844 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 78.49 -54.87 0.48 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.098 0.559 . . . . 0.0 111.581 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -53.37 -43.69 68.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.621 0.248 . . . . 0.0 110.773 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -33.31 75.5 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.413 ' CB ' HG12 ' A' ' 34' ' ' ILE . . . -66.92 -62.8 1.25 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.288 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.53 -42.1 77.88 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.867 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -60.72 -33.1 72.38 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.122 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 mt -77.82 -46.2 22.21 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.61 0.243 . . . . 0.0 110.898 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.6 mtp -57.58 -41.24 80.74 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.187 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.406 ' HB ' ' CG2' ' B' ' 104' ' ' VAL . 8.9 t -73.42 -32.33 64.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.574 0.226 . . . . 0.0 110.563 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.38 49.63 1.85 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.34 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.9 p -115.13 170.32 8.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.656 0.265 . . . . 0.0 111.081 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t -81.58 -170.88 3.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.685 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.51 -48.68 68.79 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 p -85.47 127.81 39.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.979 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.43 141.72 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 m -119.93 106.4 12.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.095 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.69 133.14 53.47 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.121 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.48 ' CB ' ' HB3' ' A' ' 59' ' ' SER . 45.8 tt0 -115.39 106.02 13.52 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.756 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.2 m -105.24 174.27 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.595 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -123.2 143.39 50.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.895 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -84.8 97.84 9.94 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.345 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.439 ' NE2' ' HA ' ' A' ' 55' ' ' ASP . 1.6 pm0 -143.35 -172.95 3.81 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.171 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.04 140.01 3.05 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.459 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.824 -179.856 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 21.9 tp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.829 0.347 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -100.76 163.03 12.51 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.806 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 94.2 p -167.83 144.04 4.04 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 111.543 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.91 173.61 15.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.49 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -146.97 128.95 15.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.406 ' CG2' ' HB ' ' A' ' 78' ' ' THR . 8.2 p . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.035 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttt . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.502 0.191 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.46 134.45 9.11 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.264 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.48 113.08 6.21 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.965 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.3 -168.02 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.059 2.506 . . . . 0.0 112.739 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 19.9 tt0 -114.99 99.1 7.21 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.7 mt -103.81 116.78 48.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.879 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 pt -142.88 149.55 18.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 111.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.3 m -111.3 120.34 41.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.055 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 85' ' ' THR . 12.6 m -96.03 169.56 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.154 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.96 114.44 8.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.801 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -135.16 164.09 28.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.248 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -96.16 144.12 26.67 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -87.86 105.33 17.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.083 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -58.56 3.89 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.588 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.86 36.55 0.4 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.774 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.65 147.37 8.0 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.352 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -52.27 64.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.603 0.239 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.93 64.33 2.35 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.718 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 4.0 pp -160.54 179.33 8.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.46 0.171 . . . . 0.0 110.727 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.3 m -138.36 151.69 47.75 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.439 0.162 . . . . 0.0 111.183 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.56 HD11 HG21 ' A' ' 34' ' ' ILE . 2.2 pp -133.72 156.53 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.5 t -137.78 133.85 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.119 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.91 128.5 35.06 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.887 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.4 143.69 46.14 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.79 0.328 . . . . 0.0 111.471 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -120.33 -179.71 4.04 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.12 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.92 -139.82 2.74 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.734 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.32 150.95 27.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.67 0.271 . . . . 0.0 110.789 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.37 38.23 93.11 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.63 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 107.5 8.1 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.711 0.291 . . . . 0.0 110.855 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -90.29 19.0 5.43 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.545 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -144.77 -169.73 3.24 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.486 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.6 tp -129.19 142.81 50.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.66 0.267 . . . . 0.0 110.962 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.17 128.28 8.93 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.754 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 21' ' ' ILE . 1.9 mp -92.15 91.63 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-O 121.155 0.503 . . . . 0.0 110.274 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -80.16 167.81 19.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.593 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -94.93 127.48 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 111.094 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -80.36 -49.11 11.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.691 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.3 p -178.96 111.08 0.05 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.114 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' A' ' 19' ' ' LEU . 9.2 m -73.58 129.34 36.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.793 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.54 141.46 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.202 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 151.82 42.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.066 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -37.68 3.38 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.742 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.43 151.81 45.58 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.428 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.29 -36.69 43.6 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.87 84.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.738 0.304 . . . . 0.0 111.137 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.0 -39.77 41.21 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.501 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.2 t -58.88 -34.03 51.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.576 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -68.53 -55.84 10.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.15 32.09 11.08 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.708 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -88.23 -43.38 11.64 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.687 0.279 . . . . 0.0 110.896 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.86 -178.77 3.51 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.886 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.89 -177.33 6.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.377 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.9 156.98 38.31 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.97 27.11 71.07 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.751 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -109.53 172.75 6.67 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.631 0.215 . . . . 0.0 110.579 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -110.05 147.42 33.6 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.6 0.238 . . . . 0.0 110.814 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.7 tp -115.84 142.17 47.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.873 0.368 . . . . 0.0 111.314 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.6 -56.27 2.21 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.4 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.4 t -147.28 156.35 42.85 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.055 0.455 . . . . 0.0 111.96 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.0 121.35 43.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.524 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 60.09 35.23 21.28 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.287 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.3 26.29 73.8 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.263 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.0 mtt-85 -96.91 -178.31 4.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.988 0.394 . . . . 0.0 110.799 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -120.67 103.47 9.15 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.9 mt -108.39 29.57 7.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.175 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.8 t -111.35 100.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.207 0.527 . . . . 0.0 110.875 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.35 30.7 3.5 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.642 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.6 mt -133.47 179.43 6.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.77 0.319 . . . . 0.0 110.307 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.07 168.5 10.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.524 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -61.43 -21.58 64.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.837 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -77.75 -38.09 47.68 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.756 0.312 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -56.66 8.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.32 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.413 ' CB ' HG12 ' A' ' 34' ' ' ILE . . . -61.49 -45.58 93.63 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.616 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.55 -55.15 37.47 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.395 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.53 -36.19 64.0 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.045 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.7 mt -72.01 -39.91 68.85 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.254 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 81.9 mtp -64.61 -55.35 20.85 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.093 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -57.38 -36.28 71.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.851 0.357 . . . . 0.0 110.429 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -83.35 52.04 2.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.656 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.08 168.75 9.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.686 0.279 . . . . 0.0 111.109 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.98 -164.64 1.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.624 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.4 m -57.19 -34.99 69.05 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.3 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -95.99 150.66 4.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.61 120.58 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.268 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 5.4 m -123.58 95.99 4.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.01 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.3 mp -108.74 141.89 40.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.409 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -107.35 106.93 17.6 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.535 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 20.9 t -96.61 149.1 4.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.675 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.25 104.36 9.68 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.835 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 7.0 mttm -68.93 133.16 47.82 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.928 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -165.4 1.51 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.241 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.16 135.72 2.64 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.326 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.404 179.869 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.451 0.167 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -114.55 164.94 13.3 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.648 0.261 . . . . 0.0 110.779 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 2.4 p -121.19 124.85 45.69 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.934 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 1.2 m -82.54 -147.98 0.08 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.763 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.8 pt-20 -178.55 54.44 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.252 1.202 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.04 -178.514 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.606 0.241 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.45 69.93 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 60.74 85.04 0.19 Allowed Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.419 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.89 -179.62 4.43 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.777 2.318 . . . . 0.0 112.78 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -107.27 94.37 5.06 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.3 mt -115.86 125.33 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.767 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.63 138.04 46.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.34 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -94.49 145.77 24.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.823 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.42 HG11 ' HB3' ' A' ' 50' ' ' ARG . 28.1 m -124.08 125.56 70.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.75 111.71 23.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.76 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.1 mt -131.9 154.49 49.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -91.4 130.48 37.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.764 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.42 122.46 21.28 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.227 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.64 -40.16 5.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.83 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -160.12 43.42 0.2 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 111.214 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.42 -165.22 49.95 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.122 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.0 mtm -127.13 90.73 3.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.768 0.284 . . . . 0.0 110.684 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.77 84.32 0.02 OUTLIER Glycine 0 C--O 1.225 -0.43 0 C-N-CA 121.394 -0.431 . . . . 0.0 113.104 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -160.84 178.57 9.29 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.748 0.309 . . . . 0.0 110.942 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.3 p -131.84 153.87 49.73 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.229 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 34' ' ' ILE . 2.9 pp -132.75 157.67 43.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.985 0.422 . . . . 0.0 112.122 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.67 138.26 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.227 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -83.6 158.01 22.07 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.24 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -153.88 141.97 20.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -131.1 179.57 5.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.044 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.62 -139.83 2.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.864 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.96 142.71 36.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.587 0.232 . . . . 0.0 110.612 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.96 36.32 92.02 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.691 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -121.91 101.16 7.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 111.013 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.26 19.29 5.21 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.248 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.26 -171.51 3.13 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.4 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.12 143.55 44.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.108 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.33 117.95 4.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.454 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.471 HG22 HD11 ' A' ' 21' ' ' ILE . 2.0 mp -93.45 87.69 2.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.177 0.513 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -80.61 172.53 13.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.626 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.4 t -103.39 148.15 8.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.644 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.0 -37.23 2.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.709 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 m -153.24 130.93 11.55 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.771 0.32 . . . . 0.0 111.205 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.4 106.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.201 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 t -68.32 135.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.374 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.14 147.56 49.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.966 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.58 -14.61 63.02 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.226 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -73.27 -155.07 3.08 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.677 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.56 -41.82 10.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.668 0.27 . . . . 0.0 111.487 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.26 -33.41 69.77 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.065 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -71.31 -38.45 71.73 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.0 t -66.31 -54.19 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 111.566 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -63.66 -50.6 68.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.136 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.7 68.43 1.23 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.212 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' HB3' HG11 ' A' ' 9' ' ' VAL . 21.6 mmt85 -145.06 33.68 1.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.821 0.343 . . . . 0.0 110.648 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mt -152.48 176.08 12.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.213 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.32 142.56 4.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.096 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.96 124.0 19.97 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.942 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.82 29.33 6.22 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.405 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -115.81 159.81 20.98 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.521 0.201 . . . . 0.0 110.805 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -96.47 154.8 17.07 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.047 0.451 . . . . 0.0 112.046 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.11 100.23 6.47 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.355 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.45 -59.73 2.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.247 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -139.44 159.04 43.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.433 HG22 ' HG2' ' A' ' 77' ' ' MET . 38.9 t -132.89 124.55 50.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.988 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.1 t70 56.42 31.36 18.65 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.031 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.96 35.44 58.96 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.804 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -101.99 14.2 32.63 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.74 87.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.38 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 73' ' ' ALA . 5.5 mt -111.82 61.87 0.62 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.302 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -130.22 98.52 3.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.109 0.48 . . . . 0.0 110.977 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.79 -25.71 4.39 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.747 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.5 mt -66.44 174.76 2.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.15 0.5 . . . . 0.0 111.334 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.0 m -88.73 162.72 16.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.989 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -52.66 -28.48 21.77 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.555 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -77.66 -54.52 6.28 Favored 'General case' 0 C--N 1.335 -0.054 0 CA-C-O 120.575 0.226 . . . . 0.0 111.057 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -56.94 -34.68 68.24 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.29 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.406 ' CB ' HG12 ' A' ' 34' ' ' ILE . . . -70.89 -59.62 2.69 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.366 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.57 -48.34 77.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.26 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -57.08 -44.72 83.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.87 -37.62 82.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.621 0.248 . . . . 0.0 111.033 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.433 ' HG2' HG22 ' A' ' 60' ' ' VAL . 56.6 mtp -61.95 -56.52 18.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.437 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.6 t -61.12 -38.13 85.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.769 0.319 . . . . 0.0 110.506 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -85.5 53.07 2.63 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.454 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.51 179.5 4.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.735 0.302 . . . . 0.0 111.1 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.53 -165.59 1.34 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.749 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.3 m -55.75 -47.51 76.85 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.28 143.74 10.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.881 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.1 t -136.65 111.05 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.054 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.57 83.76 1.91 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.541 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.62 137.48 32.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.426 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 8.4 mt-10 -103.13 140.33 37.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.677 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.8 p -128.7 138.16 55.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.366 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -109.53 116.65 32.18 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.711 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.3 120.38 10.29 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.136 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.15 -172.41 2.02 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.133 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.29 3.02 86.1 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.8 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.215 179.491 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.1 tp . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.989 0.424 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -141.56 -170.65 3.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.382 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 2.4 p -132.29 110.91 10.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.755 0.312 . . . . 0.0 111.44 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 17.4 p -98.18 -164.57 1.15 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.495 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.76 94.04 2.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.326 0.584 . . . . 0.0 110.737 178.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.252 1.232 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.038 -179.776 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.544 0.211 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.37 80.33 0.23 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -88.22 118.75 69.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.48 -179.0 2.49 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.678 2.252 . . . . 0.0 112.521 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.67 94.83 4.31 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.06 0.457 . . . . 0.0 110.813 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -91.2 135.38 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.814 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 87' ' ' GLU . 1.5 pp -142.27 138.26 29.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.259 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.2 m -104.08 98.54 8.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.2 m -89.17 169.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.44 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -125.18 109.22 12.6 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.755 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 mt -109.52 155.26 21.59 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.768 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -107.52 118.82 37.74 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.725 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -62.45 100.73 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.86 87.48 3.31 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.727 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.12 39.58 28.93 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.208 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.93 153.87 30.53 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.171 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 7.5 mtm -80.28 -79.92 0.14 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.648 0.224 . . . . 0.0 111.038 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.75 -0.74 27.45 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.149 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.86 173.8 12.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 117.071 0.436 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' B' ' 102' ' ' THR . 57.9 m -127.12 151.62 48.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.74 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.422 HD12 ' CG2' ' A' ' 34' ' ' ILE . 2.2 pp -139.75 150.83 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.554 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 37' ' ' LYS . 85.7 t -126.15 145.67 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.274 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -107.2 119.9 40.66 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.748 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.9 151.47 44.29 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.414 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.71 -179.74 3.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.63 -139.68 2.73 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.35 143.89 38.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.628 0.251 . . . . 0.0 110.801 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.37 41.59 99.56 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.652 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 107.26 7.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.719 0.295 . . . . 0.0 110.973 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.438 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 24.5 t0 -91.93 20.51 5.68 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.316 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.438 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -141.19 -167.87 2.49 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.307 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 tp -136.61 126.2 25.32 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 110.801 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.36 130.39 10.1 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.946 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.422 ' CG2' HD12 ' A' ' 21' ' ' ILE . 21.3 mm -95.19 71.13 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.073 0.463 . . . . 0.0 110.835 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.429 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 94.4 m-85 -62.16 160.51 12.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.2 t -96.25 121.22 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.731 0.3 . . . . 0.0 111.277 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.462 ' HB2' ' CG2' ' A' ' 22' ' ' VAL . 6.3 tttp -80.19 -43.66 21.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.042 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.8 p -156.41 178.23 10.55 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.94 123.05 12.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.673 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.1 p -50.4 132.03 10.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.66 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.84 92.78 8.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.01 -21.64 2.64 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.148 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.64 -167.83 7.26 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.066 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.52 -1.32 53.45 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.45 -43.14 8.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.749 0.309 . . . . 0.0 111.013 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -72.69 -44.97 61.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.524 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.4 t -64.86 -39.53 85.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.541 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.46 -47.92 62.43 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.927 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.22 44.52 6.22 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.665 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 -102.56 -38.63 7.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.547 0.213 . . . . 0.0 110.965 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.79 158.85 35.49 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.894 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.29 -174.95 4.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.193 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.54 138.94 43.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 39.42 9.98 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.875 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -116.16 138.19 51.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.514 0.197 . . . . 0.0 110.742 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.429 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -81.11 147.75 29.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.059 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 2.1 tp -101.02 154.36 18.77 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 111.563 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tt -140.54 -57.53 0.53 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.032 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.53 156.72 48.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.254 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.3 t -141.49 123.43 13.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.827 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.57 33.05 22.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.313 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.44 27.93 71.94 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.042 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -115.07 165.38 12.96 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.827 0.314 . . . . 0.0 110.825 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.43 106.99 17.66 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.99 33.22 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.89 98.86 4.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.24 0.543 . . . . 0.0 110.695 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.34 28.81 3.92 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.64 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 17.0 mt -110.42 158.44 18.47 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.764 0.316 . . . . 0.0 110.737 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.67 153.01 42.88 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.391 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -52.01 -34.55 43.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.76 -48.53 71.52 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.313 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -63.51 -44.31 94.65 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.609 0.242 . . . . 0.0 111.335 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.417 ' CB ' HG13 ' A' ' 34' ' ' ILE . . . -59.67 -56.24 24.4 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.71 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.93 -45.97 89.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.075 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -57.79 -26.3 61.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.547 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.3 mt -74.63 -47.87 29.63 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.444 ' HB2' HG21 ' B' ' 104' ' ' VAL . 4.6 mtp -60.43 -48.06 83.38 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.355 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -61.12 -36.12 78.87 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.83 0.348 . . . . 0.0 110.304 179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.98 52.57 2.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.843 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.9 p -118.01 176.48 5.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 111.072 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -92.54 -163.86 1.1 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.517 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.03 -34.03 58.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.945 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.59 140.8 22.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.904 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.0 t -136.76 118.2 18.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.137 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.63 100.54 12.1 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 mp -100.77 116.99 33.95 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.204 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 28.8 tt0 -101.4 101.52 12.16 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.547 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.02 171.32 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.625 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.31 135.94 53.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.096 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -93.98 117.04 29.55 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.457 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -160.72 167.04 27.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.52 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 150.37 -119.74 1.05 Allowed Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.406 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.69 179.911 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.4 -176.46 3.75 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.579 0.228 . . . . 0.0 111.443 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 60.2 p -168.95 146.72 3.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.814 0.34 . . . . 0.0 111.843 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 20' ' ' SER . 19.7 m -157.9 158.68 35.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.593 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -135.0 88.38 2.42 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 110.144 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 77' ' ' MET . 8.0 p . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.707 -0.664 . . . . 0.0 112.005 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 120.711 0.291 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -102.99 95.09 5.91 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.626 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -107.64 128.97 24.87 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 34.0 Cg_exo -58.97 175.27 0.65 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.812 2.341 . . . . 0.0 112.719 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.24 97.37 3.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.256 0.551 . . . . 0.0 110.842 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 58' ' ' LEU . 4.6 mp -80.03 122.33 35.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.176 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.14 138.76 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.337 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -100.37 126.58 46.75 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.38 131.22 67.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 m -105.31 123.39 47.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.917 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mt -140.72 160.18 40.6 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.118 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 mtmm -101.23 163.76 12.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -90.96 98.42 11.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -74.86 -53.14 9.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.2 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -166.46 45.28 0.06 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.347 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.75 150.38 14.31 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.226 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -60.08 3.31 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.688 0.244 . . . . 0.0 110.479 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.93 72.23 1.03 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.324 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 pp -161.14 178.02 9.7 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.446 0.165 . . . . 0.0 110.698 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -127.54 141.48 51.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.669 0.271 . . . . 0.0 111.615 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.406 HG23 ' HE3' ' A' ' 77' ' ' MET . 2.3 pp -132.59 159.91 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.409 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.44 HG23 ' HA ' ' B' ' 101' ' ' SER . 61.8 t -146.64 148.05 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.356 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -104.35 147.88 27.02 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.056 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.77 149.8 30.21 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.83 0.347 . . . . 0.0 111.762 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -121.79 -179.9 4.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.81 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.2 -144.01 3.82 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.978 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.14 145.15 37.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.603 0.24 . . . . 0.0 110.748 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.81 30.6 63.14 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.587 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.74 108.83 4.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.682 0.277 . . . . 0.0 110.67 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -93.96 27.56 2.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.384 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.471 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -116.04 -165.48 1.05 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.421 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.4 tp -144.57 136.87 26.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.632 0.253 . . . . 0.0 111.119 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.35 116.68 5.62 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.625 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.428 HG12 ' CB ' ' A' ' 73' ' ' ALA . 2.1 mp -85.48 81.54 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.368 0.604 . . . . 0.0 110.496 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 56' ' ' GLN . 93.4 m-85 -79.8 145.59 32.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.106 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.9 t -83.47 123.3 38.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.901 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.425 ' HB2' HG22 ' A' ' 22' ' ' VAL . 10.3 tptt -82.38 -43.21 17.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.846 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 t -169.01 -179.92 3.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.2 t -132.78 129.94 58.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.706 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.36 129.75 36.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.016 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.8 136.8 58.11 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.62 -26.67 17.27 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.7 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.74 158.73 46.69 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.784 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.3 -39.3 72.5 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.02 -39.62 63.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.196 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -60.35 -38.96 85.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 36.7 t -73.35 -38.76 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.335 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.46 -43.26 93.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.319 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.78 36.48 57.9 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.946 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.3 mtt-85 -98.93 -45.9 5.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.781 0.29 . . . . 0.0 110.889 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.4 pp -101.84 171.46 7.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.783 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.75 -173.13 3.8 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.281 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.42 157.75 23.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.47 30.46 71.17 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.696 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.67 -177.02 3.25 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.562 0.22 . . . . 0.0 110.792 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 65.8 tt0 -125.85 152.74 45.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.945 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -112.16 142.84 44.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.126 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.422 ' CD1' HG12 ' A' ' 6' ' ' ILE . 0.4 OUTLIER -115.17 -54.65 2.54 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.351 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.3 p -140.12 154.36 46.98 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.086 0.47 . . . . 0.0 111.95 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.409 HG21 ' CG ' ' A' ' 77' ' ' MET . 59.6 t -132.09 112.84 20.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.518 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.09 35.48 26.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.997 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.07 31.98 45.86 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.041 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -128.9 149.3 50.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.815 0.307 . . . . 0.0 110.655 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t -92.27 132.62 36.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.169 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.83 -28.9 9.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.494 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.07 99.24 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.188 0.518 . . . . 0.0 111.017 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 142.87 -35.39 1.7 Allowed Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.882 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.41 HD11 ' CB ' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -88.11 166.49 14.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.1 t -72.5 161.07 31.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.757 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.45 ' OE1' ' HB3' ' B' ' 100' ' ' PHE . 3.4 tt0 -53.46 -44.2 68.72 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.067 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -61.4 -39.61 91.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.704 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.37 -35.86 73.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.866 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.428 ' CB ' HG12 ' A' ' 34' ' ' ILE . . . -72.04 -61.01 1.94 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.383 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.23 -39.76 67.06 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.313 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -62.55 -50.11 72.62 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.843 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.83 -32.17 65.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.217 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.409 ' CG ' HG21 ' A' ' 60' ' ' VAL . 22.4 mtp -71.22 -58.83 3.17 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.565 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.8 t -59.36 -33.98 71.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.811 0.338 . . . . 0.0 110.709 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 66.4 mtp85 -86.43 51.98 2.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.516 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 p -110.09 -178.99 3.66 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.678 0.275 . . . . 0.0 110.95 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.16 -174.03 4.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.83 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.5 p -52.33 -44.11 64.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.22 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.73 140.38 16.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.844 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.28 121.27 65.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.072 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.23 80.87 1.41 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.785 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.31 121.8 32.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.938 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 24.9 tt0 -104.19 103.8 13.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.5 m -102.32 170.86 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.116 0.484 . . . . 0.0 111.64 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.8 98.11 6.65 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.993 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.89 126.67 28.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -148.86 170.42 18.31 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.327 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.39 -7.01 80.21 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.657 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.211 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.679 -179.76 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.45 ' HB3' ' OE1' ' A' ' 70' ' ' GLN . 52.1 m-85 -103.56 117.76 35.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.082 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.44 ' HA ' HG23 ' A' ' 22' ' ' VAL . 27.2 t -175.68 119.33 0.17 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.791 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 31.6 m -122.24 159.02 28.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.351 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -121.92 88.4 2.93 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.117 0.484 . . . . 0.0 110.319 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.071 -0.966 . . . . 0.0 111.688 -179.374 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 79.77 0.86 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.905 0.383 . . . . 0.0 110.676 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -135.42 146.11 56.42 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.9 -178.26 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.942 2.428 . . . . 0.0 112.91 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 8.6 tt0 -129.27 97.2 4.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.091 0.472 . . . . 0.0 110.922 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.76 125.84 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.629 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pt -141.65 142.79 28.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.262 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -99.77 116.62 32.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.887 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.2 146.54 16.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 m -119.95 127.7 52.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.833 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mt -133.38 166.1 23.3 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.407 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -109.83 176.7 4.97 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 mtpt -106.28 92.25 4.05 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.846 0.355 . . . . 0.0 111.361 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -45.41 38.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.439 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -167.05 45.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.209 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.92 145.34 15.32 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.152 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -41.3 98.56 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.643 0.222 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.77 68.3 1.74 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.051 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.46 HD13 HG12 ' A' ' 36' ' ' VAL . 2.3 pp -160.75 168.38 24.91 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.553 0.216 . . . . 0.0 111.017 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' B' ' 103' ' ' GLU . 7.5 m -116.16 153.36 31.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.122 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 pp -124.17 165.52 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.707 0.289 . . . . 0.0 111.682 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 37' ' ' LYS . 25.7 t -151.42 140.81 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.465 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.84 158.59 18.69 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -155.22 132.83 11.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.927 0.394 . . . . 0.0 111.64 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -128.9 179.85 5.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.761 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.72 -140.04 3.02 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.73 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.07 147.79 28.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.629 0.252 . . . . 0.0 110.634 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.25 36.54 92.59 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.693 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.53 106.37 7.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.64 0.257 . . . . 0.0 110.776 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -90.16 20.79 4.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.516 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.4 mmtp -144.33 -169.16 3.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.822 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -138.39 131.06 29.32 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.782 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.69 151.05 21.53 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.924 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.402 HG13 ' HB1' ' A' ' 73' ' ' ALA . 23.8 mm -106.39 110.3 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.726 0.298 . . . . 0.0 111.215 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 56' ' ' GLN . 6.4 m-85 -103.5 174.1 6.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.207 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.46 HG12 HD13 ' A' ' 19' ' ' LEU . 47.0 t -111.85 112.11 39.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.008 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.487 ' HB2' HG22 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -60.29 -49.64 76.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.592 179.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.4 p -176.61 131.4 0.2 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.0 t -82.74 127.29 39.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.427 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.8 t -80.06 127.6 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.09 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 128.45 36.38 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.74 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.56 -19.86 11.3 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.967 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.12 -162.27 5.79 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.667 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.06 -34.6 14.33 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.49 -33.8 54.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -67.96 -47.62 68.12 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.61 -42.18 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.558 0.218 . . . . 0.0 111.336 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.21 -35.67 79.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.148 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.38 45.09 88.55 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.902 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.76 -34.2 10.99 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.577 0.227 . . . . 0.0 110.954 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.7 147.61 50.13 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.006 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.57 -168.59 1.35 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.36 146.81 44.9 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.351 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.45 47.13 23.15 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.245 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.49 129.99 56.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.478 0.18 . . . . 0.0 110.782 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 35' ' ' TYR . 2.1 tm0? -80.62 145.53 31.65 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.02 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 mt -117.04 120.92 39.85 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.765 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.41 -58.33 2.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.9 p -130.76 163.92 26.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.44 HG21 ' CG ' ' A' ' 77' ' ' MET . 24.9 t -139.73 114.99 7.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.12 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.34 24.28 12.81 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.508 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.18 28.96 26.58 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.77 160.5 27.17 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 110.636 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -101.96 114.54 28.73 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.3 mt -114.63 31.91 6.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.015 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.2 t -114.26 100.85 11.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.143 0.497 . . . . 0.0 110.667 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.08 -35.45 1.47 Allowed Glycine 0 CA--C 1.517 0.207 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.627 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.9 168.64 13.22 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 110.459 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 t -64.71 157.57 27.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.181 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -52.24 -31.08 30.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.928 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.26 -52.23 65.25 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.954 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -43.19 94.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.045 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -67.45 -61.47 1.89 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.679 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.406 ' O ' HG21 ' B' ' 104' ' ' VAL . . . -55.74 -36.12 66.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.631 0.253 . . . . 0.0 111.378 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.72 -34.6 62.61 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.411 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.2 mt -68.9 -44.15 73.77 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.482 0.182 . . . . 0.0 110.968 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.44 ' CG ' HG21 ' A' ' 60' ' ' VAL . 36.2 mtp -59.75 -52.46 65.39 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.563 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.44 ' HB ' HG22 ' B' ' 104' ' ' VAL . 3.6 t -62.35 -36.75 83.21 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.665 0.269 . . . . 0.0 110.764 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -87.73 53.94 2.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.632 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.2 p -108.76 176.2 5.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 111.005 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.59 -174.55 1.75 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.429 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 m -52.27 -34.26 45.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.628 0.252 . . . . 0.0 111.125 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.71 151.4 9.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.92 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.8 t -137.65 118.37 16.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 24.0 m -104.58 94.34 5.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.843 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.4 mp -98.95 138.42 36.09 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.411 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 48.5 tt0 -114.89 99.74 7.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.714 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.1 m -101.98 173.83 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.041 0.448 . . . . 0.0 111.746 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.87 123.34 39.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.126 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 1.7 mptm? -79.42 96.46 6.05 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.607 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -135.19 -173.89 3.46 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.927 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.42 140.39 4.36 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.536 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.514 -179.868 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.66 0.267 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -112.98 164.24 13.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 4.4 t 64.21 86.17 0.13 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -137.38 17.44 2.94 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.907 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER 59.66 174.87 0.08 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.226 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.44 HG22 ' HB ' ' A' ' 78' ' ' THR . 8.0 p . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.401 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.868 0.366 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.7 mtmp? -66.8 168.37 9.75 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.657 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.82 86.95 11.59 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.942 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 26.9 Cg_exo -63.11 179.52 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.768 2.312 . . . . 0.0 112.59 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -127.61 94.3 3.93 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.773 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mt -84.06 113.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.85 141.01 45.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 27.5 m -104.87 141.33 36.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -119.59 127.93 75.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.283 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 m -99.42 103.54 15.33 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.671 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -143.9 149.01 36.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.359 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.18 167.78 14.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.208 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.66 124.89 28.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.62 85.48 2.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.38 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 m120 58.38 34.56 24.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.946 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.11 158.0 31.0 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.669 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.49 -48.57 16.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.534 0.207 . . . . 0.0 110.634 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.48 74.96 0.55 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.555 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 2.8 pp -160.74 173.82 14.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.556 0.217 . . . . 0.0 110.776 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -124.35 149.58 46.46 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.804 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.423 HD13 ' NE2' ' A' ' 70' ' ' GLN . 8.6 pt -137.71 154.48 29.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.8 t -147.12 134.97 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.251 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.96 144.43 26.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.952 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.41 159.44 35.76 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.837 0.351 . . . . 0.0 111.783 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.45 179.31 4.63 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.052 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.88 -144.06 3.85 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.888 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.07 150.31 28.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.645 0.26 . . . . 0.0 110.865 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.79 28.82 60.84 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.586 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.78 107.98 4.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.651 0.262 . . . . 0.0 110.455 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -97.57 37.42 1.37 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -133.52 -164.62 1.51 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.477 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tp -147.53 125.76 12.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.68 0.276 . . . . 0.0 110.772 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.76 137.57 13.34 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.607 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.414 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 18.8 mm -86.6 72.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.107 0.48 . . . . 0.0 110.736 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -60.23 160.18 8.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.348 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 t -100.96 115.09 41.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.964 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.4 -46.78 78.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.791 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.94 124.87 0.09 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.902 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.5 m -72.67 142.51 15.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.089 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.91 137.67 21.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.38 153.25 27.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.213 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.05 14.94 76.32 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.884 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -92.18 159.39 25.3 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.296 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.23 69.42 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.3 -34.41 25.72 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.291 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.11 -47.09 69.12 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.309 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.2 t -63.81 -46.53 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.4 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -43.95 97.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.168 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.47 64.96 1.77 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.839 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -136.78 23.47 3.1 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.632 0.253 . . . . 0.0 111.374 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -179.83 177.97 0.65 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.755 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.77 -170.05 2.07 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.187 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.44 160.23 32.67 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.914 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 91' ' ' GLN . . . 64.91 31.24 80.26 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.244 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.8 124.69 45.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.59 0.234 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.413 ' HB3' ' CB ' ' A' ' 89' ' ' ALA . 8.7 tm0? -79.47 117.57 20.55 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.057 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -88.75 136.09 33.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.198 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.54 -63.01 1.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.837 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.8 m -127.91 145.49 50.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.196 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.2 t -120.87 118.19 55.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.667 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 60.56 32.01 20.34 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.105 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.73 -6.28 70.66 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.273 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -80.53 154.62 27.41 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 117.186 0.493 . . . . 0.0 111.057 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.35 101.09 12.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.42 44.2 1.28 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.688 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.3 t -101.8 99.97 9.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.719 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.83 -29.25 5.66 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.759 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 65.7 mt -65.36 168.59 6.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 111.241 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.0 t -87.22 168.16 13.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.449 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.423 ' NE2' HD13 ' A' ' 21' ' ' ILE . 5.9 tp60 -58.24 -29.44 65.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.003 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.47 -56.01 27.39 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.786 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -63.21 -45.99 89.11 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.693 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.07 -58.39 8.87 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.972 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -49.07 -48.56 44.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.712 0.291 . . . . 0.0 111.387 179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -61.76 2.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.739 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.8 mt -56.22 -30.53 62.44 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 4.3 mmm -66.01 -64.15 0.92 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.8 -0.182 . . . . 0.0 111.175 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.4 t -62.4 -35.82 80.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.775 0.322 . . . . 0.0 110.729 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -85.33 49.4 1.75 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.333 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.89 169.56 10.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.717 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.14 -169.34 0.93 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.822 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.63 -54.55 21.98 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.697 0.284 . . . . 0.0 110.86 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.73 147.16 5.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.692 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.3 t -121.78 111.63 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.987 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.14 105.85 14.7 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.781 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.4 mp -115.2 131.13 57.03 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.942 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 2.3 mt-10 -102.16 95.55 6.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.3 m -89.66 172.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.256 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.413 ' CB ' ' HB3' ' A' ' 56' ' ' GLN . . . -130.48 118.77 21.62 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.52 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 106.78 0.27 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.643 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 1.0 OUTLIER -70.47 -178.87 1.88 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.187 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.97 145.21 5.61 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.368 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.183 179.736 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.0 mt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.693 0.282 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -171.41 36.52 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.42 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 53.9 p -162.94 78.02 0.45 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.986 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.416 ' HB ' ' CG1' ' A' ' 21' ' ' ILE . 0.7 OUTLIER -96.58 -152.51 0.38 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.73 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -176.34 48.28 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . . . . . . . . . 26.0 m . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.165 -178.701 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -75.29 158.84 32.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -118.92 104.53 46.58 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.206 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.62 -170.2 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.808 2.339 . . . . 0.0 112.556 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -132.71 102.58 5.73 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.984 0.421 . . . . 0.0 111.234 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.63 131.14 43.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.881 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.0 pt -150.74 154.89 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.198 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 m -122.49 132.25 54.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.882 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.6 t -115.78 136.8 51.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.183 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -101.68 112.14 24.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.656 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 mt -134.74 168.67 18.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.236 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.1 157.28 19.53 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -86.33 69.75 10.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -43.79 -41.27 4.88 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.701 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -172.77 44.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.294 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.46 152.23 25.17 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.178 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.4 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -74.91 -51.42 13.84 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.571 0.224 . . . . 0.0 110.821 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.06 80.77 0.12 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.083 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -160.92 -179.76 7.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.619 0.247 . . . . 0.0 110.88 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.3 m -125.28 141.69 51.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.067 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.419 HD12 ' NE2' ' A' ' 70' ' ' GLN . 2.4 pp -136.26 157.47 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.832 0.348 . . . . 0.0 111.796 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -145.32 148.59 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.235 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.09 131.97 46.76 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.235 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.86 146.89 38.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.493 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -122.83 -179.73 4.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.957 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.39 -140.57 2.91 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.751 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.3 147.27 32.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.586 0.231 . . . . 0.0 110.779 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.78 40.89 97.25 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.614 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.53 106.24 7.33 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.715 0.293 . . . . 0.0 110.907 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -90.68 24.43 2.69 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.003 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -144.35 -165.83 2.23 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.647 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tp -138.67 135.1 34.48 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.798 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.36 127.42 8.78 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.709 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 57' ' ' LEU . 1.9 mp -95.91 94.72 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 121.129 0.49 . . . . 0.0 110.562 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -78.59 168.56 19.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.375 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.2 t -101.48 133.9 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.134 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -97.53 -40.61 8.56 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.9 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.2 m -160.4 174.29 14.35 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.93 123.47 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.795 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.8 t -79.87 153.19 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.261 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -72.01 153.37 41.81 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.154 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.89 8.92 87.54 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.366 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 17' ' ' MET . . . -96.16 156.48 21.3 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.377 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.59 -43.35 68.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.622 0.249 . . . . 0.0 111.5 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.38 -34.66 74.87 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.242 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.65 -46.1 48.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.339 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.0 t -61.11 -49.34 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.164 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.69 -44.82 89.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.163 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.95 28.55 66.53 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.081 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.84 -47.52 16.46 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.805 0.303 . . . . 0.0 110.894 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -109.73 170.42 8.08 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.96 177.76 7.58 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.169 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.92 141.72 53.05 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.43 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.48 43.57 4.86 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.675 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -128.22 146.03 50.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.686 0.279 . . . . 0.0 110.887 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -83.5 152.55 24.86 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.676 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 7.0 mp -115.0 148.51 38.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.942 0.401 . . . . 0.0 111.72 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.78 -55.17 2.01 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.782 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.7 p -137.58 152.13 49.09 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.9 0.381 . . . . 0.0 111.778 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.4 t -143.38 107.52 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.962 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t0 61.14 41.86 13.07 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.161 0.505 . . . . 0.0 110.823 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.99 37.5 38.14 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.058 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.47 162.0 21.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.766 0.283 . . . . 0.0 110.689 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.22 83.66 1.87 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.591 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.7 mt -60.8 -22.68 64.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.298 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.1 t -78.21 97.83 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.186 0.517 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.71 32.95 1.04 Allowed Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.288 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.435 HD12 ' HB1' ' A' ' 73' ' ' ALA . 1.2 pp -150.16 165.34 33.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 110.57 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.0 p -79.63 161.79 25.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.946 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.419 ' NE2' HD12 ' A' ' 21' ' ' ILE . 2.8 tt0 -56.55 -32.3 65.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.325 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.84 -34.48 64.56 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.491 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -76.23 -33.22 59.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.978 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' A' ' 68' ' ' LEU . . . -76.28 -58.64 3.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.334 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -56.55 -42.88 79.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.537 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.77 -39.85 93.1 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-O 120.698 0.285 . . . . 0.0 110.812 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.18 -32.2 68.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.291 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 28.1 mtp -72.24 -53.56 12.18 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.608 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 t -60.7 -38.7 85.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.751 0.31 . . . . 0.0 110.795 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.6 mtp85 -87.87 55.94 3.68 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.644 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.4 p -106.52 178.5 4.54 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.895 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.1 p -88.1 -169.69 2.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.697 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.14 -54.77 43.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.631 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 84' ' ' VAL . 35.7 t -84.58 139.27 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 10' ' ' THR . 16.8 t -129.7 151.62 36.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.465 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.11 83.27 2.01 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.781 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.71 122.18 32.57 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.098 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.07 97.46 7.43 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.675 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.3 m -93.07 173.96 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.332 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.87 101.98 6.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.018 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.88 103.62 0.11 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.75 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.79 -167.48 1.44 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.886 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.47 134.73 2.08 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.487 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.316 -0.849 . . . . 0.0 110.988 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.639 0.257 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.7 -167.61 2.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.68 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 67.1 p -113.27 130.33 56.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.762 0.315 . . . . 0.0 111.284 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.418 ' HB ' ' CD1' ' A' ' 21' ' ' ILE . 51.8 m -124.4 159.45 30.4 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.601 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -124.78 79.75 1.8 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.002 0.43 . . . . 0.0 110.358 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.677 -0.678 . . . . 0.0 111.668 -179.446 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ptm . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.648 0.261 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -81.3 93.31 6.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.823 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.7 tt0 -73.91 117.22 59.46 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.058 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 27.7 Cg_exo -63.49 -165.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.997 2.465 . . . . 0.0 112.859 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -113.56 95.79 5.53 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.065 0.459 . . . . 0.0 111.047 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 mm -99.13 127.33 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.814 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -144.34 148.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.3 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -115.22 120.65 40.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.85 153.34 3.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.144 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.04 106.99 10.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.6 mt -138.37 169.08 18.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.141 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -104.77 175.75 5.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -87.15 135.25 33.37 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.17 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.37 84.96 2.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.327 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.45 36.75 28.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.729 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.98 144.23 16.33 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.107 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 5.9 mtm -64.84 -46.84 80.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.553 0.216 . . . . 0.0 110.69 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.53 83.66 0.07 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.944 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 2.8 pp -160.52 -179.4 7.62 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.65 0.262 . . . . 0.0 110.725 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' B' ' 102' ' ' THR . 46.4 m -131.58 142.63 49.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.309 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' B' ' 101' ' ' SER . 2.7 pp -137.68 139.83 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.405 HG22 ' HB2' ' A' ' 37' ' ' LYS . 29.7 t -129.71 132.68 65.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.13 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.09 127.5 43.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.844 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.2 147.05 52.4 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.351 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -119.76 -179.76 4.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.037 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.89 -139.85 2.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.14 143.67 38.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.588 0.233 . . . . 0.0 110.741 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.33 44.75 97.21 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.568 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 108.15 6.91 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.639 0.257 . . . . 0.0 110.916 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -92.61 20.02 6.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.363 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -140.28 -166.09 2.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.458 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 tp -136.43 152.02 50.14 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.672 0.272 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.13 111.37 2.83 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.703 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -81.43 73.0 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.215 0.531 . . . . 0.0 110.503 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -67.5 155.28 39.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.339 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.62 121.55 44.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.259 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.405 ' HB2' HG22 ' A' ' 22' ' ' VAL . 10.2 tptt -85.28 -36.15 21.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.971 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 t -170.24 175.32 4.96 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 111.23 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.6 t -138.45 118.15 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.2 t -68.55 125.88 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.019 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 153.16 37.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.472 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.01 -29.92 11.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.773 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -74.25 154.8 48.22 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.57 58.54 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -58.11 -51.36 70.03 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.26 -34.31 55.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.317 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.1 t -62.85 -34.22 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.706 0.289 . . . . 0.0 110.698 179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -71.56 -43.35 66.49 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.048 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.68 40.8 5.55 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.811 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -131.05 31.93 4.37 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.677 0.275 . . . . 0.0 110.997 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mt -150.63 160.3 43.91 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.295 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.02 143.4 3.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.097 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.83 132.86 53.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.836 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.81 29.45 6.18 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.483 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.08 -177.48 3.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.46 0.172 . . . . 0.0 110.714 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -127.57 150.77 49.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.823 0.344 . . . . 0.0 111.375 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.21 150.07 29.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.959 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.84 -57.58 1.43 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.093 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 p -139.12 153.44 47.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.461 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.2 t -137.94 129.04 38.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.624 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 57.56 34.25 24.32 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.789 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.76 21.91 76.67 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.95 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.38 157.08 18.25 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 111.06 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -101.36 98.88 9.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.614 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.95 28.84 7.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.788 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.2 t -87.36 100.95 10.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.217 0.532 . . . . 0.0 110.462 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.46 31.74 2.3 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.536 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 mt -119.93 155.57 32.49 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.723 0.297 . . . . 0.0 110.726 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 87.2 p -68.01 157.39 35.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.162 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -52.08 -40.31 61.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.049 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -58.45 -53.72 55.18 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.858 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -61.24 -39.07 88.93 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.894 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.07 -62.86 1.38 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.38 -61.25 2.72 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.56 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -40.85 -44.9 2.38 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.511 0.507 . . . . 0.0 111.881 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.8 mt -58.07 -42.19 84.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.779 0.323 . . . . 0.0 110.797 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 3.7 mtp -80.8 -28.67 36.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.384 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -31.54 72.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.66 0.267 . . . . 0.0 110.699 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -101.18 42.82 1.09 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.315 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.8 p -85.38 168.49 14.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.835 0.35 . . . . 0.0 111.196 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.0 p -91.91 -165.73 1.41 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.732 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 p -51.59 -52.34 48.21 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.083 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.45 141.86 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.219 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -128.63 110.97 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.858 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.22 97.58 8.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.919 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.18 136.36 44.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.403 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 33.5 tt0 -106.63 107.32 18.27 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.385 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 p -107.64 151.83 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.615 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.88 98.74 9.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 109.07 3.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.45 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.22 163.09 25.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.024 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.97 -6.83 88.6 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.814 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.988 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.991 179.997 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 11.3 tp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.668 0.27 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -159.8 152.3 21.15 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.468 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 85.6 p -127.03 113.1 16.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.771 0.319 . . . . 0.0 111.143 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 20' ' ' SER . 23.7 p -91.54 -166.99 1.68 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.344 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -146.81 112.11 5.51 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.875 0.369 . . . . 0.0 110.932 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.8 179.849 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 16.9 tt0 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.174 0.512 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.89 133.65 32.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.65 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pt -148.08 147.23 17.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.172 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -111.91 124.86 53.28 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 m -101.19 135.9 35.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.431 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 m -103.16 97.54 7.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.571 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 mt -122.19 163.33 19.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.896 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -108.71 141.3 40.9 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.871 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -77.87 111.01 13.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.08 -42.61 17.22 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -168.41 37.42 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.08 174.51 18.65 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.09 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.484 ' HB3' HD23 ' A' ' 19' ' ' LEU . 28.7 mtm -103.69 -46.94 4.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.714 0.257 . . . . 0.0 111.341 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.24 81.62 0.12 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.809 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' A' ' 17' ' ' MET . 2.8 pp -160.52 179.54 8.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.709 0.29 . . . . 0.0 110.868 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -132.81 146.59 51.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.718 0.294 . . . . 0.0 111.353 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.823 HD11 HG22 ' B' ' 102' ' ' THR . 2.7 pp -142.34 153.43 18.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.819 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' A' ' 37' ' ' LYS . 42.1 t -135.84 136.4 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.425 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -85.69 130.74 34.48 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.073 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.757 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -135.36 142.6 45.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.425 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -122.0 -179.6 4.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.924 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.03 -141.34 3.1 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.85 143.32 33.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.659 0.266 . . . . 0.0 110.675 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.79 34.02 88.56 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.697 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.75 105.03 7.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.686 0.279 . . . . 0.0 110.817 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.11 19.96 6.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.355 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.467 ' HG3' HG12 ' A' ' 66' ' ' VAL . 1.2 mmtp -138.48 -168.75 2.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.749 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 32' ' ' LEU . 6.7 tp -141.64 130.94 23.56 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.719 0.295 . . . . 0.0 110.927 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.51 136.25 12.71 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.741 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.5 HG13 ' HB1' ' A' ' 73' ' ' ALA . 24.5 mm -90.62 83.76 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.69 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.757 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 79.9 m-85 -74.14 162.18 29.23 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.359 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.41 134.86 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.264 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HB2' HG23 ' A' ' 22' ' ' VAL . 2.7 ttpt -105.53 -37.89 6.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 7.0 t -166.05 172.42 11.42 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.691 0.281 . . . . 0.0 110.957 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.0 t -130.89 126.71 60.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.763 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.3 145.17 10.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.009 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -68.14 150.22 48.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.323 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.34 20.23 73.2 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.917 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -93.11 157.58 23.41 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.388 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.77 62.03 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.25 -32.67 22.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.463 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.09 -44.85 59.89 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.296 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 43' ' ' GLY . 45.8 t -66.4 -44.82 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.124 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.34 -37.67 66.02 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.867 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.42 82.61 0.57 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.653 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -133.16 -61.87 0.81 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.625 0.213 . . . . 0.0 111.35 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.29 156.02 16.92 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.336 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.28 173.47 11.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.484 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -69.71 140.41 53.52 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.264 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.37 38.95 8.04 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.491 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -121.32 178.59 4.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.498 0.19 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -125.04 139.98 53.31 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.414 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.697 HD21 ' CG2' ' A' ' 60' ' ' VAL . 8.3 tp -106.9 147.87 29.27 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.064 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.52 -59.31 1.3 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.385 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.54 144.06 50.73 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.963 0.411 . . . . 0.0 111.759 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.843 HG23 HD21 ' A' ' 65' ' ' LEU . 40.4 t -133.86 123.83 45.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.542 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.01 33.13 22.84 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 23.32 77.98 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.074 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -112.96 134.61 54.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 117.018 0.409 . . . . 0.0 110.268 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -83.01 86.42 7.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.843 HD21 HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -89.47 54.75 3.01 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.126 0.489 . . . . 0.0 110.869 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.467 HG12 ' HG3' ' A' ' 31' ' ' LYS . 77.6 t -102.27 99.38 8.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.634 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.71 32.89 2.16 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.623 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.6 mt -117.66 161.75 19.15 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.4 152.87 24.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.299 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.47 ' NE2' HD13 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -47.07 -42.22 18.35 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.625 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -58.45 -49.99 75.33 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.039 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -69.76 -36.26 75.63 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.941 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -67.63 -58.23 5.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.633 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.516 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -60.96 -46.19 91.71 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.595 0.236 . . . . 0.0 111.276 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -55.42 -50.36 70.0 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.939 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.02 -40.65 96.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.393 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.519 ' HG2' HG21 ' A' ' 60' ' ' VAL . 37.9 mtp -58.48 -49.49 77.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.221 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.9 t -69.9 -27.88 65.16 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -82.96 43.93 0.89 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.801 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 p -101.37 171.26 7.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.274 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.9 m -85.27 -166.6 1.55 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.614 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -43.32 74.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.564 0.221 . . . . 0.0 110.928 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 t -93.19 140.2 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.647 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.434 HG12 ' HG ' ' A' ' 86' ' ' LEU . 30.2 t -130.36 134.51 62.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.275 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.48 89.74 3.17 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.646 HD23 HG13 ' A' ' 60' ' ' VAL . 17.1 mt -94.54 120.3 34.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.75 101.92 13.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.323 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 p -105.23 150.2 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.353 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.3 148.02 28.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.575 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.593 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 27.8 p . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.765 0.317 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.823 HG22 HD11 ' A' ' 21' ' ' ILE . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.744 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 2.6 tt0 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.153 0.501 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.73 HD12 HD12 ' A' ' 58' ' ' LEU . 34.0 mm -90.49 127.56 42.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pp -145.34 137.89 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.2 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.894 HG23 ' HG3' ' A' ' 87' ' ' GLU . 2.2 m -92.16 139.35 30.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.96 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.63 HG11 ' HB3' ' A' ' 50' ' ' ARG . 21.8 t -119.47 117.9 55.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.912 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.567 HG23 HG23 ' A' ' 85' ' ' THR . 1.5 m -111.06 102.74 11.17 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.27 157.67 42.66 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -84.19 136.0 34.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.489 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.26 96.75 0.67 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.335 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -101.75 100.08 10.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.293 0.568 . . . . 0.0 110.428 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 55.04 35.2 24.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.921 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.53 -174.51 36.52 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.4 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.1 mtm -102.69 -36.95 8.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.418 0.151 . . . . 0.0 111.095 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.63 79.75 0.13 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.599 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 51' ' ' LEU . 3.4 pp -160.71 179.81 8.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.669 0.271 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 36' ' ' VAL . 57.7 m -132.18 156.94 45.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.33 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.489 HD12 ' O ' ' A' ' 21' ' ' ILE . 2.8 pp -143.47 146.71 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.681 HG23 ' HB2' ' A' ' 37' ' ' LYS . 40.1 t -133.85 134.83 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.261 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.43 122.14 34.58 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.678 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.91 149.41 48.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.44 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.61 -179.79 3.76 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.264 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.95 -140.13 2.8 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.23 146.05 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.723 0.296 . . . . 0.0 110.771 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.26 41.05 98.15 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.606 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 106.94 7.35 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.671 0.272 . . . . 0.0 110.999 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.36 19.7 5.83 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.256 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.455 ' HG3' HG12 ' A' ' 66' ' ' VAL . 23.2 mmtt -146.97 -171.59 3.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.522 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.9 137.19 55.01 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.731 0.3 . . . . 0.0 110.886 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.83 125.31 8.5 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.627 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.443 HG13 ' HB1' ' A' ' 73' ' ' ALA . 19.3 mm -84.38 84.68 2.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.043 0.449 . . . . 0.0 110.737 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -77.66 168.83 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.512 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 20' ' ' SER . 27.0 t -104.23 129.06 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.403 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.681 ' HB2' HG23 ' A' ' 22' ' ' VAL . 3.0 tttt -83.41 -45.41 13.72 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.603 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -170.4 176.93 4.26 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.058 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.13 127.94 75.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.759 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.92 125.69 40.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.185 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.68 143.86 56.93 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.011 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.74 -15.75 60.47 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.115 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.13 -152.23 3.17 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.803 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.25 -60.47 1.67 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.556 0.217 . . . . 0.0 111.576 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -61.62 -26.45 68.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.856 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.44 -47.74 46.6 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.2 t -73.38 -37.82 52.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.268 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.96 -44.92 45.65 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.094 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.02 65.69 0.99 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.477 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.63 ' HB3' HG11 ' A' ' 9' ' ' VAL . 2.9 mmp_? -141.02 30.79 1.8 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.565 0.221 . . . . 0.0 111.375 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.571 ' CD1' HD22 ' A' ' 19' ' ' LEU . 9.3 mt -154.43 171.07 19.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.889 0.376 . . . . 0.0 111.393 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.8 141.76 3.48 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.38 117.09 5.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.6 31.41 3.71 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.617 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.24 -178.19 3.57 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.612 0.244 . . . . 0.0 110.999 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.843 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 6.0 tm0? -124.61 159.0 31.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.222 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 34' ' ' ILE . 64.2 mt -124.05 107.38 11.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.962 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.73 HD12 HD12 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -75.1 -64.44 1.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.179 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 m -147.62 159.11 44.14 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.447 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.793 HG21 ' CG ' ' A' ' 77' ' ' MET . 38.9 t -127.87 125.42 64.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.822 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 55.79 33.85 22.29 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.22 36.61 85.4 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.061 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -119.41 152.75 36.3 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 111.083 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.2 m -79.05 118.2 20.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.204 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.737 HD21 HD12 ' A' ' 76' ' ' LEU . 19.2 mt -126.1 31.4 5.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.046 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.455 HG12 ' HG3' ' A' ' 31' ' ' LYS . 62.5 t -115.1 100.34 10.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.128 0.49 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.414 ' CA ' ' HD2' ' A' ' 31' ' ' LYS . . . 132.55 -32.28 2.84 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.526 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.415 HD12 HD23 ' A' ' 65' ' ' LEU . 54.7 mt -66.5 172.04 4.46 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 110.984 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -84.03 160.03 21.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.078 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.531 ' OE1' HG23 ' B' ' 102' ' ' THR . 7.1 tt0 -51.93 -33.42 37.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.202 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -60.3 -54.87 40.56 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.022 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -60.32 -38.26 83.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.828 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -52.71 -62.44 1.65 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.237 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.84 -63.98 1.11 Allowed 'General case' 0 C--N 1.335 -0.055 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -36.07 -41.2 0.24 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.05 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.737 HD12 HD21 ' A' ' 65' ' ' LEU . 7.0 mt -66.31 -47.15 74.47 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.793 ' CG ' HG21 ' A' ' 60' ' ' VAL . 11.9 mtp -75.42 -30.45 60.07 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -32.05 69.1 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.635 0.255 . . . . 0.0 110.575 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -92.42 44.45 1.16 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.895 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.0 160.95 24.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.061 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.07 -164.66 1.1 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.038 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 82.5 p -50.27 -42.95 53.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.5 t -96.03 139.45 19.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.734 0.302 . . . . 0.0 110.807 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.88 96.22 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.567 HG23 HG23 ' A' ' 10' ' ' THR . 0.6 OUTLIER -98.02 90.3 4.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.436 ' HG ' HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -115.81 128.8 56.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.955 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.894 ' HG3' HG23 ' A' ' 8' ' ' THR . 12.2 mt-10 -98.93 111.82 24.11 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.48 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.6 142.34 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.561 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.843 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -105.14 108.76 20.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.636 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 8.1 mtmt . . . . . 0 N--CA 1.462 0.168 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.162 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.539 ' HB3' ' HD3' ' A' ' 37' ' ' LYS . 35.3 p . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.809 0.338 . . . . 0.0 111.876 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.531 HG23 ' OE1' ' A' ' 70' ' ' GLN . 39.2 p . . . . . 0 C--O 1.233 0.197 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.317 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 121.024 0.44 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.677 HG21 HD12 ' A' ' 58' ' ' LEU . 8.5 mt -94.85 113.52 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.663 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 pt -127.12 150.66 33.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.321 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.428 ' HB ' ' CG ' ' A' ' 87' ' ' GLU . 7.9 t -109.38 131.92 54.61 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.58 HG21 ' HG3' ' A' ' 50' ' ' ARG . 14.3 p -106.3 122.79 60.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.004 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -96.27 103.59 15.5 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.599 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HG ' HG22 ' A' ' 9' ' ' VAL . 7.1 mt -125.45 174.14 8.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.46 142.56 46.55 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.92 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.81 135.52 38.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.048 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -92.11 -60.75 1.77 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.307 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.86 36.38 0.26 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.725 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.16 144.79 6.88 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.024 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.0 mtm -73.03 -61.37 1.84 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.492 0.187 . . . . 0.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.4 81.25 0.2 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.569 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 pp -160.96 179.49 8.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.571 0.224 . . . . 0.0 110.807 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.8 m -136.88 149.18 47.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.227 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' B' ' 101' ' ' SER . 2.8 pp -136.74 157.32 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.603 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.558 HG23 ' HB2' ' A' ' 37' ' ' LYS . 14.8 t -127.82 145.43 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.55 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.598 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -101.85 142.0 33.84 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.823 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -142.5 142.43 32.27 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.71 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.89 -179.43 4.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.121 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.6 144.93 10.66 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.683 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.39 141.28 55.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.176 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.91 34.66 65.82 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.68 109.8 7.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.298 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -88.74 27.51 1.3 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.32 -172.81 3.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.712 0.292 . . . . 0.0 110.511 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.598 ' CD2' ' HB1' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -143.24 132.94 23.79 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.939 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.19 119.43 5.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.131 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.7 mm -88.41 105.22 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-O 120.899 0.38 . . . . 0.0 110.552 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 70.7 m-85 -99.3 169.7 9.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.248 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.79 139.49 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 111.001 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HB2' HG23 ' A' ' 22' ' ' VAL . 2.3 tptt -100.79 -45.29 5.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.743 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -161.7 169.89 20.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.61 115.14 24.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.593 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.86 126.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.109 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -59.97 149.18 32.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.85 -24.01 33.98 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.998 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.68 -166.13 6.26 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.576 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.3 -52.85 4.72 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.705 -0.291 . . . . 0.0 111.617 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.66 -38.08 44.39 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.038 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.29 -55.71 9.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.629 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.79 -31.22 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.49 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.88 -56.83 9.77 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.38 57.68 1.84 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.763 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.58 ' HG3' HG21 ' A' ' 9' ' ' VAL . 1.2 mmp_? -119.72 -45.63 2.49 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.552 0.215 . . . . 0.0 110.952 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 pp -128.3 175.81 8.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.897 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.42 -173.91 4.54 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.297 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.01 127.57 33.36 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.212 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.9 27.41 6.65 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.617 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.438 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -118.61 138.14 52.78 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.428 ' C ' HD12 ' A' ' 57' ' ' LEU . 35.5 tt0 -82.6 152.02 26.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.23 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 56' ' ' GLN . 9.5 mp -119.26 144.04 46.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.013 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.677 HD12 HG21 ' A' ' 6' ' ' ILE . 1.1 mt -116.04 -60.6 1.84 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.193 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 m -123.05 156.73 34.28 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.664 HG23 HD21 ' A' ' 65' ' ' LEU . 19.5 t -142.1 120.71 9.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.111 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.82 35.59 26.5 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.205 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.63 21.17 79.69 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.945 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.3 mtm-85 -113.7 146.86 39.19 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.863 0.331 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.9 m -102.05 103.58 14.17 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.664 HD21 HG23 ' A' ' 60' ' ' VAL . 2.1 pp -109.11 42.22 1.48 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.2 t -87.7 99.57 8.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.189 0.519 . . . . 0.0 110.809 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.06 40.87 0.94 Allowed Glycine 0 CA--C 1.52 0.346 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.393 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.449 HD13 ' HB3' ' A' ' 72' ' ' ARG . 13.2 mt -127.97 157.63 40.08 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.712 0.291 . . . . 0.0 110.784 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.1 p -70.91 159.46 34.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.126 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 5.1 tt0 -54.81 -40.15 69.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.946 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -56.91 -47.27 80.98 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.421 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.449 ' HB3' HD13 ' A' ' 68' ' ' LEU . 1.9 mmm180 -68.51 -38.68 81.14 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.596 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.85 -59.41 4.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.3 -67.02 0.42 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -35.2 -41.19 0.15 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.29 0.636 . . . . 0.0 112.173 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 76' ' ' LEU . 11.0 mt -63.58 -49.07 74.83 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.599 0.238 . . . . 0.0 111.454 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.532 ' HG2' HG11 ' A' ' 60' ' ' VAL . 7.2 mtm -70.78 -33.47 70.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.759 0.314 . . . . 0.0 110.704 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -29.2 70.58 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.31 42.67 1.11 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.721 0.296 . . . . 0.0 111.623 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 77' ' ' MET . 22.2 p -98.72 170.18 8.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.775 0.322 . . . . 0.0 111.183 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.6 p -99.9 -161.42 0.87 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.505 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.3 m -57.0 -39.71 75.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.518 0.199 . . . . 0.0 110.625 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.14 145.39 8.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.61 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.55 HG12 HD23 ' A' ' 86' ' ' LEU . 21.2 t -138.82 121.83 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.091 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.41 99.19 6.28 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.498 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.55 HD23 HG12 ' A' ' 84' ' ' VAL . 3.2 mm? -106.31 115.04 29.53 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.207 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.428 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 0.1 OUTLIER -81.36 89.48 6.1 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 110.143 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 55' ' ' ASP . 14.2 p -93.19 150.65 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.472 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.49 143.86 31.67 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.484 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.484 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 34.0 t . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.615 0.245 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.452 HG23 ' OE1' ' A' ' 70' ' ' GLN . 4.0 p . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 33.1 tt0 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 121.193 0.521 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 41.1 mm -95.59 131.35 42.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.74 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.14 144.85 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.701 HG22 HG22 ' A' ' 85' ' ' THR . 0.7 OUTLIER -113.69 126.76 55.6 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 m -99.4 113.77 35.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.981 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.462 ' OG1' HG23 ' A' ' 85' ' ' THR . 0.7 OUTLIER -99.86 92.19 5.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.486 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt -116.03 173.87 6.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.17 162.24 13.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.022 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.08 113.78 25.51 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.513 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.85 -41.47 6.49 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.412 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -163.68 44.82 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.544 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.09 153.8 28.01 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.374 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.35 -48.54 80.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.606 0.203 . . . . 0.0 111.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.09 69.53 1.39 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.819 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.3 pp -160.72 177.48 10.42 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 122.202 0.201 . . . . 0.0 110.581 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -138.24 134.13 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.688 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.968 HD13 HG23 ' A' ' 34' ' ' ILE . 2.1 pp -120.87 165.73 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG22 ' CB ' ' B' ' 101' ' ' SER . 47.8 t -149.9 137.14 13.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.501 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.85 123.84 33.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -139.14 157.79 45.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.848 0.356 . . . . 0.0 111.645 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HG3' HD12 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -122.87 179.69 4.55 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.24 -141.21 3.08 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.789 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.88 147.1 31.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.65 0.262 . . . . 0.0 110.787 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.27 37.15 92.57 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.784 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.89 106.29 8.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.65 0.262 . . . . 0.0 110.844 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.8 17.86 6.2 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HD2' ' CA ' ' A' ' 67' ' ' GLY . 19.4 mmtp -145.15 -171.06 3.57 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.632 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 32' ' ' LEU . 5.2 tp -124.03 139.23 54.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.514 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.21 133.0 11.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.991 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.968 HG23 HD13 ' A' ' 21' ' ' ILE . 29.1 mm -92.12 71.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.149 0.5 . . . . 0.0 110.512 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 53.1 m-85 -63.4 167.68 5.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.775 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 47.9 t -112.1 125.34 69.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.098 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.518 ' HD3' ' HB2' ' B' ' 101' ' ' SER . 2.3 pttt -87.01 -36.51 18.19 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.587 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -163.42 159.36 22.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.523 0.202 . . . . 0.0 111.039 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 19' ' ' LEU . 16.7 t -118.25 122.91 70.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.31 133.4 30.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.39 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 154.39 41.87 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.74 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.49 45.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.266 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.64 -163.7 4.94 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.59 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.42 -34.32 11.57 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.09 -47.13 38.49 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -59.55 -37.94 79.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.437 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 43' ' ' GLY . 42.8 t -73.79 -32.79 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.248 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.43 -41.68 80.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.087 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.71 49.78 10.22 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.787 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -105.5 -36.16 7.23 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.576 0.227 . . . . 0.0 111.349 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.52 173.71 8.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 111.277 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.68 26.84 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.176 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.25 128.44 37.01 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.537 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.85 38.77 2.46 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.016 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 4.1 p30 -116.59 141.53 48.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.668 0.271 . . . . 0.0 110.77 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -85.97 143.51 28.12 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.068 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.468 HD11 HD23 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -99.81 143.72 29.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.324 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tt -122.41 -58.83 1.67 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.2 p -140.64 154.24 46.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.978 0.418 . . . . 0.0 111.795 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.636 HG22 HD23 ' A' ' 86' ' ' LEU . 22.4 t -135.03 112.83 15.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.438 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 56.83 34.5 24.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.232 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.37 -20.33 49.98 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.383 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -70.98 151.3 44.79 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 117.27 0.535 . . . . 0.0 111.065 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.1 p -107.14 119.47 39.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.722 HD22 ' HA ' ' A' ' 73' ' ' ALA . 11.3 mt -110.23 -9.19 14.68 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.736 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 66' ' ' VAL . 8.5 p -68.88 83.62 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-O 121.692 0.758 . . . . 0.0 110.737 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.426 ' CA ' ' HD2' ' A' ' 31' ' ' LYS . . . 140.78 -23.49 2.63 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.658 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.4 mt -82.47 169.19 16.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.6 m -86.1 166.48 15.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.759 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.417 HE21 ' HB3' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -57.85 -28.73 64.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.416 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -64.74 -47.49 78.04 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-O 120.65 0.262 . . . . 0.0 110.765 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -53.78 39.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.722 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -57.27 -50.58 72.46 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.771 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB1' HG21 ' B' ' 102' ' ' THR . . . -56.41 -63.27 1.25 Allowed 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.882 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -46.37 -48.05 18.58 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.445 0.466 . . . . 0.0 112.117 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.6 mt -68.16 -27.82 66.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.569 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 77.6 mtp -86.21 -19.99 29.18 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -43.42 63.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.799 0.333 . . . . 0.0 110.61 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -95.57 65.51 2.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.946 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -83.78 147.43 27.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.068 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.51 -167.54 1.83 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.765 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -56.55 -43.85 80.33 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.921 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.08 144.49 12.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.1 t -137.69 113.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.802 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.701 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -111.23 86.77 2.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.649 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.636 HD23 HG22 ' A' ' 60' ' ' VAL . 1.3 mt -94.25 124.41 38.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.294 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 42.7 tt0 -98.9 121.41 40.82 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.289 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.4 m -117.7 168.77 9.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.733 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . . . -128.17 111.43 13.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.987 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 11.8 mmtt . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.521 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.518 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 97.8 p . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 120.747 0.308 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.523 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.416 ' HB3' ' CG ' ' A' ' 90' ' ' LYS . 10.9 tt0 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 121.07 0.462 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.79 137.15 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.598 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.45 150.08 14.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.658 ' CG2' HG22 ' A' ' 85' ' ' THR . 8.3 m -113.88 131.23 56.35 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.879 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 50' ' ' ARG . 6.5 m -102.09 116.29 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.107 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 m -105.43 98.43 8.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.544 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mt -126.87 154.74 44.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 152.96 21.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -70.72 105.15 3.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.196 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -94.37 -38.72 10.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.087 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -161.58 42.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.01 0.433 . . . . 0.0 110.56 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.94 157.8 6.11 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.118 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.784 ' SD ' HD11 ' A' ' 86' ' ' LEU . 2.7 mtm -65.02 -56.05 15.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.696 0.248 . . . . 0.0 110.564 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.13 78.74 0.14 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.894 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 20' ' ' SER . 4.0 pp -160.81 177.72 10.14 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.42 ' N ' HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -125.11 153.17 43.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.952 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.922 HD11 HG22 ' B' ' 102' ' ' THR . 2.6 pp -144.75 158.64 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 112.088 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.15 141.67 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.17 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.42 149.46 30.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.261 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -146.85 135.04 21.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.335 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -119.73 179.98 4.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.01 -137.85 2.28 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.12 142.78 41.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.665 0.269 . . . . 0.0 110.871 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.92 43.89 98.57 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.914 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.37 107.81 7.82 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.72 0.295 . . . . 0.0 111.025 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.96 22.34 3.71 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.435 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -144.13 -171.97 3.67 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.657 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 tp -136.11 136.88 40.49 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.906 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.88 161.88 19.38 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.767 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.42 HG13 ' HB1' ' A' ' 73' ' ' ALA . 27.0 mm -115.3 103.27 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 111.073 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 6.5 m-85 -90.57 163.78 14.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.83 113.08 40.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.029 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -43.01 69.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 1.9 p -172.18 167.19 5.97 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.777 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.2 m -120.0 127.89 75.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.851 0.357 . . . . 0.0 110.816 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.43 121.7 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -64.17 154.18 35.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.19 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.48 -37.01 3.83 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.703 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.534 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.7 -177.8 5.88 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.773 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 14' ' ' GLN . . . -87.1 -2.33 58.55 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.29 -38.32 11.57 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.04 -37.38 54.92 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.229 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 43' ' ' GLY . 43.1 t -64.69 -33.27 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.636 0.255 . . . . 0.0 110.95 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.92 -45.18 64.73 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.098 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.74 29.23 43.77 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.784 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.727 ' HB3' HG11 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -89.64 -33.16 16.75 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.515 0.198 . . . . 0.0 111.167 179.743 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.46 171.2 11.24 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.031 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.94 -175.71 5.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.563 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -73.82 162.15 29.43 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.94 39.82 93.36 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.334 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.05 142.79 51.45 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.639 0.257 . . . . 0.0 111.055 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -89.79 160.3 16.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 34' ' ' ILE . 16.8 mt -124.44 155.41 38.92 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 111.617 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.0 -55.95 1.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.072 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -136.09 142.06 44.27 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.695 0.284 . . . . 0.0 111.429 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.784 HG11 ' HG2' ' A' ' 77' ' ' MET . 18.3 t -135.69 140.89 43.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.998 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 43.65 44.88 5.61 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.534 0.521 . . . . 0.0 111.841 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.5 32.52 81.95 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.663 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -138.69 161.94 35.91 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.855 0.328 . . . . 0.0 110.577 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 p -112.77 137.32 51.26 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.767 0.318 . . . . 0.0 111.11 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.62 ' HA ' HD21 ' A' ' 68' ' ' LEU . 19.7 mt -117.38 45.41 1.91 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.0 t -109.36 100.9 11.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.187 0.518 . . . . 0.0 110.896 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.77 -37.68 2.85 Favored Glycine 0 C--N 1.328 0.139 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.347 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 65' ' ' LEU . 3.8 pp -73.48 147.26 44.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.777 0.322 . . . . 0.0 110.948 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -64.16 156.76 27.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.649 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.74 ' CD ' HD13 ' A' ' 21' ' ' ILE . 38.6 tp60 -52.62 -39.11 61.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.631 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 4.5 tt0 -51.59 -43.99 62.66 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -74.43 -40.79 61.74 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.2 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.497 ' HB3' ' NE2' ' A' ' 70' ' ' GLN . . . -56.18 -58.45 7.88 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.651 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -58.75 -64.38 0.95 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.06 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 4.3 tm-20 -38.04 -46.81 1.04 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.549 0.531 . . . . 0.0 111.764 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 mt -60.1 -43.52 95.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.007 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.784 ' HG2' HG11 ' A' ' 60' ' ' VAL . 9.1 mtp -76.71 -30.28 56.61 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.258 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -27.88 69.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.544 0.211 . . . . 0.0 110.816 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -96.47 32.82 1.92 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.208 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 77' ' ' MET . 1.2 p -60.21 146.34 43.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 111.412 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -85.93 -165.94 1.39 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.665 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -56.51 -31.35 64.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.038 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.45 141.58 19.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.965 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.48 114.65 43.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.619 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.658 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -116.52 88.54 2.92 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.784 HD11 ' SD ' ' A' ' 17' ' ' MET . 5.7 mt -101.77 133.31 46.7 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.317 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -115.72 127.33 55.05 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.926 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.58 170.64 13.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.326 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.35 133.19 51.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.903 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.416 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 48.6 mmtm . . . . . 0 N--CA 1.464 0.228 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.425 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 120.694 0.283 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.922 HG22 HD11 ' A' ' 21' ' ' ILE . 1.6 t . . . . . 0 C--O 1.233 0.233 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.788 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.029 0.442 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.665 HD12 HD12 ' A' ' 58' ' ' LEU . 44.3 mm -95.85 128.98 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.2 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.14 141.49 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.129 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.568 ' OG1' HG22 ' A' ' 85' ' ' THR . 10.0 t -112.08 149.71 31.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.813 0.339 . . . . 0.0 111.019 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 50' ' ' ARG . 7.0 m -114.22 118.37 58.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.0 m -94.28 101.13 13.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.463 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.9 mt -131.3 163.07 28.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -92.2 129.92 38.03 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.927 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HB2' ' CG2' ' A' ' 84' ' ' VAL . 8.4 ttpp -83.03 139.39 33.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.186 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -93.37 -57.78 2.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -158.99 38.11 0.21 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.723 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.43 -167.99 22.35 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.999 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.708 ' SD ' HD11 ' A' ' 86' ' ' LEU . 6.7 mtm -115.9 -42.73 3.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.69 0.245 . . . . 0.0 111.385 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.99 73.96 0.63 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.038 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 20' ' ' SER . 4.0 pp -160.8 177.94 9.92 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.646 0.26 . . . . 0.0 111.072 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.423 ' N ' HD12 ' A' ' 19' ' ' LEU . 72.8 m -130.49 150.69 51.59 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.447 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.608 HD11 HG22 ' B' ' 102' ' ' THR . 2.7 pp -142.61 152.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.807 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.836 HG23 ' HB2' ' A' ' 37' ' ' LYS . 46.4 t -133.69 135.71 55.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.66 135.18 33.47 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.167 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.564 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -144.71 152.56 40.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.351 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.591 ' HG3' HD12 ' A' ' 32' ' ' LEU . 10.7 tttt -124.2 -179.54 4.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.938 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.78 -140.42 2.98 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.41 140.96 44.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.687 0.28 . . . . 0.0 110.728 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.32 45.79 95.74 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.597 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.4 107.9 7.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.707 0.289 . . . . 0.0 111.127 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -90.1 21.0 3.93 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -144.02 -168.89 2.98 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.678 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.591 HD12 ' HG3' ' A' ' 25' ' ' LYS . 3.1 tp -136.91 146.76 45.87 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.929 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.12 128.71 9.14 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.845 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.477 HG13 ' HB1' ' A' ' 73' ' ' ALA . 27.6 mm -87.14 87.25 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.994 0.426 . . . . 0.0 110.871 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 66.0 m-85 -79.17 168.07 20.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.603 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.8 t -99.11 135.73 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.606 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.836 ' HB2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -100.58 -41.33 7.0 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.286 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -178.0 125.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.055 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.9 m -87.55 136.19 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.247 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.2 t -92.29 128.0 44.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -62.48 148.5 45.51 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.323 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.55 -30.35 10.42 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.579 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.649 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.97 152.49 51.88 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.428 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.75 -36.55 26.16 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.85 -44.26 64.14 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.651 0.263 . . . . 0.0 111.382 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -39.03 92.91 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.45 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 43' ' ' GLY . 42.0 t -57.79 -39.37 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.27 -49.58 13.44 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.058 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.79 76.9 1.06 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.171 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.527 ' CB ' HG11 ' A' ' 9' ' ' VAL . 12.9 mmm-85 -139.18 22.48 2.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.03 153.65 1.67 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.654 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.47 -179.99 6.61 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.487 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.71 139.44 58.38 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.034 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.73 22.06 32.13 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.862 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.87 175.68 5.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.64 0.22 . . . . 0.0 110.613 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.434 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 3.7 tt0 -125.17 142.36 51.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.053 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.443 HD21 HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -107.94 164.17 12.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.338 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.665 HD12 HD12 ' A' ' 6' ' ' ILE . 1.2 mt -140.21 -55.52 0.54 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.362 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.7 m -127.08 154.62 44.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.689 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 77' ' ' MET . 22.6 t -141.91 107.76 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.048 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.71 50.71 10.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.97 0.414 . . . . 0.0 111.03 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.76 21.4 76.5 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.859 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.424 ' CZ ' HD22 ' A' ' 76' ' ' LEU . 6.2 mtt-85 -113.74 160.8 18.28 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.734 0.267 . . . . 0.0 110.37 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -114.41 110.94 20.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.032 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.533 HD23 HD12 ' A' ' 68' ' ' LEU . 27.1 mt -96.33 43.67 1.08 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.6 t -105.53 100.09 9.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.186 0.517 . . . . 0.0 110.572 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.87 30.48 5.15 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.553 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD12 HD23 ' A' ' 65' ' ' LEU . 45.5 mt -122.02 158.06 30.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 110.929 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.2 p -79.9 162.11 25.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.738 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -54.28 -36.42 63.62 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.768 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.81 -59.69 4.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.091 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -59.71 -36.6 76.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.099 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -65.44 -62.02 1.77 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.493 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' B' ' 102' ' ' THR . . . -56.19 -47.07 79.06 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.412 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -56.3 -54.85 40.47 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.956 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.424 HD22 ' CZ ' ' A' ' 63' ' ' ARG . 14.6 mt -53.69 -33.55 55.8 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.316 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.483 ' CG ' HG11 ' A' ' 60' ' ' VAL . 13.5 mtp -74.78 -51.38 14.27 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 75' ' ' GLU . 8.6 t -63.2 -33.58 75.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.55 0.214 . . . . 0.0 111.161 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -84.2 47.48 1.34 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.878 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -98.2 179.54 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.868 0.366 . . . . 0.0 111.207 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -93.83 -165.63 1.36 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -55.81 -44.09 77.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 110.925 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.16 145.91 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.852 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 13' ' ' LYS . 22.5 t -128.39 126.76 66.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.532 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.568 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.2 OUTLIER -129.67 83.5 2.14 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.765 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.708 HD11 ' SD ' ' A' ' 17' ' ' MET . 7.3 mt -93.67 118.79 31.85 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.495 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HG3' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -86.34 113.86 22.66 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.547 179.328 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.75 150.56 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.54 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.568 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . . . -106.02 160.4 15.32 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.26 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt . . . . . 0 C--O 1.233 0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.763 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.887 0.375 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.608 HG22 HD11 ' A' ' 21' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.681 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 34.8 tt0 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.252 0.548 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.4 mt -93.33 136.68 24.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.844 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.5 153.17 13.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.448 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 5.0 m -111.27 141.16 45.16 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.553 HG11 ' HD2' ' A' ' 50' ' ' ARG . 10.8 m -120.7 133.54 67.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 m -109.68 95.17 5.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.709 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.0 mt -116.49 173.29 6.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -99.57 163.02 12.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.057 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -77.46 100.3 5.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.73 80.47 5.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.477 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.13 34.55 23.35 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.967 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.96 152.79 29.09 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.239 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -56.41 22.44 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.69 0.281 . . . . 0.0 110.666 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.26 72.75 0.84 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.661 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.667 ' CD1' HG23 ' A' ' 21' ' ' ILE . 3.6 pp -160.61 178.12 9.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.732 0.301 . . . . 0.0 110.672 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.464 ' N ' HD12 ' A' ' 19' ' ' LEU . 7.9 m -135.17 126.25 27.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.41 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.669 HD13 ' CG2' ' A' ' 34' ' ' ILE . 2.1 pp -118.09 129.73 74.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.322 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.896 HG22 ' HA ' ' B' ' 101' ' ' SER . 93.7 t -112.5 136.8 47.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.099 0.476 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.796 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -95.27 120.03 34.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.199 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.85 148.65 52.3 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.946 0.403 . . . . 0.0 111.768 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.58 -179.86 4.67 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.667 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.8 -141.53 3.15 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.715 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.34 148.52 27.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.614 0.245 . . . . 0.0 110.66 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.78 33.22 82.05 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.744 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.25 103.46 6.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.684 0.278 . . . . 0.0 110.927 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 7.1 t0 -90.64 21.6 3.94 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.227 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -142.01 -168.15 2.63 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.5 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.5 HD21 ' HB1' ' A' ' 23' ' ' ALA . 12.7 tp -142.14 123.91 15.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.747 0.308 . . . . 0.0 110.889 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.78 116.94 5.61 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.411 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.669 ' CG2' HD13 ' A' ' 21' ' ' ILE . 31.3 mm -77.85 87.19 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.957 0.408 . . . . 0.0 110.413 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.94 162.32 28.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.648 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -104.33 108.01 23.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.835 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.701 ' HB2' HG23 ' A' ' 22' ' ' VAL . 17.9 tttt -62.52 -47.02 85.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.859 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 p -175.34 137.83 0.4 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.28 137.79 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.513 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -76.07 141.68 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 153.01 35.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.236 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.98 19.24 69.65 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.007 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.25 -158.03 33.72 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.442 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.17 -35.18 10.86 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.22 -33.59 20.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.377 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -40.93 94.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.539 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.96 -41.85 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.52 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.5 -55.1 34.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.361 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.9 49.85 1.72 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.438 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.553 ' HD2' HG11 ' A' ' 9' ' ' VAL . 72.8 mmt-85 -105.77 -58.16 1.94 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 110.643 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 pp -117.15 149.72 39.89 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.669 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.63 -175.22 3.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.183 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.2 131.1 42.31 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.008 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.35 27.6 10.58 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.739 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.18 171.36 7.53 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.589 0.194 . . . . 0.0 110.768 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -120.26 137.9 53.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.307 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.607 HD23 HG22 ' A' ' 88' ' ' VAL . 86.6 mt -101.35 162.19 13.08 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.178 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD23 ' CG2' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -141.48 -53.26 0.45 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.188 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.0 m -124.04 151.03 44.23 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.979 0.418 . . . . 0.0 111.712 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.64 HG23 HD13 ' A' ' 65' ' ' LEU . 21.7 t -139.34 133.23 38.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.765 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 53.65 38.0 27.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.37 26.98 72.32 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.337 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 mtp-105 -128.89 148.24 50.89 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.897 0.348 . . . . 0.0 110.723 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.5 m -89.66 135.23 33.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.982 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 60' ' ' VAL . 4.2 mp -130.0 50.02 2.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.974 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.421 ' CG2' HD23 ' A' ' 58' ' ' LEU . 58.0 t -94.14 99.62 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 110.876 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 105.54 35.35 3.09 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.64 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.7 mt -122.11 153.77 38.25 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.755 0.312 . . . . 0.0 110.768 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.8 m -75.33 158.2 33.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.796 ' HG3' ' HB2' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -57.25 -25.52 59.28 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.725 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.15 -49.58 76.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.692 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -51.89 52.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.47 81.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.584 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.585 ' O ' HG22 ' A' ' 78' ' ' THR . . . -58.79 -56.89 16.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.331 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -53.15 60.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.309 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.52 -32.28 71.31 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.982 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.788 ' SD ' HD21 ' A' ' 86' ' ' LEU . 30.5 mmm -69.58 -64.32 0.9 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.92 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 74' ' ' ALA . 4.7 t -56.01 -36.23 67.71 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.684 0.278 . . . . 0.0 111.024 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -86.86 52.58 2.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.264 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 77' ' ' MET . 1.2 p -94.2 168.47 10.9 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.773 0.32 . . . . 0.0 110.746 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -97.62 -163.08 1.01 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.591 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -59.04 -26.78 64.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.165 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.82 149.21 5.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.952 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.01 87.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.1 m -91.88 80.68 5.2 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.788 HD21 ' SD ' ' A' ' 77' ' ' MET . 9.1 mt -103.94 133.97 48.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.44 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 27.2 tt0 -107.19 112.11 24.84 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.603 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.607 HG22 HD23 ' A' ' 57' ' ' LEU . 19.8 t -110.73 147.56 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.206 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . . . -97.37 132.86 42.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.8 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.564 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.896 ' HA ' HG22 ' A' ' 22' ' ' VAL . 8.2 t . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.488 0.185 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.433 ' HB ' HG13 ' A' ' 21' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.013 0.435 . . . . 0.0 111.841 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.026 0.441 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mt -102.84 141.16 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.737 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 pt -146.26 151.84 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.371 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 87' ' ' GLU . 1.3 m -112.88 140.0 48.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.955 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 m -123.19 127.92 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.183 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 15.6 m -108.65 112.38 24.68 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mt -138.97 162.27 35.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.636 ' HE3' HG22 ' A' ' 83' ' ' VAL . 2.6 mptt -98.08 176.6 5.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.877 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.51 150.42 26.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 111.408 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.98 -58.66 0.96 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.579 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -138.02 35.67 2.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.61 152.81 28.91 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.106 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 mtm -64.41 -48.87 73.74 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.629 0.214 . . . . 0.0 110.723 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.85 82.51 0.07 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.938 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -160.76 179.61 8.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.628 0.252 . . . . 0.0 110.781 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -129.45 144.78 51.39 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.27 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.465 HD13 HG23 ' A' ' 34' ' ' ILE . 2.7 pp -140.55 146.14 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.799 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 37' ' ' LYS . 22.7 t -132.71 137.08 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.544 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.49 158.85 25.73 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.705 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.876 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -159.51 141.53 13.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 111.377 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HD2' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -126.31 -179.67 4.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.82 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.37 -141.33 3.12 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.8 139.25 40.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.681 0.277 . . . . 0.0 110.597 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.43 35.47 91.75 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.707 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.05 103.76 7.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.672 0.272 . . . . 0.0 110.89 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -92.18 28.41 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.1 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -136.57 -170.16 2.62 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.449 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 32' ' ' LEU . 5.9 tp -151.96 124.47 8.34 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.672 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.22 150.5 20.2 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.025 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.636 HG13 ' HB1' ' A' ' 73' ' ' ALA . 14.7 mm -104.86 81.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 121.049 0.452 . . . . 0.0 110.786 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.876 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 61.8 m-85 -71.57 166.37 21.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.316 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.3 t -106.43 128.99 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.107 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.54 ' HB2' HG23 ' A' ' 22' ' ' VAL . 8.5 ttpt -91.37 -42.6 10.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.3 172.84 15.9 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.726 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.05 121.97 30.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.558 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 t -72.13 124.96 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.721 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 124.12 21.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.79 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.11 -31.6 3.82 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.352 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -68.66 157.23 53.17 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.621 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.16 18.81 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.553 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -63.87 -49.67 71.83 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.683 0.277 . . . . 0.0 111.203 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.48 -41.16 96.64 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.163 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.9 t -61.02 -32.96 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.25 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -68.25 -55.88 10.63 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.238 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.44 51.43 2.92 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.85 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -128.24 -66.99 0.82 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.729 0.264 . . . . 0.0 110.805 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.553 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.4 pp -70.4 161.59 30.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.98 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.93 -174.83 4.37 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.368 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.9 120.91 28.68 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.982 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.1 31.26 3.14 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.023 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -116.78 139.2 50.86 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.705 0.252 . . . . 0.0 110.955 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.9 tt0 -81.9 145.33 30.4 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -97.53 168.94 10.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.012 0.434 . . . . 0.0 111.321 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -148.18 -59.02 0.24 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.035 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.5 p -128.3 150.6 49.99 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.963 0.411 . . . . 0.0 111.713 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.622 HG11 ' CG ' ' A' ' 77' ' ' MET . 39.9 t -141.97 96.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.46 41.99 31.63 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.962 0.41 . . . . 0.0 111.0 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.36 25.86 49.66 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.952 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -120.64 129.78 53.86 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.19 111.14 21.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.967 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 60' ' ' VAL . 41.5 mt -99.72 26.84 5.84 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.056 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.2 p -107.39 73.43 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.661 0.743 . . . . 0.0 110.638 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.66 -22.4 1.49 Allowed Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.199 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.4 mt -81.32 159.26 24.47 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.966 0.412 . . . . 0.0 111.188 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.5 m -74.73 147.17 41.6 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.024 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.455 ' HG2' ' CG2' ' B' ' 102' ' ' THR . 0.0 OUTLIER -42.45 -41.25 2.86 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.178 0.299 . . . . 0.0 111.412 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.94 -56.94 12.24 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.306 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -60.44 -40.83 92.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.636 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -58.73 -60.84 3.19 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.702 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.509 ' O ' HG22 ' A' ' 78' ' ' THR . . . -63.49 -36.86 85.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.353 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -35.82 76.93 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.433 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.45 -44.18 58.7 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.622 ' CG ' HG11 ' A' ' 60' ' ' VAL . 11.1 mtp -59.53 -48.17 82.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.433 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 74' ' ' ALA . 7.8 t -64.51 -33.46 75.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.63 0.252 . . . . 0.0 110.611 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.72 50.19 1.92 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.892 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.0 p -103.79 172.72 6.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.646 0.26 . . . . 0.0 110.865 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 t -79.73 -169.93 2.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.49 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -53.4 -40.59 65.19 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.254 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.636 HG22 ' HE3' ' A' ' 12' ' ' LYS . 21.1 t -97.35 143.63 12.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.121 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 10' ' ' THR . 23.9 t -119.74 149.13 22.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.14 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.9 m -143.54 85.56 1.85 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.436 HD23 HG22 ' A' ' 60' ' ' VAL . 3.8 mt -98.27 140.45 32.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.365 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HB2' HG23 ' A' ' 8' ' ' THR . 41.9 tt0 -121.78 110.07 15.46 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.735 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.84 169.19 2.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.204 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.17 137.67 53.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.17 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.548 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.476 ' HB2' HG22 ' A' ' 22' ' ' VAL . 21.5 t . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.975 0.417 . . . . 0.0 111.507 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.455 ' CG2' ' HG2' ' A' ' 70' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.235 0.292 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.155 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.875 0.369 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mt -100.49 139.14 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.318 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.02 139.19 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.145 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.433 ' HB ' ' CG ' ' A' ' 87' ' ' GLU . 7.3 t -109.41 159.25 17.17 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 110.98 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.61 132.7 31.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.326 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 m -90.99 97.0 10.92 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.471 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.21 169.12 8.94 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.357 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -113.54 153.84 28.11 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.752 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -82.61 102.8 11.68 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.212 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -100.46 78.55 2.03 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.279 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 57.74 36.97 27.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.905 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.73 148.04 16.22 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.091 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.4 mtm -65.64 -68.8 0.34 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.733 0.266 . . . . 0.0 111.007 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.53 70.09 1.09 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.045 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 20' ' ' SER . 3.9 pp -160.65 176.82 11.12 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.401 0.143 . . . . 0.0 110.633 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.466 ' N ' HD12 ' A' ' 19' ' ' LEU . 49.0 m -134.21 142.14 47.28 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.631 ' CD1' HG22 ' B' ' 102' ' ' THR . 0.0 OUTLIER -131.96 163.19 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.036 0.446 . . . . 0.0 112.069 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.06 131.83 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.974 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.445 ' CB ' ' HB2' ' A' ' 70' ' ' GLN . . . -99.31 118.58 36.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -120.49 132.62 55.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.569 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.442 ' HG3' ' CD1' ' A' ' 32' ' ' LEU . 4.6 tttt -114.51 -179.69 3.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.889 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.16 -140.52 3.01 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.69 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.46 152.63 23.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.56 0.219 . . . . 0.0 110.766 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.18 37.46 86.56 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.501 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.27 107.74 7.36 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.609 0.242 . . . . 0.0 110.801 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.472 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 7.8 p-10 -90.7 15.11 11.69 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 111.47 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -144.36 -171.38 3.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.383 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.442 ' CD1' ' HG3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -145.1 135.34 24.02 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 111.002 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.03 127.85 9.32 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.822 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.73 78.78 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 121.031 0.443 . . . . 0.0 110.513 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.439 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 73.0 m-85 -68.79 157.8 35.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.623 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.12 135.19 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.308 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -92.77 -47.77 6.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.622 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.17 130.57 0.17 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.03 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.13 132.22 31.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.667 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -81.74 139.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.19 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.72 145.17 55.4 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.206 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.57 -26.25 23.88 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.869 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.2 150.12 51.58 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.149 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.59 -36.69 67.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.53 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -61.22 -40.93 95.84 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.689 0.281 . . . . 0.0 110.86 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -40.64 63.5 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 43' ' ' GLY . 40.6 t -63.83 -36.38 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.397 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.28 -38.21 60.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.26 64.27 2.69 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.494 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -49.04 1.86 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.583 0.23 . . . . 0.0 111.383 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.53 HD21 ' HB1' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -103.84 165.72 10.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.261 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.8 177.77 7.95 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.519 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.77 140.31 42.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.047 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.61 27.94 28.27 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.871 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . 1.4 m-20 -110.67 155.22 22.73 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.635 0.218 . . . . 0.0 110.536 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 4.8 tt0 -96.67 144.56 26.58 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.091 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.96 169.24 8.62 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.65 -57.61 0.22 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.241 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 t -126.52 144.23 50.94 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.112 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.752 HG21 ' SD ' ' A' ' 77' ' ' MET . 23.4 t -135.47 112.22 13.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.576 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.09 39.04 23.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.333 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.48 4.64 84.88 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.321 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -98.96 142.33 30.6 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.42 0.61 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.05 108.78 21.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.828 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.8 mt -100.33 32.42 3.03 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.472 HG12 ' HG2' ' A' ' 31' ' ' LYS . 62.5 t -90.09 99.96 10.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.189 0.519 . . . . 0.0 110.826 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 110.93 32.35 2.66 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.521 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 68' ' ' LEU . 23.3 mt -129.18 161.5 29.97 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.695 0.284 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.81 154.23 30.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.445 ' HB2' ' CB ' ' A' ' 23' ' ' ALA . 1.2 tm0? -52.29 -36.24 52.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -54.66 -53.1 59.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.715 0.293 . . . . 0.0 110.384 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -63.2 -41.33 99.16 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.738 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 77' ' ' MET . . . -60.4 -59.92 4.64 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.229 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 78' ' ' THR . . . -56.07 -33.96 65.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.626 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -45.08 57.82 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.602 0.239 . . . . 0.0 111.327 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.9 mt -67.69 -32.46 73.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.464 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 60' ' ' VAL . 6.6 mtm -73.83 -48.2 32.98 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.491 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 74' ' ' ALA . 9.9 t -64.1 -34.2 77.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.615 0.245 . . . . 0.0 110.793 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -83.8 49.04 1.53 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.669 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.7 -175.9 3.58 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.545 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 m -104.3 -164.59 1.07 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.3 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 13.7 p -56.77 -31.71 64.9 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.753 0.311 . . . . 0.0 110.714 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.48 148.34 13.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.629 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.41 139.46 21.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.28 95.2 4.45 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.73 104.69 17.25 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.078 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.433 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 1.8 mt-10 -80.23 83.14 6.14 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.227 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 55' ' ' ASP . 14.8 p -84.41 142.85 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.434 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.61 117.98 31.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 mttm . . . . . 0 N--CA 1.464 0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.936 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.631 HG22 ' CD1' ' A' ' 21' ' ' ILE . 1.5 t . . . . . 0 CA--C 1.531 0.226 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.284 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 40.0 tt0 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.222 0.534 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.763 HD12 HD12 ' A' ' 58' ' ' LEU . 42.6 mm -84.52 125.69 40.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.608 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.48 HD12 HG13 ' A' ' 9' ' ' VAL . 1.2 pp -140.49 137.67 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.848 0.356 . . . . 0.0 111.119 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.683 HG23 ' HB2' ' A' ' 87' ' ' GLU . 1.0 OUTLIER -105.08 113.03 26.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.887 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.48 HG13 HD12 ' A' ' 7' ' ' ILE . 26.9 m -100.51 151.91 5.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.166 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.22 119.69 25.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.771 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mt -132.97 162.54 31.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.41 ' HG2' HG22 ' A' ' 83' ' ' VAL . 9.6 mtmt -110.03 138.06 46.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.727 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -64.85 121.47 14.68 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.216 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.34 -50.89 5.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -164.95 41.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.795 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.43 147.28 16.72 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.151 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.7 mmm -68.38 -68.06 0.42 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.453 0.168 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.96 78.57 0.53 Allowed Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.855 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 pp -160.46 179.47 8.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.52 0.2 . . . . 0.0 110.857 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.6 m -129.04 141.56 51.19 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.716 0.293 . . . . 0.0 111.665 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.718 HD11 HG22 ' B' ' 102' ' ' THR . 2.9 pp -137.68 154.77 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.806 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.57 135.13 26.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.989 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.71 146.62 23.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.777 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.63 158.03 43.8 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 111.935 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.31 179.16 4.19 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.856 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.89 -143.61 3.75 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.07 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.66 150.54 28.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.551 0.215 . . . . 0.0 110.878 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.83 28.57 63.41 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.502 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -146.55 106.93 4.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 110.565 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -97.44 39.27 1.21 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.936 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -137.29 -159.83 1.0 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.256 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 32' ' ' LEU . 2.7 tp -146.54 126.81 13.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.507 0.194 . . . . 0.0 110.747 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.15 142.69 15.64 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.822 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.666 HG12 ' HB1' ' A' ' 73' ' ' ALA . 1.6 mp -86.69 135.16 25.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.774 0.321 . . . . 0.0 110.502 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -125.66 143.93 50.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.011 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 53' ' ' ALA . 39.3 t -81.37 130.01 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.005 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -100.54 -40.74 7.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.327 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -179.48 128.13 0.09 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.633 0.254 . . . . 0.0 110.993 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 m -90.64 133.38 32.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.124 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.9 t -73.56 131.21 35.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -61.56 115.48 3.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.065 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.27 -30.03 3.38 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.786 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.494 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.58 151.19 50.85 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.689 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.66 65.07 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.72 -36.64 84.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -76.22 -45.91 30.73 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.243 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 43' ' ' GLY . 25.3 t -60.26 -38.52 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.365 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.74 -41.57 62.31 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.145 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.24 33.09 18.37 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.984 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -83.83 -54.3 4.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.806 0.336 . . . . 0.0 110.689 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.19 152.64 32.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.818 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.99 175.12 10.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.138 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -61.01 122.81 15.87 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.315 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.4 38.77 2.2 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.926 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 36' ' ' VAL . 29.4 m-20 -135.24 142.31 45.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.517 0.199 . . . . 0.0 110.796 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -93.55 152.97 18.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.933 0.397 . . . . 0.0 110.774 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.427 HD21 HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -101.53 172.12 7.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.023 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.763 HD12 HD12 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -149.87 -54.25 0.16 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.329 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 t -133.87 140.73 47.04 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.66 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.958 HG23 HD11 ' A' ' 65' ' ' LEU . 37.5 t -129.1 120.24 51.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.594 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.59 34.92 25.27 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.184 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.74 35.65 39.64 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.106 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 175.22 8.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.655 0.264 . . . . 0.0 110.851 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -121.34 121.59 37.98 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.139 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.958 HD11 HG23 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -106.18 29.18 6.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.263 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.7 t -87.27 100.27 9.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.231 0.538 . . . . 0.0 110.878 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.97 27.58 5.07 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.593 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 mt -118.84 164.68 15.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -83.97 152.29 24.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.275 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -51.39 -30.89 20.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.337 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -65.37 -51.16 62.31 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.771 0.319 . . . . 0.0 110.498 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -62.97 -40.43 97.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.666 ' HB1' HG12 ' A' ' 34' ' ' ILE . . . -58.32 -60.31 3.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.45 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.567 ' O ' HG22 ' A' ' 78' ' ' THR . . . -61.3 -44.68 96.82 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.848 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -39.09 81.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.048 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.88 -34.89 76.18 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.027 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.595 ' CG ' HG11 ' A' ' 60' ' ' VAL . 11.3 mtp -76.31 -41.6 48.01 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.738 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 74' ' ' ALA . 5.3 t -70.85 -37.36 73.13 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.648 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -89.95 56.08 3.35 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.444 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 p -110.52 178.84 4.25 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.877 0.37 . . . . 0.0 111.246 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -175.75 4.02 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.714 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 m -52.63 -39.29 61.59 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.137 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.41 HG22 ' HG2' ' A' ' 12' ' ' LYS . 24.4 t -97.84 147.84 6.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.925 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.41 134.18 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.64 85.0 2.35 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.427 HD23 HD21 ' A' ' 57' ' ' LEU . 4.1 mt -92.23 139.08 30.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.258 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.683 ' HB2' HG23 ' A' ' 8' ' ' THR . 27.8 tt0 -124.86 98.9 5.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.3 m -105.07 172.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.803 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.43 107.15 17.57 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.942 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 1.7 mmtt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 80.6 p . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 120.559 0.219 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.718 HG22 HD11 ' A' ' 21' ' ' ILE . 1.7 t . . . . . 0 CA--C 1.534 0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.685 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 121.239 0.542 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -96.43 128.08 47.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.666 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 pt -142.66 155.98 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.025 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.568 ' OG1' HG22 ' A' ' 85' ' ' THR . 14.5 t -118.6 128.83 54.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.199 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 t -87.85 91.62 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.634 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 32.4 m -81.51 105.16 12.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.934 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.8 mt -139.4 177.58 7.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.27 153.06 20.8 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.684 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 100.75 0.21 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.879 0.371 . . . . 0.0 111.12 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.38 80.35 2.4 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.406 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m120 56.55 35.62 26.32 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.079 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.05 160.72 28.48 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.614 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.473 ' HB3' HD23 ' A' ' 19' ' ' LEU . 42.1 mtm -77.62 -38.91 46.96 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.497 0.189 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.85 70.4 1.06 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.903 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' CD1' HG23 ' A' ' 21' ' ' ILE . 3.4 pp -160.62 176.76 11.21 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.793 0.33 . . . . 0.0 111.009 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.89 129.23 34.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.668 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 21' ' ' ILE . 2.8 pp -121.83 153.43 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.891 0.377 . . . . 0.0 111.535 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' B' ' 101' ' ' SER . 43.2 t -142.33 146.92 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.231 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.519 ' HB1' ' HG ' ' A' ' 32' ' ' LEU . . . -107.08 147.32 30.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.196 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.74 155.09 39.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.64 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -120.1 179.47 4.27 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.772 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.13 -143.31 3.65 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.908 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.91 146.08 31.44 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.8 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.12 27.89 63.22 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.693 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.57 105.6 3.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.673 0.273 . . . . 0.0 110.486 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -96.3 28.16 3.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.412 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -120.19 -165.53 1.2 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.358 179.423 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.519 ' HG ' ' HB1' ' A' ' 23' ' ' ALA . 1.4 tp -145.03 124.5 13.13 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.628 0.252 . . . . 0.0 110.828 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.23 119.48 5.47 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.478 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 18.6 mm -80.09 74.62 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.938 0.399 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -71.2 168.19 17.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.426 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.52 108.7 25.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.057 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.49 ' HB2' HG23 ' A' ' 22' ' ' VAL . 6.5 tttt -64.33 -45.94 85.66 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.903 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 60.4 p -176.62 155.85 1.39 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 46' ' ' ASP . 11.0 t -103.49 131.79 51.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.881 0.372 . . . . 0.0 110.797 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 t -79.61 132.32 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.974 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 127.98 34.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.008 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.59 -21.43 30.37 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.877 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.582 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.57 157.19 45.17 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.962 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.08 -38.37 76.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.25 -35.65 58.85 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.536 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.503 ' HB2' HG12 ' A' ' 39' ' ' VAL . 16.7 t70 -64.47 -45.11 88.78 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 43' ' ' GLY . 39.5 t -61.77 -34.75 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.5 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.06 -53.95 21.87 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.687 0.28 . . . . 0.0 111.442 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.73 30.58 23.48 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.923 -0.655 . . . . 0.0 113.085 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -44.14 16.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.863 0.363 . . . . 0.0 110.724 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.82 178.77 4.16 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.95 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.22 175.99 11.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.366 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -69.68 132.76 46.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.676 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.77 28.89 8.5 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.5 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.33 174.57 5.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.459 0.171 . . . . 0.0 110.687 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -118.3 144.78 45.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.35 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.588 HD21 HG23 ' A' ' 60' ' ' VAL . 6.6 tt -113.28 140.84 47.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.192 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.47 -58.74 1.83 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.98 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.0 m -136.63 156.77 48.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.935 0.398 . . . . 0.0 111.459 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.751 HG21 ' SD ' ' A' ' 77' ' ' MET . 40.4 t -128.9 122.88 57.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.516 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 t70 67.35 11.68 8.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.445 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.3 18.74 30.11 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.557 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.46 142.63 51.4 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.376 0.588 . . . . 0.0 111.164 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.3 m -74.58 128.67 36.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.391 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.808 HD22 ' HA ' ' A' ' 73' ' ' ALA . 1.4 mt -132.66 31.57 3.96 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.16 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.618 ' O ' HG13 ' A' ' 66' ' ' VAL . 8.0 p -104.35 83.54 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.596 0.713 . . . . 0.0 110.467 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 157.62 -28.92 0.49 Allowed Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.523 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.9 167.91 12.84 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.856 0.36 . . . . 0.0 110.84 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -71.07 158.77 35.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.145 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.609 ' CD ' HD13 ' A' ' 21' ' ' ILE . 12.5 tp60 -54.83 -28.73 51.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.301 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -60.53 -36.48 78.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.348 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.22 -42.39 31.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.645 0.259 . . . . 0.0 110.883 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.808 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -72.47 -51.76 18.78 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.617 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.682 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -59.47 -46.35 89.05 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.415 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 2.9 tp10 -57.37 -45.26 84.62 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.685 0.278 . . . . 0.0 110.569 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.71 -33.49 75.75 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.32 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -60.69 -57.14 13.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.138 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -62.38 -39.3 92.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 110.391 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -84.08 51.92 2.19 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.779 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.37 176.8 5.57 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 111.048 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.43 -173.46 4.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.233 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 t -54.91 -33.4 62.04 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.626 0.25 . . . . 0.0 111.135 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.5 144.35 15.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.063 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 10' ' ' THR . 19.9 t -112.64 145.97 17.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.568 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.6 OUTLIER -143.75 81.14 1.68 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.92 113.16 24.85 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.172 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.08 91.81 6.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.615 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.64 136.13 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.245 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.88 145.56 26.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.423 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.195 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.535 ' HA ' HG22 ' A' ' 22' ' ' VAL . 40.2 t . . . . . 0 N--CA 1.462 0.146 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.682 HG21 ' CB ' ' A' ' 74' ' ' ALA . 18.7 p . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.733 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 19.4 tt0 . . . . . 0 C--O 1.233 0.213 0 CA-C-O 121.064 0.459 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.14 135.97 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.655 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.55 145.9 22.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.634 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -106.62 126.61 52.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.839 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.01 163.77 15.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.176 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -126.44 113.19 16.52 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.597 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.83 143.33 50.88 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -95.1 155.35 16.77 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.04 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -80.11 126.96 31.74 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.043 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' A' ' 44' ' ' ALA . 8.3 mm-40 -95.12 -52.85 4.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.503 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -164.62 44.24 0.09 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.532 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.97 151.01 17.69 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.226 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.1 mmm -74.28 -70.89 0.37 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.481 0.181 . . . . 0.0 110.683 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.31 77.09 0.58 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.82 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.716 ' HB3' HG23 ' A' ' 39' ' ' VAL . 3.4 pp -161.21 177.68 9.99 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.671 0.272 . . . . 0.0 110.992 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 m -130.17 155.76 45.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.477 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.939 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -144.12 164.33 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.778 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 37' ' ' LYS . 64.8 t -140.79 138.75 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.701 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.603 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -88.26 94.97 10.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.804 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.75 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -93.57 146.04 24.09 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.041 0.448 . . . . 0.0 112.109 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -132.65 -179.89 5.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.67 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -177.3 -142.63 4.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.775 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.83 149.34 25.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.615 0.245 . . . . 0.0 110.718 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.92 31.32 75.81 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.779 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.13 103.9 7.24 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.627 0.251 . . . . 0.0 110.731 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -91.1 23.06 3.41 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.222 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -140.77 -164.11 1.67 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.541 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.603 ' CD2' ' HB1' ' A' ' 23' ' ' ALA . 7.0 tp -140.55 116.62 10.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.477 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.26 133.25 11.8 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.471 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.8 mp -92.45 88.74 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 121.054 0.454 . . . . 0.0 110.498 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.75 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 47.0 m-85 -82.28 173.03 12.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.918 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.16 136.34 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 111.356 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.408 ' HB2' HG23 ' A' ' 22' ' ' VAL . 11.6 tttp -98.37 -43.99 6.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.815 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.97 107.9 0.07 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.012 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.716 HG23 ' HB3' ' A' ' 19' ' ' LEU . 14.8 p -81.65 137.41 21.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.1 132.44 32.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.051 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 151.51 47.39 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.94 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.05 -28.79 12.96 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.679 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -68.85 157.65 53.23 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.27 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.478 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . . . -49.33 -40.32 34.85 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.82 -36.82 70.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.398 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -86.09 -39.99 16.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.247 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 43' ' ' GLY . 21.9 t -67.36 -37.68 79.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.87 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -68.7 -43.55 75.8 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.511 0.196 . . . . 0.0 111.202 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.06 75.5 1.09 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.762 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.19 -50.88 0.76 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.538 0.209 . . . . 0.0 110.819 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -123.78 177.57 5.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.099 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.54 -174.31 4.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.413 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.1 152.07 44.75 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.392 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.57 26.16 63.79 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.365 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.03 169.12 8.74 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.629 0.252 . . . . 0.0 110.766 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.437 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 1.3 tt0 -100.25 166.55 10.93 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.59 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.788 HD21 HD12 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -156.05 130.8 9.07 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.99 -44.65 1.04 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.877 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' A' ' 87' ' ' GLU . 22.8 t -95.65 143.34 27.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.583 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.734 HG21 HD12 ' A' ' 65' ' ' LEU . 39.4 t -144.47 121.75 5.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.805 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.12 35.09 25.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.268 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.5 24.04 68.9 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.873 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.4 mtp85 -125.13 -176.55 3.6 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.3 p -123.65 116.24 22.76 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.689 0.28 . . . . 0.0 110.979 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.734 HD12 HG21 ' A' ' 60' ' ' VAL . 37.4 mt -110.68 31.29 6.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.004 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -89.87 101.21 11.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.123 0.487 . . . . 0.0 110.415 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.93 42.85 0.55 Allowed Glycine 0 CA--C 1.518 0.233 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.444 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 65' ' ' LEU . 84.0 mt -117.82 -178.81 3.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.773 0.321 . . . . 0.0 110.764 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.21 19.45 10.61 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.844 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 5.5 tt0 78.49 -54.87 0.48 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.098 0.559 . . . . 0.0 111.581 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -53.37 -43.69 68.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.621 0.248 . . . . 0.0 110.773 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -33.31 75.5 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.657 ' HA ' HD13 ' A' ' 65' ' ' LEU . . . -66.92 -62.8 1.25 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.288 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.939 ' HB2' HD11 ' A' ' 21' ' ' ILE . . . -56.53 -42.1 77.88 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.867 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -60.72 -33.1 72.38 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.122 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 76' ' ' LEU . 7.4 mt -77.82 -46.2 22.21 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.61 0.243 . . . . 0.0 110.898 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.734 ' HG3' HG11 ' A' ' 60' ' ' VAL . 4.6 mtp -57.58 -41.24 80.74 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.187 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 74' ' ' ALA . 8.9 t -73.42 -32.33 64.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.574 0.226 . . . . 0.0 110.563 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.38 49.63 1.85 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.34 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.9 p -115.13 170.32 8.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.656 0.265 . . . . 0.0 111.081 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t -81.58 -170.88 3.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.685 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.51 -48.68 68.79 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 p -85.47 127.81 39.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.979 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.521 HG12 HD22 ' A' ' 86' ' ' LEU . 6.5 t -122.43 141.72 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 m -119.93 106.4 12.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.095 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.788 HD12 HD21 ' A' ' 57' ' ' LEU . 3.3 mm? -109.69 133.14 53.47 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.121 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 45.8 tt0 -115.39 106.02 13.52 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.756 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.538 HG12 HD12 ' A' ' 57' ' ' LEU . 34.2 m -105.24 174.27 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.595 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -123.2 143.39 50.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.895 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.276 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.345 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 94.2 p . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.218 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.49 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 19.9 tt0 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.98 0.419 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.627 HG21 HD12 ' A' ' 58' ' ' LEU . 33.7 mt -103.81 116.78 48.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 pt -142.88 149.55 18.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 111.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.722 HG22 HG22 ' A' ' 85' ' ' THR . 1.3 m -111.3 120.34 41.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.055 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' THR . 12.6 m -96.03 169.56 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.154 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.96 114.44 8.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.801 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -135.16 164.09 28.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.248 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -96.16 144.12 26.67 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -87.86 105.33 17.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.083 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -58.56 3.89 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.588 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.86 36.55 0.4 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.774 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.65 147.37 8.0 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.352 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -52.27 64.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.603 0.239 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.93 64.33 2.35 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.718 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 20' ' ' SER . 4.0 pp -160.54 179.33 8.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.46 0.171 . . . . 0.0 110.727 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.529 ' N ' HD12 ' A' ' 19' ' ' LEU . 75.3 m -138.36 151.69 47.75 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.439 0.162 . . . . 0.0 111.183 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.048 HD13 HG23 ' A' ' 34' ' ' ILE . 2.2 pp -133.72 156.53 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.68 HG23 ' HB2' ' A' ' 37' ' ' LYS . 30.5 t -137.78 133.85 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.91 128.5 35.06 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.887 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.786 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -135.4 143.69 46.14 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.79 0.328 . . . . 0.0 111.471 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -120.33 -179.71 4.04 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.12 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.92 -139.82 2.74 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.734 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.32 150.95 27.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.67 0.271 . . . . 0.0 110.789 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.37 38.23 93.11 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.63 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 107.5 8.1 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.711 0.291 . . . . 0.0 110.855 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -90.29 19.0 5.43 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.545 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -144.77 -169.73 3.24 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.486 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 32' ' ' LEU . 10.6 tp -129.19 142.81 50.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.66 0.267 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.17 128.28 8.93 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.754 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.048 HG23 HD13 ' A' ' 21' ' ' ILE . 1.9 mp -92.15 91.63 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-O 121.155 0.503 . . . . 0.0 110.274 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.786 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 75.8 m-85 -80.16 167.81 19.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.593 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.402 HG11 HG13 ' A' ' 39' ' ' VAL . 43.4 t -94.93 127.48 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 111.094 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.68 ' HB2' HG23 ' A' ' 22' ' ' VAL . 7.8 tptt -80.36 -49.11 11.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.691 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.473 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 52.3 p -178.96 111.08 0.05 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.114 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.402 HG13 HG11 ' A' ' 36' ' ' VAL . 9.2 m -73.58 129.34 36.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.793 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.54 141.46 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.202 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 151.82 42.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.066 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -37.68 3.38 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.742 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.43 151.81 45.58 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.428 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.29 -36.69 43.6 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.87 84.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.738 0.304 . . . . 0.0 111.137 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.0 -39.77 41.21 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.501 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.2 t -58.88 -34.03 51.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.576 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB2' HD21 ' A' ' 11' ' ' LEU . 32.4 t0 -68.53 -55.84 10.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.886 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.15 32.09 11.08 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.708 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -88.23 -43.38 11.64 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.687 0.279 . . . . 0.0 110.896 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.596 ' HB3' HG21 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -116.86 -178.77 3.51 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.886 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.89 -177.33 6.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.377 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -72.9 156.98 38.31 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.97 27.11 71.07 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.751 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -109.53 172.75 6.67 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.631 0.215 . . . . 0.0 110.579 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.632 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 8.5 tm0? -110.05 147.42 33.6 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.6 0.238 . . . . 0.0 110.814 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.895 HD11 HD23 ' A' ' 86' ' ' LEU . 1.7 tp -115.84 142.17 47.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.873 0.368 . . . . 0.0 111.314 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.627 HD12 HG21 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -106.6 -56.27 2.21 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.4 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.4 t -147.28 156.35 42.85 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.055 0.455 . . . . 0.0 111.96 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.888 HG21 ' HG2' ' A' ' 77' ' ' MET . 41.8 t -133.0 121.35 43.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.524 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 60.09 35.23 21.28 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.287 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.3 26.29 73.8 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.263 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.576 ' HD3' HD22 ' A' ' 76' ' ' LEU . 10.0 mtt-85 -96.91 -178.31 4.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.988 0.394 . . . . 0.0 110.799 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -120.67 103.47 9.15 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.66 HD22 ' HA ' ' A' ' 73' ' ' ALA . 36.9 mt -108.39 29.57 7.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.175 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.8 t -111.35 100.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.207 0.527 . . . . 0.0 110.875 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.35 30.7 3.5 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.642 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.612 HD22 ' HG2' ' A' ' 72' ' ' ARG . 10.6 mt -133.47 179.43 6.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.77 0.319 . . . . 0.0 110.307 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.07 168.5 10.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.524 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -61.43 -21.58 64.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.837 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -77.75 -38.09 47.68 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.756 0.312 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HG2' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.09 -56.66 8.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.32 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -61.49 -45.58 93.63 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.616 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.727 ' HB1' HG21 ' B' ' 102' ' ' THR . . . -56.55 -55.15 37.47 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.395 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.53 -36.19 64.0 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.045 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.576 HD22 ' HD3' ' A' ' 63' ' ' ARG . 56.7 mt -72.01 -39.91 68.85 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.254 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.888 ' HG2' HG21 ' A' ' 60' ' ' VAL . 81.9 mtp -64.61 -55.35 20.85 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 74' ' ' ALA . 1.8 t -57.38 -36.28 71.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.851 0.357 . . . . 0.0 110.429 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -83.35 52.04 2.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.656 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.08 168.75 9.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.686 0.279 . . . . 0.0 111.109 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.98 -164.64 1.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.624 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.4 m -57.19 -34.99 69.05 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.3 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -95.99 150.66 4.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG12 ' CD1' ' A' ' 86' ' ' LEU . 21.4 t -132.61 120.58 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.268 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.722 HG22 HG22 ' A' ' 8' ' ' THR . 5.4 m -123.58 95.99 4.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.01 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.895 HD23 HD11 ' A' ' 57' ' ' LEU . 5.3 mp -108.74 141.89 40.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.409 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -107.35 106.93 17.6 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.535 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 51' ' ' LEU . 20.9 t -96.61 149.1 4.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.675 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -121.25 104.36 9.68 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.835 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 7.0 mttm . . . . . 0 C--O 1.233 0.205 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 2.4 p . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.523 0.202 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.727 HG21 ' HB1' ' A' ' 74' ' ' ALA . 1.2 m . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.763 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 30.0 tt0 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.937 0.399 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.3 mt -115.86 125.33 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.767 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.63 138.04 46.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.34 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.732 HG23 ' HG3' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -94.49 145.77 24.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.823 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' ' 50' ' ' ARG . 28.1 m -124.08 125.56 70.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.75 111.71 23.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.76 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.1 mt -131.9 154.49 49.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -91.4 130.48 37.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.764 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.42 122.46 21.28 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.227 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.64 -40.16 5.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.83 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -160.12 43.42 0.2 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 111.214 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.42 -165.22 49.95 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.122 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.0 mtm -127.13 90.73 3.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.768 0.284 . . . . 0.0 110.684 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.77 84.32 0.02 OUTLIER Glycine 0 C--O 1.225 -0.43 0 C-N-CA 121.394 -0.431 . . . . 0.0 113.104 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 20' ' ' SER . 4.1 pp -160.84 178.57 9.29 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.748 0.309 . . . . 0.0 110.942 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.454 ' N ' HD12 ' A' ' 19' ' ' LEU . 2.3 p -131.84 153.87 49.73 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.229 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.815 HD13 HG23 ' A' ' 34' ' ' ILE . 2.9 pp -132.75 157.67 43.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.985 0.422 . . . . 0.0 112.122 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.67 138.26 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.227 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.493 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -83.6 158.01 22.07 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.24 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.707 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -153.88 141.97 20.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -131.1 179.57 5.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.044 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.62 -139.83 2.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.864 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.96 142.71 36.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.587 0.232 . . . . 0.0 110.612 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.96 36.32 92.02 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.691 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -121.91 101.16 7.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 111.013 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.26 19.29 5.21 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.248 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.442 ' O ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -139.26 -171.51 3.13 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.4 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.493 HD12 ' HB1' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -136.12 143.55 44.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.108 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.33 117.95 4.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.454 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.815 HG23 HD13 ' A' ' 21' ' ' ILE . 2.0 mp -93.45 87.69 2.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.177 0.513 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HE1' ' HB3' ' A' ' 24' ' ' ALA . 45.6 m-85 -80.61 172.53 13.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.626 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.4 t -103.39 148.15 8.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.644 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.0 -37.23 2.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.709 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 m -153.24 130.93 11.55 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.771 0.32 . . . . 0.0 111.205 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.4 106.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.201 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 t -68.32 135.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.374 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.14 147.56 49.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.966 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.58 -14.61 63.02 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.226 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.634 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.27 -155.07 3.08 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.677 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.56 -41.82 10.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.668 0.27 . . . . 0.0 111.487 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.469 ' HB1' HD12 ' A' ' 51' ' ' LEU . . . -71.26 -33.41 69.77 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.065 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -71.31 -38.45 71.73 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' GLY . 50.0 t -66.31 -54.19 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 111.566 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -63.66 -50.6 68.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.136 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.7 68.43 1.23 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.212 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.556 ' HB3' HG11 ' A' ' 9' ' ' VAL . 21.6 mmt85 -145.06 33.68 1.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.821 0.343 . . . . 0.0 110.648 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.469 HD12 ' HB1' ' A' ' 45' ' ' ALA . 4.0 mt -152.48 176.08 12.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.213 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.32 142.56 4.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.096 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.96 124.0 19.97 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.942 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.82 29.33 6.22 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.405 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.567 ' HB3' HG23 ' A' ' 88' ' ' VAL . 4.0 m-20 -115.81 159.81 20.98 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.521 0.201 . . . . 0.0 110.805 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 48.3 tt0 -96.47 154.8 17.07 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.047 0.451 . . . . 0.0 112.046 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.11 100.23 6.47 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.355 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -69.45 -59.73 2.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.247 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -139.44 159.04 43.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.852 HG13 ' HG ' ' A' ' 86' ' ' LEU . 38.9 t -132.89 124.55 50.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.988 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.1 t70 56.42 31.36 18.65 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.031 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.96 35.44 58.96 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.804 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -101.99 14.2 32.63 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.74 87.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.38 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.895 HD23 HD12 ' A' ' 68' ' ' LEU . 5.5 mt -111.82 61.87 0.62 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.302 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -130.22 98.52 3.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.109 0.48 . . . . 0.0 110.977 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.79 -25.71 4.39 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.747 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.895 HD12 HD23 ' A' ' 65' ' ' LEU . 88.5 mt -66.44 174.76 2.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.15 0.5 . . . . 0.0 111.334 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.0 m -88.73 162.72 16.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.989 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -52.66 -28.48 21.77 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.555 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -77.66 -54.52 6.28 Favored 'General case' 0 C--N 1.335 -0.054 0 CA-C-O 120.575 0.226 . . . . 0.0 111.057 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -56.94 -34.68 68.24 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.29 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.495 ' HB3' HG12 ' A' ' 34' ' ' ILE . . . -70.89 -59.62 2.69 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.366 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.656 ' O ' HG22 ' A' ' 78' ' ' THR . . . -56.57 -48.34 77.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.26 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -57.08 -44.72 83.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.87 -37.62 82.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.621 0.248 . . . . 0.0 111.033 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.781 ' HG2' HG21 ' A' ' 60' ' ' VAL . 56.6 mtp -61.95 -56.52 18.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.437 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 74' ' ' ALA . 1.6 t -61.12 -38.13 85.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.769 0.319 . . . . 0.0 110.506 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -85.5 53.07 2.63 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.454 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.51 179.5 4.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.735 0.302 . . . . 0.0 111.1 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.53 -165.59 1.34 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.749 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.3 m -55.75 -47.51 76.85 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.28 143.74 10.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.881 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.1 t -136.65 111.05 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.054 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.494 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -106.57 83.76 1.91 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.541 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.852 ' HG ' HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -93.62 137.48 32.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.426 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.732 ' HG3' HG23 ' A' ' 8' ' ' THR . 8.4 mt-10 -103.13 140.33 37.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.677 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 55' ' ' ASP . 11.8 p -128.7 138.16 55.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.366 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -109.53 116.65 32.18 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.711 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.216 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.136 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.755 0.312 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 C--O 1.233 0.206 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.495 179.586 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.06 0.457 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.647 HG21 HD13 ' A' ' 58' ' ' LEU . 4.5 mp -91.2 135.38 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.814 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.568 HD12 HG13 ' A' ' 9' ' ' VAL . 1.5 pp -142.27 138.26 29.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.259 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.918 HG22 HG22 ' A' ' 85' ' ' THR . 3.2 m -104.08 98.54 8.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.568 HG13 HD12 ' A' ' 7' ' ' ILE . 19.2 m -89.17 169.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.44 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -125.18 109.22 12.6 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.755 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 50' ' ' ARG . 2.6 mt -109.52 155.26 21.59 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.768 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -107.52 118.82 37.74 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.725 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -62.45 100.73 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.86 87.48 3.31 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.727 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.12 39.58 28.93 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.208 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.93 153.87 30.53 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.171 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.856 ' O ' HG11 ' A' ' 40' ' ' VAL . 7.5 mtm -80.28 -79.92 0.14 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.648 0.224 . . . . 0.0 111.038 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.75 -0.74 27.45 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.149 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 20' ' ' SER . 3.5 pp -79.86 173.8 12.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 117.071 0.436 . . . . 0.0 110.828 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.467 ' N ' HD12 ' A' ' 19' ' ' LEU . 57.9 m -127.12 151.62 48.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.74 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 34' ' ' ILE . 2.2 pp -139.75 150.83 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.554 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.857 HG23 ' HB2' ' A' ' 37' ' ' LYS . 85.7 t -126.15 145.67 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.274 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . . . -107.2 119.9 40.66 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.748 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.9 151.47 44.29 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.414 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.401 ' HG3' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -118.71 -179.74 3.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.048 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.63 -139.68 2.73 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.35 143.89 38.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.628 0.251 . . . . 0.0 110.801 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.37 41.59 99.56 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.652 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 107.26 7.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.719 0.295 . . . . 0.0 110.973 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.429 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 24.5 t0 -91.93 20.51 5.68 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.316 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.429 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -141.19 -167.87 2.49 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.307 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 25' ' ' LYS . 5.6 tp -136.61 126.2 25.32 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.36 130.39 10.1 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.946 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 21' ' ' ILE . 21.3 mm -95.19 71.13 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.073 0.463 . . . . 0.0 110.835 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 94.4 m-85 -62.16 160.51 12.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 55' ' ' ASP . 23.2 t -96.25 121.22 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.731 0.3 . . . . 0.0 111.277 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.857 ' HB2' HG23 ' A' ' 22' ' ' VAL . 6.3 tttp -80.19 -43.66 21.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.042 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.8 p -156.41 178.23 10.55 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.94 123.05 12.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.673 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.856 HG11 ' O ' ' A' ' 17' ' ' MET . 2.1 p -50.4 132.03 10.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.66 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.84 92.78 8.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.01 -21.64 2.64 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.148 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.64 -167.83 7.26 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.066 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.52 -1.32 53.45 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.45 -43.14 8.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.749 0.309 . . . . 0.0 111.013 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -72.69 -44.97 61.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.524 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.4 t -64.86 -39.53 85.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.541 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.46 -47.92 62.43 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.927 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.22 44.52 6.22 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.665 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.496 ' HB3' HG11 ' A' ' 9' ' ' VAL . 21.9 mmt85 -102.56 -38.63 7.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.547 0.213 . . . . 0.0 110.965 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.437 HD23 HD11 ' A' ' 11' ' ' LEU . 3.9 pp -126.79 158.85 35.49 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.894 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.29 -174.95 4.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.193 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.54 138.94 43.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 39.42 9.98 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.875 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 36' ' ' VAL . 63.5 m-20 -116.16 138.19 51.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.514 0.197 . . . . 0.0 110.742 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.444 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -81.11 147.75 29.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.059 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 2.1 tp -101.02 154.36 18.77 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 111.563 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.647 HD13 HG21 ' A' ' 6' ' ' ILE . 2.3 tt -140.54 -57.53 0.53 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.032 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.53 156.72 48.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.254 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG11 ' CG ' ' A' ' 77' ' ' MET . 29.3 t -141.49 123.43 13.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.827 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.57 33.05 22.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.313 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.44 27.93 71.94 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.042 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -115.07 165.38 12.96 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.827 0.314 . . . . 0.0 110.825 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.43 106.99 17.66 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.547 HD21 HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -119.99 33.22 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.571 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.89 98.86 4.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.24 0.543 . . . . 0.0 110.695 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.34 28.81 3.92 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.64 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 68' ' ' LEU . 17.0 mt -110.42 158.44 18.47 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.764 0.316 . . . . 0.0 110.737 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.67 153.01 42.88 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.391 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 49.3 tt0 -52.01 -34.55 43.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.76 -48.53 71.52 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.313 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -63.51 -44.31 94.65 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.609 0.242 . . . . 0.0 111.335 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -59.67 -56.24 24.4 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.71 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.584 ' O ' HG22 ' A' ' 78' ' ' THR . . . -62.93 -45.97 89.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.075 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -57.79 -26.3 61.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.547 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.3 mt -74.63 -47.87 29.63 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.606 ' CG ' HG11 ' A' ' 60' ' ' VAL . 4.6 mtp -60.43 -48.06 83.38 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.355 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 74' ' ' ALA . 1.4 t -61.12 -36.12 78.87 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.83 0.348 . . . . 0.0 110.304 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.98 52.57 2.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.843 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.456 HG21 HG13 ' A' ' 84' ' ' VAL . 34.9 p -118.01 176.48 5.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 111.072 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -92.54 -163.86 1.1 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.517 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.03 -34.03 58.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.945 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.59 140.8 22.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.904 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.53 HG12 ' CD1' ' A' ' 86' ' ' LEU . 15.0 t -136.76 118.2 18.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.918 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -96.63 100.54 12.1 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.53 ' CD1' HG12 ' A' ' 84' ' ' VAL . 4.8 mp -100.77 116.99 33.95 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.204 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 28.8 tt0 -101.4 101.52 12.16 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.547 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.02 171.32 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.625 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.31 135.94 53.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.096 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt . . . . . 0 C--O 1.232 0.156 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.457 179.885 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 120.814 0.34 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.449 HG21 ' CB ' ' A' ' 74' ' ' ALA . 19.7 m . . . . . 0 N--CA 1.465 0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.593 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.256 0.551 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.448 HG12 ' CD1' ' A' ' 58' ' ' LEU . 4.6 mp -80.03 122.33 35.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.176 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.14 138.76 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.337 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.795 HG22 HG22 ' A' ' 85' ' ' THR . 0.2 OUTLIER -100.37 126.58 46.75 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.476 HG13 ' HD2' ' A' ' 50' ' ' ARG . 22.0 t -114.38 131.22 67.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 m -105.31 123.39 47.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.917 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.505 HD21 ' CG ' ' A' ' 48' ' ' ASP . 10.3 mt -140.72 160.18 40.6 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.118 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 mtmm -101.23 163.76 12.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -90.96 98.42 11.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -74.86 -53.14 9.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.2 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -166.46 45.28 0.06 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.347 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.75 150.38 14.31 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.226 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -60.08 3.31 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.688 0.244 . . . . 0.0 110.479 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.93 72.23 1.03 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.324 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 pp -161.14 178.02 9.7 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.446 0.165 . . . . 0.0 110.698 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -127.54 141.48 51.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.669 0.271 . . . . 0.0 111.615 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 21' ' ' ILE . 2.3 pp -132.59 159.91 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.409 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' B' ' 101' ' ' SER . 61.8 t -146.64 148.05 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.356 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -104.35 147.88 27.02 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.056 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.77 149.8 30.21 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.83 0.347 . . . . 0.0 111.762 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -121.79 -179.9 4.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.81 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.2 -144.01 3.82 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.978 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.14 145.15 37.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.603 0.24 . . . . 0.0 110.748 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.81 30.6 63.14 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.587 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.74 108.83 4.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.682 0.277 . . . . 0.0 110.67 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -93.96 27.56 2.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.384 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -116.04 -165.48 1.05 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.421 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.4 tp -144.57 136.87 26.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.632 0.253 . . . . 0.0 111.119 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.35 116.68 5.62 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.625 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.1 mp -85.48 81.54 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.368 0.604 . . . . 0.0 110.496 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 56' ' ' GLN . 93.4 m-85 -79.8 145.59 32.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.106 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.9 t -83.47 123.3 38.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.901 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HB2' HG23 ' A' ' 22' ' ' VAL . 10.3 tptt -82.38 -43.21 17.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.846 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 t -169.01 -179.92 3.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.2 t -132.78 129.94 58.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.706 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.36 129.75 36.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.016 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.8 136.8 58.11 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.62 -26.67 17.27 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.7 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.74 158.73 46.69 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.784 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.3 -39.3 72.5 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.02 -39.62 63.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.196 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -60.35 -38.96 85.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 43' ' ' GLY . 36.7 t -73.35 -38.76 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.335 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.505 ' CG ' HD21 ' A' ' 11' ' ' LEU . 1.1 t0 -59.46 -43.26 93.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.319 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.78 36.48 57.9 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.946 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.476 ' HD2' HG13 ' A' ' 9' ' ' VAL . 19.3 mtt-85 -98.93 -45.9 5.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.781 0.29 . . . . 0.0 110.889 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.4 pp -101.84 171.46 7.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.783 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.75 -173.13 3.8 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.281 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.42 157.75 23.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.47 30.46 71.17 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.696 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.67 -177.02 3.25 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.562 0.22 . . . . 0.0 110.792 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 65.8 tt0 -125.85 152.74 45.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.945 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.754 HD11 HD21 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -112.16 142.84 44.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.126 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -115.17 -54.65 2.54 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.351 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.3 p -140.12 154.36 46.98 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.086 0.47 . . . . 0.0 111.95 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.84 HG23 HD11 ' A' ' 65' ' ' LEU . 59.6 t -132.09 112.84 20.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.518 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.09 35.48 26.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.997 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.07 31.98 45.86 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.041 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -128.9 149.3 50.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.815 0.307 . . . . 0.0 110.655 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t -92.27 132.62 36.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.169 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.84 HD11 HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -107.83 -28.9 9.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.494 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.07 99.24 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.188 0.518 . . . . 0.0 111.017 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 142.87 -35.39 1.7 Allowed Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.882 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.797 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -88.11 166.49 14.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.1 t -72.5 161.07 31.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.757 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 23' ' ' ALA . 3.4 tt0 -53.46 -44.2 68.72 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.067 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -61.4 -39.61 91.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.704 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.37 -35.86 73.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.866 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.797 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . . . -72.04 -61.01 1.94 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.383 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.526 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -54.23 -39.76 67.06 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.313 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HG3' ' CD ' ' A' ' 79' ' ' ARG . 1.7 tt0 -62.55 -50.11 72.62 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.843 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.83 -32.17 65.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.217 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.555 ' CG ' HG21 ' A' ' 60' ' ' VAL . 22.4 mtp -71.22 -58.83 3.17 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.565 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.8 t -59.36 -33.98 71.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.811 0.338 . . . . 0.0 110.709 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.409 ' CD ' ' HG3' ' A' ' 75' ' ' GLU . 66.4 mtp85 -86.43 51.98 2.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.516 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 p -110.09 -178.99 3.66 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.678 0.275 . . . . 0.0 110.95 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.16 -174.03 4.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.83 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.5 p -52.33 -44.11 64.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.22 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.73 140.38 16.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.844 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.28 121.27 65.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.072 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.795 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -113.23 80.87 1.41 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.785 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.754 HD21 HD11 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -90.31 121.8 32.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.938 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.671 ' HB2' HG23 ' A' ' 8' ' ' THR . 24.9 tt0 -104.19 103.8 13.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.5 m -102.32 170.86 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.116 0.484 . . . . 0.0 111.64 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.8 98.11 6.65 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.993 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.491 ' HA ' HG22 ' A' ' 22' ' ' VAL . 27.2 t . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 120.802 0.334 . . . . 0.0 111.791 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.526 HG21 ' CB ' ' A' ' 74' ' ' ALA . 31.6 m . . . . . 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.351 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 8.6 tt0 . . . . . 0 C--O 1.233 0.2 0 CA-C-O 121.091 0.472 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.76 125.84 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.629 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.626 HD12 HG13 ' A' ' 9' ' ' VAL . 1.3 pt -141.65 142.79 28.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.262 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.746 HG23 ' HB2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -99.77 116.62 32.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.887 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.626 HG13 HD12 ' A' ' 7' ' ' ILE . 27.2 m -111.2 146.54 16.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.41 HG22 ' CG1' ' A' ' 83' ' ' VAL . 2.1 m -119.95 127.7 52.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.833 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mt -133.38 166.1 23.3 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.407 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -109.83 176.7 4.97 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 mtpt -106.28 92.25 4.05 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.846 0.355 . . . . 0.0 111.361 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -45.41 38.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.439 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -167.05 45.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.209 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.92 145.34 15.32 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.152 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -41.3 98.56 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.643 0.222 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.77 68.3 1.74 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.051 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.487 ' HA ' HG23 ' A' ' 40' ' ' VAL . 2.3 pp -160.75 168.38 24.91 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.553 0.216 . . . . 0.0 111.017 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 m -116.16 153.36 31.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.122 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.089 HD11 HG22 ' B' ' 102' ' ' THR . 2.6 pp -124.17 165.52 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.707 0.289 . . . . 0.0 111.682 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.502 HG23 ' HB2' ' A' ' 37' ' ' LYS . 25.7 t -151.42 140.81 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.465 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.84 158.59 18.69 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.714 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -155.22 132.83 11.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.927 0.394 . . . . 0.0 111.64 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -128.9 179.85 5.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.761 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.72 -140.04 3.02 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.73 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.07 147.79 28.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.629 0.252 . . . . 0.0 110.634 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.25 36.54 92.59 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.693 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.53 106.37 7.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.64 0.257 . . . . 0.0 110.776 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -90.16 20.79 4.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.516 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.595 ' CB ' HG12 ' A' ' 66' ' ' VAL . 21.4 mmtp -144.33 -169.16 3.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.822 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 24' ' ' ALA . 4.7 mt -138.39 131.06 29.32 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.782 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.69 151.05 21.53 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.924 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.675 HG13 ' HB1' ' A' ' 73' ' ' ALA . 23.8 mm -106.39 110.3 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.726 0.298 . . . . 0.0 111.215 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.714 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 6.4 m-85 -103.5 174.1 6.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.207 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.405 HG13 HD13 ' A' ' 19' ' ' LEU . 47.0 t -111.85 112.11 39.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.008 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.502 ' HB2' HG23 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -60.29 -49.64 76.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.592 179.394 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.4 p -176.61 131.4 0.2 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.0 t -82.74 127.29 39.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.427 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 19' ' ' LEU . 14.8 t -80.06 127.6 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.09 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 128.45 36.38 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.74 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.56 -19.86 11.3 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.967 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.12 -162.27 5.79 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.667 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.06 -34.6 14.33 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.49 -33.8 54.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -67.96 -47.62 68.12 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 43' ' ' GLY . 55.7 t -60.61 -42.18 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.558 0.218 . . . . 0.0 111.336 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.21 -35.67 79.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.148 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.38 45.09 88.55 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.902 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.76 -34.2 10.99 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.577 0.227 . . . . 0.0 110.954 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.7 147.61 50.13 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.006 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.57 -168.59 1.35 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.36 146.81 44.9 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.351 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.45 47.13 23.15 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.245 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.49 129.99 56.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.478 0.18 . . . . 0.0 110.782 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 35' ' ' TYR . 2.1 tm0? -80.62 145.53 31.65 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.02 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.46 HD22 HD23 ' A' ' 86' ' ' LEU . 6.6 mt -117.04 120.92 39.85 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.765 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.41 -58.33 2.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.9 p -130.76 163.92 26.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.579 HG11 ' HG2' ' A' ' 77' ' ' MET . 24.9 t -139.73 114.99 7.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.12 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.34 24.28 12.81 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.508 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.18 28.96 26.58 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.77 160.5 27.17 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 110.636 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -101.96 114.54 28.73 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.698 ' CD2' HD13 ' A' ' 76' ' ' LEU . 51.3 mt -114.63 31.91 6.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.015 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.595 HG12 ' CB ' ' A' ' 31' ' ' LYS . 69.2 t -114.26 100.85 11.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.143 0.497 . . . . 0.0 110.667 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.08 -35.45 1.47 Allowed Glycine 0 CA--C 1.517 0.207 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.627 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.9 168.64 13.22 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 110.459 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 t -64.71 157.57 27.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.181 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.76 ' CD ' HD13 ' A' ' 21' ' ' ILE . 8.6 tp-100 -52.24 -31.08 30.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.928 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.26 -52.23 65.25 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.954 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -43.19 94.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.045 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.675 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -67.45 -61.47 1.89 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.679 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 78' ' ' THR . . . -55.74 -36.12 66.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.631 0.253 . . . . 0.0 111.378 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.408 ' HG2' ' NH2' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -74.72 -34.6 62.61 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.411 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.698 HD13 ' CD2' ' A' ' 65' ' ' LEU . 3.2 mt -68.9 -44.15 73.77 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.482 0.182 . . . . 0.0 110.968 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.579 ' HG2' HG11 ' A' ' 60' ' ' VAL . 36.2 mtp -59.75 -52.46 65.39 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.563 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 74' ' ' ALA . 3.6 t -62.35 -36.75 83.21 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.665 0.269 . . . . 0.0 110.764 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 75' ' ' GLU . 60.0 mtm180 -87.73 53.94 2.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.632 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.2 p -108.76 176.2 5.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 111.005 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.59 -174.55 1.75 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.429 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 m -52.27 -34.26 45.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.628 0.252 . . . . 0.0 111.125 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.41 ' CG1' HG22 ' A' ' 10' ' ' THR . 21.3 t -107.71 151.4 9.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.92 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.8 t -137.65 118.37 16.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.518 HG22 HG22 ' A' ' 8' ' ' THR . 24.0 m -104.58 94.34 5.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.843 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.46 HD23 HD22 ' A' ' 57' ' ' LEU . 3.4 mp -98.95 138.42 36.09 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.411 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.746 ' HB2' HG23 ' A' ' 8' ' ' THR . 48.5 tt0 -114.89 99.74 7.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.714 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.1 m -101.98 173.83 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.041 0.448 . . . . 0.0 111.746 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.87 123.34 39.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.126 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 1.7 mptm? . . . . . 0 C--O 1.233 0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.607 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.804 0.335 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 102' ' ' THR . . . . . 1.089 HG22 HD11 ' A' ' 21' ' ' ILE . 5.2 t . . . . . 0 CA--C 1.53 0.204 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.907 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 121.052 0.453 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mt -84.06 113.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.85 141.01 45.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 27.5 m -104.87 141.33 36.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -119.59 127.93 75.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.283 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 m -99.42 103.54 15.33 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.671 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -143.9 149.01 36.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.359 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.18 167.78 14.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.208 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.66 124.89 28.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.62 85.48 2.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.38 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 m120 58.38 34.56 24.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.946 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.11 158.0 31.0 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.669 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.49 -48.57 16.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.534 0.207 . . . . 0.0 110.634 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.48 74.96 0.55 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.555 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 pp -160.74 173.82 14.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.556 0.217 . . . . 0.0 110.776 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -124.35 149.58 46.46 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.804 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' HG22 ' A' ' 34' ' ' ILE . 8.6 pt -137.71 154.48 29.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.8 t -147.12 134.97 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.251 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.664 ' HB2' ' OE1' ' A' ' 70' ' ' GLN . . . -88.96 144.43 26.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.952 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.41 159.44 35.76 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.837 0.351 . . . . 0.0 111.783 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.45 179.31 4.63 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.052 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.88 -144.06 3.85 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.888 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.07 150.31 28.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.645 0.26 . . . . 0.0 110.865 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.79 28.82 60.84 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.586 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -146.78 107.98 4.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.651 0.262 . . . . 0.0 110.455 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -97.57 37.42 1.37 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -133.52 -164.62 1.51 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.477 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tp -147.53 125.76 12.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.68 0.276 . . . . 0.0 110.772 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.76 137.57 13.34 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.607 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.601 HG13 ' HB1' ' A' ' 73' ' ' ALA . 18.8 mm -86.6 72.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.107 0.48 . . . . 0.0 110.736 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -60.23 160.18 8.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.348 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 t -100.96 115.09 41.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.964 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.4 -46.78 78.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.791 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -178.94 124.87 0.09 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.902 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.5 m -72.67 142.51 15.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.089 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.91 137.67 21.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.38 153.25 27.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.213 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.05 14.94 76.32 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.884 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -92.18 159.39 25.3 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.296 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.23 69.42 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -83.3 -34.41 25.72 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.291 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.11 -47.09 69.12 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.309 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.2 t -63.81 -46.53 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.4 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -43.95 97.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.168 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.47 64.96 1.77 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.839 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -136.78 23.47 3.1 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.632 0.253 . . . . 0.0 111.374 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.1 pp -179.83 177.97 0.65 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.755 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.77 -170.05 2.07 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.187 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.406 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -72.44 160.23 32.67 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.914 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.91 31.24 80.26 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.244 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.8 124.69 45.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.59 0.234 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.643 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 8.7 tm0? -79.47 117.57 20.55 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.057 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.539 HD11 HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -88.75 136.09 33.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.198 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.451 HD13 ' CG2' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -108.54 -63.01 1.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.837 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 58.8 m -127.91 145.49 50.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.196 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' A' ' 77' ' ' MET . 39.2 t -120.87 118.19 55.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.667 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 60.56 32.01 20.34 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.105 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.73 -6.28 70.66 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.273 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -80.53 154.62 27.41 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 117.186 0.493 . . . . 0.0 111.057 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.35 101.09 12.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.658 HD23 HD12 ' A' ' 68' ' ' LEU . 6.4 mt -110.42 44.2 1.28 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.688 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.451 ' CG2' HD13 ' A' ' 58' ' ' LEU . 60.3 t -101.8 99.97 9.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.719 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.83 -29.25 5.66 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.759 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.658 HD12 HD23 ' A' ' 65' ' ' LEU . 65.7 mt -65.36 168.59 6.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 111.241 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.0 t -87.22 168.16 13.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.449 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.664 ' OE1' ' HB2' ' A' ' 23' ' ' ALA . 5.9 tp60 -58.24 -29.44 65.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.003 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.47 -56.01 27.39 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.786 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -63.21 -45.99 89.11 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.693 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -59.07 -58.39 8.87 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.972 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.893 ' HB1' HG21 ' B' ' 102' ' ' THR . . . -49.07 -48.56 44.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.712 0.291 . . . . 0.0 111.387 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -61.76 2.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.739 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.59 HD12 HD21 ' A' ' 65' ' ' LEU . 16.8 mt -56.22 -30.53 62.44 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.494 ' HA ' HG11 ' A' ' 60' ' ' VAL . 4.3 mmm -66.01 -64.15 0.92 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.8 -0.182 . . . . 0.0 111.175 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 74' ' ' ALA . 3.4 t -62.4 -35.82 80.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.775 0.322 . . . . 0.0 110.729 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -85.33 49.4 1.75 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.333 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.89 169.56 10.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.717 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.14 -169.34 0.93 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.822 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.63 -54.55 21.98 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.697 0.284 . . . . 0.0 110.86 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.73 147.16 5.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.692 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.489 HG12 HD13 ' A' ' 86' ' ' LEU . 33.3 t -121.78 111.63 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.987 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.14 105.85 14.7 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.781 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.539 HD23 HD11 ' A' ' 57' ' ' LEU . 5.4 mp -115.2 131.13 57.03 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.942 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 2.3 mt-10 -102.16 95.55 6.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.3 m -89.66 172.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.256 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -130.48 118.77 21.62 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.52 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.228 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.643 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 53.9 p . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 120.716 0.294 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.893 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.73 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 1.4 tt0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.984 0.421 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.63 131.14 43.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.881 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.0 pt -150.74 154.89 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.198 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.72 ' CG2' HG22 ' A' ' 85' ' ' THR . 1.8 m -122.49 132.25 54.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.6 t -115.78 136.8 51.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.183 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -101.68 112.14 24.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.656 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 mt -134.74 168.67 18.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.236 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.1 157.28 19.53 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -86.33 69.75 10.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.488 HE22 ' HB2' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -43.79 -41.27 4.88 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.701 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -172.77 44.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.294 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.46 152.23 25.17 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.178 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.421 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -74.91 -51.42 13.84 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.571 0.224 . . . . 0.0 110.821 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.06 80.77 0.12 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.083 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -160.92 -179.76 7.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.619 0.247 . . . . 0.0 110.88 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 37' ' ' LYS . 15.3 m -125.28 141.69 51.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.067 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.538 HD13 HG23 ' A' ' 34' ' ' ILE . 2.4 pp -136.26 157.47 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.832 0.348 . . . . 0.0 111.796 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -145.32 148.59 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.235 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.09 131.97 46.76 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.235 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.86 146.89 38.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.493 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HG3' HD12 ' A' ' 32' ' ' LEU . 11.5 tttt -122.83 -179.73 4.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.957 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.39 -140.57 2.91 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.751 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.3 147.27 32.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.586 0.231 . . . . 0.0 110.779 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.78 40.89 97.25 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.614 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.53 106.24 7.33 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.715 0.293 . . . . 0.0 110.907 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -90.68 24.43 2.69 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.003 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -144.35 -165.83 2.23 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.647 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.425 HD12 ' HG3' ' A' ' 25' ' ' LYS . 6.9 tp -138.67 135.1 34.48 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.798 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.36 127.42 8.78 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.709 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -95.91 94.72 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 121.129 0.49 . . . . 0.0 110.562 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -78.59 168.56 19.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.375 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.412 ' CG2' HD11 ' A' ' 57' ' ' LEU . 21.2 t -101.48 133.9 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.134 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 20' ' ' SER . 4.7 ttpt -97.53 -40.61 8.56 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.9 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.2 m -160.4 174.29 14.35 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.93 123.47 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.795 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.8 t -79.87 153.19 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.261 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -72.01 153.37 41.81 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.154 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.89 8.92 87.54 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.366 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.675 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -96.16 156.48 21.3 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.377 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' HB2' HE22 ' A' ' 14' ' ' GLN . . . -53.59 -43.35 68.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.622 0.249 . . . . 0.0 111.5 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.38 -34.66 74.87 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.242 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.65 -46.1 48.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.339 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.0 t -61.11 -49.34 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.164 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.69 -44.82 89.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.163 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.95 28.55 66.53 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.081 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.84 -47.52 16.46 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.805 0.303 . . . . 0.0 110.894 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.581 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.1 pp -109.73 170.42 8.08 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.96 177.76 7.58 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.169 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.92 141.72 53.05 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.43 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.48 43.57 4.86 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.675 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -128.22 146.03 50.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.686 0.279 . . . . 0.0 110.887 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -83.5 152.55 24.86 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.676 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.578 ' HB3' HD12 ' A' ' 65' ' ' LEU . 7.0 mp -115.0 148.51 38.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.942 0.401 . . . . 0.0 111.72 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.78 -55.17 2.01 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.782 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.7 p -137.58 152.13 49.09 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.9 0.381 . . . . 0.0 111.778 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.782 HG13 ' HG ' ' A' ' 86' ' ' LEU . 38.4 t -143.38 107.52 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.962 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t0 61.14 41.86 13.07 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.161 0.505 . . . . 0.0 110.823 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.99 37.5 38.14 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.058 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.47 162.0 21.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.766 0.283 . . . . 0.0 110.689 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.22 83.66 1.87 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.591 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.691 HD11 ' CG2' ' A' ' 60' ' ' VAL . 40.7 mt -60.8 -22.68 64.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.298 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.1 t -78.21 97.83 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.186 0.517 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.71 32.95 1.04 Allowed Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.288 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.876 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.2 pp -150.16 165.34 33.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 110.57 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.0 p -79.63 161.79 25.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.946 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -56.55 -32.3 65.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.325 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.84 -34.48 64.56 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.491 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -76.23 -33.22 59.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.978 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.876 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . . . -76.28 -58.64 3.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.334 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.69 ' O ' HG22 ' A' ' 78' ' ' THR . . . -56.55 -42.88 79.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.537 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.77 -39.85 93.1 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-O 120.698 0.285 . . . . 0.0 110.812 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.18 -32.2 68.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.291 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.578 ' HG2' HG11 ' A' ' 60' ' ' VAL . 28.1 mtp -72.24 -53.56 12.18 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.608 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 74' ' ' ALA . 2.0 t -60.7 -38.7 85.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.751 0.31 . . . . 0.0 110.795 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.6 mtp85 -87.87 55.94 3.68 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.644 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.4 p -106.52 178.5 4.54 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.895 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.1 p -88.1 -169.69 2.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.697 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.14 -54.77 43.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.631 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.7 t -84.58 139.27 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' THR . 16.8 t -129.7 151.62 36.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.465 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.72 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -135.11 83.27 2.01 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.781 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.782 ' HG ' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -89.71 122.18 32.57 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.098 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.07 97.46 7.43 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.675 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 51' ' ' LEU . 14.3 m -93.07 173.96 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.332 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.87 101.98 6.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.018 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.233 0.221 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.75 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 67.1 p . . . . . 0 CA--C 1.531 0.221 0 CA-C-O 120.762 0.315 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.532 HG21 ' CB ' ' A' ' 74' ' ' ALA . 51.8 m . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.601 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.065 0.459 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 44.4 mm -99.13 127.33 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.814 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -144.34 148.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.3 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.498 HG22 HG22 ' A' ' 85' ' ' THR . 0.2 OUTLIER -115.22 120.65 40.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 50' ' ' ARG . 15.9 m -94.85 153.34 3.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.144 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.04 106.99 10.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.477 HD21 ' CG ' ' A' ' 48' ' ' ASP . 6.6 mt -138.37 169.08 18.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.141 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -104.77 175.75 5.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -87.15 135.25 33.37 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.17 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.37 84.96 2.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.327 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.45 36.75 28.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.729 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.98 144.23 16.33 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.107 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.426 ' HB3' HD23 ' A' ' 19' ' ' LEU . 5.9 mtm -64.84 -46.84 80.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.553 0.216 . . . . 0.0 110.69 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.53 83.66 0.07 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.944 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 17' ' ' MET . 2.8 pp -160.52 -179.4 7.62 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.65 0.262 . . . . 0.0 110.725 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' B' ' 102' ' ' THR . 46.4 m -131.58 142.63 49.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.309 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 21' ' ' ILE . 2.7 pp -137.68 139.83 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.682 HG23 ' HB2' ' A' ' 37' ' ' LYS . 29.7 t -129.71 132.68 65.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.13 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.09 127.5 43.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.844 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.2 147.05 52.4 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.351 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HG3' HD12 ' A' ' 32' ' ' LEU . 4.4 tttt -119.76 -179.76 4.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.037 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.89 -139.85 2.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.14 143.67 38.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.588 0.233 . . . . 0.0 110.741 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.33 44.75 97.21 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.568 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 108.15 6.91 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.639 0.257 . . . . 0.0 110.916 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -92.61 20.02 6.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.363 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -140.28 -166.09 2.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.458 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 32' ' ' LEU . 5.2 tp -136.43 152.02 50.14 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.672 0.272 . . . . 0.0 110.814 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.13 111.37 2.83 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.703 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -81.43 73.0 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.215 0.531 . . . . 0.0 110.503 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -67.5 155.28 39.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.339 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.62 121.55 44.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.259 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.682 ' HB2' HG23 ' A' ' 22' ' ' VAL . 10.2 tptt -85.28 -36.15 21.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.971 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 5.7 t -170.24 175.32 4.96 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 111.23 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.6 t -138.45 118.15 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.2 t -68.55 125.88 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.019 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 153.16 37.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.472 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.01 -29.92 11.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.773 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.678 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.25 154.8 48.22 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.57 58.54 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.802 ' HB1' HD12 ' A' ' 51' ' ' LEU . . . -58.11 -51.36 70.03 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.26 -34.31 55.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.317 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 43' ' ' GLY . 48.1 t -62.85 -34.22 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.706 0.289 . . . . 0.0 110.698 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.477 ' CG ' HD21 ' A' ' 11' ' ' LEU . 16.2 t70 -71.56 -43.35 66.49 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.048 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.68 40.8 5.55 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.811 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HB3' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -131.05 31.93 4.37 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.677 0.275 . . . . 0.0 110.997 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.802 HD12 ' HB1' ' A' ' 45' ' ' ALA . 8.1 mt -150.63 160.3 43.91 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.295 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.02 143.4 3.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.097 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -62.83 132.86 53.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.836 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.81 29.45 6.18 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.483 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.08 -177.48 3.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.46 0.172 . . . . 0.0 110.714 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -127.57 150.77 49.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.823 0.344 . . . . 0.0 111.375 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.21 150.07 29.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.959 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.84 -57.58 1.43 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.093 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 p -139.12 153.44 47.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.461 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.811 HG11 ' HG2' ' A' ' 77' ' ' MET . 23.2 t -137.94 129.04 38.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.624 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 57.56 34.25 24.32 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.789 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.76 21.91 76.67 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.95 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.432 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -107.38 157.08 18.25 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 111.06 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -101.36 98.88 9.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.614 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.696 HD21 HG23 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -105.95 28.84 7.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.788 179.531 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.2 t -87.36 100.95 10.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.217 0.532 . . . . 0.0 110.462 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.46 31.74 2.3 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.536 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 mt -119.93 155.57 32.49 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.723 0.297 . . . . 0.0 110.726 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 87.2 p -68.01 157.39 35.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.162 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.87 ' NE2' HG23 ' B' ' 102' ' ' THR . 23.9 tt0 -52.08 -40.31 61.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.049 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -58.45 -53.72 55.18 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.858 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -61.24 -39.07 88.93 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.894 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.07 -62.86 1.38 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.38 -61.25 2.72 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.56 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -40.85 -44.9 2.38 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.511 0.507 . . . . 0.0 111.881 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.432 HD11 ' CZ ' ' A' ' 63' ' ' ARG . 8.8 mt -58.07 -42.19 84.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.779 0.323 . . . . 0.0 110.797 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.811 ' HG2' HG11 ' A' ' 60' ' ' VAL . 3.7 mtp -80.8 -28.67 36.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.384 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -31.54 72.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.66 0.267 . . . . 0.0 110.699 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -101.18 42.82 1.09 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.315 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 77' ' ' MET . 7.8 p -85.38 168.49 14.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.835 0.35 . . . . 0.0 111.196 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.0 p -91.91 -165.73 1.41 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.732 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 p -51.59 -52.34 48.21 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.083 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.45 141.86 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.219 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -128.63 110.97 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.858 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.498 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -101.22 97.58 8.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.919 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.481 HD23 HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -105.18 136.36 44.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.403 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 33.5 tt0 -106.63 107.32 18.27 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.385 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 p -107.64 151.83 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.615 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . . . -100.88 98.74 9.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.194 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.45 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 85.6 p . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.771 0.319 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' THR . . . . . 0.87 HG23 ' NE2' ' A' ' 70' ' ' GLN . 23.7 p . . . . . 0 N--CA 1.463 0.179 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.344 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ptt? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.833 0.349 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.49 41.43 0.21 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.047 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 7.9 mt-10 62.18 98.97 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.274 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.58 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 3' ' ' GLU . 41.2 Cg_endo -67.31 -173.77 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.755 2.304 . . . . 0.0 112.962 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 16.9 tt0 -116.5 93.31 4.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.174 0.512 . . . . 0.0 110.986 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.89 133.65 32.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.65 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pt -148.08 147.23 17.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.172 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -111.91 124.86 53.28 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 m -101.19 135.9 35.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.431 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 m -103.16 97.54 7.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.571 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 mt -122.19 163.33 19.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.896 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -108.71 141.3 40.9 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.871 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -77.87 111.01 13.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.08 -42.61 17.22 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -168.41 37.42 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.08 174.51 18.65 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.09 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.484 ' HB3' HD23 ' A' ' 19' ' ' LEU . 28.7 mtm -103.69 -46.94 4.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.714 0.257 . . . . 0.0 111.341 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.24 81.62 0.12 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.809 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.492 HD11 ' CG1' ' B' ' 104' ' ' VAL . 2.8 pp -160.52 179.54 8.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.709 0.29 . . . . 0.0 110.868 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -132.81 146.59 51.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.718 0.294 . . . . 0.0 111.353 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.823 HD11 HG22 ' B' ' 102' ' ' THR . 2.7 pp -142.34 153.43 18.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.819 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' A' ' 37' ' ' LYS . 42.1 t -135.84 136.4 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.425 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.564 ' O ' HD22 ' B' ' 99' ' ' LEU . . . -85.69 130.74 34.48 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.073 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.757 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -135.36 142.6 45.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.425 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -122.0 -179.6 4.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.924 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.03 -141.34 3.1 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.85 143.32 33.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.659 0.266 . . . . 0.0 110.675 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.79 34.02 88.56 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.697 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.75 105.03 7.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.686 0.279 . . . . 0.0 110.817 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.11 19.96 6.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.355 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.467 ' HG3' HG12 ' A' ' 66' ' ' VAL . 1.2 mmtp -138.48 -168.75 2.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.749 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 32' ' ' LEU . 6.7 tp -141.64 130.94 23.56 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.719 0.295 . . . . 0.0 110.927 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.51 136.25 12.71 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.741 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.5 HG13 ' HB1' ' A' ' 73' ' ' ALA . 24.5 mm -90.62 83.76 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.69 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.757 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 79.9 m-85 -74.14 162.18 29.23 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.359 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.41 134.86 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.264 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HB2' HG23 ' A' ' 22' ' ' VAL . 2.7 ttpt -105.53 -37.89 6.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 7.0 t -166.05 172.42 11.42 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.691 0.281 . . . . 0.0 110.957 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.0 t -130.89 126.71 60.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.763 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.3 145.17 10.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.009 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -68.14 150.22 48.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.323 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.34 20.23 73.2 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.917 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -93.11 157.58 23.41 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.388 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.77 62.03 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.25 -32.67 22.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.463 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.09 -44.85 59.89 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.296 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 43' ' ' GLY . 45.8 t -66.4 -44.82 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.124 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.34 -37.67 66.02 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.867 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.42 82.61 0.57 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.653 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -133.16 -61.87 0.81 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.625 0.213 . . . . 0.0 111.35 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.29 156.02 16.92 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.336 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.28 173.47 11.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.484 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -69.71 140.41 53.52 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.264 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.37 38.95 8.04 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.491 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -121.32 178.59 4.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.498 0.19 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -125.04 139.98 53.31 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.414 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.697 HD21 ' CG2' ' A' ' 60' ' ' VAL . 8.3 tp -106.9 147.87 29.27 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.064 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.52 -59.31 1.3 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.385 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.54 144.06 50.73 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.963 0.411 . . . . 0.0 111.759 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.843 HG23 HD21 ' A' ' 65' ' ' LEU . 40.4 t -133.86 123.83 45.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.542 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.01 33.13 22.84 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 23.32 77.98 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.074 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -112.96 134.61 54.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 117.018 0.409 . . . . 0.0 110.268 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -83.01 86.42 7.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.843 HD21 HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -89.47 54.75 3.01 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.126 0.489 . . . . 0.0 110.869 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.467 HG12 ' HG3' ' A' ' 31' ' ' LYS . 77.6 t -102.27 99.38 8.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.634 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.71 32.89 2.16 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.623 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.6 mt -117.66 161.75 19.15 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.4 152.87 24.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.299 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.47 ' NE2' HD13 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -47.07 -42.22 18.35 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.625 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -58.45 -49.99 75.33 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.039 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -69.76 -36.26 75.63 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.941 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -67.63 -58.23 5.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.633 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.516 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -60.96 -46.19 91.71 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.595 0.236 . . . . 0.0 111.276 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -55.42 -50.36 70.0 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.939 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.02 -40.65 96.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.393 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.519 ' HG2' HG21 ' A' ' 60' ' ' VAL . 37.9 mtp -58.48 -49.49 77.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.221 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.708 ' HB ' HG23 ' B' ' 104' ' ' VAL . 8.9 t -69.9 -27.88 65.16 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -82.96 43.93 0.89 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.801 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 p -101.37 171.26 7.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.274 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.9 m -85.27 -166.6 1.55 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.614 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -43.32 74.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.564 0.221 . . . . 0.0 110.928 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 t -93.19 140.2 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.647 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.434 HG12 ' HG ' ' A' ' 86' ' ' LEU . 30.2 t -130.36 134.51 62.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.275 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.48 89.74 3.17 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.646 HD23 HG13 ' A' ' 60' ' ' VAL . 17.1 mt -94.54 120.3 34.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.75 101.92 13.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.323 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 p -105.23 150.2 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.353 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.3 148.02 28.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.575 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -101.11 116.13 32.11 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.593 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -165.47 -173.98 2.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.26 139.61 2.79 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.631 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.193 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.564 HD22 ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.04 172.96 6.61 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.481 0.181 . . . . 0.0 110.574 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 27.8 p -124.21 99.28 6.15 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.765 0.317 . . . . 0.0 111.293 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.823 HG22 HD11 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -92.2 -172.59 3.17 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.744 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.464 ' N ' HG23 ' B' ' 102' ' ' THR . 30.6 tt0 -141.53 118.34 11.11 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.755 0.312 . . . . 0.0 110.408 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.708 HG23 ' HB ' ' A' ' 78' ' ' THR . 12.6 p . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.706 -0.664 . . . . 0.0 111.401 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.604 0.24 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt 62.55 -174.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.037 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.59 131.01 31.73 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.66 -164.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.771 2.314 . . . . 0.0 112.692 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 2.6 tt0 -132.44 101.68 5.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.153 0.501 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.73 HD12 HD12 ' A' ' 58' ' ' LEU . 34.0 mm -90.49 127.56 42.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pp -145.34 137.89 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.2 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.894 HG23 ' HG3' ' A' ' 87' ' ' GLU . 2.2 m -92.16 139.35 30.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.96 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.63 HG11 ' HB3' ' A' ' 50' ' ' ARG . 21.8 t -119.47 117.9 55.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.912 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.567 HG23 HG23 ' A' ' 85' ' ' THR . 1.5 m -111.06 102.74 11.17 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.27 157.67 42.66 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -84.19 136.0 34.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.489 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.26 96.75 0.67 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.335 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 14' ' ' GLN . 0.9 OUTLIER -101.75 100.08 10.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.293 0.568 . . . . 0.0 110.428 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 55.04 35.2 24.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.921 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.53 -174.51 36.52 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.4 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.1 mtm -102.69 -36.95 8.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.418 0.151 . . . . 0.0 111.095 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.63 79.75 0.13 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.599 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 51' ' ' LEU . 3.4 pp -160.71 179.81 8.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.669 0.271 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 36' ' ' VAL . 57.7 m -132.18 156.94 45.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.33 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.489 HD12 ' O ' ' A' ' 21' ' ' ILE . 2.8 pp -143.47 146.71 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.681 HG23 ' HB2' ' A' ' 37' ' ' LYS . 40.1 t -133.85 134.83 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.261 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.43 122.14 34.58 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.678 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.91 149.41 48.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.44 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.61 -179.79 3.76 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.264 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.95 -140.13 2.8 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.23 146.05 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.723 0.296 . . . . 0.0 110.771 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.26 41.05 98.15 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.606 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 106.94 7.35 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.671 0.272 . . . . 0.0 110.999 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.36 19.7 5.83 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.256 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.455 ' HG3' HG12 ' A' ' 66' ' ' VAL . 23.2 mmtt -146.97 -171.59 3.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.522 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.9 137.19 55.01 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.731 0.3 . . . . 0.0 110.886 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.83 125.31 8.5 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.627 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.443 HG13 ' HB1' ' A' ' 73' ' ' ALA . 19.3 mm -84.38 84.68 2.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.043 0.449 . . . . 0.0 110.737 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -77.66 168.83 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.512 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 20' ' ' SER . 27.0 t -104.23 129.06 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.403 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.681 ' HB2' HG23 ' A' ' 22' ' ' VAL . 3.0 tttt -83.41 -45.41 13.72 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.603 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -170.4 176.93 4.26 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.058 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.13 127.94 75.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.759 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.92 125.69 40.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.185 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.68 143.86 56.93 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.011 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.74 -15.75 60.47 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.115 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.13 -152.23 3.17 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.803 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.25 -60.47 1.67 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.556 0.217 . . . . 0.0 111.576 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -61.62 -26.45 68.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.856 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.44 -47.74 46.6 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.2 t -73.38 -37.82 52.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.268 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.96 -44.92 45.65 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.094 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.02 65.69 0.99 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.477 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.63 ' HB3' HG11 ' A' ' 9' ' ' VAL . 2.9 mmp_? -141.02 30.79 1.8 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.565 0.221 . . . . 0.0 111.375 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' CD1' HD22 ' A' ' 19' ' ' LEU . 9.3 mt -154.43 171.07 19.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.889 0.376 . . . . 0.0 111.393 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.8 141.76 3.48 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.38 117.09 5.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.6 31.41 3.71 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.617 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.24 -178.19 3.57 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.612 0.244 . . . . 0.0 110.999 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.843 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 6.0 tm0? -124.61 159.0 31.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.222 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 34' ' ' ILE . 64.2 mt -124.05 107.38 11.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.962 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.73 HD12 HD12 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -75.1 -64.44 1.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.179 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 m -147.62 159.11 44.14 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.447 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.793 HG21 ' CG ' ' A' ' 77' ' ' MET . 38.9 t -127.87 125.42 64.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.822 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 55.79 33.85 22.29 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.22 36.61 85.4 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.061 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -119.41 152.75 36.3 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 111.083 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.2 m -79.05 118.2 20.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.204 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.737 HD21 HD12 ' A' ' 76' ' ' LEU . 19.2 mt -126.1 31.4 5.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.046 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.455 HG12 ' HG3' ' A' ' 31' ' ' LYS . 62.5 t -115.1 100.34 10.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.128 0.49 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.414 ' CA ' ' HD2' ' A' ' 31' ' ' LYS . . . 132.55 -32.28 2.84 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.526 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.415 HD12 HD23 ' A' ' 65' ' ' LEU . 54.7 mt -66.5 172.04 4.46 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 110.984 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -84.03 160.03 21.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.078 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.719 HE21 HG23 ' B' ' 102' ' ' THR . 36.8 tt0 -51.93 -33.42 37.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.202 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -60.3 -54.87 40.56 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.022 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -60.32 -38.26 83.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.828 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -52.71 -62.44 1.65 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.237 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.84 -63.98 1.11 Allowed 'General case' 0 C--N 1.335 -0.055 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -36.07 -41.2 0.24 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.05 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.737 HD12 HD21 ' A' ' 65' ' ' LEU . 7.0 mt -66.31 -47.15 74.47 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.793 ' CG ' HG21 ' A' ' 60' ' ' VAL . 11.9 mtp -75.42 -30.45 60.07 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -32.05 69.1 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.635 0.255 . . . . 0.0 110.575 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -92.42 44.45 1.16 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.895 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.0 160.95 24.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.061 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.07 -164.66 1.1 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.038 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 82.5 p -50.27 -42.95 53.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.5 t -96.03 139.45 19.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.734 0.302 . . . . 0.0 110.807 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.88 96.22 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.567 HG23 HG23 ' A' ' 10' ' ' THR . 0.6 OUTLIER -98.02 90.3 4.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.436 ' HG ' HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -115.81 128.8 56.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.955 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.894 ' HG3' HG23 ' A' ' 8' ' ' THR . 12.2 mt-10 -98.93 111.82 24.11 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.48 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.6 142.34 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.561 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.843 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -105.14 108.76 20.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.636 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 8.1 mtmt -71.01 133.68 46.53 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.162 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -94.08 174.7 7.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.22 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -97.38 1.45 60.42 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.812 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.222 179.654 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 mt . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.921 0.391 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.463 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -121.75 -174.96 2.99 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.31 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.539 ' HB3' ' HD3' ' A' ' 37' ' ' LYS . 35.3 p -138.7 102.85 4.69 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.809 0.338 . . . . 0.0 111.876 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.719 HG23 HE21 ' A' ' 70' ' ' GLN . 39.2 p -94.57 -173.12 2.94 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.317 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.6 pt-20 -141.26 101.6 4.05 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.803 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.699 HG21 ' HB2' ' A' ' 77' ' ' MET . 10.2 p . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.421 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.715 0.293 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 33.83 4.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.918 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -133.51 97.97 15.5 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -58.36 -178.53 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.071 2.514 . . . . 0.0 112.821 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -116.2 93.12 4.1 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.13 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.677 HG21 HD12 ' A' ' 58' ' ' LEU . 8.5 mt -94.85 113.52 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.663 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 pt -127.12 150.66 33.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.321 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.428 ' HB ' ' CG ' ' A' ' 87' ' ' GLU . 7.9 t -109.38 131.92 54.61 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.58 HG21 ' HG3' ' A' ' 50' ' ' ARG . 14.3 p -106.3 122.79 60.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.004 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -96.27 103.59 15.5 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.599 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HG ' HG22 ' A' ' 9' ' ' VAL . 7.1 mt -125.45 174.14 8.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.46 142.56 46.55 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.92 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.81 135.52 38.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.048 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -92.11 -60.75 1.77 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.307 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.86 36.38 0.26 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.725 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.16 144.79 6.88 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.024 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.0 mtm -73.03 -61.37 1.84 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.492 0.187 . . . . 0.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.4 81.25 0.2 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.569 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.499 HD11 ' CG1' ' B' ' 104' ' ' VAL . 2.2 pp -160.96 179.49 8.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.571 0.224 . . . . 0.0 110.807 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.8 m -136.88 149.18 47.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.227 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.475 HD12 HE21 ' A' ' 70' ' ' GLN . 2.8 pp -136.74 157.32 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.603 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.589 HG22 ' O ' ' B' ' 100' ' ' PHE . 14.8 t -127.82 145.43 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.55 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.598 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -101.85 142.0 33.84 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.823 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -142.5 142.43 32.27 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.71 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.89 -179.43 4.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.121 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.6 144.93 10.66 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.683 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.39 141.28 55.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.176 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.91 34.66 65.82 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.68 109.8 7.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.298 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -88.74 27.51 1.3 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.32 -172.81 3.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.712 0.292 . . . . 0.0 110.511 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.598 ' CD2' ' HB1' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -143.24 132.94 23.79 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.939 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.19 119.43 5.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.131 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.7 mm -88.41 105.22 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-O 120.899 0.38 . . . . 0.0 110.552 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 70.7 m-85 -99.3 169.7 9.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.248 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.79 139.49 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 111.001 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HB2' HG23 ' A' ' 22' ' ' VAL . 2.3 tptt -100.79 -45.29 5.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.743 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -161.7 169.89 20.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.61 115.14 24.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.593 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.86 126.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.109 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -59.97 149.18 32.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.85 -24.01 33.98 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.998 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.68 -166.13 6.26 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.576 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.3 -52.85 4.72 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.705 -0.291 . . . . 0.0 111.617 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.66 -38.08 44.39 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.038 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.29 -55.71 9.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.629 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.79 -31.22 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.49 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.88 -56.83 9.77 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.38 57.68 1.84 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.763 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.58 ' HG3' HG21 ' A' ' 9' ' ' VAL . 1.2 mmp_? -119.72 -45.63 2.49 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.552 0.215 . . . . 0.0 110.952 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 pp -128.3 175.81 8.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.897 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.42 -173.91 4.54 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.297 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.01 127.57 33.36 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.212 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.9 27.41 6.65 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.617 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.438 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -118.61 138.14 52.78 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.428 ' C ' HD12 ' A' ' 57' ' ' LEU . 35.5 tt0 -82.6 152.02 26.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.23 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 56' ' ' GLN . 9.5 mp -119.26 144.04 46.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.013 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.677 HD12 HG21 ' A' ' 6' ' ' ILE . 1.1 mt -116.04 -60.6 1.84 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.193 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 m -123.05 156.73 34.28 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.664 HG23 HD21 ' A' ' 65' ' ' LEU . 19.5 t -142.1 120.71 9.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.111 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.82 35.59 26.5 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.205 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.63 21.17 79.69 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.945 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.3 mtm-85 -113.7 146.86 39.19 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.863 0.331 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.9 m -102.05 103.58 14.17 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.664 HD21 HG23 ' A' ' 60' ' ' VAL . 2.1 pp -109.11 42.22 1.48 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.2 t -87.7 99.57 8.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.189 0.519 . . . . 0.0 110.809 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.06 40.87 0.94 Allowed Glycine 0 CA--C 1.52 0.346 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.393 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.449 HD13 ' HB3' ' A' ' 72' ' ' ARG . 13.2 mt -127.97 157.63 40.08 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.712 0.291 . . . . 0.0 110.784 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.1 p -70.91 159.46 34.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.126 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.602 ' NE2' HG23 ' B' ' 102' ' ' THR . 37.5 tt0 -54.81 -40.15 69.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.946 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -56.91 -47.27 80.98 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.421 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.449 ' HB3' HD13 ' A' ' 68' ' ' LEU . 1.9 mmm180 -68.51 -38.68 81.14 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.596 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.85 -59.41 4.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.3 -67.02 0.42 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -35.2 -41.19 0.15 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.29 0.636 . . . . 0.0 112.173 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 76' ' ' LEU . 11.0 mt -63.58 -49.07 74.83 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.599 0.238 . . . . 0.0 111.454 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.866 ' HB2' HG21 ' B' ' 104' ' ' VAL . 7.2 mtm -70.78 -33.47 70.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.759 0.314 . . . . 0.0 110.704 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.481 ' OG1' HG23 ' B' ' 104' ' ' VAL . 0.2 OUTLIER -63.25 -29.2 70.58 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.31 42.67 1.11 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.721 0.296 . . . . 0.0 111.623 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 77' ' ' MET . 22.2 p -98.72 170.18 8.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.775 0.322 . . . . 0.0 111.183 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.6 p -99.9 -161.42 0.87 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.505 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.3 m -57.0 -39.71 75.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.518 0.199 . . . . 0.0 110.625 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.14 145.39 8.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.61 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.55 HG12 HD23 ' A' ' 86' ' ' LEU . 21.2 t -138.82 121.83 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.091 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.41 99.19 6.28 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.498 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.55 HD23 HG12 ' A' ' 84' ' ' VAL . 3.2 mm? -106.31 115.04 29.53 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.207 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.428 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 0.1 OUTLIER -81.36 89.48 6.1 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 110.143 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 55' ' ' ASP . 14.2 p -93.19 150.65 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.472 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.49 143.86 31.67 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.484 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.77 77.11 8.65 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.484 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -125.7 177.53 6.21 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.986 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.32 -141.88 10.21 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.414 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.187 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 17.1 mt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.589 ' O ' HG22 ' A' ' 22' ' ' VAL . 64.9 m-85 -60.92 173.12 0.82 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.671 0.272 . . . . 0.0 111.284 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 34.0 t 179.53 100.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.406 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.602 HG23 ' NE2' ' A' ' 70' ' ' GLN . 4.0 p -98.37 -163.67 1.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -150.13 111.36 4.4 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 111.113 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.866 HG21 ' HB2' ' A' ' 77' ' ' MET . 9.1 p . . . . . 0 C--O 1.253 1.287 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.213 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttm . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.545 0.212 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 tttm 63.54 82.5 0.18 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.805 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.25 89.27 46.48 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.992 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.5 -171.47 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.9 2.4 . . . . 0.0 112.802 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 33.1 tt0 -112.83 92.26 3.95 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.193 0.521 . . . . 0.0 110.674 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 41.1 mm -95.59 131.35 42.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.74 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.14 144.85 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.701 HG22 HG22 ' A' ' 85' ' ' THR . 0.7 OUTLIER -113.69 126.76 55.6 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 m -99.4 113.77 35.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.981 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.462 ' OG1' HG23 ' A' ' 85' ' ' THR . 0.7 OUTLIER -99.86 92.19 5.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.486 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt -116.03 173.87 6.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.17 162.24 13.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.022 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.08 113.78 25.51 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.513 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.85 -41.47 6.49 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.412 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -163.68 44.82 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.544 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.09 153.8 28.01 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.374 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.35 -48.54 80.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.606 0.203 . . . . 0.0 111.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.09 69.53 1.39 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.819 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 3.3 pp -160.72 177.48 10.42 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 122.202 0.201 . . . . 0.0 110.581 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -138.24 134.13 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.688 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.968 HD13 HG23 ' A' ' 34' ' ' ILE . 2.1 pp -120.87 165.73 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.443 HG22 ' CB ' ' B' ' 101' ' ' SER . 47.8 t -149.9 137.14 13.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.501 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.85 123.84 33.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -139.14 157.79 45.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.848 0.356 . . . . 0.0 111.645 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HG3' HD12 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -122.87 179.69 4.55 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.24 -141.21 3.08 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.789 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.88 147.1 31.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.65 0.262 . . . . 0.0 110.787 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.27 37.15 92.57 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.784 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.89 106.29 8.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.65 0.262 . . . . 0.0 110.844 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.8 17.86 6.2 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HD2' ' CA ' ' A' ' 67' ' ' GLY . 19.4 mmtp -145.15 -171.06 3.57 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.632 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 32' ' ' LEU . 5.2 tp -124.03 139.23 54.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.514 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.21 133.0 11.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.991 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.968 HG23 HD13 ' A' ' 21' ' ' ILE . 29.1 mm -92.12 71.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.149 0.5 . . . . 0.0 110.512 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 53.1 m-85 -63.4 167.68 5.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.775 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 47.9 t -112.1 125.34 69.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.098 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.518 ' HD3' ' HB2' ' B' ' 101' ' ' SER . 2.3 pttt -87.01 -36.51 18.19 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.587 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -163.42 159.36 22.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.523 0.202 . . . . 0.0 111.039 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 19' ' ' LEU . 16.7 t -118.25 122.91 70.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.31 133.4 30.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.39 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 154.39 41.87 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.74 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.49 45.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.266 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.64 -163.7 4.94 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.59 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.42 -34.32 11.57 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.09 -47.13 38.49 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -59.55 -37.94 79.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.437 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 43' ' ' GLY . 42.8 t -73.79 -32.79 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.248 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.43 -41.68 80.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.087 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.71 49.78 10.22 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.787 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -105.5 -36.16 7.23 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.576 0.227 . . . . 0.0 111.349 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.52 173.71 8.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 111.277 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.68 26.84 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.176 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.25 128.44 37.01 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.537 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.85 38.77 2.46 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.016 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 4.1 p30 -116.59 141.53 48.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.668 0.271 . . . . 0.0 110.77 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -85.97 143.51 28.12 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.068 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.468 HD11 HD23 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -99.81 143.72 29.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.324 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tt -122.41 -58.83 1.67 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.2 p -140.64 154.24 46.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.978 0.418 . . . . 0.0 111.795 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.636 HG22 HD23 ' A' ' 86' ' ' LEU . 22.4 t -135.03 112.83 15.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.438 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 56.83 34.5 24.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.232 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.37 -20.33 49.98 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.383 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -70.98 151.3 44.79 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 117.27 0.535 . . . . 0.0 111.065 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.1 p -107.14 119.47 39.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.722 HD22 ' HA ' ' A' ' 73' ' ' ALA . 11.3 mt -110.23 -9.19 14.68 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.736 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 66' ' ' VAL . 8.5 p -68.88 83.62 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-O 121.692 0.758 . . . . 0.0 110.737 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.426 ' CA ' ' HD2' ' A' ' 31' ' ' LYS . . . 140.78 -23.49 2.63 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.658 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.4 mt -82.47 169.19 16.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.6 m -86.1 166.48 15.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.759 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -57.85 -28.73 64.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.416 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -64.74 -47.49 78.04 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-O 120.65 0.262 . . . . 0.0 110.765 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -53.78 39.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.722 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -57.27 -50.58 72.46 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.771 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB1' HG21 ' B' ' 102' ' ' THR . . . -56.41 -63.27 1.25 Allowed 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.882 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -46.37 -48.05 18.58 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.445 0.466 . . . . 0.0 112.117 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.6 mt -68.16 -27.82 66.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.569 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . 1.046 ' HE1' HG21 ' B' ' 104' ' ' VAL . 77.6 mtp -86.21 -19.99 29.18 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -43.42 63.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.799 0.333 . . . . 0.0 110.61 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -95.57 65.51 2.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.946 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -83.78 147.43 27.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.068 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.51 -167.54 1.83 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.765 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -56.55 -43.85 80.33 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.921 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.08 144.49 12.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.1 t -137.69 113.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.802 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.701 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -111.23 86.77 2.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.649 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.636 HD23 HG22 ' A' ' 60' ' ' VAL . 1.3 mt -94.25 124.41 38.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.294 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 42.7 tt0 -98.9 121.41 40.82 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.289 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.4 m -117.7 168.77 9.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.733 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . . . -128.17 111.43 13.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.987 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 11.8 mmtt -65.18 110.12 2.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.521 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.47 -177.62 6.34 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.171 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.76 137.26 2.18 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.478 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.142 -0.933 . . . . 0.0 111.108 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.022 0.439 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -121.19 176.24 5.71 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.477 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.518 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 97.8 p -118.67 133.36 55.91 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.747 0.308 . . . . 0.0 111.793 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.523 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -98.96 -151.89 0.4 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.523 ' H ' HG22 ' B' ' 102' ' ' THR . 0.3 OUTLIER -174.11 44.89 0.01 OUTLIER 'General case' 0 C--N 1.341 0.22 0 CA-C-O 121.665 0.745 . . . . 0.0 109.404 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.046 HG21 ' HE1' ' A' ' 77' ' ' MET . 34.7 m . . . . . 0 C--O 1.248 1.026 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.035 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 ptt? . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.38 114.34 1.78 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.611 0.243 . . . . 0.0 110.974 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -106.04 92.12 6.18 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.723 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.72 -170.81 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.432 2.088 . . . . 0.0 112.589 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.416 ' HB3' ' CG ' ' A' ' 90' ' ' LYS . 10.9 tt0 -129.42 103.86 7.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.07 0.462 . . . . 0.0 110.79 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.79 137.15 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.598 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.45 150.08 14.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.658 ' CG2' HG22 ' A' ' 85' ' ' THR . 8.3 m -113.88 131.23 56.35 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.879 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 50' ' ' ARG . 6.5 m -102.09 116.29 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.107 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 m -105.43 98.43 8.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.544 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mt -126.87 154.74 44.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 152.96 21.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -70.72 105.15 3.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.196 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -94.37 -38.72 10.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.087 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -161.58 42.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.01 0.433 . . . . 0.0 110.56 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.94 157.8 6.11 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.118 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.784 ' SD ' HD11 ' A' ' 86' ' ' LEU . 2.7 mtm -65.02 -56.05 15.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.696 0.248 . . . . 0.0 110.564 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.13 78.74 0.14 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.894 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 4.0 pp -160.81 177.72 10.14 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.42 ' N ' HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -125.11 153.17 43.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.952 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.922 HD11 HG22 ' B' ' 102' ' ' THR . 2.6 pp -144.75 158.64 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 112.088 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' B' ' 100' ' ' PHE . 2.5 p -150.15 141.67 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.17 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.42 149.46 30.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.261 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -146.85 135.04 21.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.335 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -119.73 179.98 4.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.01 -137.85 2.28 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.12 142.78 41.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.665 0.269 . . . . 0.0 110.871 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.92 43.89 98.57 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.914 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.37 107.81 7.82 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.72 0.295 . . . . 0.0 111.025 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.96 22.34 3.71 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.435 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -144.13 -171.97 3.67 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.657 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 tp -136.11 136.88 40.49 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.906 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.88 161.88 19.38 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.767 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.42 HG13 ' HB1' ' A' ' 73' ' ' ALA . 27.0 mm -115.3 103.27 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 111.073 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 6.5 m-85 -90.57 163.78 14.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.83 113.08 40.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.029 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -43.01 69.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 1.9 p -172.18 167.19 5.97 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.777 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.2 m -120.0 127.89 75.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.851 0.357 . . . . 0.0 110.816 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.43 121.7 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -64.17 154.18 35.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.19 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.48 -37.01 3.83 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.703 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.534 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.7 -177.8 5.88 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.773 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 14' ' ' GLN . . . -87.1 -2.33 58.55 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.29 -38.32 11.57 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.04 -37.38 54.92 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.229 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 43' ' ' GLY . 43.1 t -64.69 -33.27 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.636 0.255 . . . . 0.0 110.95 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.92 -45.18 64.73 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.098 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.74 29.23 43.77 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.784 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.727 ' HB3' HG11 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -89.64 -33.16 16.75 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.515 0.198 . . . . 0.0 111.167 179.743 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.46 171.2 11.24 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.031 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.94 -175.71 5.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.563 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -73.82 162.15 29.43 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.94 39.82 93.36 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.334 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.05 142.79 51.45 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.639 0.257 . . . . 0.0 111.055 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -89.79 160.3 16.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 34' ' ' ILE . 16.8 mt -124.44 155.41 38.92 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 111.617 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.0 -55.95 1.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.072 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -136.09 142.06 44.27 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.695 0.284 . . . . 0.0 111.429 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.784 HG11 ' HG2' ' A' ' 77' ' ' MET . 18.3 t -135.69 140.89 43.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.998 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 43.65 44.88 5.61 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.534 0.521 . . . . 0.0 111.841 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.5 32.52 81.95 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.663 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -138.69 161.94 35.91 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.855 0.328 . . . . 0.0 110.577 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 p -112.77 137.32 51.26 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.767 0.318 . . . . 0.0 111.11 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.62 ' HA ' HD21 ' A' ' 68' ' ' LEU . 19.7 mt -117.38 45.41 1.91 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.0 t -109.36 100.9 11.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.187 0.518 . . . . 0.0 110.896 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.77 -37.68 2.85 Favored Glycine 0 C--N 1.328 0.139 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.347 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 65' ' ' LEU . 3.8 pp -73.48 147.26 44.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.777 0.322 . . . . 0.0 110.948 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -64.16 156.76 27.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.649 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.74 ' CD ' HD13 ' A' ' 21' ' ' ILE . 38.6 tp60 -52.62 -39.11 61.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.631 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 4.5 tt0 -51.59 -43.99 62.66 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -74.43 -40.79 61.74 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.2 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.497 ' HB3' ' NE2' ' A' ' 70' ' ' GLN . . . -56.18 -58.45 7.88 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.651 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -58.75 -64.38 0.95 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.06 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 4.3 tm-20 -38.04 -46.81 1.04 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.549 0.531 . . . . 0.0 111.764 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 mt -60.1 -43.52 95.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.007 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.784 ' HG2' HG11 ' A' ' 60' ' ' VAL . 9.1 mtp -76.71 -30.28 56.61 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.258 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -27.88 69.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.544 0.211 . . . . 0.0 110.816 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -96.47 32.82 1.92 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.208 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 77' ' ' MET . 1.2 p -60.21 146.34 43.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 111.412 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -85.93 -165.94 1.39 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.665 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -56.51 -31.35 64.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.038 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.45 141.58 19.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.965 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.48 114.65 43.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.619 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.658 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -116.52 88.54 2.92 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.784 HD11 ' SD ' ' A' ' 17' ' ' MET . 5.7 mt -101.77 133.31 46.7 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.317 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -115.72 127.33 55.05 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.926 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.58 170.64 13.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.326 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.35 133.19 51.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.903 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.416 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 48.6 mmtm -70.1 93.02 0.78 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.425 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.28 174.35 15.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.918 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.19 0.33 65.68 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.682 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.369 179.823 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 120.622 0.249 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.489 ' HB2' HG23 ' A' ' 22' ' ' VAL . 2.7 p90 -170.54 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.689 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 4.6 p 168.98 43.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.694 0.283 . . . . 0.0 110.812 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.922 HG22 HD11 ' A' ' 21' ' ' ILE . 1.6 t -84.7 -174.74 5.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.2 mp0 -130.36 80.11 1.93 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.649 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 77' ' ' MET . 14.8 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.555 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.679 0.276 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.28 127.06 29.82 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.087 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -133.97 111.38 12.15 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.73 -170.89 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.726 2.284 . . . . 0.0 112.605 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -121.69 98.41 5.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.029 0.442 . . . . 0.0 110.674 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.665 HD12 HD12 ' A' ' 58' ' ' LEU . 44.3 mm -95.85 128.98 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.2 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.14 141.49 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.129 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.568 ' OG1' HG22 ' A' ' 85' ' ' THR . 10.0 t -112.08 149.71 31.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.813 0.339 . . . . 0.0 111.019 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 50' ' ' ARG . 7.0 m -114.22 118.37 58.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.0 m -94.28 101.13 13.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.463 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.9 mt -131.3 163.07 28.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -92.2 129.92 38.03 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.927 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HB2' ' CG2' ' A' ' 84' ' ' VAL . 8.4 ttpp -83.03 139.39 33.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.186 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -93.37 -57.78 2.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -158.99 38.11 0.21 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.723 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.43 -167.99 22.35 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.999 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.708 ' SD ' HD11 ' A' ' 86' ' ' LEU . 6.7 mtm -115.9 -42.73 3.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.69 0.245 . . . . 0.0 111.385 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.99 73.96 0.63 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.038 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.445 HD11 ' CG1' ' B' ' 104' ' ' VAL . 4.0 pp -160.8 177.94 9.92 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.646 0.26 . . . . 0.0 111.072 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.423 ' N ' HD12 ' A' ' 19' ' ' LEU . 72.8 m -130.49 150.69 51.59 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.447 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.608 HD11 HG22 ' B' ' 102' ' ' THR . 2.7 pp -142.61 152.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.807 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.836 HG23 ' HB2' ' A' ' 37' ' ' LYS . 46.4 t -133.69 135.71 55.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.66 135.18 33.47 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.167 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.564 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -144.71 152.56 40.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.351 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.591 ' HG3' HD12 ' A' ' 32' ' ' LEU . 10.7 tttt -124.2 -179.54 4.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.938 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.78 -140.42 2.98 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.41 140.96 44.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.687 0.28 . . . . 0.0 110.728 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.32 45.79 95.74 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.597 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.4 107.9 7.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.707 0.289 . . . . 0.0 111.127 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -90.1 21.0 3.93 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -144.02 -168.89 2.98 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.678 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.591 HD12 ' HG3' ' A' ' 25' ' ' LYS . 3.1 tp -136.91 146.76 45.87 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.929 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.12 128.71 9.14 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.845 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.477 HG13 ' HB1' ' A' ' 73' ' ' ALA . 27.6 mm -87.14 87.25 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.994 0.426 . . . . 0.0 110.871 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 66.0 m-85 -79.17 168.07 20.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.603 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.8 t -99.11 135.73 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.606 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.836 ' HB2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -100.58 -41.33 7.0 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.286 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -178.0 125.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.055 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.9 m -87.55 136.19 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.247 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.2 t -92.29 128.0 44.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -62.48 148.5 45.51 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.323 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.55 -30.35 10.42 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.579 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.649 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.97 152.49 51.88 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.428 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.75 -36.55 26.16 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.85 -44.26 64.14 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.651 0.263 . . . . 0.0 111.382 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -39.03 92.91 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.45 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 43' ' ' GLY . 42.0 t -57.79 -39.37 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.27 -49.58 13.44 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.058 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.79 76.9 1.06 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.171 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.527 ' CB ' HG11 ' A' ' 9' ' ' VAL . 12.9 mmm-85 -139.18 22.48 2.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.03 153.65 1.67 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.654 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.47 -179.99 6.61 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.487 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.71 139.44 58.38 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.034 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.73 22.06 32.13 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.862 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.87 175.68 5.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.64 0.22 . . . . 0.0 110.613 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.434 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 3.7 tt0 -125.17 142.36 51.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.053 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.443 HD21 HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -107.94 164.17 12.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.338 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.665 HD12 HD12 ' A' ' 6' ' ' ILE . 1.2 mt -140.21 -55.52 0.54 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.362 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.7 m -127.08 154.62 44.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.689 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 77' ' ' MET . 22.6 t -141.91 107.76 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.048 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.71 50.71 10.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.97 0.414 . . . . 0.0 111.03 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.76 21.4 76.5 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.859 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.424 ' CZ ' HD22 ' A' ' 76' ' ' LEU . 6.2 mtt-85 -113.74 160.8 18.28 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.734 0.267 . . . . 0.0 110.37 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -114.41 110.94 20.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.032 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.533 HD23 HD12 ' A' ' 68' ' ' LEU . 27.1 mt -96.33 43.67 1.08 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.6 t -105.53 100.09 9.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.186 0.517 . . . . 0.0 110.572 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.87 30.48 5.15 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.553 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD12 HD23 ' A' ' 65' ' ' LEU . 45.5 mt -122.02 158.06 30.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 110.929 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.2 p -79.9 162.11 25.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.738 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -54.28 -36.42 63.62 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.768 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.81 -59.69 4.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.091 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -59.71 -36.6 76.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.099 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -65.44 -62.02 1.77 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.493 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' B' ' 102' ' ' THR . . . -56.19 -47.07 79.06 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.412 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -56.3 -54.85 40.47 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.956 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.424 HD22 ' CZ ' ' A' ' 63' ' ' ARG . 14.6 mt -53.69 -33.55 55.8 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.316 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.485 ' HB2' HG21 ' B' ' 104' ' ' VAL . 13.5 mtp -74.78 -51.38 14.27 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.764 ' HB ' HG23 ' B' ' 104' ' ' VAL . 8.6 t -63.2 -33.58 75.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.55 0.214 . . . . 0.0 111.161 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -84.2 47.48 1.34 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.878 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -98.2 179.54 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.868 0.366 . . . . 0.0 111.207 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -93.83 -165.63 1.36 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -55.81 -44.09 77.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 110.925 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.16 145.91 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.852 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 13' ' ' LYS . 22.5 t -128.39 126.76 66.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.532 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.568 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.2 OUTLIER -129.67 83.5 2.14 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.765 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.708 HD11 ' SD ' ' A' ' 17' ' ' MET . 7.3 mt -93.67 118.79 31.85 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.495 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HG3' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -86.34 113.86 22.66 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.547 179.328 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.75 150.56 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.54 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.568 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . . . -106.02 160.4 15.32 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.26 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -114.36 103.84 11.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.763 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.19 177.75 8.41 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.244 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.69 -0.77 71.86 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.853 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.464 179.697 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.413 ' O ' HG13 ' A' ' 22' ' ' VAL . 13.3 m-85 -132.89 169.92 16.07 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -120.93 90.99 3.43 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.887 0.375 . . . . 0.0 110.774 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.608 HG22 HD11 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -80.49 175.44 10.66 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.681 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.448 ' N ' HG23 ' B' ' 102' ' ' THR . 0.3 OUTLIER -128.54 129.34 45.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.804 0.335 . . . . 0.0 110.835 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.764 HG23 ' HB ' ' A' ' 78' ' ' THR . 8.4 p . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.194 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.677 0.275 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.84 36.61 1.91 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.923 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.5 tt0 -82.6 123.88 78.1 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 32.2 Cg_exo -62.71 -166.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.861 2.374 . . . . 0.0 112.822 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 34.8 tt0 -108.52 90.75 3.39 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.252 0.548 . . . . 0.0 110.952 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.4 mt -93.33 136.68 24.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.844 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.5 153.17 13.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.448 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 5.0 m -111.27 141.16 45.16 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.553 HG11 ' HD2' ' A' ' 50' ' ' ARG . 10.8 m -120.7 133.54 67.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 m -109.68 95.17 5.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.709 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.0 mt -116.49 173.29 6.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -99.57 163.02 12.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.057 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -77.46 100.3 5.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.73 80.47 5.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.477 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.13 34.55 23.35 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.967 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.96 152.79 29.09 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.239 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -56.41 22.44 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.69 0.281 . . . . 0.0 110.666 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.26 72.75 0.84 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.661 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.667 ' CD1' HG23 ' A' ' 21' ' ' ILE . 3.6 pp -160.61 178.12 9.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.732 0.301 . . . . 0.0 110.672 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.464 ' N ' HD12 ' A' ' 19' ' ' LEU . 7.9 m -135.17 126.25 27.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.41 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.669 HD13 ' CG2' ' A' ' 34' ' ' ILE . 2.1 pp -118.09 129.73 74.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.322 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.896 HG22 ' HA ' ' B' ' 101' ' ' SER . 93.7 t -112.5 136.8 47.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.099 0.476 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.796 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -95.27 120.03 34.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.199 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.85 148.65 52.3 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.946 0.403 . . . . 0.0 111.768 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.58 -179.86 4.67 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.667 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.8 -141.53 3.15 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.715 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.34 148.52 27.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.614 0.245 . . . . 0.0 110.66 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.78 33.22 82.05 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.744 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.25 103.46 6.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.684 0.278 . . . . 0.0 110.927 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 7.1 t0 -90.64 21.6 3.94 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.227 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -142.01 -168.15 2.63 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.5 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.5 HD21 ' HB1' ' A' ' 23' ' ' ALA . 12.7 tp -142.14 123.91 15.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.747 0.308 . . . . 0.0 110.889 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.78 116.94 5.61 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.411 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.669 ' CG2' HD13 ' A' ' 21' ' ' ILE . 31.3 mm -77.85 87.19 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.957 0.408 . . . . 0.0 110.413 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.94 162.32 28.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.648 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -104.33 108.01 23.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.835 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.701 ' HB2' HG23 ' A' ' 22' ' ' VAL . 17.9 tttt -62.52 -47.02 85.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.859 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 p -175.34 137.83 0.4 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.28 137.79 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.513 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -76.07 141.68 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 153.01 35.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.236 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.98 19.24 69.65 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.007 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.25 -158.03 33.72 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.442 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.17 -35.18 10.86 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.22 -33.59 20.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.377 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -40.93 94.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.539 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.96 -41.85 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.52 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.5 -55.1 34.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.361 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.9 49.85 1.72 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.438 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.553 ' HD2' HG11 ' A' ' 9' ' ' VAL . 72.8 mmt-85 -105.77 -58.16 1.94 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 110.643 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 pp -117.15 149.72 39.89 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.669 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.63 -175.22 3.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.183 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.2 131.1 42.31 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.008 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.35 27.6 10.58 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.739 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.18 171.36 7.53 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.589 0.194 . . . . 0.0 110.768 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -120.26 137.9 53.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.307 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.607 HD23 HG22 ' A' ' 88' ' ' VAL . 86.6 mt -101.35 162.19 13.08 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.178 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.421 HD23 ' CG2' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -141.48 -53.26 0.45 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.188 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.0 m -124.04 151.03 44.23 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.979 0.418 . . . . 0.0 111.712 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.64 HG23 HD13 ' A' ' 65' ' ' LEU . 21.7 t -139.34 133.23 38.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.765 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 53.65 38.0 27.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.37 26.98 72.32 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.337 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 mtp-105 -128.89 148.24 50.89 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.897 0.348 . . . . 0.0 110.723 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.5 m -89.66 135.23 33.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.982 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 60' ' ' VAL . 4.2 mp -130.0 50.02 2.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.974 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.421 ' CG2' HD23 ' A' ' 58' ' ' LEU . 58.0 t -94.14 99.62 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 110.876 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 105.54 35.35 3.09 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.64 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.7 mt -122.11 153.77 38.25 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.755 0.312 . . . . 0.0 110.768 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.8 m -75.33 158.2 33.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.796 ' HG3' ' HB2' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -57.25 -25.52 59.28 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.725 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.15 -49.58 76.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.692 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -51.89 52.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.47 81.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.584 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.585 ' O ' HG22 ' A' ' 78' ' ' THR . . . -58.79 -56.89 16.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.331 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -53.15 60.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.309 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.52 -32.28 71.31 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.982 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.788 ' SD ' HD21 ' A' ' 86' ' ' LEU . 30.5 mmm -69.58 -64.32 0.9 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.92 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 74' ' ' ALA . 4.7 t -56.01 -36.23 67.71 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.684 0.278 . . . . 0.0 111.024 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -86.86 52.58 2.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.264 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 77' ' ' MET . 1.2 p -94.2 168.47 10.9 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.773 0.32 . . . . 0.0 110.746 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -97.62 -163.08 1.01 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.591 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -59.04 -26.78 64.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.165 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.82 149.21 5.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.952 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.01 87.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.1 m -91.88 80.68 5.2 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.788 HD21 ' SD ' ' A' ' 77' ' ' MET . 9.1 mt -103.94 133.97 48.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.44 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 27.2 tt0 -107.19 112.11 24.84 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.603 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.607 HG22 HD23 ' A' ' 57' ' ' LEU . 19.8 t -110.73 147.56 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.206 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . . . -97.37 132.86 42.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.8 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -69.02 91.37 0.48 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.564 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.43 -177.82 4.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.912 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.06 140.43 3.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.567 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.518 179.829 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.569 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.8 m-85 70.05 94.03 0.08 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 110.712 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.896 ' HA ' HG22 ' A' ' 22' ' ' VAL . 8.2 t -154.23 -50.9 0.09 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.702 HG22 ' H ' ' B' ' 103' ' ' GLU . 0.8 OUTLIER 53.65 -172.74 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.013 0.435 . . . . 0.0 111.841 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.702 ' H ' HG22 ' B' ' 102' ' ' THR . 0.1 OUTLIER 179.35 51.94 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.564 HG21 ' CE ' ' A' ' 77' ' ' MET . 30.8 m . . . . . 0 C--O 1.251 1.153 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.811 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 tpp . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.35 115.22 2.58 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.673 0.273 . . . . 0.0 110.92 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.75 102.39 22.66 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.98 -172.18 0.57 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.828 2.352 . . . . 0.0 112.679 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -128.21 104.32 7.68 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.026 0.441 . . . . 0.0 111.117 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mt -102.84 141.16 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.737 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 pt -146.26 151.84 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.371 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 87' ' ' GLU . 1.3 m -112.88 140.0 48.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.955 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 m -123.19 127.92 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.183 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 15.6 m -108.65 112.38 24.68 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mt -138.97 162.27 35.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.636 ' HE3' HG22 ' A' ' 83' ' ' VAL . 2.6 mptt -98.08 176.6 5.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.877 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.51 150.42 26.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 111.408 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.98 -58.66 0.96 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.579 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -138.02 35.67 2.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.61 152.81 28.91 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.106 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 mtm -64.41 -48.87 73.74 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.629 0.214 . . . . 0.0 110.723 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.85 82.51 0.07 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.938 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.524 HD11 HG12 ' B' ' 104' ' ' VAL . 3.6 pp -160.76 179.61 8.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.628 0.252 . . . . 0.0 110.781 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -129.45 144.78 51.39 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.27 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.465 HD13 HG23 ' A' ' 34' ' ' ILE . 2.7 pp -140.55 146.14 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.799 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.58 HG13 ' O ' ' B' ' 100' ' ' PHE . 22.7 t -132.71 137.08 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.544 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.49 158.85 25.73 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.705 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.876 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -159.51 141.53 13.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 111.377 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HD2' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -126.31 -179.67 4.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.82 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.37 -141.33 3.12 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.8 139.25 40.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.681 0.277 . . . . 0.0 110.597 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.43 35.47 91.75 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.707 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.05 103.76 7.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.672 0.272 . . . . 0.0 110.89 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -92.18 28.41 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.1 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -136.57 -170.16 2.62 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.449 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 32' ' ' LEU . 5.9 tp -151.96 124.47 8.34 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.672 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.22 150.5 20.2 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.025 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.636 HG13 ' HB1' ' A' ' 73' ' ' ALA . 14.7 mm -104.86 81.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 121.049 0.452 . . . . 0.0 110.786 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.876 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 61.8 m-85 -71.57 166.37 21.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.316 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.3 t -106.43 128.99 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.107 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.54 ' HB2' HG23 ' A' ' 22' ' ' VAL . 8.5 ttpt -91.37 -42.6 10.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.3 172.84 15.9 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.726 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.05 121.97 30.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.558 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 t -72.13 124.96 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.721 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 124.12 21.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.79 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.11 -31.6 3.82 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.352 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -68.66 157.23 53.17 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.621 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.16 18.81 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.553 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -63.87 -49.67 71.83 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.683 0.277 . . . . 0.0 111.203 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.48 -41.16 96.64 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.163 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.9 t -61.02 -32.96 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.25 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -68.25 -55.88 10.63 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.238 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.44 51.43 2.92 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.85 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -128.24 -66.99 0.82 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.729 0.264 . . . . 0.0 110.805 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.553 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.4 pp -70.4 161.59 30.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.98 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.93 -174.83 4.37 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.368 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.9 120.91 28.68 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.982 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.1 31.26 3.14 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.023 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -116.78 139.2 50.86 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.705 0.252 . . . . 0.0 110.955 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.9 tt0 -81.9 145.33 30.4 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -97.53 168.94 10.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.012 0.434 . . . . 0.0 111.321 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -148.18 -59.02 0.24 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.035 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.5 p -128.3 150.6 49.99 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.963 0.411 . . . . 0.0 111.713 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.622 HG11 ' CG ' ' A' ' 77' ' ' MET . 39.9 t -141.97 96.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.46 41.99 31.63 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.962 0.41 . . . . 0.0 111.0 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.36 25.86 49.66 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.952 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -120.64 129.78 53.86 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.19 111.14 21.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.967 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 60' ' ' VAL . 41.5 mt -99.72 26.84 5.84 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.056 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.2 p -107.39 73.43 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.661 0.743 . . . . 0.0 110.638 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.66 -22.4 1.49 Allowed Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.199 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.4 mt -81.32 159.26 24.47 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.966 0.412 . . . . 0.0 111.188 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.5 m -74.73 147.17 41.6 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.024 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.455 ' HG2' ' CG2' ' B' ' 102' ' ' THR . 0.0 OUTLIER -42.45 -41.25 2.86 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.178 0.299 . . . . 0.0 111.412 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.94 -56.94 12.24 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.306 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -60.44 -40.83 92.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.636 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -58.73 -60.84 3.19 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.702 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.509 ' O ' HG22 ' A' ' 78' ' ' THR . . . -63.49 -36.86 85.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.353 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -35.82 76.93 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.433 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.45 -44.18 58.7 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.622 ' CG ' HG11 ' A' ' 60' ' ' VAL . 11.1 mtp -59.53 -48.17 82.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.433 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.708 ' HB ' HG23 ' B' ' 104' ' ' VAL . 7.8 t -64.51 -33.46 75.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.63 0.252 . . . . 0.0 110.611 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.72 50.19 1.92 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.892 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.0 p -103.79 172.72 6.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.646 0.26 . . . . 0.0 110.865 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 t -79.73 -169.93 2.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.49 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -53.4 -40.59 65.19 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.254 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.636 HG22 ' HE3' ' A' ' 12' ' ' LYS . 21.1 t -97.35 143.63 12.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.121 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 10' ' ' THR . 23.9 t -119.74 149.13 22.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.14 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.9 m -143.54 85.56 1.85 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.436 HD23 HG22 ' A' ' 60' ' ' VAL . 3.8 mt -98.27 140.45 32.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.365 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HB2' HG23 ' A' ' 8' ' ' THR . 41.9 tt0 -121.78 110.07 15.46 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.735 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.84 169.19 2.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.204 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.17 137.67 53.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.17 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.62 121.44 36.18 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.548 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.46 -171.83 3.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.871 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.5 138.99 2.53 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.489 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.244 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.479 0.181 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.58 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER 73.65 144.25 0.07 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.991 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.476 ' HB2' HG22 ' A' ' 22' ' ' VAL . 21.5 t -121.75 134.92 54.94 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.975 0.417 . . . . 0.0 111.507 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.455 ' CG2' ' HG2' ' A' ' 70' ' ' GLN . 0.9 OUTLIER -120.55 -176.23 3.19 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.155 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 6.1 mt-10 -135.94 116.86 14.2 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 110.783 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.708 HG23 ' HB ' ' A' ' 78' ' ' THR . 14.2 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.157 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttp . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.664 0.269 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -174.45 116.54 0.2 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.695 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 66.57 108.35 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.541 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.85 -174.84 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.592 2.195 . . . . 0.0 112.64 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.5 100.95 5.97 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.875 0.369 . . . . 0.0 111.025 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mt -100.49 139.14 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.318 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.02 139.19 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.145 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.433 ' HB ' ' CG ' ' A' ' 87' ' ' GLU . 7.3 t -109.41 159.25 17.17 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 110.98 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.61 132.7 31.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.326 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 m -90.99 97.0 10.92 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.471 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.21 169.12 8.94 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.357 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -113.54 153.84 28.11 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.752 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -82.61 102.8 11.68 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.212 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -100.46 78.55 2.03 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.279 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 57.74 36.97 27.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.905 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.73 148.04 16.22 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.091 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.4 mtm -65.64 -68.8 0.34 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.733 0.266 . . . . 0.0 111.007 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.53 70.09 1.09 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.045 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 20' ' ' SER . 3.9 pp -160.65 176.82 11.12 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.401 0.143 . . . . 0.0 110.633 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.466 ' N ' HD12 ' A' ' 19' ' ' LEU . 49.0 m -134.21 142.14 47.28 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.631 ' CD1' HG22 ' B' ' 102' ' ' THR . 0.0 OUTLIER -131.96 163.19 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.036 0.446 . . . . 0.0 112.069 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.923 HG13 ' HB2' ' B' ' 100' ' ' PHE . 21.2 t -142.06 131.83 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.445 ' CB ' ' HB2' ' A' ' 70' ' ' GLN . . . -99.31 118.58 36.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -120.49 132.62 55.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.569 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.442 ' HG3' ' CD1' ' A' ' 32' ' ' LEU . 4.6 tttt -114.51 -179.69 3.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.889 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.16 -140.52 3.01 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.69 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.46 152.63 23.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.56 0.219 . . . . 0.0 110.766 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.18 37.46 86.56 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.501 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.27 107.74 7.36 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.609 0.242 . . . . 0.0 110.801 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.472 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 7.8 p-10 -90.7 15.11 11.69 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 111.47 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -144.36 -171.38 3.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.383 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.442 ' CD1' ' HG3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -145.1 135.34 24.02 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 111.002 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.03 127.85 9.32 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.822 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.73 78.78 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 121.031 0.443 . . . . 0.0 110.513 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.439 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 73.0 m-85 -68.79 157.8 35.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.623 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.12 135.19 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.308 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -92.77 -47.77 6.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.622 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.17 130.57 0.17 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.03 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.13 132.22 31.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.667 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -81.74 139.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.19 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.72 145.17 55.4 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.206 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.57 -26.25 23.88 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.869 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.2 150.12 51.58 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.149 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.59 -36.69 67.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.53 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -61.22 -40.93 95.84 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.689 0.281 . . . . 0.0 110.86 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -40.64 63.5 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 43' ' ' GLY . 40.6 t -63.83 -36.38 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.397 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.28 -38.21 60.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.26 64.27 2.69 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.494 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -49.04 1.86 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.583 0.23 . . . . 0.0 111.383 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.53 HD21 ' HB1' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -103.84 165.72 10.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.261 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.8 177.77 7.95 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.519 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.77 140.31 42.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.047 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.61 27.94 28.27 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.871 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . 1.4 m-20 -110.67 155.22 22.73 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.635 0.218 . . . . 0.0 110.536 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 4.8 tt0 -96.67 144.56 26.58 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.091 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.96 169.24 8.62 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.65 -57.61 0.22 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.241 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 t -126.52 144.23 50.94 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.112 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.752 HG21 ' SD ' ' A' ' 77' ' ' MET . 23.4 t -135.47 112.22 13.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.576 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.09 39.04 23.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.333 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.48 4.64 84.88 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.321 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -98.96 142.33 30.6 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.42 0.61 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.05 108.78 21.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.828 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.8 mt -100.33 32.42 3.03 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.472 HG12 ' HG2' ' A' ' 31' ' ' LYS . 62.5 t -90.09 99.96 10.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.189 0.519 . . . . 0.0 110.826 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 110.93 32.35 2.66 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.521 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 68' ' ' LEU . 23.3 mt -129.18 161.5 29.97 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.695 0.284 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.81 154.23 30.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.445 ' HB2' ' CB ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -52.29 -36.24 52.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.885 -179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -54.66 -53.1 59.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.715 0.293 . . . . 0.0 110.384 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -63.2 -41.33 99.16 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.738 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 77' ' ' MET . . . -60.4 -59.92 4.64 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.229 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 78' ' ' THR . . . -56.07 -33.96 65.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.626 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -45.08 57.82 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.602 0.239 . . . . 0.0 111.327 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.9 mt -67.69 -32.46 73.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.464 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 60' ' ' VAL . 6.6 mtm -73.83 -48.2 32.98 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.491 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.777 ' HB ' HG23 ' B' ' 104' ' ' VAL . 9.9 t -64.1 -34.2 77.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.615 0.245 . . . . 0.0 110.793 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -83.8 49.04 1.53 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.669 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.7 -175.9 3.58 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.545 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 m -104.3 -164.59 1.07 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.3 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 13.7 p -56.77 -31.71 64.9 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.753 0.311 . . . . 0.0 110.714 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.48 148.34 13.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.629 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.41 139.46 21.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.28 95.2 4.45 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.73 104.69 17.25 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.078 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 1.8 mt-10 -80.23 83.14 6.14 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.227 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 55' ' ' ASP . 14.8 p -84.41 142.85 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.434 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.61 117.98 31.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -71.21 148.29 47.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -139.13 169.02 18.54 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.859 0.361 . . . . 0.0 111.572 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.22 -4.25 62.92 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.544 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.989 179.812 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.923 ' HB2' HG13 ' A' ' 22' ' ' VAL . 55.6 p90 -62.85 170.73 2.48 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.734 0.302 . . . . 0.0 111.645 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 59.8 p 53.84 70.17 0.63 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.582 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.631 HG22 ' CD1' ' A' ' 21' ' ' ILE . 1.5 t -111.34 -164.59 0.93 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.284 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.451 ' N ' HG23 ' B' ' 102' ' ' THR . 1.3 pt-20 -131.32 127.52 37.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.777 HG23 ' HB ' ' A' ' 78' ' ' THR . 10.8 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.66 0.267 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -102.67 25.66 8.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.209 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -153.3 88.7 3.7 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.026 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.71 -171.57 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.982 2.454 . . . . 0.0 112.834 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 40.0 tt0 -116.41 87.26 2.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.222 0.534 . . . . 0.0 111.119 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.763 HD12 HD12 ' A' ' 58' ' ' LEU . 42.6 mm -84.52 125.69 40.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.608 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.48 HD12 HG13 ' A' ' 9' ' ' VAL . 1.2 pp -140.49 137.67 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.848 0.356 . . . . 0.0 111.119 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.683 HG23 ' HB2' ' A' ' 87' ' ' GLU . 1.0 OUTLIER -105.08 113.03 26.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.887 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.48 HG13 HD12 ' A' ' 7' ' ' ILE . 26.9 m -100.51 151.91 5.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.166 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.22 119.69 25.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.771 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mt -132.97 162.54 31.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.41 ' HG2' HG22 ' A' ' 83' ' ' VAL . 9.6 mtmt -110.03 138.06 46.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.727 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -64.85 121.47 14.68 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.216 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.34 -50.89 5.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -164.95 41.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.795 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.43 147.28 16.72 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.151 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.7 mmm -68.38 -68.06 0.42 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.453 0.168 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.96 78.57 0.53 Allowed Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.855 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.515 HD11 ' CG1' ' B' ' 104' ' ' VAL . 3.7 pp -160.46 179.47 8.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.52 0.2 . . . . 0.0 110.857 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.6 m -129.04 141.56 51.19 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.716 0.293 . . . . 0.0 111.665 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.718 HD11 HG22 ' B' ' 102' ' ' THR . 2.9 pp -137.68 154.77 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.806 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.648 HG13 ' O ' ' B' ' 100' ' ' PHE . 49.1 t -142.57 135.13 26.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.71 146.62 23.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.777 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.63 158.03 43.8 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 111.935 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.31 179.16 4.19 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.856 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.89 -143.61 3.75 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.07 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.66 150.54 28.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.551 0.215 . . . . 0.0 110.878 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.83 28.57 63.41 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.502 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -146.55 106.93 4.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 110.565 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -97.44 39.27 1.21 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.936 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -137.29 -159.83 1.0 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.256 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 32' ' ' LEU . 2.7 tp -146.54 126.81 13.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.507 0.194 . . . . 0.0 110.747 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.15 142.69 15.64 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.822 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.666 HG12 ' HB1' ' A' ' 73' ' ' ALA . 1.6 mp -86.69 135.16 25.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.774 0.321 . . . . 0.0 110.502 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -125.66 143.93 50.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.011 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 53' ' ' ALA . 39.3 t -81.37 130.01 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.005 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -100.54 -40.74 7.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.327 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -179.48 128.13 0.09 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.633 0.254 . . . . 0.0 110.993 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 m -90.64 133.38 32.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.124 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.9 t -73.56 131.21 35.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -61.56 115.48 3.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.065 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.27 -30.03 3.38 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.786 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.494 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.58 151.19 50.85 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.689 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.66 65.07 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.72 -36.64 84.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -76.22 -45.91 30.73 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.243 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 43' ' ' GLY . 25.3 t -60.26 -38.52 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.365 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.74 -41.57 62.31 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.145 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.24 33.09 18.37 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.984 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -83.83 -54.3 4.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.806 0.336 . . . . 0.0 110.689 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.19 152.64 32.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.818 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.99 175.12 10.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.138 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -61.01 122.81 15.87 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.315 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.4 38.77 2.2 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.926 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 36' ' ' VAL . 29.4 m-20 -135.24 142.31 45.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.517 0.199 . . . . 0.0 110.796 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -93.55 152.97 18.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.933 0.397 . . . . 0.0 110.774 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.427 HD21 HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -101.53 172.12 7.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.023 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.763 HD12 HD12 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -149.87 -54.25 0.16 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.329 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 t -133.87 140.73 47.04 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.66 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.958 HG23 HD11 ' A' ' 65' ' ' LEU . 37.5 t -129.1 120.24 51.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.594 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.59 34.92 25.27 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.184 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.74 35.65 39.64 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.106 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 175.22 8.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.655 0.264 . . . . 0.0 110.851 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -121.34 121.59 37.98 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.139 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.958 HD11 HG23 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -106.18 29.18 6.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.263 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.7 t -87.27 100.27 9.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.231 0.538 . . . . 0.0 110.878 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.97 27.58 5.07 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.593 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 mt -118.84 164.68 15.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -83.97 152.29 24.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.275 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -51.39 -30.89 20.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.337 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -65.37 -51.16 62.31 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.771 0.319 . . . . 0.0 110.498 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -62.97 -40.43 97.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.666 ' HB1' HG12 ' A' ' 34' ' ' ILE . . . -58.32 -60.31 3.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.45 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.567 ' O ' HG22 ' A' ' 78' ' ' THR . . . -61.3 -44.68 96.82 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.848 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -39.09 81.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.048 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.88 -34.89 76.18 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.027 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.666 ' HB2' HG21 ' B' ' 104' ' ' VAL . 11.3 mtp -76.31 -41.6 48.01 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.738 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.641 ' HB ' HG23 ' B' ' 104' ' ' VAL . 5.3 t -70.85 -37.36 73.13 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.648 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -89.95 56.08 3.35 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.444 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 p -110.52 178.84 4.25 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.877 0.37 . . . . 0.0 111.246 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -175.75 4.02 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.714 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 m -52.63 -39.29 61.59 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.137 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.41 HG22 ' HG2' ' A' ' 12' ' ' LYS . 24.4 t -97.84 147.84 6.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.925 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.41 134.18 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.64 85.0 2.35 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.427 HD23 HD21 ' A' ' 57' ' ' LEU . 4.1 mt -92.23 139.08 30.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.258 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.683 ' HB2' HG23 ' A' ' 8' ' ' THR . 27.8 tt0 -124.86 98.9 5.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.3 m -105.07 172.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.803 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.43 107.15 17.57 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.942 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 1.7 mmtt -63.97 104.15 0.67 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -135.84 158.68 43.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.317 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.83 1.16 56.59 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.715 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.593 -0.718 . . . . 0.0 111.471 179.773 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.648 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -138.91 160.38 39.86 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.602 0.239 . . . . 0.0 110.859 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 80.6 p -128.99 118.62 22.9 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.698 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.718 HG22 HD11 ' A' ' 21' ' ' ILE . 1.7 t -111.58 -164.25 0.9 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.685 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.462 ' N ' HG23 ' B' ' 102' ' ' THR . 0.0 OUTLIER -143.06 114.03 7.68 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.85 0.357 . . . . 0.0 110.748 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.666 HG21 ' HB2' ' A' ' 77' ' ' MET . 9.0 p . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.083 -0.961 . . . . 0.0 111.032 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtm . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.684 0.278 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 62.91 89.11 0.09 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.126 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -69.59 117.19 50.69 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.987 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -64.09 -163.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.939 2.426 . . . . 0.0 112.634 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -100.43 86.44 3.17 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.239 0.542 . . . . 0.0 111.019 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -96.43 128.08 47.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.666 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 pt -142.66 155.98 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.025 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.568 ' OG1' HG22 ' A' ' 85' ' ' THR . 14.5 t -118.6 128.83 54.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.199 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 t -87.85 91.62 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.634 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 32.4 m -81.51 105.16 12.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.934 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.8 mt -139.4 177.58 7.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.27 153.06 20.8 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.684 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 100.75 0.21 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.879 0.371 . . . . 0.0 111.12 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.38 80.35 2.4 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.406 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m120 56.55 35.62 26.32 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.079 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.05 160.72 28.48 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.614 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.473 ' HB3' HD23 ' A' ' 19' ' ' LEU . 42.1 mtm -77.62 -38.91 46.96 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.497 0.189 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.85 70.4 1.06 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.903 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' CD1' HG23 ' A' ' 21' ' ' ILE . 3.4 pp -160.62 176.76 11.21 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.793 0.33 . . . . 0.0 111.009 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.89 129.23 34.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.668 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 21' ' ' ILE . 2.8 pp -121.83 153.43 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.891 0.377 . . . . 0.0 111.535 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' B' ' 101' ' ' SER . 43.2 t -142.33 146.92 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.231 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' B' ' 99' ' ' LEU . . . -107.08 147.32 30.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.196 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.74 155.09 39.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.64 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -120.1 179.47 4.27 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.772 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.13 -143.31 3.65 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.908 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.91 146.08 31.44 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.8 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.12 27.89 63.22 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.693 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.57 105.6 3.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.673 0.273 . . . . 0.0 110.486 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -96.3 28.16 3.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.412 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -120.19 -165.53 1.2 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.358 179.423 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.519 ' HG ' ' HB1' ' A' ' 23' ' ' ALA . 1.4 tp -145.03 124.5 13.13 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.628 0.252 . . . . 0.0 110.828 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.23 119.48 5.47 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.478 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.416 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 18.6 mm -80.09 74.62 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.938 0.399 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -71.2 168.19 17.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.426 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.52 108.7 25.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.057 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.49 ' HB2' HG23 ' A' ' 22' ' ' VAL . 6.5 tttt -64.33 -45.94 85.66 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.903 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 60.4 p -176.62 155.85 1.39 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 46' ' ' ASP . 11.0 t -103.49 131.79 51.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.881 0.372 . . . . 0.0 110.797 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 t -79.61 132.32 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.974 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 127.98 34.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.008 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.59 -21.43 30.37 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.877 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.582 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.57 157.19 45.17 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.962 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.08 -38.37 76.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.25 -35.65 58.85 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.536 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.503 ' HB2' HG12 ' A' ' 39' ' ' VAL . 16.7 t70 -64.47 -45.11 88.78 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 43' ' ' GLY . 39.5 t -61.77 -34.75 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.5 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.06 -53.95 21.87 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.687 0.28 . . . . 0.0 111.442 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.73 30.58 23.48 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.923 -0.655 . . . . 0.0 113.085 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -44.14 16.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.863 0.363 . . . . 0.0 110.724 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.82 178.77 4.16 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.95 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.22 175.99 11.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.366 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -69.68 132.76 46.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.676 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.77 28.89 8.5 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.5 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.33 174.57 5.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.459 0.171 . . . . 0.0 110.687 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -118.3 144.78 45.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.35 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.588 HD21 HG23 ' A' ' 60' ' ' VAL . 6.6 tt -113.28 140.84 47.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.192 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.47 -58.74 1.83 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.98 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.0 m -136.63 156.77 48.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.935 0.398 . . . . 0.0 111.459 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.751 HG21 ' SD ' ' A' ' 77' ' ' MET . 40.4 t -128.9 122.88 57.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.516 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 t70 67.35 11.68 8.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.445 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.3 18.74 30.11 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.557 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.46 142.63 51.4 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.376 0.588 . . . . 0.0 111.164 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.3 m -74.58 128.67 36.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.391 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.808 HD22 ' HA ' ' A' ' 73' ' ' ALA . 1.4 mt -132.66 31.57 3.96 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.16 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.618 ' O ' HG13 ' A' ' 66' ' ' VAL . 8.0 p -104.35 83.54 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.596 0.713 . . . . 0.0 110.467 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 157.62 -28.92 0.49 Allowed Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.523 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.9 167.91 12.84 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.856 0.36 . . . . 0.0 110.84 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -71.07 158.77 35.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.145 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.609 ' CD ' HD13 ' A' ' 21' ' ' ILE . 12.5 tp60 -54.83 -28.73 51.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.301 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -60.53 -36.48 78.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.348 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.22 -42.39 31.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.645 0.259 . . . . 0.0 110.883 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.808 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -72.47 -51.76 18.78 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.617 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.682 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -59.47 -46.35 89.05 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.415 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 2.9 tp10 -57.37 -45.26 84.62 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.685 0.278 . . . . 0.0 110.569 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.71 -33.49 75.75 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.32 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -60.69 -57.14 13.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.138 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -62.38 -39.3 92.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 110.391 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -84.08 51.92 2.19 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.779 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.37 176.8 5.57 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 111.048 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.43 -173.46 4.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.233 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 t -54.91 -33.4 62.04 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.626 0.25 . . . . 0.0 111.135 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.5 144.35 15.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.063 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 10' ' ' THR . 19.9 t -112.64 145.97 17.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.568 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.6 OUTLIER -143.75 81.14 1.68 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.92 113.16 24.85 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.172 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.08 91.81 6.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.615 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.64 136.13 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.245 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.88 145.56 26.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.423 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.07 122.62 41.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -163.76 -174.9 3.86 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.53 139.8 2.77 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.625 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.409 179.68 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 99' ' ' LEU . . . . . 0.528 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.997 0.427 . . . . 0.0 111.301 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.59 177.7 7.75 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.535 ' HA ' HG22 ' A' ' 22' ' ' VAL . 40.2 t -103.03 104.51 14.69 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.682 HG21 ' CB ' ' A' ' 74' ' ' ALA . 18.7 p -85.18 -149.8 0.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.733 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 14.1 pt-20 -170.78 48.13 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.905 0.86 . . . . 0.0 109.297 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.679 HG21 ' CE ' ' A' ' 77' ' ' MET . 20.1 m . . . . . 0 C--O 1.248 1.004 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.135 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.9 ttm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.874 0.369 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 129.04 34.96 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.65 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -125.27 150.0 65.86 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.27 172.03 11.8 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.739 2.293 . . . . 0.0 112.596 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 19.4 tt0 -132.84 100.62 4.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.731 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.14 135.97 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.655 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.55 145.9 22.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.634 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -106.62 126.61 52.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.839 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.01 163.77 15.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.176 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -126.44 113.19 16.52 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.597 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.83 143.33 50.88 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -95.1 155.35 16.77 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.04 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -80.11 126.96 31.74 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.043 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' A' ' 44' ' ' ALA . 8.3 mm-40 -95.12 -52.85 4.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.503 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -164.62 44.24 0.09 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.532 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.97 151.01 17.69 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.226 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.1 mmm -74.28 -70.89 0.37 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.481 0.181 . . . . 0.0 110.683 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.31 77.09 0.58 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.82 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.716 ' HB3' HG23 ' A' ' 39' ' ' VAL . 3.4 pp -161.21 177.68 9.99 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.671 0.272 . . . . 0.0 110.992 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 m -130.17 155.76 45.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.477 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.939 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -144.12 164.33 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.778 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' B' ' 100' ' ' PHE . 64.8 t -140.79 138.75 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.701 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.603 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -88.26 94.97 10.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.804 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.75 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -93.57 146.04 24.09 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.041 0.448 . . . . 0.0 112.109 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -132.65 -179.89 5.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.67 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -177.3 -142.63 4.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.775 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.83 149.34 25.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.615 0.245 . . . . 0.0 110.718 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.92 31.32 75.81 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.779 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.13 103.9 7.24 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.627 0.251 . . . . 0.0 110.731 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -91.1 23.06 3.41 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.222 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -140.77 -164.11 1.67 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.541 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.603 ' CD2' ' HB1' ' A' ' 23' ' ' ALA . 7.0 tp -140.55 116.62 10.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.477 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.26 133.25 11.8 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.471 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.8 mp -92.45 88.74 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 121.054 0.454 . . . . 0.0 110.498 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.75 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 47.0 m-85 -82.28 173.03 12.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.918 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.16 136.34 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 111.356 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.408 ' HB2' HG23 ' A' ' 22' ' ' VAL . 11.6 tttp -98.37 -43.99 6.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.815 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.97 107.9 0.07 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.012 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.716 HG23 ' HB3' ' A' ' 19' ' ' LEU . 14.8 p -81.65 137.41 21.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.1 132.44 32.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.051 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 151.51 47.39 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.94 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.05 -28.79 12.96 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.679 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -68.85 157.65 53.23 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.27 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.478 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . . . -49.33 -40.32 34.85 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.82 -36.82 70.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.398 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -86.09 -39.99 16.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.247 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 43' ' ' GLY . 21.9 t -67.36 -37.68 79.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.87 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -68.7 -43.55 75.8 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.511 0.196 . . . . 0.0 111.202 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.06 75.5 1.09 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.762 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.19 -50.88 0.76 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.538 0.209 . . . . 0.0 110.819 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -123.78 177.57 5.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.099 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.54 -174.31 4.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.413 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.1 152.07 44.75 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.392 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.57 26.16 63.79 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.365 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.452 ' HA ' ' NE2' ' A' ' 91' ' ' GLN . 0.8 OUTLIER -107.03 169.12 8.74 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.629 0.252 . . . . 0.0 110.766 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.437 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 1.3 tt0 -100.25 166.55 10.93 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.59 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.788 HD21 HD12 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -156.05 130.8 9.07 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.99 -44.65 1.04 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.877 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' A' ' 87' ' ' GLU . 22.8 t -95.65 143.34 27.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.583 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.734 HG21 HD12 ' A' ' 65' ' ' LEU . 39.4 t -144.47 121.75 5.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.805 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.12 35.09 25.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.268 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.5 24.04 68.9 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.873 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.4 mtp85 -125.13 -176.55 3.6 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.3 p -123.65 116.24 22.76 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.689 0.28 . . . . 0.0 110.979 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.734 HD12 HG21 ' A' ' 60' ' ' VAL . 37.4 mt -110.68 31.29 6.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.004 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -89.87 101.21 11.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.123 0.487 . . . . 0.0 110.415 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.93 42.85 0.55 Allowed Glycine 0 CA--C 1.518 0.233 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.444 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 65' ' ' LEU . 84.0 mt -117.82 -178.81 3.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.773 0.321 . . . . 0.0 110.764 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.21 19.45 10.61 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.844 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 5.5 tt0 78.49 -54.87 0.48 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.098 0.559 . . . . 0.0 111.581 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -53.37 -43.69 68.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.621 0.248 . . . . 0.0 110.773 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -33.31 75.5 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.657 ' HA ' HD13 ' A' ' 65' ' ' LEU . . . -66.92 -62.8 1.25 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.288 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.939 ' HB2' HD11 ' A' ' 21' ' ' ILE . . . -56.53 -42.1 77.88 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.867 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -60.72 -33.1 72.38 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.122 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 76' ' ' LEU . 7.4 mt -77.82 -46.2 22.21 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.61 0.243 . . . . 0.0 110.898 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.734 ' HG3' HG11 ' A' ' 60' ' ' VAL . 4.6 mtp -57.58 -41.24 80.74 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.187 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.868 ' HB ' HG23 ' B' ' 104' ' ' VAL . 8.9 t -73.42 -32.33 64.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.574 0.226 . . . . 0.0 110.563 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.38 49.63 1.85 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.34 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.9 p -115.13 170.32 8.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.656 0.265 . . . . 0.0 111.081 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t -81.58 -170.88 3.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.685 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.51 -48.68 68.79 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 p -85.47 127.81 39.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.979 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.521 HG12 HD22 ' A' ' 86' ' ' LEU . 6.5 t -122.43 141.72 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 m -119.93 106.4 12.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.095 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.788 HD12 HD21 ' A' ' 57' ' ' LEU . 3.3 mm? -109.69 133.14 53.47 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.121 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 45.8 tt0 -115.39 106.02 13.52 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.756 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.538 HG12 HD12 ' A' ' 57' ' ' LEU . 34.2 m -105.24 174.27 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.595 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -123.2 143.39 50.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.895 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -84.8 97.84 9.94 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.345 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.452 ' NE2' ' HA ' ' A' ' 55' ' ' ASP . 1.6 pm0 -143.35 -172.95 3.81 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.171 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.04 140.01 3.05 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.459 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.824 -179.856 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 21.9 tp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.829 0.347 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 23' ' ' ALA . 10.2 m-85 -100.76 163.03 12.51 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.806 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 94.2 p -167.83 144.04 4.04 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 111.543 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.91 173.61 15.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.49 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -146.97 128.95 15.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.868 HG23 ' HB ' ' A' ' 78' ' ' THR . 8.2 p . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.035 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttt . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.502 0.191 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.46 134.45 9.11 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.264 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.48 113.08 6.21 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.965 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.3 -168.02 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.059 2.506 . . . . 0.0 112.739 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 19.9 tt0 -114.99 99.1 7.21 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.627 HG21 HD12 ' A' ' 58' ' ' LEU . 33.7 mt -103.81 116.78 48.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 pt -142.88 149.55 18.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 111.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.722 HG22 HG22 ' A' ' 85' ' ' THR . 1.3 m -111.3 120.34 41.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.055 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' THR . 12.6 m -96.03 169.56 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.154 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.96 114.44 8.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.801 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -135.16 164.09 28.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.248 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -96.16 144.12 26.67 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -87.86 105.33 17.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.083 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -58.56 3.89 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.588 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.86 36.55 0.4 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.774 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.65 147.37 8.0 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.352 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -52.27 64.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.603 0.239 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.93 64.33 2.35 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.718 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 20' ' ' SER . 4.0 pp -160.54 179.33 8.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.46 0.171 . . . . 0.0 110.727 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.529 ' N ' HD12 ' A' ' 19' ' ' LEU . 75.3 m -138.36 151.69 47.75 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.439 0.162 . . . . 0.0 111.183 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.048 HD13 HG23 ' A' ' 34' ' ' ILE . 2.2 pp -133.72 156.53 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.68 HG23 ' HB2' ' A' ' 37' ' ' LYS . 30.5 t -137.78 133.85 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.91 128.5 35.06 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.887 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.786 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -135.4 143.69 46.14 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.79 0.328 . . . . 0.0 111.471 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -120.33 -179.71 4.04 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.12 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.92 -139.82 2.74 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.734 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.32 150.95 27.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.67 0.271 . . . . 0.0 110.789 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.37 38.23 93.11 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.63 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 107.5 8.1 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.711 0.291 . . . . 0.0 110.855 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -90.29 19.0 5.43 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.545 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -144.77 -169.73 3.24 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.486 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 32' ' ' LEU . 10.6 tp -129.19 142.81 50.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.66 0.267 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.17 128.28 8.93 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.754 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.048 HG23 HD13 ' A' ' 21' ' ' ILE . 1.9 mp -92.15 91.63 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-O 121.155 0.503 . . . . 0.0 110.274 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.786 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 75.8 m-85 -80.16 167.81 19.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.593 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.402 HG11 HG13 ' A' ' 39' ' ' VAL . 43.4 t -94.93 127.48 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 111.094 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.68 ' HB2' HG23 ' A' ' 22' ' ' VAL . 7.8 tptt -80.36 -49.11 11.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.691 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.473 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 52.3 p -178.96 111.08 0.05 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.114 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.402 HG13 HG11 ' A' ' 36' ' ' VAL . 9.2 m -73.58 129.34 36.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.793 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.54 141.46 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.202 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 151.82 42.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.066 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -37.68 3.38 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.742 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.43 151.81 45.58 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.428 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.29 -36.69 43.6 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.87 84.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.738 0.304 . . . . 0.0 111.137 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.0 -39.77 41.21 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.501 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.2 t -58.88 -34.03 51.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.576 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB2' HD21 ' A' ' 11' ' ' LEU . 32.4 t0 -68.53 -55.84 10.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.886 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.15 32.09 11.08 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.708 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -88.23 -43.38 11.64 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.687 0.279 . . . . 0.0 110.896 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.596 ' HB3' HG21 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -116.86 -178.77 3.51 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.886 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.89 -177.33 6.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.377 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -72.9 156.98 38.31 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.97 27.11 71.07 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.751 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -109.53 172.75 6.67 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.631 0.215 . . . . 0.0 110.579 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.632 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 8.5 tm0? -110.05 147.42 33.6 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.6 0.238 . . . . 0.0 110.814 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.895 HD11 HD23 ' A' ' 86' ' ' LEU . 1.7 tp -115.84 142.17 47.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.873 0.368 . . . . 0.0 111.314 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.627 HD12 HG21 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -106.6 -56.27 2.21 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.4 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.4 t -147.28 156.35 42.85 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.055 0.455 . . . . 0.0 111.96 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.888 HG21 ' HG2' ' A' ' 77' ' ' MET . 41.8 t -133.0 121.35 43.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.524 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 60.09 35.23 21.28 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.287 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.3 26.29 73.8 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.263 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.576 ' HD3' HD22 ' A' ' 76' ' ' LEU . 10.0 mtt-85 -96.91 -178.31 4.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.988 0.394 . . . . 0.0 110.799 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -120.67 103.47 9.15 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.66 HD22 ' HA ' ' A' ' 73' ' ' ALA . 36.9 mt -108.39 29.57 7.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.175 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.8 t -111.35 100.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.207 0.527 . . . . 0.0 110.875 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.35 30.7 3.5 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.642 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.612 HD22 ' HG2' ' A' ' 72' ' ' ARG . 10.6 mt -133.47 179.43 6.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.77 0.319 . . . . 0.0 110.307 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.07 168.5 10.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.524 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -61.43 -21.58 64.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.837 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -77.75 -38.09 47.68 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.756 0.312 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HG2' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.09 -56.66 8.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.32 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -61.49 -45.58 93.63 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.616 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.727 ' HB1' HG21 ' B' ' 102' ' ' THR . . . -56.55 -55.15 37.47 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.395 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.53 -36.19 64.0 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.045 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.576 HD22 ' HD3' ' A' ' 63' ' ' ARG . 56.7 mt -72.01 -39.91 68.85 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.254 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.888 ' HG2' HG21 ' A' ' 60' ' ' VAL . 81.9 mtp -64.61 -55.35 20.85 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 74' ' ' ALA . 1.8 t -57.38 -36.28 71.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.851 0.357 . . . . 0.0 110.429 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -83.35 52.04 2.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.656 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.08 168.75 9.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.686 0.279 . . . . 0.0 111.109 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.98 -164.64 1.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.624 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.4 m -57.19 -34.99 69.05 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.3 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -95.99 150.66 4.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG12 ' CD1' ' A' ' 86' ' ' LEU . 21.4 t -132.61 120.58 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.268 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.722 HG22 HG22 ' A' ' 8' ' ' THR . 5.4 m -123.58 95.99 4.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.01 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.895 HD23 HD11 ' A' ' 57' ' ' LEU . 5.3 mp -108.74 141.89 40.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.409 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -107.35 106.93 17.6 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.535 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 51' ' ' LEU . 20.9 t -96.61 149.1 4.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.675 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -121.25 104.36 9.68 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.835 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 7.0 mttm -68.93 133.16 47.82 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.928 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -165.4 1.51 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.241 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.16 135.72 2.64 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.326 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.404 179.869 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.451 0.167 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.667 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.7 t80 -114.55 164.94 13.3 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.648 0.261 . . . . 0.0 110.779 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 2.4 p -121.19 124.85 45.69 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.934 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.727 HG21 ' HB1' ' A' ' 74' ' ' ALA . 1.2 m -82.54 -147.98 0.08 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.763 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.582 ' H ' HG22 ' B' ' 102' ' ' THR . 1.8 pt-20 -178.55 54.44 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.518 HG21 ' HE1' ' A' ' 77' ' ' MET . 25.2 m . . . . . 0 C--O 1.252 1.202 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.04 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.606 0.241 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.45 69.93 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 60.74 85.04 0.19 Allowed Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.419 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.89 -179.62 4.43 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.777 2.318 . . . . 0.0 112.78 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 30.0 tt0 -107.27 94.37 5.06 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.3 mt -115.86 125.33 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.767 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.63 138.04 46.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.34 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.732 HG23 ' HG3' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -94.49 145.77 24.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.823 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' ' 50' ' ' ARG . 28.1 m -124.08 125.56 70.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.75 111.71 23.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.76 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.1 mt -131.9 154.49 49.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -91.4 130.48 37.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.764 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.42 122.46 21.28 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.227 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.64 -40.16 5.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.83 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -160.12 43.42 0.2 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 111.214 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.42 -165.22 49.95 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.122 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.0 mtm -127.13 90.73 3.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.768 0.284 . . . . 0.0 110.684 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.77 84.32 0.02 OUTLIER Glycine 0 C--O 1.225 -0.43 0 C-N-CA 121.394 -0.431 . . . . 0.0 113.104 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 20' ' ' SER . 4.1 pp -160.84 178.57 9.29 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.748 0.309 . . . . 0.0 110.942 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.454 ' N ' HD12 ' A' ' 19' ' ' LEU . 2.3 p -131.84 153.87 49.73 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.229 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.815 HD13 HG23 ' A' ' 34' ' ' ILE . 2.9 pp -132.75 157.67 43.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.985 0.422 . . . . 0.0 112.122 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG22 ' O ' ' B' ' 100' ' ' PHE . 59.6 t -135.67 138.26 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.227 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.493 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -83.6 158.01 22.07 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.24 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.707 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -153.88 141.97 20.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -131.1 179.57 5.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.044 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.62 -139.83 2.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.864 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.96 142.71 36.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.587 0.232 . . . . 0.0 110.612 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.96 36.32 92.02 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.691 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -121.91 101.16 7.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 111.013 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.26 19.29 5.21 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.248 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' O ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -139.26 -171.51 3.13 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.4 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.493 HD12 ' HB1' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -136.12 143.55 44.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.108 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.33 117.95 4.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.454 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.815 HG23 HD13 ' A' ' 21' ' ' ILE . 2.0 mp -93.45 87.69 2.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.177 0.513 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HE1' ' HB3' ' A' ' 24' ' ' ALA . 45.6 m-85 -80.61 172.53 13.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.626 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.4 t -103.39 148.15 8.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.644 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.0 -37.23 2.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.709 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 m -153.24 130.93 11.55 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.771 0.32 . . . . 0.0 111.205 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.4 106.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.201 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 t -68.32 135.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.374 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.14 147.56 49.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.966 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.58 -14.61 63.02 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.226 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.634 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.27 -155.07 3.08 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.677 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.56 -41.82 10.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.668 0.27 . . . . 0.0 111.487 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.469 ' HB1' HD12 ' A' ' 51' ' ' LEU . . . -71.26 -33.41 69.77 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.065 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -71.31 -38.45 71.73 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' GLY . 50.0 t -66.31 -54.19 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 111.566 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -63.66 -50.6 68.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.136 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.7 68.43 1.23 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.212 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.556 ' HB3' HG11 ' A' ' 9' ' ' VAL . 21.6 mmt85 -145.06 33.68 1.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.821 0.343 . . . . 0.0 110.648 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.469 HD12 ' HB1' ' A' ' 45' ' ' ALA . 4.0 mt -152.48 176.08 12.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.213 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.32 142.56 4.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.096 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.96 124.0 19.97 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.942 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.82 29.33 6.22 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.405 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.567 ' HB3' HG23 ' A' ' 88' ' ' VAL . 4.0 m-20 -115.81 159.81 20.98 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.521 0.201 . . . . 0.0 110.805 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 48.3 tt0 -96.47 154.8 17.07 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.047 0.451 . . . . 0.0 112.046 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.11 100.23 6.47 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.355 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -69.45 -59.73 2.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.247 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -139.44 159.04 43.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.852 HG13 ' HG ' ' A' ' 86' ' ' LEU . 38.9 t -132.89 124.55 50.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.988 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.1 t70 56.42 31.36 18.65 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.031 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.96 35.44 58.96 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.804 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -101.99 14.2 32.63 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.74 87.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.38 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.895 HD23 HD12 ' A' ' 68' ' ' LEU . 5.5 mt -111.82 61.87 0.62 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.302 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -130.22 98.52 3.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.109 0.48 . . . . 0.0 110.977 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.79 -25.71 4.39 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.747 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.895 HD12 HD23 ' A' ' 65' ' ' LEU . 88.5 mt -66.44 174.76 2.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.15 0.5 . . . . 0.0 111.334 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.0 m -88.73 162.72 16.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.989 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.551 HE21 HG23 ' B' ' 102' ' ' THR . 40.2 tt0 -52.66 -28.48 21.77 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.555 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -77.66 -54.52 6.28 Favored 'General case' 0 C--N 1.335 -0.054 0 CA-C-O 120.575 0.226 . . . . 0.0 111.057 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -56.94 -34.68 68.24 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.29 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.495 ' HB3' HG12 ' A' ' 34' ' ' ILE . . . -70.89 -59.62 2.69 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.366 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.656 ' O ' HG22 ' A' ' 78' ' ' THR . . . -56.57 -48.34 77.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.26 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -57.08 -44.72 83.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.87 -37.62 82.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.621 0.248 . . . . 0.0 111.033 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.781 ' HG2' HG21 ' A' ' 60' ' ' VAL . 56.6 mtp -61.95 -56.52 18.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.437 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 74' ' ' ALA . 1.6 t -61.12 -38.13 85.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.769 0.319 . . . . 0.0 110.506 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -85.5 53.07 2.63 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.454 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.51 179.5 4.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.735 0.302 . . . . 0.0 111.1 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.53 -165.59 1.34 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.749 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.3 m -55.75 -47.51 76.85 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.28 143.74 10.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.881 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.1 t -136.65 111.05 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.054 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.494 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -106.57 83.76 1.91 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.541 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.852 ' HG ' HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -93.62 137.48 32.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.426 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.732 ' HG3' HG23 ' A' ' 8' ' ' THR . 8.4 mt-10 -103.13 140.33 37.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.677 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 55' ' ' ASP . 11.8 p -128.7 138.16 55.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.366 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -109.53 116.65 32.18 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.711 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -61.3 120.38 10.29 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.136 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.15 -172.41 2.02 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.133 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.29 3.02 86.1 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.8 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.215 179.491 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.1 tp . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.989 0.424 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.486 ' O ' HG22 ' A' ' 22' ' ' VAL . 32.1 m-85 -141.56 -170.65 3.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.382 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 2.4 p -132.29 110.91 10.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.755 0.312 . . . . 0.0 111.44 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.551 HG23 HE21 ' A' ' 70' ' ' GLN . 17.4 p -98.18 -164.57 1.15 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.76 94.04 2.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.326 0.584 . . . . 0.0 110.737 178.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.461 HG21 ' CB ' ' A' ' 77' ' ' MET . 5.3 p . . . . . 0 C--O 1.252 1.232 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.038 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.544 0.211 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.37 80.33 0.23 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -88.22 118.75 69.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.48 -179.0 2.49 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.678 2.252 . . . . 0.0 112.521 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.67 94.83 4.31 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.06 0.457 . . . . 0.0 110.813 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.647 HG21 HD13 ' A' ' 58' ' ' LEU . 4.5 mp -91.2 135.38 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.814 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.568 HD12 HG13 ' A' ' 9' ' ' VAL . 1.5 pp -142.27 138.26 29.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.259 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.918 HG22 HG22 ' A' ' 85' ' ' THR . 3.2 m -104.08 98.54 8.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.568 HG13 HD12 ' A' ' 7' ' ' ILE . 19.2 m -89.17 169.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.44 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -125.18 109.22 12.6 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.755 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 50' ' ' ARG . 2.6 mt -109.52 155.26 21.59 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.768 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -107.52 118.82 37.74 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.725 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -62.45 100.73 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.86 87.48 3.31 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.727 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.12 39.58 28.93 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.208 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.93 153.87 30.53 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.171 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.856 ' O ' HG11 ' A' ' 40' ' ' VAL . 7.5 mtm -80.28 -79.92 0.14 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.648 0.224 . . . . 0.0 111.038 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.75 -0.74 27.45 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.149 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 20' ' ' SER . 3.5 pp -79.86 173.8 12.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 117.071 0.436 . . . . 0.0 110.828 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.467 ' N ' HD12 ' A' ' 19' ' ' LEU . 57.9 m -127.12 151.62 48.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.74 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 34' ' ' ILE . 2.2 pp -139.75 150.83 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.554 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.857 HG23 ' HB2' ' A' ' 37' ' ' LYS . 85.7 t -126.15 145.67 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.274 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . . . -107.2 119.9 40.66 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.748 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.9 151.47 44.29 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.414 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.401 ' HG3' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -118.71 -179.74 3.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.048 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.63 -139.68 2.73 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.35 143.89 38.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.628 0.251 . . . . 0.0 110.801 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.37 41.59 99.56 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.652 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 107.26 7.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.719 0.295 . . . . 0.0 110.973 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.429 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 24.5 t0 -91.93 20.51 5.68 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.316 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.429 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -141.19 -167.87 2.49 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.307 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 25' ' ' LYS . 5.6 tp -136.61 126.2 25.32 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.36 130.39 10.1 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.946 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 21' ' ' ILE . 21.3 mm -95.19 71.13 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.073 0.463 . . . . 0.0 110.835 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 94.4 m-85 -62.16 160.51 12.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 55' ' ' ASP . 23.2 t -96.25 121.22 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.731 0.3 . . . . 0.0 111.277 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.857 ' HB2' HG23 ' A' ' 22' ' ' VAL . 6.3 tttp -80.19 -43.66 21.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.042 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.8 p -156.41 178.23 10.55 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.94 123.05 12.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.673 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.856 HG11 ' O ' ' A' ' 17' ' ' MET . 2.1 p -50.4 132.03 10.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.66 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.84 92.78 8.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.01 -21.64 2.64 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.148 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.64 -167.83 7.26 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.066 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.52 -1.32 53.45 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.45 -43.14 8.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.749 0.309 . . . . 0.0 111.013 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -72.69 -44.97 61.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.524 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.4 t -64.86 -39.53 85.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.541 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.46 -47.92 62.43 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.927 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.22 44.52 6.22 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.665 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.496 ' HB3' HG11 ' A' ' 9' ' ' VAL . 21.9 mmt85 -102.56 -38.63 7.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.547 0.213 . . . . 0.0 110.965 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.437 HD23 HD11 ' A' ' 11' ' ' LEU . 3.9 pp -126.79 158.85 35.49 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.894 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.29 -174.95 4.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.193 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.54 138.94 43.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 39.42 9.98 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.875 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 36' ' ' VAL . 63.5 m-20 -116.16 138.19 51.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.514 0.197 . . . . 0.0 110.742 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.444 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -81.11 147.75 29.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.059 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 2.1 tp -101.02 154.36 18.77 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 111.563 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.647 HD13 HG21 ' A' ' 6' ' ' ILE . 2.3 tt -140.54 -57.53 0.53 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.032 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.53 156.72 48.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.254 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG11 ' CG ' ' A' ' 77' ' ' MET . 29.3 t -141.49 123.43 13.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.827 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.57 33.05 22.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.313 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.44 27.93 71.94 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.042 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -115.07 165.38 12.96 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.827 0.314 . . . . 0.0 110.825 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.43 106.99 17.66 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.547 HD21 HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -119.99 33.22 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.571 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.89 98.86 4.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.24 0.543 . . . . 0.0 110.695 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.34 28.81 3.92 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.64 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 68' ' ' LEU . 17.0 mt -110.42 158.44 18.47 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.764 0.316 . . . . 0.0 110.737 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.67 153.01 42.88 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.391 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 6.7 tt0 -52.01 -34.55 43.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.76 -48.53 71.52 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.313 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -63.51 -44.31 94.65 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.609 0.242 . . . . 0.0 111.335 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -59.67 -56.24 24.4 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.71 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.584 ' O ' HG22 ' A' ' 78' ' ' THR . . . -62.93 -45.97 89.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.075 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -57.79 -26.3 61.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.547 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.3 mt -74.63 -47.87 29.63 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.795 ' HB2' HG21 ' B' ' 104' ' ' VAL . 4.6 mtp -60.43 -48.06 83.38 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.355 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 74' ' ' ALA . 1.4 t -61.12 -36.12 78.87 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.83 0.348 . . . . 0.0 110.304 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.98 52.57 2.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.843 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.456 HG21 HG13 ' A' ' 84' ' ' VAL . 34.9 p -118.01 176.48 5.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 111.072 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -92.54 -163.86 1.1 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.517 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.03 -34.03 58.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.945 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.59 140.8 22.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.904 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.53 HG12 ' CD1' ' A' ' 86' ' ' LEU . 15.0 t -136.76 118.2 18.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.918 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -96.63 100.54 12.1 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.53 ' CD1' HG12 ' A' ' 84' ' ' VAL . 4.8 mp -100.77 116.99 33.95 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.204 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 28.8 tt0 -101.4 101.52 12.16 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.547 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.02 171.32 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.625 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.31 135.94 53.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.096 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -93.98 117.04 29.55 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.457 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.72 167.04 27.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.52 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 150.37 -119.74 1.05 Allowed Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.406 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.69 179.911 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.4 -176.46 3.75 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.579 0.228 . . . . 0.0 111.443 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 60.2 p -168.95 146.72 3.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.814 0.34 . . . . 0.0 111.843 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.449 HG21 ' CB ' ' A' ' 74' ' ' ALA . 19.7 m -157.9 158.68 35.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.593 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -135.0 88.38 2.42 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 110.144 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.795 HG21 ' HB2' ' A' ' 77' ' ' MET . 8.0 p . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.707 -0.664 . . . . 0.0 112.005 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 120.711 0.291 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -102.99 95.09 5.91 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.626 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -107.64 128.97 24.87 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 34.0 Cg_exo -58.97 175.27 0.65 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.812 2.341 . . . . 0.0 112.719 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.24 97.37 3.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.256 0.551 . . . . 0.0 110.842 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.448 HG12 ' CD1' ' A' ' 58' ' ' LEU . 4.6 mp -80.03 122.33 35.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.176 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.14 138.76 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.337 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.795 HG22 HG22 ' A' ' 85' ' ' THR . 0.2 OUTLIER -100.37 126.58 46.75 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.476 HG13 ' HD2' ' A' ' 50' ' ' ARG . 22.0 t -114.38 131.22 67.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 m -105.31 123.39 47.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.917 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.505 HD21 ' CG ' ' A' ' 48' ' ' ASP . 10.3 mt -140.72 160.18 40.6 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.118 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 mtmm -101.23 163.76 12.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -90.96 98.42 11.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -74.86 -53.14 9.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.2 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -166.46 45.28 0.06 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.347 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.75 150.38 14.31 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.226 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -60.08 3.31 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.688 0.244 . . . . 0.0 110.479 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.93 72.23 1.03 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.324 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.487 HD11 ' CG1' ' B' ' 104' ' ' VAL . 3.3 pp -161.14 178.02 9.7 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.446 0.165 . . . . 0.0 110.698 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -127.54 141.48 51.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.669 0.271 . . . . 0.0 111.615 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 21' ' ' ILE . 2.3 pp -132.59 159.91 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.409 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG13 ' O ' ' B' ' 100' ' ' PHE . 61.8 t -146.64 148.05 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.356 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -104.35 147.88 27.02 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.056 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.77 149.8 30.21 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.83 0.347 . . . . 0.0 111.762 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -121.79 -179.9 4.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.81 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.2 -144.01 3.82 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.978 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.14 145.15 37.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.603 0.24 . . . . 0.0 110.748 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.81 30.6 63.14 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.587 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.74 108.83 4.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.682 0.277 . . . . 0.0 110.67 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -93.96 27.56 2.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.384 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -116.04 -165.48 1.05 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.421 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.4 tp -144.57 136.87 26.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.632 0.253 . . . . 0.0 111.119 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.35 116.68 5.62 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.625 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.1 mp -85.48 81.54 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.368 0.604 . . . . 0.0 110.496 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 56' ' ' GLN . 93.4 m-85 -79.8 145.59 32.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.106 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.9 t -83.47 123.3 38.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.901 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HB2' HG23 ' A' ' 22' ' ' VAL . 10.3 tptt -82.38 -43.21 17.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.846 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 t -169.01 -179.92 3.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.2 t -132.78 129.94 58.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.706 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.36 129.75 36.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.016 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.8 136.8 58.11 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.62 -26.67 17.27 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.7 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.74 158.73 46.69 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.784 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.3 -39.3 72.5 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.02 -39.62 63.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.196 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -60.35 -38.96 85.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 43' ' ' GLY . 36.7 t -73.35 -38.76 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.335 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.505 ' CG ' HD21 ' A' ' 11' ' ' LEU . 1.1 t0 -59.46 -43.26 93.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.319 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.78 36.48 57.9 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.946 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.476 ' HD2' HG13 ' A' ' 9' ' ' VAL . 19.3 mtt-85 -98.93 -45.9 5.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.781 0.29 . . . . 0.0 110.889 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.4 pp -101.84 171.46 7.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.783 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.75 -173.13 3.8 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.281 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.42 157.75 23.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.47 30.46 71.17 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.696 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.67 -177.02 3.25 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.562 0.22 . . . . 0.0 110.792 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 65.8 tt0 -125.85 152.74 45.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.945 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.754 HD11 HD21 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -112.16 142.84 44.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.126 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -115.17 -54.65 2.54 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.351 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.3 p -140.12 154.36 46.98 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.086 0.47 . . . . 0.0 111.95 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.84 HG23 HD11 ' A' ' 65' ' ' LEU . 59.6 t -132.09 112.84 20.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.518 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.09 35.48 26.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.997 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.07 31.98 45.86 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.041 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -128.9 149.3 50.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.815 0.307 . . . . 0.0 110.655 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t -92.27 132.62 36.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.169 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.84 HD11 HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -107.83 -28.9 9.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.494 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.07 99.24 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.188 0.518 . . . . 0.0 111.017 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 142.87 -35.39 1.7 Allowed Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.882 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.797 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -88.11 166.49 14.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.1 t -72.5 161.07 31.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.757 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' B' ' 100' ' ' PHE . 3.4 tt0 -53.46 -44.2 68.72 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.067 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -61.4 -39.61 91.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.704 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.37 -35.86 73.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.866 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.797 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . . . -72.04 -61.01 1.94 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.383 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.526 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -54.23 -39.76 67.06 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.313 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HG3' ' CD ' ' A' ' 79' ' ' ARG . 1.7 tt0 -62.55 -50.11 72.62 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.843 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.83 -32.17 65.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.217 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.582 ' HE1' HG11 ' B' ' 104' ' ' VAL . 22.4 mtp -71.22 -58.83 3.17 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.565 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.535 ' HB ' HG23 ' B' ' 104' ' ' VAL . 4.8 t -59.36 -33.98 71.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.811 0.338 . . . . 0.0 110.709 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.409 ' CD ' ' HG3' ' A' ' 75' ' ' GLU . 66.4 mtp85 -86.43 51.98 2.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.516 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 p -110.09 -178.99 3.66 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.678 0.275 . . . . 0.0 110.95 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.16 -174.03 4.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.83 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.5 p -52.33 -44.11 64.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.22 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.73 140.38 16.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.844 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.28 121.27 65.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.072 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.795 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -113.23 80.87 1.41 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.785 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.754 HD21 HD11 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -90.31 121.8 32.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.938 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.671 ' HB2' HG23 ' A' ' 8' ' ' THR . 24.9 tt0 -104.19 103.8 13.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.5 m -102.32 170.86 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.116 0.484 . . . . 0.0 111.64 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.8 98.11 6.65 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.993 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.89 126.67 28.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -148.86 170.42 18.31 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.327 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.39 -7.01 80.21 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.657 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.211 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.679 -179.76 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.496 ' O ' HG13 ' A' ' 22' ' ' VAL . 52.1 m-85 -103.56 117.76 35.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.082 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.491 ' HA ' HG22 ' A' ' 22' ' ' VAL . 27.2 t -175.68 119.33 0.17 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.791 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.526 HG21 ' CB ' ' A' ' 74' ' ' ALA . 31.6 m -122.24 159.02 28.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.351 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -121.92 88.4 2.93 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.117 0.484 . . . . 0.0 110.319 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.582 HG11 ' HE1' ' A' ' 77' ' ' MET . 8.0 p . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.071 -0.966 . . . . 0.0 111.688 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 79.77 0.86 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.905 0.383 . . . . 0.0 110.676 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -135.42 146.11 56.42 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.9 -178.26 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.942 2.428 . . . . 0.0 112.91 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 8.6 tt0 -129.27 97.2 4.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.091 0.472 . . . . 0.0 110.922 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.76 125.84 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.629 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.626 HD12 HG13 ' A' ' 9' ' ' VAL . 1.3 pt -141.65 142.79 28.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.262 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.746 HG23 ' HB2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -99.77 116.62 32.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.887 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.626 HG13 HD12 ' A' ' 7' ' ' ILE . 27.2 m -111.2 146.54 16.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.41 HG22 ' CG1' ' A' ' 83' ' ' VAL . 2.1 m -119.95 127.7 52.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.833 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mt -133.38 166.1 23.3 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.407 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -109.83 176.7 4.97 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 mtpt -106.28 92.25 4.05 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.846 0.355 . . . . 0.0 111.361 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -45.41 38.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.439 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -167.05 45.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.209 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.92 145.34 15.32 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.152 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -41.3 98.56 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.643 0.222 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.77 68.3 1.74 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.051 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.487 ' HA ' HG23 ' A' ' 40' ' ' VAL . 2.3 pp -160.75 168.38 24.91 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.553 0.216 . . . . 0.0 111.017 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' B' ' 103' ' ' GLU . 7.5 m -116.16 153.36 31.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.122 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.089 HD11 HG22 ' B' ' 102' ' ' THR . 2.6 pp -124.17 165.52 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.707 0.289 . . . . 0.0 111.682 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.747 HG13 ' HB2' ' B' ' 100' ' ' PHE . 25.7 t -151.42 140.81 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.465 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.84 158.59 18.69 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.714 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -155.22 132.83 11.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.927 0.394 . . . . 0.0 111.64 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -128.9 179.85 5.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.761 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.72 -140.04 3.02 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.73 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.07 147.79 28.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.629 0.252 . . . . 0.0 110.634 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.25 36.54 92.59 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.693 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.53 106.37 7.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.64 0.257 . . . . 0.0 110.776 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -90.16 20.79 4.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.516 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.595 ' CB ' HG12 ' A' ' 66' ' ' VAL . 21.4 mmtp -144.33 -169.16 3.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.822 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 24' ' ' ALA . 4.7 mt -138.39 131.06 29.32 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.782 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.69 151.05 21.53 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.924 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.675 HG13 ' HB1' ' A' ' 73' ' ' ALA . 23.8 mm -106.39 110.3 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.726 0.298 . . . . 0.0 111.215 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.714 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 6.4 m-85 -103.5 174.1 6.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.207 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.405 HG13 HD13 ' A' ' 19' ' ' LEU . 47.0 t -111.85 112.11 39.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.008 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.502 ' HB2' HG23 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -60.29 -49.64 76.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.592 179.394 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.4 p -176.61 131.4 0.2 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.0 t -82.74 127.29 39.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.427 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 19' ' ' LEU . 14.8 t -80.06 127.6 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.09 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 128.45 36.38 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.74 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.56 -19.86 11.3 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.967 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.12 -162.27 5.79 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.667 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.06 -34.6 14.33 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.49 -33.8 54.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -67.96 -47.62 68.12 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 43' ' ' GLY . 55.7 t -60.61 -42.18 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.558 0.218 . . . . 0.0 111.336 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.21 -35.67 79.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.148 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.38 45.09 88.55 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.902 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.76 -34.2 10.99 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.577 0.227 . . . . 0.0 110.954 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.7 147.61 50.13 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.006 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.57 -168.59 1.35 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.36 146.81 44.9 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.351 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.45 47.13 23.15 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.245 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.49 129.99 56.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.478 0.18 . . . . 0.0 110.782 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 35' ' ' TYR . 2.1 tm0? -80.62 145.53 31.65 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.02 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.46 HD22 HD23 ' A' ' 86' ' ' LEU . 6.6 mt -117.04 120.92 39.85 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.765 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.41 -58.33 2.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.9 p -130.76 163.92 26.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.579 HG11 ' HG2' ' A' ' 77' ' ' MET . 24.9 t -139.73 114.99 7.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.12 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.34 24.28 12.81 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.508 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.18 28.96 26.58 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.77 160.5 27.17 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 110.636 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -101.96 114.54 28.73 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.698 ' CD2' HD13 ' A' ' 76' ' ' LEU . 51.3 mt -114.63 31.91 6.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.015 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.595 HG12 ' CB ' ' A' ' 31' ' ' LYS . 69.2 t -114.26 100.85 11.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.143 0.497 . . . . 0.0 110.667 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.08 -35.45 1.47 Allowed Glycine 0 CA--C 1.517 0.207 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.627 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.9 168.64 13.22 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 110.459 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 t -64.71 157.57 27.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.181 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.76 ' CD ' HD13 ' A' ' 21' ' ' ILE . 8.6 tp-100 -52.24 -31.08 30.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.928 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.26 -52.23 65.25 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.954 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -43.19 94.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.045 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.675 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -67.45 -61.47 1.89 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.679 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 78' ' ' THR . . . -55.74 -36.12 66.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.631 0.253 . . . . 0.0 111.378 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.408 ' HG2' ' NH2' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -74.72 -34.6 62.61 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.411 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.698 HD13 ' CD2' ' A' ' 65' ' ' LEU . 3.2 mt -68.9 -44.15 73.77 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.482 0.182 . . . . 0.0 110.968 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.579 ' HG2' HG11 ' A' ' 60' ' ' VAL . 36.2 mtp -59.75 -52.46 65.39 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.563 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 74' ' ' ALA . 3.6 t -62.35 -36.75 83.21 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.665 0.269 . . . . 0.0 110.764 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 75' ' ' GLU . 60.0 mtm180 -87.73 53.94 2.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.632 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.2 p -108.76 176.2 5.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 111.005 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.59 -174.55 1.75 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.429 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 m -52.27 -34.26 45.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.628 0.252 . . . . 0.0 111.125 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.41 ' CG1' HG22 ' A' ' 10' ' ' THR . 21.3 t -107.71 151.4 9.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.92 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.8 t -137.65 118.37 16.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.518 HG22 HG22 ' A' ' 8' ' ' THR . 24.0 m -104.58 94.34 5.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.843 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.46 HD23 HD22 ' A' ' 57' ' ' LEU . 3.4 mp -98.95 138.42 36.09 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.411 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.746 ' HB2' HG23 ' A' ' 8' ' ' THR . 48.5 tt0 -114.89 99.74 7.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.714 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.1 m -101.98 173.83 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.041 0.448 . . . . 0.0 111.746 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.87 123.34 39.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.126 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 1.7 mptm? -79.42 96.46 6.05 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.607 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -135.19 -173.89 3.46 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.927 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.42 140.39 4.36 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.536 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.514 -179.868 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.66 0.267 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.747 ' HB2' HG13 ' A' ' 22' ' ' VAL . 33.5 p90 -112.98 164.24 13.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 4.4 t 64.21 86.17 0.13 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' THR . . . . . 1.089 HG22 HD11 ' A' ' 21' ' ' ILE . 5.2 t -137.38 17.44 2.94 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.907 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 0.6 OUTLIER 59.66 174.87 0.08 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.226 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 74' ' ' ALA . 8.0 p . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.401 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.868 0.366 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.7 mtmp? -66.8 168.37 9.75 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.657 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.82 86.95 11.59 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.942 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 26.9 Cg_exo -63.11 179.52 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.768 2.312 . . . . 0.0 112.59 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -127.61 94.3 3.93 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.773 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mt -84.06 113.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.85 141.01 45.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 27.5 m -104.87 141.33 36.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -119.59 127.93 75.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.283 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 m -99.42 103.54 15.33 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.671 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -143.9 149.01 36.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.359 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.18 167.78 14.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.208 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.66 124.89 28.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.62 85.48 2.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.38 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 m120 58.38 34.56 24.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.946 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.11 158.0 31.0 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.669 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.49 -48.57 16.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.534 0.207 . . . . 0.0 110.634 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.48 74.96 0.55 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.555 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 2.8 pp -160.74 173.82 14.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.556 0.217 . . . . 0.0 110.776 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -124.35 149.58 46.46 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.804 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' HG22 ' A' ' 34' ' ' ILE . 8.6 pt -137.71 154.48 29.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.627 HG13 ' O ' ' B' ' 100' ' ' PHE . 61.8 t -147.12 134.97 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.251 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.664 ' HB2' ' OE1' ' A' ' 70' ' ' GLN . . . -88.96 144.43 26.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.952 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.41 159.44 35.76 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.837 0.351 . . . . 0.0 111.783 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.45 179.31 4.63 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.052 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.88 -144.06 3.85 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.888 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.07 150.31 28.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.645 0.26 . . . . 0.0 110.865 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.79 28.82 60.84 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.586 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -146.78 107.98 4.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.651 0.262 . . . . 0.0 110.455 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -97.57 37.42 1.37 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -133.52 -164.62 1.51 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.477 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tp -147.53 125.76 12.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.68 0.276 . . . . 0.0 110.772 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.76 137.57 13.34 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.607 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.601 HG13 ' HB1' ' A' ' 73' ' ' ALA . 18.8 mm -86.6 72.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.107 0.48 . . . . 0.0 110.736 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -60.23 160.18 8.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.348 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 t -100.96 115.09 41.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.964 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.4 -46.78 78.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.791 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -178.94 124.87 0.09 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.902 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.5 m -72.67 142.51 15.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.089 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.91 137.67 21.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.38 153.25 27.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.213 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.05 14.94 76.32 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.884 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -92.18 159.39 25.3 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.296 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.23 69.42 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -83.3 -34.41 25.72 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.291 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.11 -47.09 69.12 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.309 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.2 t -63.81 -46.53 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.4 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -43.95 97.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.168 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.47 64.96 1.77 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.839 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -136.78 23.47 3.1 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.632 0.253 . . . . 0.0 111.374 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.1 pp -179.83 177.97 0.65 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.755 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.77 -170.05 2.07 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.187 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.406 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -72.44 160.23 32.67 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.914 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 91' ' ' GLN . . . 64.91 31.24 80.26 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.244 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.8 124.69 45.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.59 0.234 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.643 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 8.7 tm0? -79.47 117.57 20.55 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.057 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.539 HD11 HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -88.75 136.09 33.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.198 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.451 HD13 ' CG2' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -108.54 -63.01 1.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.837 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 58.8 m -127.91 145.49 50.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.196 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' A' ' 77' ' ' MET . 39.2 t -120.87 118.19 55.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.667 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 60.56 32.01 20.34 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.105 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.73 -6.28 70.66 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.273 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -80.53 154.62 27.41 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 117.186 0.493 . . . . 0.0 111.057 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.35 101.09 12.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.658 HD23 HD12 ' A' ' 68' ' ' LEU . 6.4 mt -110.42 44.2 1.28 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.688 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.451 ' CG2' HD13 ' A' ' 58' ' ' LEU . 60.3 t -101.8 99.97 9.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.719 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.83 -29.25 5.66 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.759 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.658 HD12 HD23 ' A' ' 65' ' ' LEU . 65.7 mt -65.36 168.59 6.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 111.241 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.0 t -87.22 168.16 13.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.449 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.664 ' OE1' ' HB2' ' A' ' 23' ' ' ALA . 5.9 tp60 -58.24 -29.44 65.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.003 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.47 -56.01 27.39 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.786 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -63.21 -45.99 89.11 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.693 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -59.07 -58.39 8.87 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.972 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.893 ' HB1' HG21 ' B' ' 102' ' ' THR . . . -49.07 -48.56 44.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.712 0.291 . . . . 0.0 111.387 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -61.76 2.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.739 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.59 HD12 HD21 ' A' ' 65' ' ' LEU . 16.8 mt -56.22 -30.53 62.44 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.703 ' CE ' HG21 ' B' ' 104' ' ' VAL . 4.3 mmm -66.01 -64.15 0.92 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.8 -0.182 . . . . 0.0 111.175 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 74' ' ' ALA . 3.4 t -62.4 -35.82 80.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.775 0.322 . . . . 0.0 110.729 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -85.33 49.4 1.75 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.333 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.89 169.56 10.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.717 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.14 -169.34 0.93 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.822 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.63 -54.55 21.98 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.697 0.284 . . . . 0.0 110.86 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.73 147.16 5.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.692 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.489 HG12 HD13 ' A' ' 86' ' ' LEU . 33.3 t -121.78 111.63 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.987 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.14 105.85 14.7 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.781 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.539 HD23 HD11 ' A' ' 57' ' ' LEU . 5.4 mp -115.2 131.13 57.03 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.942 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 2.3 mt-10 -102.16 95.55 6.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.3 m -89.66 172.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.256 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -130.48 118.77 21.62 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.52 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 106.78 0.27 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.643 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 54' ' ' GLY . 1.5 tp-100 -70.47 -178.87 1.88 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.187 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.97 145.21 5.61 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.368 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.183 179.736 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.0 mt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.693 0.282 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.627 ' O ' HG13 ' A' ' 22' ' ' VAL . 22.7 p90 -171.41 36.52 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.42 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 53.9 p -162.94 78.02 0.45 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.986 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.893 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -96.58 -152.51 0.38 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.73 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.561 ' H ' HG22 ' B' ' 102' ' ' THR . 0.2 OUTLIER -176.34 48.28 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.703 HG21 ' CE ' ' A' ' 77' ' ' MET . 26.0 m . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.165 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -75.29 158.84 32.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -118.92 104.53 46.58 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.206 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.62 -170.2 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.808 2.339 . . . . 0.0 112.556 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 1.4 tt0 -132.71 102.58 5.73 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.984 0.421 . . . . 0.0 111.234 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.63 131.14 43.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.881 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.0 pt -150.74 154.89 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.198 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.72 ' CG2' HG22 ' A' ' 85' ' ' THR . 1.8 m -122.49 132.25 54.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.6 t -115.78 136.8 51.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.183 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -101.68 112.14 24.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.656 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 mt -134.74 168.67 18.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.236 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.1 157.28 19.53 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -86.33 69.75 10.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.488 HE22 ' HB2' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -43.79 -41.27 4.88 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.701 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -172.77 44.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.294 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.46 152.23 25.17 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.178 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.421 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -74.91 -51.42 13.84 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.571 0.224 . . . . 0.0 110.821 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.06 80.77 0.12 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.083 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.446 HD11 ' CG1' ' B' ' 104' ' ' VAL . 3.0 pp -160.92 -179.76 7.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.619 0.247 . . . . 0.0 110.88 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 37' ' ' LYS . 15.3 m -125.28 141.69 51.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.067 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.538 HD13 HG23 ' A' ' 34' ' ' ILE . 2.4 pp -136.26 157.47 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.832 0.348 . . . . 0.0 111.796 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -145.32 148.59 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.235 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.09 131.97 46.76 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.235 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.86 146.89 38.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.493 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HG3' HD12 ' A' ' 32' ' ' LEU . 11.5 tttt -122.83 -179.73 4.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.957 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.39 -140.57 2.91 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.751 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.3 147.27 32.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.586 0.231 . . . . 0.0 110.779 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.78 40.89 97.25 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.614 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.53 106.24 7.33 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.715 0.293 . . . . 0.0 110.907 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -90.68 24.43 2.69 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.003 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -144.35 -165.83 2.23 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.647 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.425 HD12 ' HG3' ' A' ' 25' ' ' LYS . 6.9 tp -138.67 135.1 34.48 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.798 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.36 127.42 8.78 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.709 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -95.91 94.72 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 121.129 0.49 . . . . 0.0 110.562 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -78.59 168.56 19.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.375 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.412 ' CG2' HD11 ' A' ' 57' ' ' LEU . 21.2 t -101.48 133.9 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.134 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 20' ' ' SER . 4.7 ttpt -97.53 -40.61 8.56 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.9 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.2 m -160.4 174.29 14.35 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.93 123.47 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.795 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.8 t -79.87 153.19 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.261 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -72.01 153.37 41.81 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.154 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.89 8.92 87.54 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.366 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.675 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -96.16 156.48 21.3 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.377 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' HB2' HE22 ' A' ' 14' ' ' GLN . . . -53.59 -43.35 68.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.622 0.249 . . . . 0.0 111.5 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.38 -34.66 74.87 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.242 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.65 -46.1 48.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.339 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.0 t -61.11 -49.34 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.164 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.69 -44.82 89.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.163 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.95 28.55 66.53 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.081 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.84 -47.52 16.46 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.805 0.303 . . . . 0.0 110.894 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.581 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.1 pp -109.73 170.42 8.08 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.96 177.76 7.58 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.169 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.92 141.72 53.05 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.43 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.48 43.57 4.86 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.675 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -128.22 146.03 50.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.686 0.279 . . . . 0.0 110.887 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -83.5 152.55 24.86 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.676 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.578 ' HB3' HD12 ' A' ' 65' ' ' LEU . 7.0 mp -115.0 148.51 38.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.942 0.401 . . . . 0.0 111.72 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.78 -55.17 2.01 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.782 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.7 p -137.58 152.13 49.09 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.9 0.381 . . . . 0.0 111.778 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.782 HG13 ' HG ' ' A' ' 86' ' ' LEU . 38.4 t -143.38 107.52 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.962 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t0 61.14 41.86 13.07 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.161 0.505 . . . . 0.0 110.823 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.99 37.5 38.14 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.058 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.47 162.0 21.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.766 0.283 . . . . 0.0 110.689 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.22 83.66 1.87 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.591 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.691 HD11 ' CG2' ' A' ' 60' ' ' VAL . 40.7 mt -60.8 -22.68 64.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.298 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.1 t -78.21 97.83 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.186 0.517 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.71 32.95 1.04 Allowed Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.288 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.876 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.2 pp -150.16 165.34 33.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 110.57 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.0 p -79.63 161.79 25.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.946 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -56.55 -32.3 65.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.325 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.84 -34.48 64.56 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.491 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -76.23 -33.22 59.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.978 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.876 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . . . -76.28 -58.64 3.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.334 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.69 ' O ' HG22 ' A' ' 78' ' ' THR . . . -56.55 -42.88 79.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.537 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.77 -39.85 93.1 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-O 120.698 0.285 . . . . 0.0 110.812 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.18 -32.2 68.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.291 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.578 ' HG2' HG11 ' A' ' 60' ' ' VAL . 28.1 mtp -72.24 -53.56 12.18 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.608 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 74' ' ' ALA . 2.0 t -60.7 -38.7 85.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.751 0.31 . . . . 0.0 110.795 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.6 mtp85 -87.87 55.94 3.68 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.644 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.4 p -106.52 178.5 4.54 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.895 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.1 p -88.1 -169.69 2.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.697 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.14 -54.77 43.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.631 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.7 t -84.58 139.27 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' THR . 16.8 t -129.7 151.62 36.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.465 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.72 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -135.11 83.27 2.01 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.781 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.782 ' HG ' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -89.71 122.18 32.57 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.098 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.07 97.46 7.43 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.675 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 51' ' ' LEU . 14.3 m -93.07 173.96 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.332 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.87 101.98 6.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.018 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -55.88 103.62 0.11 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.75 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.79 -167.48 1.44 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.886 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.47 134.73 2.08 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.487 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.316 -0.849 . . . . 0.0 110.988 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.639 0.257 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.7 -167.61 2.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.68 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 67.1 p -113.27 130.33 56.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.762 0.315 . . . . 0.0 111.284 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.532 HG21 ' CB ' ' A' ' 74' ' ' ALA . 51.8 m -124.4 159.45 30.4 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.601 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.2 mt-10 -124.78 79.75 1.8 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.002 0.43 . . . . 0.0 110.358 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.551 HG11 ' HE1' ' A' ' 77' ' ' MET . 11.5 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.677 -0.678 . . . . 0.0 111.668 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ptm . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.648 0.261 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -81.3 93.31 6.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.823 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.7 tt0 -73.91 117.22 59.46 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.058 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 27.7 Cg_exo -63.49 -165.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.997 2.465 . . . . 0.0 112.859 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -113.56 95.79 5.53 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.065 0.459 . . . . 0.0 111.047 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 44.4 mm -99.13 127.33 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.814 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -144.34 148.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.3 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.498 HG22 HG22 ' A' ' 85' ' ' THR . 0.2 OUTLIER -115.22 120.65 40.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 50' ' ' ARG . 15.9 m -94.85 153.34 3.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.144 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.04 106.99 10.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.477 HD21 ' CG ' ' A' ' 48' ' ' ASP . 6.6 mt -138.37 169.08 18.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.141 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -104.77 175.75 5.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -87.15 135.25 33.37 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.17 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.37 84.96 2.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.327 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.45 36.75 28.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.729 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.98 144.23 16.33 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.107 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.426 ' HB3' HD23 ' A' ' 19' ' ' LEU . 5.9 mtm -64.84 -46.84 80.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.553 0.216 . . . . 0.0 110.69 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.53 83.66 0.07 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.944 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.634 HD11 HG12 ' B' ' 104' ' ' VAL . 2.8 pp -160.52 -179.4 7.62 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.65 0.262 . . . . 0.0 110.725 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' B' ' 102' ' ' THR . 46.4 m -131.58 142.63 49.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.309 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 21' ' ' ILE . 2.7 pp -137.68 139.83 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.682 HG23 ' HB2' ' A' ' 37' ' ' LYS . 29.7 t -129.71 132.68 65.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.13 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.09 127.5 43.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.844 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.2 147.05 52.4 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.351 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HG3' HD12 ' A' ' 32' ' ' LEU . 4.4 tttt -119.76 -179.76 4.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.037 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.89 -139.85 2.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.14 143.67 38.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.588 0.233 . . . . 0.0 110.741 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.33 44.75 97.21 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.568 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 108.15 6.91 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.639 0.257 . . . . 0.0 110.916 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -92.61 20.02 6.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.363 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -140.28 -166.09 2.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.458 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 32' ' ' LEU . 5.2 tp -136.43 152.02 50.14 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.672 0.272 . . . . 0.0 110.814 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.13 111.37 2.83 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.703 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -81.43 73.0 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.215 0.531 . . . . 0.0 110.503 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -67.5 155.28 39.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.339 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.62 121.55 44.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.259 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.682 ' HB2' HG23 ' A' ' 22' ' ' VAL . 10.2 tptt -85.28 -36.15 21.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.971 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 5.7 t -170.24 175.32 4.96 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 111.23 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.6 t -138.45 118.15 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.2 t -68.55 125.88 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.019 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 153.16 37.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.472 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.01 -29.92 11.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.773 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.678 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.25 154.8 48.22 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.57 58.54 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.802 ' HB1' HD12 ' A' ' 51' ' ' LEU . . . -58.11 -51.36 70.03 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.26 -34.31 55.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.317 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 43' ' ' GLY . 48.1 t -62.85 -34.22 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.706 0.289 . . . . 0.0 110.698 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.477 ' CG ' HD21 ' A' ' 11' ' ' LEU . 16.2 t70 -71.56 -43.35 66.49 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.048 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.68 40.8 5.55 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.811 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HB3' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -131.05 31.93 4.37 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.677 0.275 . . . . 0.0 110.997 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.802 HD12 ' HB1' ' A' ' 45' ' ' ALA . 8.1 mt -150.63 160.3 43.91 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.295 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.02 143.4 3.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.097 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -62.83 132.86 53.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.836 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.81 29.45 6.18 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.483 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.08 -177.48 3.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.46 0.172 . . . . 0.0 110.714 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -127.57 150.77 49.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.823 0.344 . . . . 0.0 111.375 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.21 150.07 29.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.959 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.84 -57.58 1.43 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.093 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 p -139.12 153.44 47.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.461 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.811 HG11 ' HG2' ' A' ' 77' ' ' MET . 23.2 t -137.94 129.04 38.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.624 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 57.56 34.25 24.32 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.789 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.76 21.91 76.67 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.95 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.432 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -107.38 157.08 18.25 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 111.06 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -101.36 98.88 9.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.614 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.696 HD21 HG23 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -105.95 28.84 7.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.788 179.531 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.2 t -87.36 100.95 10.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.217 0.532 . . . . 0.0 110.462 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.46 31.74 2.3 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.536 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 mt -119.93 155.57 32.49 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.723 0.297 . . . . 0.0 110.726 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 87.2 p -68.01 157.39 35.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.162 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.87 ' NE2' HG23 ' B' ' 102' ' ' THR . 23.9 tt0 -52.08 -40.31 61.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.049 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -58.45 -53.72 55.18 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.858 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -61.24 -39.07 88.93 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.894 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.07 -62.86 1.38 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.38 -61.25 2.72 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.56 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -40.85 -44.9 2.38 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.511 0.507 . . . . 0.0 111.881 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.432 HD11 ' CZ ' ' A' ' 63' ' ' ARG . 8.8 mt -58.07 -42.19 84.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.779 0.323 . . . . 0.0 110.797 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.811 ' HG2' HG11 ' A' ' 60' ' ' VAL . 3.7 mtp -80.8 -28.67 36.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.384 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -31.54 72.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.66 0.267 . . . . 0.0 110.699 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -101.18 42.82 1.09 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.315 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 77' ' ' MET . 7.8 p -85.38 168.49 14.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.835 0.35 . . . . 0.0 111.196 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.0 p -91.91 -165.73 1.41 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.732 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 p -51.59 -52.34 48.21 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.083 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.45 141.86 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.219 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -128.63 110.97 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.858 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.498 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -101.22 97.58 8.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.919 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.481 HD23 HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -105.18 136.36 44.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.403 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 33.5 tt0 -106.63 107.32 18.27 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.385 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 p -107.64 151.83 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.615 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . . . -100.88 98.74 9.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 109.07 3.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.45 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.22 163.09 25.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.024 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.97 -6.83 88.6 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.814 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.988 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.991 179.997 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 11.3 tp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.668 0.27 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.479 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -159.8 152.3 21.15 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.468 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 101' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 85.6 p -127.03 113.1 16.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.771 0.319 . . . . 0.0 111.143 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.87 HG23 ' NE2' ' A' ' 70' ' ' GLN . 23.7 p -91.54 -166.99 1.68 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.344 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -146.81 112.11 5.51 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.875 0.369 . . . . 0.0 110.932 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 77' ' ' MET . 12.5 p . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.8 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 16.9 tt0 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 121.174 0.512 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.89 133.65 32.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.65 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pt -148.08 147.23 17.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.172 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -111.91 124.86 53.28 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 m -101.19 135.9 35.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.431 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 m -103.16 97.54 7.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.571 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 mt -122.19 163.33 19.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.896 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -108.71 141.3 40.9 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.871 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -77.87 111.01 13.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.08 -42.61 17.22 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -168.41 37.42 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.08 174.51 18.65 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.09 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.484 ' HB3' HD23 ' A' ' 19' ' ' LEU . 28.7 mtm -103.69 -46.94 4.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.714 0.257 . . . . 0.0 111.341 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.24 81.62 0.12 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.809 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' A' ' 17' ' ' MET . 2.8 pp -160.52 179.54 8.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.709 0.29 . . . . 0.0 110.868 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -132.81 146.59 51.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.718 0.294 . . . . 0.0 111.353 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.823 HD11 HG22 ' B' ' 102' ' ' THR . 2.7 pp -142.34 153.43 18.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.819 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' A' ' 37' ' ' LYS . 42.1 t -135.84 136.4 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.425 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.434 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -85.69 130.74 34.48 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.073 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.757 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -135.36 142.6 45.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.425 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -122.0 -179.6 4.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.924 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.03 -141.34 3.1 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.85 143.32 33.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.659 0.266 . . . . 0.0 110.675 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.79 34.02 88.56 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.697 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.75 105.03 7.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.686 0.279 . . . . 0.0 110.817 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.11 19.96 6.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.355 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.467 ' HG3' HG12 ' A' ' 66' ' ' VAL . 1.2 mmtp -138.48 -168.75 2.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.749 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 32' ' ' LEU . 6.7 tp -141.64 130.94 23.56 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.719 0.295 . . . . 0.0 110.927 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.51 136.25 12.71 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.741 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.5 HG13 ' HB1' ' A' ' 73' ' ' ALA . 24.5 mm -90.62 83.76 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.69 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.757 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 79.9 m-85 -74.14 162.18 29.23 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.359 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.41 134.86 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.264 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HB2' HG23 ' A' ' 22' ' ' VAL . 2.7 ttpt -105.53 -37.89 6.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 7.0 t -166.05 172.42 11.42 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.691 0.281 . . . . 0.0 110.957 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.0 t -130.89 126.71 60.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.763 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.3 145.17 10.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.009 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -68.14 150.22 48.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.323 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.34 20.23 73.2 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.917 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -93.11 157.58 23.41 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.388 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.77 62.03 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.25 -32.67 22.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.463 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.09 -44.85 59.89 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.296 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 43' ' ' GLY . 45.8 t -66.4 -44.82 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.124 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.34 -37.67 66.02 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.867 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.42 82.61 0.57 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.653 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -133.16 -61.87 0.81 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.625 0.213 . . . . 0.0 111.35 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.29 156.02 16.92 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.336 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.28 173.47 11.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.484 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -69.71 140.41 53.52 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.264 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.37 38.95 8.04 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.491 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -121.32 178.59 4.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.498 0.19 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -125.04 139.98 53.31 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.414 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.697 HD21 ' CG2' ' A' ' 60' ' ' VAL . 8.3 tp -106.9 147.87 29.27 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.064 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.52 -59.31 1.3 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.385 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.54 144.06 50.73 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.963 0.411 . . . . 0.0 111.759 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.843 HG23 HD21 ' A' ' 65' ' ' LEU . 40.4 t -133.86 123.83 45.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.542 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.01 33.13 22.84 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 23.32 77.98 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.074 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -112.96 134.61 54.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 117.018 0.409 . . . . 0.0 110.268 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -83.01 86.42 7.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.843 HD21 HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -89.47 54.75 3.01 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.126 0.489 . . . . 0.0 110.869 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.467 HG12 ' HG3' ' A' ' 31' ' ' LYS . 77.6 t -102.27 99.38 8.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.634 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.71 32.89 2.16 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.623 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.6 mt -117.66 161.75 19.15 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.4 152.87 24.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.299 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.47 ' NE2' HD13 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -47.07 -42.22 18.35 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.625 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -58.45 -49.99 75.33 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.039 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -69.76 -36.26 75.63 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.941 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -67.63 -58.23 5.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.633 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.516 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -60.96 -46.19 91.71 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.595 0.236 . . . . 0.0 111.276 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -55.42 -50.36 70.0 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.939 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.02 -40.65 96.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.393 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.519 ' HG2' HG21 ' A' ' 60' ' ' VAL . 37.9 mtp -58.48 -49.49 77.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.221 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.9 t -69.9 -27.88 65.16 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -82.96 43.93 0.89 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.801 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 p -101.37 171.26 7.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.274 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.9 m -85.27 -166.6 1.55 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.614 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -43.32 74.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.564 0.221 . . . . 0.0 110.928 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 t -93.19 140.2 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.647 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.434 HG12 ' HG ' ' A' ' 86' ' ' LEU . 30.2 t -130.36 134.51 62.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.275 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.48 89.74 3.17 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.646 HD23 HG13 ' A' ' 60' ' ' VAL . 17.1 mt -94.54 120.3 34.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.75 101.92 13.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.323 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 p -105.23 150.2 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.353 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.3 148.02 28.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.575 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.21 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.593 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 27.8 p . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.765 0.317 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.823 HG22 HD11 ' A' ' 21' ' ' ILE . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.744 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 2.6 tt0 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.153 0.501 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.73 HD12 HD12 ' A' ' 58' ' ' LEU . 34.0 mm -90.49 127.56 42.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pp -145.34 137.89 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.2 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.894 HG23 ' HG3' ' A' ' 87' ' ' GLU . 2.2 m -92.16 139.35 30.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.96 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.63 HG11 ' HB3' ' A' ' 50' ' ' ARG . 21.8 t -119.47 117.9 55.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.912 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.567 HG23 HG23 ' A' ' 85' ' ' THR . 1.5 m -111.06 102.74 11.17 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.27 157.67 42.66 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -84.19 136.0 34.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.489 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.26 96.75 0.67 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.335 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -101.75 100.08 10.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.293 0.568 . . . . 0.0 110.428 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 55.04 35.2 24.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.921 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.53 -174.51 36.52 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.4 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.1 mtm -102.69 -36.95 8.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.418 0.151 . . . . 0.0 111.095 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.63 79.75 0.13 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.599 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 51' ' ' LEU . 3.4 pp -160.71 179.81 8.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.669 0.271 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 36' ' ' VAL . 57.7 m -132.18 156.94 45.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.33 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.489 HD12 ' O ' ' A' ' 21' ' ' ILE . 2.8 pp -143.47 146.71 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.681 HG23 ' HB2' ' A' ' 37' ' ' LYS . 40.1 t -133.85 134.83 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.261 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.43 122.14 34.58 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.678 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.91 149.41 48.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.44 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.61 -179.79 3.76 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.264 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.95 -140.13 2.8 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.23 146.05 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.723 0.296 . . . . 0.0 110.771 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.26 41.05 98.15 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.606 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 106.94 7.35 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.671 0.272 . . . . 0.0 110.999 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.36 19.7 5.83 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.256 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.455 ' HG3' HG12 ' A' ' 66' ' ' VAL . 23.2 mmtt -146.97 -171.59 3.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.522 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.9 137.19 55.01 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.731 0.3 . . . . 0.0 110.886 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.83 125.31 8.5 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.627 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.443 HG13 ' HB1' ' A' ' 73' ' ' ALA . 19.3 mm -84.38 84.68 2.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.043 0.449 . . . . 0.0 110.737 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -77.66 168.83 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.512 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 20' ' ' SER . 27.0 t -104.23 129.06 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.403 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.681 ' HB2' HG23 ' A' ' 22' ' ' VAL . 3.0 tttt -83.41 -45.41 13.72 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.603 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -170.4 176.93 4.26 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.058 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.13 127.94 75.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.759 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.92 125.69 40.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.185 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.68 143.86 56.93 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.011 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.74 -15.75 60.47 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.115 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.13 -152.23 3.17 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.803 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.25 -60.47 1.67 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.556 0.217 . . . . 0.0 111.576 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -61.62 -26.45 68.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.856 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.44 -47.74 46.6 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.2 t -73.38 -37.82 52.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.268 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.96 -44.92 45.65 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.094 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.02 65.69 0.99 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.477 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.63 ' HB3' HG11 ' A' ' 9' ' ' VAL . 2.9 mmp_? -141.02 30.79 1.8 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.565 0.221 . . . . 0.0 111.375 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.571 ' CD1' HD22 ' A' ' 19' ' ' LEU . 9.3 mt -154.43 171.07 19.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.889 0.376 . . . . 0.0 111.393 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.8 141.76 3.48 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.38 117.09 5.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.6 31.41 3.71 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.617 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.24 -178.19 3.57 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.612 0.244 . . . . 0.0 110.999 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.843 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 6.0 tm0? -124.61 159.0 31.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.222 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 34' ' ' ILE . 64.2 mt -124.05 107.38 11.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.962 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.73 HD12 HD12 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -75.1 -64.44 1.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.179 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 m -147.62 159.11 44.14 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.447 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.793 HG21 ' CG ' ' A' ' 77' ' ' MET . 38.9 t -127.87 125.42 64.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.822 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 55.79 33.85 22.29 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.22 36.61 85.4 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.061 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -119.41 152.75 36.3 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 111.083 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.2 m -79.05 118.2 20.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.204 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.737 HD21 HD12 ' A' ' 76' ' ' LEU . 19.2 mt -126.1 31.4 5.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.046 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.455 HG12 ' HG3' ' A' ' 31' ' ' LYS . 62.5 t -115.1 100.34 10.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.128 0.49 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.414 ' CA ' ' HD2' ' A' ' 31' ' ' LYS . . . 132.55 -32.28 2.84 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.526 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.415 HD12 HD23 ' A' ' 65' ' ' LEU . 54.7 mt -66.5 172.04 4.46 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 110.984 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -84.03 160.03 21.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.078 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.719 HE21 HG23 ' B' ' 102' ' ' THR . 36.8 tt0 -51.93 -33.42 37.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.202 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -60.3 -54.87 40.56 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.022 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -60.32 -38.26 83.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.828 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -52.71 -62.44 1.65 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.237 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.84 -63.98 1.11 Allowed 'General case' 0 C--N 1.335 -0.055 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -36.07 -41.2 0.24 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.05 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.737 HD12 HD21 ' A' ' 65' ' ' LEU . 7.0 mt -66.31 -47.15 74.47 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.793 ' CG ' HG21 ' A' ' 60' ' ' VAL . 11.9 mtp -75.42 -30.45 60.07 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -32.05 69.1 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.635 0.255 . . . . 0.0 110.575 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -92.42 44.45 1.16 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.895 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.0 160.95 24.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.061 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.07 -164.66 1.1 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.038 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 82.5 p -50.27 -42.95 53.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.5 t -96.03 139.45 19.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.734 0.302 . . . . 0.0 110.807 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.88 96.22 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.567 HG23 HG23 ' A' ' 10' ' ' THR . 0.6 OUTLIER -98.02 90.3 4.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.436 ' HG ' HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -115.81 128.8 56.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.955 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.894 ' HG3' HG23 ' A' ' 8' ' ' THR . 12.2 mt-10 -98.93 111.82 24.11 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.48 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.6 142.34 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.561 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.843 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -105.14 108.76 20.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.636 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 8.1 mtmt . . . . . 0 N--CA 1.462 0.168 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.162 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.539 ' HB3' ' HD3' ' A' ' 37' ' ' LYS . 35.3 p . . . . . 0 C--O 1.233 0.227 0 CA-C-O 120.809 0.338 . . . . 0.0 111.876 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.719 HG23 HE21 ' A' ' 70' ' ' GLN . 39.2 p . . . . . 0 C--O 1.233 0.197 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.317 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 121.024 0.44 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.677 HG21 HD12 ' A' ' 58' ' ' LEU . 8.5 mt -94.85 113.52 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.663 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 pt -127.12 150.66 33.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.321 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.428 ' HB ' ' CG ' ' A' ' 87' ' ' GLU . 7.9 t -109.38 131.92 54.61 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.58 HG21 ' HG3' ' A' ' 50' ' ' ARG . 14.3 p -106.3 122.79 60.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.004 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -96.27 103.59 15.5 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.599 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HG ' HG22 ' A' ' 9' ' ' VAL . 7.1 mt -125.45 174.14 8.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.46 142.56 46.55 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.92 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.81 135.52 38.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.048 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -92.11 -60.75 1.77 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.307 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.86 36.38 0.26 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.725 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.16 144.79 6.88 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.024 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.0 mtm -73.03 -61.37 1.84 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.492 0.187 . . . . 0.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.4 81.25 0.2 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.569 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 pp -160.96 179.49 8.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.571 0.224 . . . . 0.0 110.807 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.8 m -136.88 149.18 47.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.227 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.475 HD12 HE21 ' A' ' 70' ' ' GLN . 2.8 pp -136.74 157.32 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.603 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.558 HG23 ' HB2' ' A' ' 37' ' ' LYS . 14.8 t -127.82 145.43 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.55 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.598 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -101.85 142.0 33.84 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.823 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -142.5 142.43 32.27 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.71 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.89 -179.43 4.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.121 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.6 144.93 10.66 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.683 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.39 141.28 55.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.176 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.91 34.66 65.82 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.68 109.8 7.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.298 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -88.74 27.51 1.3 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.32 -172.81 3.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.712 0.292 . . . . 0.0 110.511 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.598 ' CD2' ' HB1' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -143.24 132.94 23.79 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.939 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.19 119.43 5.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.131 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.7 mm -88.41 105.22 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-O 120.899 0.38 . . . . 0.0 110.552 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 70.7 m-85 -99.3 169.7 9.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.248 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.79 139.49 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 111.001 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HB2' HG23 ' A' ' 22' ' ' VAL . 2.3 tptt -100.79 -45.29 5.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.743 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -161.7 169.89 20.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.61 115.14 24.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.593 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.86 126.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.109 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -59.97 149.18 32.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.85 -24.01 33.98 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.998 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.68 -166.13 6.26 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.576 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.3 -52.85 4.72 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.705 -0.291 . . . . 0.0 111.617 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.66 -38.08 44.39 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.038 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.29 -55.71 9.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.629 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.79 -31.22 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.49 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.88 -56.83 9.77 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.38 57.68 1.84 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.763 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.58 ' HG3' HG21 ' A' ' 9' ' ' VAL . 1.2 mmp_? -119.72 -45.63 2.49 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.552 0.215 . . . . 0.0 110.952 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 pp -128.3 175.81 8.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.897 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.42 -173.91 4.54 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.297 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.01 127.57 33.36 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.212 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.9 27.41 6.65 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.617 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.438 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -118.61 138.14 52.78 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.428 ' C ' HD12 ' A' ' 57' ' ' LEU . 35.5 tt0 -82.6 152.02 26.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.23 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 56' ' ' GLN . 9.5 mp -119.26 144.04 46.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.013 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.677 HD12 HG21 ' A' ' 6' ' ' ILE . 1.1 mt -116.04 -60.6 1.84 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.193 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 m -123.05 156.73 34.28 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.664 HG23 HD21 ' A' ' 65' ' ' LEU . 19.5 t -142.1 120.71 9.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.111 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.82 35.59 26.5 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.205 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.63 21.17 79.69 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.945 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.3 mtm-85 -113.7 146.86 39.19 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.863 0.331 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.9 m -102.05 103.58 14.17 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.664 HD21 HG23 ' A' ' 60' ' ' VAL . 2.1 pp -109.11 42.22 1.48 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.2 t -87.7 99.57 8.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.189 0.519 . . . . 0.0 110.809 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.06 40.87 0.94 Allowed Glycine 0 CA--C 1.52 0.346 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.393 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.449 HD13 ' HB3' ' A' ' 72' ' ' ARG . 13.2 mt -127.97 157.63 40.08 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.712 0.291 . . . . 0.0 110.784 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.1 p -70.91 159.46 34.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.126 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.602 ' NE2' HG23 ' B' ' 102' ' ' THR . 37.5 tt0 -54.81 -40.15 69.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.946 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -56.91 -47.27 80.98 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.421 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.449 ' HB3' HD13 ' A' ' 68' ' ' LEU . 1.9 mmm180 -68.51 -38.68 81.14 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.596 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.85 -59.41 4.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.3 -67.02 0.42 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -35.2 -41.19 0.15 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.29 0.636 . . . . 0.0 112.173 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 76' ' ' LEU . 11.0 mt -63.58 -49.07 74.83 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.599 0.238 . . . . 0.0 111.454 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.532 ' HG2' HG11 ' A' ' 60' ' ' VAL . 7.2 mtm -70.78 -33.47 70.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.759 0.314 . . . . 0.0 110.704 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -29.2 70.58 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.31 42.67 1.11 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.721 0.296 . . . . 0.0 111.623 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 77' ' ' MET . 22.2 p -98.72 170.18 8.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.775 0.322 . . . . 0.0 111.183 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.6 p -99.9 -161.42 0.87 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.505 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.3 m -57.0 -39.71 75.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.518 0.199 . . . . 0.0 110.625 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.14 145.39 8.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.61 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.55 HG12 HD23 ' A' ' 86' ' ' LEU . 21.2 t -138.82 121.83 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.091 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.41 99.19 6.28 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.498 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.55 HD23 HG12 ' A' ' 84' ' ' VAL . 3.2 mm? -106.31 115.04 29.53 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.207 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.428 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 0.1 OUTLIER -81.36 89.48 6.1 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 110.143 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 55' ' ' ASP . 14.2 p -93.19 150.65 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.472 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.49 143.86 31.67 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.484 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.484 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 34.0 t . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.615 0.245 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.602 HG23 ' NE2' ' A' ' 70' ' ' GLN . 4.0 p . . . . . 0 N--CA 1.464 0.258 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 33.1 tt0 . . . . . 0 C--O 1.234 0.267 0 CA-C-O 121.193 0.521 . . . . 0.0 110.674 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 41.1 mm -95.59 131.35 42.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.74 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.14 144.85 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.701 HG22 HG22 ' A' ' 85' ' ' THR . 0.7 OUTLIER -113.69 126.76 55.6 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 m -99.4 113.77 35.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.981 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.462 ' OG1' HG23 ' A' ' 85' ' ' THR . 0.7 OUTLIER -99.86 92.19 5.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.486 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt -116.03 173.87 6.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.17 162.24 13.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.022 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.08 113.78 25.51 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.513 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.85 -41.47 6.49 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.412 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -163.68 44.82 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.544 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.09 153.8 28.01 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.374 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.35 -48.54 80.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.606 0.203 . . . . 0.0 111.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.09 69.53 1.39 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.819 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 3.3 pp -160.72 177.48 10.42 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 122.202 0.201 . . . . 0.0 110.581 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -138.24 134.13 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.688 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.968 HD13 HG23 ' A' ' 34' ' ' ILE . 2.1 pp -120.87 165.73 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG22 ' CB ' ' B' ' 101' ' ' SER . 47.8 t -149.9 137.14 13.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.501 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.85 123.84 33.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -139.14 157.79 45.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.848 0.356 . . . . 0.0 111.645 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HG3' HD12 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -122.87 179.69 4.55 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.24 -141.21 3.08 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.789 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.88 147.1 31.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.65 0.262 . . . . 0.0 110.787 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.27 37.15 92.57 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.784 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.89 106.29 8.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.65 0.262 . . . . 0.0 110.844 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.8 17.86 6.2 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HD2' ' CA ' ' A' ' 67' ' ' GLY . 19.4 mmtp -145.15 -171.06 3.57 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.632 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 32' ' ' LEU . 5.2 tp -124.03 139.23 54.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.514 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.21 133.0 11.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.991 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.968 HG23 HD13 ' A' ' 21' ' ' ILE . 29.1 mm -92.12 71.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.149 0.5 . . . . 0.0 110.512 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 53.1 m-85 -63.4 167.68 5.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.775 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 47.9 t -112.1 125.34 69.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.098 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.518 ' HD3' ' HB2' ' B' ' 101' ' ' SER . 2.3 pttt -87.01 -36.51 18.19 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.587 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -163.42 159.36 22.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.523 0.202 . . . . 0.0 111.039 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 19' ' ' LEU . 16.7 t -118.25 122.91 70.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.31 133.4 30.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.39 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 154.39 41.87 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.74 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.49 45.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.266 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.64 -163.7 4.94 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.59 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.42 -34.32 11.57 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.09 -47.13 38.49 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -59.55 -37.94 79.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.437 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 43' ' ' GLY . 42.8 t -73.79 -32.79 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.248 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.43 -41.68 80.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.087 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.71 49.78 10.22 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.787 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -105.5 -36.16 7.23 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.576 0.227 . . . . 0.0 111.349 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.52 173.71 8.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 111.277 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.68 26.84 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.176 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.25 128.44 37.01 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.537 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.85 38.77 2.46 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.016 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 4.1 p30 -116.59 141.53 48.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.668 0.271 . . . . 0.0 110.77 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -85.97 143.51 28.12 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.068 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.468 HD11 HD23 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -99.81 143.72 29.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.324 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tt -122.41 -58.83 1.67 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.2 p -140.64 154.24 46.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.978 0.418 . . . . 0.0 111.795 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.636 HG22 HD23 ' A' ' 86' ' ' LEU . 22.4 t -135.03 112.83 15.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.438 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 56.83 34.5 24.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.232 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.37 -20.33 49.98 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.383 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -70.98 151.3 44.79 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 117.27 0.535 . . . . 0.0 111.065 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.1 p -107.14 119.47 39.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.722 HD22 ' HA ' ' A' ' 73' ' ' ALA . 11.3 mt -110.23 -9.19 14.68 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.736 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 66' ' ' VAL . 8.5 p -68.88 83.62 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-O 121.692 0.758 . . . . 0.0 110.737 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.426 ' CA ' ' HD2' ' A' ' 31' ' ' LYS . . . 140.78 -23.49 2.63 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.658 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.4 mt -82.47 169.19 16.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.6 m -86.1 166.48 15.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.759 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -57.85 -28.73 64.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.416 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -64.74 -47.49 78.04 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-O 120.65 0.262 . . . . 0.0 110.765 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -53.78 39.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.722 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -57.27 -50.58 72.46 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.771 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB1' HG21 ' B' ' 102' ' ' THR . . . -56.41 -63.27 1.25 Allowed 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.882 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -46.37 -48.05 18.58 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.445 0.466 . . . . 0.0 112.117 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.6 mt -68.16 -27.82 66.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.569 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 77.6 mtp -86.21 -19.99 29.18 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -43.42 63.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.799 0.333 . . . . 0.0 110.61 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -95.57 65.51 2.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.946 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -83.78 147.43 27.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.068 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.51 -167.54 1.83 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.765 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -56.55 -43.85 80.33 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.921 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.08 144.49 12.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.1 t -137.69 113.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.802 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.701 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -111.23 86.77 2.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.649 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.636 HD23 HG22 ' A' ' 60' ' ' VAL . 1.3 mt -94.25 124.41 38.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.294 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 42.7 tt0 -98.9 121.41 40.82 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.289 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.4 m -117.7 168.77 9.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.733 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . . . -128.17 111.43 13.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.987 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 11.8 mmtt . . . . . 0 N--CA 1.464 0.27 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.521 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.518 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 97.8 p . . . . . 0 CA--C 1.532 0.257 0 CA-C-O 120.747 0.308 . . . . 0.0 111.793 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.523 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.3 OUTLIER . . . . . 0 CA--C 1.538 0.49 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.416 ' HB3' ' CG ' ' A' ' 90' ' ' LYS . 10.9 tt0 . . . . . 0 C--O 1.233 0.221 0 CA-C-O 121.07 0.462 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.79 137.15 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.598 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.45 150.08 14.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.658 ' CG2' HG22 ' A' ' 85' ' ' THR . 8.3 m -113.88 131.23 56.35 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.879 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 50' ' ' ARG . 6.5 m -102.09 116.29 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.107 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 m -105.43 98.43 8.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.544 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mt -126.87 154.74 44.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 152.96 21.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -70.72 105.15 3.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.196 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -94.37 -38.72 10.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.087 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -161.58 42.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.01 0.433 . . . . 0.0 110.56 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.94 157.8 6.11 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.118 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.784 ' SD ' HD11 ' A' ' 86' ' ' LEU . 2.7 mtm -65.02 -56.05 15.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.696 0.248 . . . . 0.0 110.564 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.13 78.74 0.14 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.894 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 20' ' ' SER . 4.0 pp -160.81 177.72 10.14 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.42 ' N ' HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -125.11 153.17 43.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.952 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.922 HD11 HG22 ' B' ' 102' ' ' THR . 2.6 pp -144.75 158.64 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 112.088 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.15 141.67 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.17 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.42 149.46 30.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.261 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -146.85 135.04 21.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.335 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -119.73 179.98 4.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.01 -137.85 2.28 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.12 142.78 41.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.665 0.269 . . . . 0.0 110.871 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.92 43.89 98.57 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.914 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.37 107.81 7.82 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.72 0.295 . . . . 0.0 111.025 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.96 22.34 3.71 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.435 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -144.13 -171.97 3.67 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.657 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 tp -136.11 136.88 40.49 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.906 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.88 161.88 19.38 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.767 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.617 HG23 HE22 ' A' ' 70' ' ' GLN . 27.0 mm -115.3 103.27 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 111.073 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 6.5 m-85 -90.57 163.78 14.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.83 113.08 40.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.029 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -43.01 69.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 1.9 p -172.18 167.19 5.97 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.777 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.2 m -120.0 127.89 75.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.851 0.357 . . . . 0.0 110.816 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.43 121.7 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -64.17 154.18 35.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.19 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.48 -37.01 3.83 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.703 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.534 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.7 -177.8 5.88 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.773 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 14' ' ' GLN . . . -87.1 -2.33 58.55 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.29 -38.32 11.57 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.04 -37.38 54.92 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.229 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 43' ' ' GLY . 43.1 t -64.69 -33.27 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.636 0.255 . . . . 0.0 110.95 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.92 -45.18 64.73 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.098 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.74 29.23 43.77 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.784 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.727 ' HB3' HG11 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -89.64 -33.16 16.75 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.515 0.198 . . . . 0.0 111.167 179.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.46 171.2 11.24 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.031 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.94 -175.71 5.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.563 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -73.82 162.15 29.43 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.94 39.82 93.36 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.334 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.05 142.79 51.45 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.639 0.257 . . . . 0.0 111.055 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -89.79 160.3 16.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 34' ' ' ILE . 16.8 mt -124.44 155.41 38.92 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 111.617 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.0 -55.95 1.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.072 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -136.09 142.06 44.27 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.695 0.284 . . . . 0.0 111.429 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.784 HG11 ' HG2' ' A' ' 77' ' ' MET . 18.3 t -135.69 140.89 43.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.998 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 43.65 44.88 5.61 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.534 0.521 . . . . 0.0 111.841 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.5 32.52 81.95 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.663 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -138.69 161.94 35.91 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.855 0.328 . . . . 0.0 110.577 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 p -112.77 137.32 51.26 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.767 0.318 . . . . 0.0 111.11 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.62 ' HA ' HD21 ' A' ' 68' ' ' LEU . 19.7 mt -117.38 45.41 1.91 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.0 t -109.36 100.9 11.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.187 0.518 . . . . 0.0 110.896 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.77 -37.68 2.85 Favored Glycine 0 C--N 1.328 0.139 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.347 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 65' ' ' LEU . 3.8 pp -73.48 147.26 44.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.777 0.322 . . . . 0.0 110.948 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -64.16 156.76 27.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.649 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.74 ' CD ' HD13 ' A' ' 21' ' ' ILE . 8.9 tp-100 -52.62 -39.11 61.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.631 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 4.5 tt0 -51.59 -43.99 62.66 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -74.43 -40.79 61.74 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.2 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -56.18 -58.45 7.88 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.651 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -58.75 -64.38 0.95 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.06 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 4.3 tm-20 -38.04 -46.81 1.04 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.549 0.531 . . . . 0.0 111.764 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 mt -60.1 -43.52 95.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.007 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.784 ' HG2' HG11 ' A' ' 60' ' ' VAL . 9.1 mtp -76.71 -30.28 56.61 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.258 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -27.88 69.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.544 0.211 . . . . 0.0 110.816 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -96.47 32.82 1.92 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.208 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 77' ' ' MET . 1.2 p -60.21 146.34 43.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 111.412 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -85.93 -165.94 1.39 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.665 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -56.51 -31.35 64.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.038 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.45 141.58 19.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.965 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.48 114.65 43.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.619 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.658 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -116.52 88.54 2.92 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.784 HD11 ' SD ' ' A' ' 17' ' ' MET . 5.7 mt -101.77 133.31 46.7 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.317 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -115.72 127.33 55.05 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.926 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.58 170.64 13.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.326 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.35 133.19 51.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.903 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.416 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 48.6 mmtm . . . . . 0 N--CA 1.464 0.228 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.425 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.469 0.492 0 CA-C-O 120.694 0.283 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.922 HG22 HD11 ' A' ' 21' ' ' ILE . 1.6 t . . . . . 0 C--O 1.233 0.233 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.788 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 121.029 0.442 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.665 HD12 HD12 ' A' ' 58' ' ' LEU . 44.3 mm -95.85 128.98 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.2 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.14 141.49 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.129 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.568 ' OG1' HG22 ' A' ' 85' ' ' THR . 10.0 t -112.08 149.71 31.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.813 0.339 . . . . 0.0 111.019 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 50' ' ' ARG . 7.0 m -114.22 118.37 58.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.0 m -94.28 101.13 13.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.463 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.9 mt -131.3 163.07 28.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -92.2 129.92 38.03 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.927 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HB2' ' CG2' ' A' ' 84' ' ' VAL . 8.4 ttpp -83.03 139.39 33.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.186 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -93.37 -57.78 2.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -158.99 38.11 0.21 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.723 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.43 -167.99 22.35 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.999 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.708 ' SD ' HD11 ' A' ' 86' ' ' LEU . 6.7 mtm -115.9 -42.73 3.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.69 0.245 . . . . 0.0 111.385 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.99 73.96 0.63 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.038 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 20' ' ' SER . 4.0 pp -160.8 177.94 9.92 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.646 0.26 . . . . 0.0 111.072 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.423 ' N ' HD12 ' A' ' 19' ' ' LEU . 72.8 m -130.49 150.69 51.59 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.447 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.608 HD11 HG22 ' B' ' 102' ' ' THR . 2.7 pp -142.61 152.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.807 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.836 HG23 ' HB2' ' A' ' 37' ' ' LYS . 46.4 t -133.69 135.71 55.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.66 135.18 33.47 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.167 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.564 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -144.71 152.56 40.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.351 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.591 ' HG3' HD12 ' A' ' 32' ' ' LEU . 10.7 tttt -124.2 -179.54 4.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.938 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.78 -140.42 2.98 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.41 140.96 44.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.687 0.28 . . . . 0.0 110.728 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.32 45.79 95.74 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.597 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.4 107.9 7.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.707 0.289 . . . . 0.0 111.127 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -90.1 21.0 3.93 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -144.02 -168.89 2.98 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.678 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.591 HD12 ' HG3' ' A' ' 25' ' ' LYS . 3.1 tp -136.91 146.76 45.87 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.929 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.12 128.71 9.14 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.845 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.477 HG13 ' HB1' ' A' ' 73' ' ' ALA . 27.6 mm -87.14 87.25 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.994 0.426 . . . . 0.0 110.871 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 66.0 m-85 -79.17 168.07 20.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.603 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.8 t -99.11 135.73 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.606 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.836 ' HB2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -100.58 -41.33 7.0 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.286 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -178.0 125.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.055 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.9 m -87.55 136.19 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.247 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.2 t -92.29 128.0 44.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -62.48 148.5 45.51 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.323 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.55 -30.35 10.42 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.579 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.649 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.97 152.49 51.88 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.428 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.75 -36.55 26.16 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.85 -44.26 64.14 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.651 0.263 . . . . 0.0 111.382 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -39.03 92.91 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.45 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 43' ' ' GLY . 42.0 t -57.79 -39.37 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.27 -49.58 13.44 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.058 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.79 76.9 1.06 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.171 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.527 ' CB ' HG11 ' A' ' 9' ' ' VAL . 12.9 mmm-85 -139.18 22.48 2.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.03 153.65 1.67 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.654 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.47 -179.99 6.61 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.487 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.71 139.44 58.38 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.034 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.73 22.06 32.13 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.862 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.87 175.68 5.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.64 0.22 . . . . 0.0 110.613 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.434 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 3.7 tt0 -125.17 142.36 51.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.053 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.443 HD21 HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -107.94 164.17 12.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.338 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.665 HD12 HD12 ' A' ' 6' ' ' ILE . 1.2 mt -140.21 -55.52 0.54 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.362 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.7 m -127.08 154.62 44.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.689 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 77' ' ' MET . 22.6 t -141.91 107.76 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.048 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.71 50.71 10.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.97 0.414 . . . . 0.0 111.03 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.76 21.4 76.5 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.859 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.424 ' CZ ' HD22 ' A' ' 76' ' ' LEU . 6.2 mtt-85 -113.74 160.8 18.28 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.734 0.267 . . . . 0.0 110.37 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -114.41 110.94 20.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.032 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.533 HD23 HD12 ' A' ' 68' ' ' LEU . 27.1 mt -96.33 43.67 1.08 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.6 t -105.53 100.09 9.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.186 0.517 . . . . 0.0 110.572 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.87 30.48 5.15 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.553 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD12 HD23 ' A' ' 65' ' ' LEU . 45.5 mt -122.02 158.06 30.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 110.929 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.2 p -79.9 162.11 25.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.738 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -54.28 -36.42 63.62 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.768 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.81 -59.69 4.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.091 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -59.71 -36.6 76.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.099 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -65.44 -62.02 1.77 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.493 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' B' ' 102' ' ' THR . . . -56.19 -47.07 79.06 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.412 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -56.3 -54.85 40.47 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.956 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.424 HD22 ' CZ ' ' A' ' 63' ' ' ARG . 14.6 mt -53.69 -33.55 55.8 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.316 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.483 ' CG ' HG11 ' A' ' 60' ' ' VAL . 13.5 mtp -74.78 -51.38 14.27 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 75' ' ' GLU . 8.6 t -63.2 -33.58 75.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.55 0.214 . . . . 0.0 111.161 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -84.2 47.48 1.34 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.878 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -98.2 179.54 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.868 0.366 . . . . 0.0 111.207 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -93.83 -165.63 1.36 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -55.81 -44.09 77.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 110.925 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.16 145.91 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.852 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 13' ' ' LYS . 22.5 t -128.39 126.76 66.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.532 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.568 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.2 OUTLIER -129.67 83.5 2.14 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.765 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.708 HD11 ' SD ' ' A' ' 17' ' ' MET . 7.3 mt -93.67 118.79 31.85 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.495 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HG3' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -86.34 113.86 22.66 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.547 179.328 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.75 150.56 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.54 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.568 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . . . -106.02 160.4 15.32 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.26 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt . . . . . 0 C--O 1.233 0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.763 179.798 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.887 0.375 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.608 HG22 HD11 ' A' ' 21' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.681 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 34.8 tt0 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 121.252 0.548 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.4 mt -93.33 136.68 24.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.844 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.5 153.17 13.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.448 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 5.0 m -111.27 141.16 45.16 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.553 HG11 ' HD2' ' A' ' 50' ' ' ARG . 10.8 m -120.7 133.54 67.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 m -109.68 95.17 5.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.709 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.0 mt -116.49 173.29 6.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -99.57 163.02 12.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.057 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -77.46 100.3 5.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.73 80.47 5.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.477 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.13 34.55 23.35 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.967 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.96 152.79 29.09 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.239 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -56.41 22.44 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.69 0.281 . . . . 0.0 110.666 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.26 72.75 0.84 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.661 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.667 ' CD1' HG23 ' A' ' 21' ' ' ILE . 3.6 pp -160.61 178.12 9.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.732 0.301 . . . . 0.0 110.672 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.464 ' N ' HD12 ' A' ' 19' ' ' LEU . 7.9 m -135.17 126.25 27.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.41 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.669 HD13 ' CG2' ' A' ' 34' ' ' ILE . 2.1 pp -118.09 129.73 74.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.322 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.896 HG22 ' HA ' ' B' ' 101' ' ' SER . 93.7 t -112.5 136.8 47.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.099 0.476 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.796 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -95.27 120.03 34.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.199 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.85 148.65 52.3 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.946 0.403 . . . . 0.0 111.768 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.58 -179.86 4.67 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.667 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.8 -141.53 3.15 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.715 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.34 148.52 27.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.614 0.245 . . . . 0.0 110.66 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.78 33.22 82.05 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.744 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.25 103.46 6.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.684 0.278 . . . . 0.0 110.927 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 7.1 t0 -90.64 21.6 3.94 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.227 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -142.01 -168.15 2.63 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.5 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.5 HD21 ' HB1' ' A' ' 23' ' ' ALA . 12.7 tp -142.14 123.91 15.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.747 0.308 . . . . 0.0 110.889 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.78 116.94 5.61 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.411 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.669 ' CG2' HD13 ' A' ' 21' ' ' ILE . 31.3 mm -77.85 87.19 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.957 0.408 . . . . 0.0 110.413 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.94 162.32 28.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.648 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -104.33 108.01 23.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.835 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.701 ' HB2' HG23 ' A' ' 22' ' ' VAL . 17.9 tttt -62.52 -47.02 85.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.859 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 p -175.34 137.83 0.4 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.28 137.79 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.513 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -76.07 141.68 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 153.01 35.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.236 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.98 19.24 69.65 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.007 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.25 -158.03 33.72 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.442 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.17 -35.18 10.86 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.22 -33.59 20.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.377 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -40.93 94.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.539 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.96 -41.85 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.52 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.5 -55.1 34.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.361 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.9 49.85 1.72 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.438 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.553 ' HD2' HG11 ' A' ' 9' ' ' VAL . 72.8 mmt-85 -105.77 -58.16 1.94 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 110.643 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 pp -117.15 149.72 39.89 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.669 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.63 -175.22 3.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.183 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.2 131.1 42.31 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.008 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.35 27.6 10.58 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.739 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.18 171.36 7.53 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.589 0.194 . . . . 0.0 110.768 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -120.26 137.9 53.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.307 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.607 HD23 HG22 ' A' ' 88' ' ' VAL . 86.6 mt -101.35 162.19 13.08 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.178 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD23 ' CG2' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -141.48 -53.26 0.45 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.188 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.0 m -124.04 151.03 44.23 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.979 0.418 . . . . 0.0 111.712 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.64 HG23 HD13 ' A' ' 65' ' ' LEU . 21.7 t -139.34 133.23 38.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.765 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 53.65 38.0 27.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.37 26.98 72.32 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.337 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 mtp-105 -128.89 148.24 50.89 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.897 0.348 . . . . 0.0 110.723 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.5 m -89.66 135.23 33.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.982 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 60' ' ' VAL . 4.2 mp -130.0 50.02 2.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.974 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.421 ' CG2' HD23 ' A' ' 58' ' ' LEU . 58.0 t -94.14 99.62 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 110.876 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 105.54 35.35 3.09 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.64 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.7 mt -122.11 153.77 38.25 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.755 0.312 . . . . 0.0 110.768 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.8 m -75.33 158.2 33.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.796 ' HG3' ' HB2' ' A' ' 23' ' ' ALA . 2.3 tt0 -57.25 -25.52 59.28 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.725 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.15 -49.58 76.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.692 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -51.89 52.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.47 81.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.584 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.585 ' O ' HG22 ' A' ' 78' ' ' THR . . . -58.79 -56.89 16.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.331 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -53.15 60.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.309 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.52 -32.28 71.31 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.982 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.788 ' SD ' HD21 ' A' ' 86' ' ' LEU . 30.5 mmm -69.58 -64.32 0.9 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.92 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 74' ' ' ALA . 4.7 t -56.01 -36.23 67.71 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.684 0.278 . . . . 0.0 111.024 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -86.86 52.58 2.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.264 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 77' ' ' MET . 1.2 p -94.2 168.47 10.9 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.773 0.32 . . . . 0.0 110.746 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -97.62 -163.08 1.01 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.591 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -59.04 -26.78 64.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.165 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.82 149.21 5.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.952 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.01 87.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.1 m -91.88 80.68 5.2 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.788 HD21 ' SD ' ' A' ' 77' ' ' MET . 9.1 mt -103.94 133.97 48.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.44 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 27.2 tt0 -107.19 112.11 24.84 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.603 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.607 HG22 HD23 ' A' ' 57' ' ' LEU . 19.8 t -110.73 147.56 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.206 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . . . -97.37 132.86 42.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.8 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.564 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.896 ' HA ' HG22 ' A' ' 22' ' ' VAL . 8.2 t . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.488 0.185 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.433 ' HB ' HG13 ' A' ' 21' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 121.013 0.435 . . . . 0.0 111.841 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 C--O 1.234 0.274 0 CA-C-O 121.026 0.441 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mt -102.84 141.16 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.737 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 pt -146.26 151.84 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.371 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 87' ' ' GLU . 1.3 m -112.88 140.0 48.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.955 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 m -123.19 127.92 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.183 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 15.6 m -108.65 112.38 24.68 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mt -138.97 162.27 35.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.636 ' HE3' HG22 ' A' ' 83' ' ' VAL . 2.6 mptt -98.08 176.6 5.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.877 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.51 150.42 26.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 111.408 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.98 -58.66 0.96 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.579 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -138.02 35.67 2.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.61 152.81 28.91 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.106 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 mtm -64.41 -48.87 73.74 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.629 0.214 . . . . 0.0 110.723 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.85 82.51 0.07 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.938 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.6 pp -160.76 179.61 8.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.628 0.252 . . . . 0.0 110.781 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -129.45 144.78 51.39 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.27 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.465 HD13 HG23 ' A' ' 34' ' ' ILE . 2.7 pp -140.55 146.14 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.799 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 37' ' ' LYS . 22.7 t -132.71 137.08 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.544 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.49 158.85 25.73 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.705 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.876 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -159.51 141.53 13.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 111.377 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HD2' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -126.31 -179.67 4.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.82 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.37 -141.33 3.12 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.8 139.25 40.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.681 0.277 . . . . 0.0 110.597 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.43 35.47 91.75 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.707 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.05 103.76 7.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.672 0.272 . . . . 0.0 110.89 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -92.18 28.41 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.1 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -136.57 -170.16 2.62 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.449 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 32' ' ' LEU . 5.9 tp -151.96 124.47 8.34 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.672 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.22 150.5 20.2 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.025 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.636 HG13 ' HB1' ' A' ' 73' ' ' ALA . 14.7 mm -104.86 81.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 121.049 0.452 . . . . 0.0 110.786 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.876 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 61.8 m-85 -71.57 166.37 21.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.316 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.3 t -106.43 128.99 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.107 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.54 ' HB2' HG23 ' A' ' 22' ' ' VAL . 8.5 ttpt -91.37 -42.6 10.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.3 172.84 15.9 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.726 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.05 121.97 30.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.558 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 t -72.13 124.96 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.721 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 124.12 21.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.79 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.11 -31.6 3.82 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.352 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -68.66 157.23 53.17 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.621 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.16 18.81 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.553 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -63.87 -49.67 71.83 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.683 0.277 . . . . 0.0 111.203 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.48 -41.16 96.64 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.163 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.9 t -61.02 -32.96 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.25 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -68.25 -55.88 10.63 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.238 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.44 51.43 2.92 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.85 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -128.24 -66.99 0.82 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.729 0.264 . . . . 0.0 110.805 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.553 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.4 pp -70.4 161.59 30.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.98 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.93 -174.83 4.37 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.368 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.9 120.91 28.68 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.982 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.1 31.26 3.14 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.023 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -116.78 139.2 50.86 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.705 0.252 . . . . 0.0 110.955 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.9 tt0 -81.9 145.33 30.4 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -97.53 168.94 10.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.012 0.434 . . . . 0.0 111.321 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.43 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -148.18 -59.02 0.24 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.035 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.5 p -128.3 150.6 49.99 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.963 0.411 . . . . 0.0 111.713 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.622 HG11 ' CG ' ' A' ' 77' ' ' MET . 39.9 t -141.97 96.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.46 41.99 31.63 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.962 0.41 . . . . 0.0 111.0 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.36 25.86 49.66 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.952 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -120.64 129.78 53.86 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.19 111.14 21.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.967 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 60' ' ' VAL . 41.5 mt -99.72 26.84 5.84 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.056 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.2 p -107.39 73.43 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.661 0.743 . . . . 0.0 110.638 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.66 -22.4 1.49 Allowed Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.199 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.4 mt -81.32 159.26 24.47 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.966 0.412 . . . . 0.0 111.188 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.5 m -74.73 147.17 41.6 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.024 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.455 ' HG2' ' CG2' ' B' ' 102' ' ' THR . 0.0 OUTLIER -42.45 -41.25 2.86 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.178 0.299 . . . . 0.0 111.412 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.94 -56.94 12.24 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.306 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -60.44 -40.83 92.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.636 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -58.73 -60.84 3.19 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.702 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.509 ' O ' HG22 ' A' ' 78' ' ' THR . . . -63.49 -36.86 85.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.353 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -35.82 76.93 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.433 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.45 -44.18 58.7 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.622 ' CG ' HG11 ' A' ' 60' ' ' VAL . 11.1 mtp -59.53 -48.17 82.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.433 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 74' ' ' ALA . 7.8 t -64.51 -33.46 75.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.63 0.252 . . . . 0.0 110.611 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.72 50.19 1.92 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.892 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.0 p -103.79 172.72 6.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.646 0.26 . . . . 0.0 110.865 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 t -79.73 -169.93 2.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.49 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -53.4 -40.59 65.19 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.254 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.636 HG22 ' HE3' ' A' ' 12' ' ' LYS . 21.1 t -97.35 143.63 12.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.121 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 10' ' ' THR . 23.9 t -119.74 149.13 22.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.14 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.9 m -143.54 85.56 1.85 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.436 HD23 HG22 ' A' ' 60' ' ' VAL . 3.8 mt -98.27 140.45 32.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.365 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HB2' HG23 ' A' ' 8' ' ' THR . 41.9 tt0 -121.78 110.07 15.46 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.735 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.84 169.19 2.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.204 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.17 137.67 53.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.17 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.548 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.476 ' HB2' HG22 ' A' ' 22' ' ' VAL . 21.5 t . . . . . 0 C--O 1.234 0.244 0 CA-C-O 120.975 0.417 . . . . 0.0 111.507 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.455 ' CG2' ' HG2' ' A' ' 70' ' ' GLN . 0.9 OUTLIER . . . . . 0 C--O 1.235 0.292 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.155 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.875 0.369 . . . . 0.0 111.025 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mt -100.49 139.14 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.318 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.02 139.19 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.145 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.433 ' HB ' ' CG ' ' A' ' 87' ' ' GLU . 7.3 t -109.41 159.25 17.17 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 110.98 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.61 132.7 31.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.326 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 m -90.99 97.0 10.92 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.471 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.21 169.12 8.94 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.357 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -113.54 153.84 28.11 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.752 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -82.61 102.8 11.68 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.212 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -100.46 78.55 2.03 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.279 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 57.74 36.97 27.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.905 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.73 148.04 16.22 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.091 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.4 mtm -65.64 -68.8 0.34 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.733 0.266 . . . . 0.0 111.007 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.53 70.09 1.09 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.045 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 20' ' ' SER . 3.9 pp -160.65 176.82 11.12 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.401 0.143 . . . . 0.0 110.633 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.466 ' N ' HD12 ' A' ' 19' ' ' LEU . 49.0 m -134.21 142.14 47.28 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.631 ' CD1' HG22 ' B' ' 102' ' ' THR . 0.0 OUTLIER -131.96 163.19 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.036 0.446 . . . . 0.0 112.069 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.06 131.83 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.974 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.445 ' CB ' ' HB2' ' A' ' 70' ' ' GLN . . . -99.31 118.58 36.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -120.49 132.62 55.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.569 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.442 ' HG3' ' CD1' ' A' ' 32' ' ' LEU . 4.6 tttt -114.51 -179.69 3.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.889 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.16 -140.52 3.01 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.69 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.46 152.63 23.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.56 0.219 . . . . 0.0 110.766 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.18 37.46 86.56 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.501 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.27 107.74 7.36 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.609 0.242 . . . . 0.0 110.801 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.472 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 7.8 p-10 -90.7 15.11 11.69 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 111.47 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -144.36 -171.38 3.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.383 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.442 ' CD1' ' HG3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -145.1 135.34 24.02 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 111.002 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.03 127.85 9.32 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.822 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.73 78.78 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 121.031 0.443 . . . . 0.0 110.513 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.439 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 73.0 m-85 -68.79 157.8 35.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.623 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.12 135.19 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.308 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -92.77 -47.77 6.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.622 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.17 130.57 0.17 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.03 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.13 132.22 31.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.667 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -81.74 139.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.19 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.72 145.17 55.4 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.206 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.57 -26.25 23.88 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.869 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.2 150.12 51.58 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.149 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.59 -36.69 67.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.53 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -61.22 -40.93 95.84 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.689 0.281 . . . . 0.0 110.86 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -40.64 63.5 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 43' ' ' GLY . 40.6 t -63.83 -36.38 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.397 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.28 -38.21 60.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.26 64.27 2.69 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.494 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -49.04 1.86 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.583 0.23 . . . . 0.0 111.383 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.53 HD21 ' HB1' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -103.84 165.72 10.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.261 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.8 177.77 7.95 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.519 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.77 140.31 42.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.047 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.61 27.94 28.27 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.871 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . 1.4 m-20 -110.67 155.22 22.73 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.635 0.218 . . . . 0.0 110.536 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 4.8 tt0 -96.67 144.56 26.58 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.091 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.96 169.24 8.62 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.65 -57.61 0.22 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.241 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 t -126.52 144.23 50.94 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.112 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.752 HG21 ' SD ' ' A' ' 77' ' ' MET . 23.4 t -135.47 112.22 13.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.576 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.09 39.04 23.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.333 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.48 4.64 84.88 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.321 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -98.96 142.33 30.6 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.42 0.61 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.05 108.78 21.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.828 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.8 mt -100.33 32.42 3.03 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.472 HG12 ' HG2' ' A' ' 31' ' ' LYS . 62.5 t -90.09 99.96 10.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.189 0.519 . . . . 0.0 110.826 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 110.93 32.35 2.66 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.521 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 68' ' ' LEU . 23.3 mt -129.18 161.5 29.97 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.695 0.284 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.81 154.23 30.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.445 ' HB2' ' CB ' ' A' ' 23' ' ' ALA . 1.2 tm0? -52.29 -36.24 52.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -54.66 -53.1 59.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.715 0.293 . . . . 0.0 110.384 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -63.2 -41.33 99.16 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.738 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 77' ' ' MET . . . -60.4 -59.92 4.64 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.229 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 78' ' ' THR . . . -56.07 -33.96 65.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.626 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -45.08 57.82 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.602 0.239 . . . . 0.0 111.327 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.9 mt -67.69 -32.46 73.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.464 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 60' ' ' VAL . 6.6 mtm -73.83 -48.2 32.98 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.491 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 74' ' ' ALA . 9.9 t -64.1 -34.2 77.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.615 0.245 . . . . 0.0 110.793 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -83.8 49.04 1.53 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.669 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.7 -175.9 3.58 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.545 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 m -104.3 -164.59 1.07 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.3 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 13.7 p -56.77 -31.71 64.9 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.753 0.311 . . . . 0.0 110.714 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.48 148.34 13.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.629 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.41 139.46 21.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.28 95.2 4.45 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.73 104.69 17.25 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.078 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.433 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 1.8 mt-10 -80.23 83.14 6.14 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.227 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 55' ' ' ASP . 14.8 p -84.41 142.85 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.434 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.61 117.98 31.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 mttm . . . . . 0 N--CA 1.464 0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.936 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 121.053 0.454 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.631 HG22 ' CD1' ' A' ' 21' ' ' ILE . 1.5 t . . . . . 0 CA--C 1.531 0.226 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.284 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 40.0 tt0 . . . . . 0 C--O 1.233 0.198 0 CA-C-O 121.222 0.534 . . . . 0.0 111.119 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.763 HD12 HD12 ' A' ' 58' ' ' LEU . 42.6 mm -84.52 125.69 40.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.608 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.48 HD12 HG13 ' A' ' 9' ' ' VAL . 1.2 pp -140.49 137.67 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.848 0.356 . . . . 0.0 111.119 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.683 HG23 ' HB2' ' A' ' 87' ' ' GLU . 1.0 OUTLIER -105.08 113.03 26.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.887 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.48 HG13 HD12 ' A' ' 7' ' ' ILE . 26.9 m -100.51 151.91 5.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.166 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.22 119.69 25.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.771 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mt -132.97 162.54 31.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.41 ' HG2' HG22 ' A' ' 83' ' ' VAL . 9.6 mtmt -110.03 138.06 46.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.727 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -64.85 121.47 14.68 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.216 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.34 -50.89 5.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -164.95 41.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.795 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.43 147.28 16.72 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.151 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.7 mmm -68.38 -68.06 0.42 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.453 0.168 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.96 78.57 0.53 Allowed Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.855 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 pp -160.46 179.47 8.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.52 0.2 . . . . 0.0 110.857 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.6 m -129.04 141.56 51.19 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.716 0.293 . . . . 0.0 111.665 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.718 HD11 HG22 ' B' ' 102' ' ' THR . 2.9 pp -137.68 154.77 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.806 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -142.57 135.13 26.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.989 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.71 146.62 23.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.777 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.63 158.03 43.8 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 111.935 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.31 179.16 4.19 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.856 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.89 -143.61 3.75 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.07 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.66 150.54 28.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.551 0.215 . . . . 0.0 110.878 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.83 28.57 63.41 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.502 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.55 106.93 4.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 110.565 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -97.44 39.27 1.21 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.936 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -137.29 -159.83 1.0 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.256 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 32' ' ' LEU . 2.7 tp -146.54 126.81 13.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.507 0.194 . . . . 0.0 110.747 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.15 142.69 15.64 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.822 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.666 HG12 ' HB1' ' A' ' 73' ' ' ALA . 1.6 mp -86.69 135.16 25.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.774 0.321 . . . . 0.0 110.502 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -125.66 143.93 50.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.011 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 53' ' ' ALA . 39.3 t -81.37 130.01 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.005 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -100.54 -40.74 7.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.327 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -179.48 128.13 0.09 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.633 0.254 . . . . 0.0 110.993 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 m -90.64 133.38 32.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.124 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.9 t -73.56 131.21 35.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -61.56 115.48 3.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.065 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.27 -30.03 3.38 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.786 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.494 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.58 151.19 50.85 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.689 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.66 65.07 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.72 -36.64 84.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -76.22 -45.91 30.73 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.243 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 43' ' ' GLY . 25.3 t -60.26 -38.52 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.365 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.74 -41.57 62.31 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.145 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.24 33.09 18.37 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.984 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -83.83 -54.3 4.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.806 0.336 . . . . 0.0 110.689 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.19 152.64 32.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.818 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.99 175.12 10.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.138 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -61.01 122.81 15.87 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.315 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.4 38.77 2.2 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.926 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 36' ' ' VAL . 29.4 m-20 -135.24 142.31 45.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.517 0.199 . . . . 0.0 110.796 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -93.55 152.97 18.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.933 0.397 . . . . 0.0 110.774 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.427 HD21 HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -101.53 172.12 7.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.023 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.763 HD12 HD12 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -149.87 -54.25 0.16 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.329 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 t -133.87 140.73 47.04 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.66 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.958 HG23 HD11 ' A' ' 65' ' ' LEU . 37.5 t -129.1 120.24 51.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.594 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.59 34.92 25.27 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.184 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.74 35.65 39.64 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.106 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 175.22 8.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.655 0.264 . . . . 0.0 110.851 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -121.34 121.59 37.98 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.139 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.958 HD11 HG23 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -106.18 29.18 6.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.263 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.7 t -87.27 100.27 9.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.231 0.538 . . . . 0.0 110.878 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.97 27.58 5.07 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.593 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 mt -118.84 164.68 15.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -83.97 152.29 24.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.275 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -51.39 -30.89 20.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.337 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -65.37 -51.16 62.31 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.771 0.319 . . . . 0.0 110.498 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -62.97 -40.43 97.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.666 ' HB1' HG12 ' A' ' 34' ' ' ILE . . . -58.32 -60.31 3.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.45 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.567 ' O ' HG22 ' A' ' 78' ' ' THR . . . -61.3 -44.68 96.82 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.848 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -39.09 81.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.048 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.88 -34.89 76.18 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.027 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.595 ' CG ' HG11 ' A' ' 60' ' ' VAL . 11.3 mtp -76.31 -41.6 48.01 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.738 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 74' ' ' ALA . 5.3 t -70.85 -37.36 73.13 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.648 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -89.95 56.08 3.35 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.444 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 p -110.52 178.84 4.25 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.877 0.37 . . . . 0.0 111.246 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -175.75 4.02 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.714 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 m -52.63 -39.29 61.59 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.137 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.41 HG22 ' HG2' ' A' ' 12' ' ' LYS . 24.4 t -97.84 147.84 6.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.925 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.41 134.18 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.64 85.0 2.35 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.427 HD23 HD21 ' A' ' 57' ' ' LEU . 4.1 mt -92.23 139.08 30.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.258 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.683 ' HB2' HG23 ' A' ' 8' ' ' THR . 27.8 tt0 -124.86 98.9 5.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.3 m -105.07 172.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.803 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.43 107.15 17.57 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.942 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 1.7 mmtt . . . . . 0 C--O 1.232 0.178 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 80.6 p . . . . . 0 CA--C 1.53 0.194 0 CA-C-O 120.559 0.219 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.718 HG22 HD11 ' A' ' 21' ' ' ILE . 1.7 t . . . . . 0 CA--C 1.534 0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.685 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 . . . . . 0 C--O 1.233 0.214 0 CA-C-O 121.239 0.542 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -96.43 128.08 47.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.666 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 pt -142.66 155.98 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.025 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.568 ' OG1' HG22 ' A' ' 85' ' ' THR . 14.5 t -118.6 128.83 54.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.199 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 t -87.85 91.62 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.634 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 32.4 m -81.51 105.16 12.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.934 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.8 mt -139.4 177.58 7.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.27 153.06 20.8 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.684 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 100.75 0.21 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.879 0.371 . . . . 0.0 111.12 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.38 80.35 2.4 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.406 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m120 56.55 35.62 26.32 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.079 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.05 160.72 28.48 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.614 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.473 ' HB3' HD23 ' A' ' 19' ' ' LEU . 42.1 mtm -77.62 -38.91 46.96 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.497 0.189 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.85 70.4 1.06 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.903 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' CD1' HG23 ' A' ' 21' ' ' ILE . 3.4 pp -160.62 176.76 11.21 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.793 0.33 . . . . 0.0 111.009 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.89 129.23 34.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.668 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 21' ' ' ILE . 2.8 pp -121.83 153.43 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.891 0.377 . . . . 0.0 111.535 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' B' ' 101' ' ' SER . 43.2 t -142.33 146.92 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.231 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.519 ' HB1' ' HG ' ' A' ' 32' ' ' LEU . . . -107.08 147.32 30.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.196 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.74 155.09 39.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.64 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -120.1 179.47 4.27 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.772 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.13 -143.31 3.65 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.908 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.91 146.08 31.44 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.8 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.12 27.89 63.22 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.693 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.57 105.6 3.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.673 0.273 . . . . 0.0 110.486 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -96.3 28.16 3.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.412 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -120.19 -165.53 1.2 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.358 179.423 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.519 ' HG ' ' HB1' ' A' ' 23' ' ' ALA . 1.4 tp -145.03 124.5 13.13 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.628 0.252 . . . . 0.0 110.828 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.23 119.48 5.47 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.478 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.605 HG23 HE22 ' A' ' 70' ' ' GLN . 18.6 mm -80.09 74.62 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.938 0.399 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -71.2 168.19 17.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.426 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.52 108.7 25.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.057 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.49 ' HB2' HG23 ' A' ' 22' ' ' VAL . 6.5 tttt -64.33 -45.94 85.66 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.903 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 60.4 p -176.62 155.85 1.39 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 46' ' ' ASP . 11.0 t -103.49 131.79 51.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.881 0.372 . . . . 0.0 110.797 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 t -79.61 132.32 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.974 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 127.98 34.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.008 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.59 -21.43 30.37 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.877 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.582 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.57 157.19 45.17 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.962 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.08 -38.37 76.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.25 -35.65 58.85 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.536 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.503 ' HB2' HG12 ' A' ' 39' ' ' VAL . 16.7 t70 -64.47 -45.11 88.78 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 43' ' ' GLY . 39.5 t -61.77 -34.75 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.5 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.06 -53.95 21.87 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.687 0.28 . . . . 0.0 111.442 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.73 30.58 23.48 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.923 -0.655 . . . . 0.0 113.085 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -44.14 16.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.863 0.363 . . . . 0.0 110.724 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.82 178.77 4.16 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.95 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.22 175.99 11.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.366 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -69.68 132.76 46.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.676 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.77 28.89 8.5 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.5 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.33 174.57 5.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.459 0.171 . . . . 0.0 110.687 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -118.3 144.78 45.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.35 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.588 HD21 HG23 ' A' ' 60' ' ' VAL . 6.6 tt -113.28 140.84 47.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.192 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.47 -58.74 1.83 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.98 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.0 m -136.63 156.77 48.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.935 0.398 . . . . 0.0 111.459 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.751 HG21 ' SD ' ' A' ' 77' ' ' MET . 40.4 t -128.9 122.88 57.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.516 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 t70 67.35 11.68 8.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.445 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.3 18.74 30.11 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.557 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.46 142.63 51.4 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.376 0.588 . . . . 0.0 111.164 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.3 m -74.58 128.67 36.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.391 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.808 HD22 ' HA ' ' A' ' 73' ' ' ALA . 1.4 mt -132.66 31.57 3.96 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.16 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.618 ' O ' HG13 ' A' ' 66' ' ' VAL . 8.0 p -104.35 83.54 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.596 0.713 . . . . 0.0 110.467 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 157.62 -28.92 0.49 Allowed Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.523 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.9 167.91 12.84 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.856 0.36 . . . . 0.0 110.84 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -71.07 158.77 35.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.145 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.609 ' CD ' HD13 ' A' ' 21' ' ' ILE . 5.6 tp-100 -54.83 -28.73 51.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.301 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -60.53 -36.48 78.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.348 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.22 -42.39 31.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.645 0.259 . . . . 0.0 110.883 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.808 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -72.47 -51.76 18.78 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.617 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.682 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -59.47 -46.35 89.05 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.415 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 2.9 tp10 -57.37 -45.26 84.62 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.685 0.278 . . . . 0.0 110.569 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.71 -33.49 75.75 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.32 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -60.69 -57.14 13.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.138 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -62.38 -39.3 92.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 110.391 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -84.08 51.92 2.19 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.779 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.37 176.8 5.57 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 111.048 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.43 -173.46 4.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.233 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 t -54.91 -33.4 62.04 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.626 0.25 . . . . 0.0 111.135 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.5 144.35 15.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.063 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 10' ' ' THR . 19.9 t -112.64 145.97 17.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.568 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.6 OUTLIER -143.75 81.14 1.68 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.92 113.16 24.85 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.172 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.08 91.81 6.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.615 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.64 136.13 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.245 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.88 145.56 26.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.423 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.195 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.535 ' HA ' HG22 ' A' ' 22' ' ' VAL . 40.2 t . . . . . 0 N--CA 1.462 0.146 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.682 HG21 ' CB ' ' A' ' 74' ' ' ALA . 18.7 p . . . . . 0 CA--C 1.533 0.32 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.733 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 19.4 tt0 . . . . . 0 C--O 1.233 0.213 0 CA-C-O 121.064 0.459 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.14 135.97 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.655 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.55 145.9 22.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.634 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -106.62 126.61 52.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.839 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.01 163.77 15.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.176 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -126.44 113.19 16.52 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.597 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.83 143.33 50.88 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -95.1 155.35 16.77 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.04 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -80.11 126.96 31.74 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.043 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' A' ' 44' ' ' ALA . 8.3 mm-40 -95.12 -52.85 4.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.503 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -164.62 44.24 0.09 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.532 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.97 151.01 17.69 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.226 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.1 mmm -74.28 -70.89 0.37 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.481 0.181 . . . . 0.0 110.683 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.31 77.09 0.58 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.82 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.716 ' HB3' HG23 ' A' ' 39' ' ' VAL . 3.4 pp -161.21 177.68 9.99 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.671 0.272 . . . . 0.0 110.992 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 m -130.17 155.76 45.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.477 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.939 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -144.12 164.33 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.778 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.408 HG23 ' HB2' ' A' ' 37' ' ' LYS . 64.8 t -140.79 138.75 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.701 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.603 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -88.26 94.97 10.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.804 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.75 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -93.57 146.04 24.09 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.041 0.448 . . . . 0.0 112.109 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -132.65 -179.89 5.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.67 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -177.3 -142.63 4.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.775 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.83 149.34 25.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.615 0.245 . . . . 0.0 110.718 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.92 31.32 75.81 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.779 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.13 103.9 7.24 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.627 0.251 . . . . 0.0 110.731 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -91.1 23.06 3.41 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.222 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -140.77 -164.11 1.67 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.541 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.603 ' CD2' ' HB1' ' A' ' 23' ' ' ALA . 7.0 tp -140.55 116.62 10.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.477 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.26 133.25 11.8 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.471 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.8 mp -92.45 88.74 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 121.054 0.454 . . . . 0.0 110.498 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.75 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 47.0 m-85 -82.28 173.03 12.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.918 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.16 136.34 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 111.356 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.408 ' HB2' HG23 ' A' ' 22' ' ' VAL . 11.6 tttp -98.37 -43.99 6.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.815 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.97 107.9 0.07 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.012 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.716 HG23 ' HB3' ' A' ' 19' ' ' LEU . 14.8 p -81.65 137.41 21.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.1 132.44 32.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.051 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 151.51 47.39 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.94 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.05 -28.79 12.96 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.679 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -68.85 157.65 53.23 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.27 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.478 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . . . -49.33 -40.32 34.85 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.82 -36.82 70.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.398 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -86.09 -39.99 16.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.247 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 43' ' ' GLY . 21.9 t -67.36 -37.68 79.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.87 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -68.7 -43.55 75.8 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.511 0.196 . . . . 0.0 111.202 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.06 75.5 1.09 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.762 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.19 -50.88 0.76 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.538 0.209 . . . . 0.0 110.819 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -123.78 177.57 5.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.099 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.54 -174.31 4.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.413 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.1 152.07 44.75 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.392 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.57 26.16 63.79 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.365 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.03 169.12 8.74 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.629 0.252 . . . . 0.0 110.766 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.437 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 1.3 tt0 -100.25 166.55 10.93 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.59 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.788 HD21 HD12 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -156.05 130.8 9.07 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.99 -44.65 1.04 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.877 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' A' ' 87' ' ' GLU . 22.8 t -95.65 143.34 27.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.583 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.734 HG21 HD12 ' A' ' 65' ' ' LEU . 39.4 t -144.47 121.75 5.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.805 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.12 35.09 25.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.268 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.5 24.04 68.9 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.873 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.4 mtp85 -125.13 -176.55 3.6 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.3 p -123.65 116.24 22.76 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.689 0.28 . . . . 0.0 110.979 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.734 HD12 HG21 ' A' ' 60' ' ' VAL . 37.4 mt -110.68 31.29 6.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.004 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -89.87 101.21 11.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.123 0.487 . . . . 0.0 110.415 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.93 42.85 0.55 Allowed Glycine 0 CA--C 1.518 0.233 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.444 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 65' ' ' LEU . 84.0 mt -117.82 -178.81 3.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.773 0.321 . . . . 0.0 110.764 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.21 19.45 10.61 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.844 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 40.3 tt0 78.49 -54.87 0.48 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.098 0.559 . . . . 0.0 111.581 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -53.37 -43.69 68.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.621 0.248 . . . . 0.0 110.773 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -33.31 75.5 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.657 ' HA ' HD13 ' A' ' 65' ' ' LEU . . . -66.92 -62.8 1.25 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.288 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.939 ' HB2' HD11 ' A' ' 21' ' ' ILE . . . -56.53 -42.1 77.88 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.867 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -60.72 -33.1 72.38 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.122 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 76' ' ' LEU . 7.4 mt -77.82 -46.2 22.21 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.61 0.243 . . . . 0.0 110.898 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.734 ' HG3' HG11 ' A' ' 60' ' ' VAL . 4.6 mtp -57.58 -41.24 80.74 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.187 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 74' ' ' ALA . 8.9 t -73.42 -32.33 64.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.574 0.226 . . . . 0.0 110.563 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.38 49.63 1.85 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.34 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.9 p -115.13 170.32 8.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.656 0.265 . . . . 0.0 111.081 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t -81.58 -170.88 3.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.685 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.51 -48.68 68.79 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 p -85.47 127.81 39.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.979 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.521 HG12 HD22 ' A' ' 86' ' ' LEU . 6.5 t -122.43 141.72 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 m -119.93 106.4 12.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.095 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.788 HD12 HD21 ' A' ' 57' ' ' LEU . 3.3 mm? -109.69 133.14 53.47 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.121 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 45.8 tt0 -115.39 106.02 13.52 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.756 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.538 HG12 HD12 ' A' ' 57' ' ' LEU . 34.2 m -105.24 174.27 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.595 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -123.2 143.39 50.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.895 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.276 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.345 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 94.2 p . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.218 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.49 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 19.9 tt0 . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.98 0.419 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.627 HG21 HD12 ' A' ' 58' ' ' LEU . 33.7 mt -103.81 116.78 48.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 pt -142.88 149.55 18.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 111.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.722 HG22 HG22 ' A' ' 85' ' ' THR . 1.3 m -111.3 120.34 41.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.055 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' THR . 12.6 m -96.03 169.56 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.154 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.96 114.44 8.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.801 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -135.16 164.09 28.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.248 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -96.16 144.12 26.67 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -87.86 105.33 17.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.083 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -58.56 3.89 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.588 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.86 36.55 0.4 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.774 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.65 147.37 8.0 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.352 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -52.27 64.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.603 0.239 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.93 64.33 2.35 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.718 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 20' ' ' SER . 4.0 pp -160.54 179.33 8.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.46 0.171 . . . . 0.0 110.727 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.529 ' N ' HD12 ' A' ' 19' ' ' LEU . 75.3 m -138.36 151.69 47.75 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.439 0.162 . . . . 0.0 111.183 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.048 HD13 HG23 ' A' ' 34' ' ' ILE . 2.2 pp -133.72 156.53 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.68 HG23 ' HB2' ' A' ' 37' ' ' LYS . 30.5 t -137.78 133.85 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.91 128.5 35.06 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.887 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.786 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -135.4 143.69 46.14 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.79 0.328 . . . . 0.0 111.471 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -120.33 -179.71 4.04 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.12 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.92 -139.82 2.74 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.734 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.32 150.95 27.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.67 0.271 . . . . 0.0 110.789 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.37 38.23 93.11 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.63 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 107.5 8.1 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.711 0.291 . . . . 0.0 110.855 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -90.29 19.0 5.43 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.545 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -144.77 -169.73 3.24 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.486 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 32' ' ' LEU . 10.6 tp -129.19 142.81 50.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.66 0.267 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.17 128.28 8.93 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.754 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.048 HG23 HD13 ' A' ' 21' ' ' ILE . 1.9 mp -92.15 91.63 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-O 121.155 0.503 . . . . 0.0 110.274 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.786 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 75.8 m-85 -80.16 167.81 19.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.593 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.402 HG11 HG13 ' A' ' 39' ' ' VAL . 43.4 t -94.93 127.48 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 111.094 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.68 ' HB2' HG23 ' A' ' 22' ' ' VAL . 7.8 tptt -80.36 -49.11 11.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.691 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.473 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 52.3 p -178.96 111.08 0.05 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.114 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.402 HG13 HG11 ' A' ' 36' ' ' VAL . 9.2 m -73.58 129.34 36.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.793 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.54 141.46 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.202 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 151.82 42.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.066 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -37.68 3.38 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.742 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.43 151.81 45.58 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.428 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.29 -36.69 43.6 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.87 84.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.738 0.304 . . . . 0.0 111.137 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.0 -39.77 41.21 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.501 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.2 t -58.88 -34.03 51.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.576 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB2' HD21 ' A' ' 11' ' ' LEU . 32.4 t0 -68.53 -55.84 10.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.886 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.15 32.09 11.08 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.708 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -88.23 -43.38 11.64 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.687 0.279 . . . . 0.0 110.896 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.596 ' HB3' HG21 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -116.86 -178.77 3.51 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.886 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.89 -177.33 6.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.377 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -72.9 156.98 38.31 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.97 27.11 71.07 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.751 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -109.53 172.75 6.67 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.631 0.215 . . . . 0.0 110.579 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.632 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 8.5 tm0? -110.05 147.42 33.6 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.6 0.238 . . . . 0.0 110.814 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.895 HD11 HD23 ' A' ' 86' ' ' LEU . 1.7 tp -115.84 142.17 47.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.873 0.368 . . . . 0.0 111.314 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.627 HD12 HG21 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -106.6 -56.27 2.21 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.4 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.4 t -147.28 156.35 42.85 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.055 0.455 . . . . 0.0 111.96 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.888 HG21 ' HG2' ' A' ' 77' ' ' MET . 41.8 t -133.0 121.35 43.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.524 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 60.09 35.23 21.28 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.287 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.3 26.29 73.8 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.263 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.576 ' HD3' HD22 ' A' ' 76' ' ' LEU . 10.0 mtt-85 -96.91 -178.31 4.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.988 0.394 . . . . 0.0 110.799 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -120.67 103.47 9.15 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.66 HD22 ' HA ' ' A' ' 73' ' ' ALA . 36.9 mt -108.39 29.57 7.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.175 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.8 t -111.35 100.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.207 0.527 . . . . 0.0 110.875 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.35 30.7 3.5 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.642 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.612 HD22 ' HG2' ' A' ' 72' ' ' ARG . 10.6 mt -133.47 179.43 6.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.77 0.319 . . . . 0.0 110.307 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.07 168.5 10.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.524 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -61.43 -21.58 64.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.837 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -77.75 -38.09 47.68 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.756 0.312 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HG2' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.09 -56.66 8.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.32 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -61.49 -45.58 93.63 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.616 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.727 ' HB1' HG21 ' B' ' 102' ' ' THR . . . -56.55 -55.15 37.47 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.395 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.53 -36.19 64.0 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.045 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.576 HD22 ' HD3' ' A' ' 63' ' ' ARG . 56.7 mt -72.01 -39.91 68.85 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.254 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.888 ' HG2' HG21 ' A' ' 60' ' ' VAL . 81.9 mtp -64.61 -55.35 20.85 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 74' ' ' ALA . 1.8 t -57.38 -36.28 71.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.851 0.357 . . . . 0.0 110.429 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -83.35 52.04 2.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.656 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.08 168.75 9.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.686 0.279 . . . . 0.0 111.109 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.98 -164.64 1.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.624 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.4 m -57.19 -34.99 69.05 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.3 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -95.99 150.66 4.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.432 HG12 ' CD1' ' A' ' 86' ' ' LEU . 21.4 t -132.61 120.58 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.268 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.722 HG22 HG22 ' A' ' 8' ' ' THR . 5.4 m -123.58 95.99 4.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.01 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.895 HD23 HD11 ' A' ' 57' ' ' LEU . 5.3 mp -108.74 141.89 40.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.409 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -107.35 106.93 17.6 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.535 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 51' ' ' LEU . 20.9 t -96.61 149.1 4.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.675 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -121.25 104.36 9.68 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.835 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 7.0 mttm . . . . . 0 C--O 1.233 0.205 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 2.4 p . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.523 0.202 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.727 HG21 ' HB1' ' A' ' 74' ' ' ALA . 1.2 m . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.763 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 30.0 tt0 . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.937 0.399 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.3 mt -115.86 125.33 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.767 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.63 138.04 46.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.34 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.732 HG23 ' HG3' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -94.49 145.77 24.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.823 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' ' 50' ' ' ARG . 28.1 m -124.08 125.56 70.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.75 111.71 23.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.76 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.1 mt -131.9 154.49 49.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -91.4 130.48 37.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.764 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.42 122.46 21.28 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.227 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.64 -40.16 5.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.83 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -160.12 43.42 0.2 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 111.214 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.42 -165.22 49.95 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.122 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.0 mtm -127.13 90.73 3.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.768 0.284 . . . . 0.0 110.684 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.77 84.32 0.02 OUTLIER Glycine 0 C--O 1.225 -0.43 0 C-N-CA 121.394 -0.431 . . . . 0.0 113.104 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 20' ' ' SER . 4.1 pp -160.84 178.57 9.29 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.748 0.309 . . . . 0.0 110.942 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.454 ' N ' HD12 ' A' ' 19' ' ' LEU . 2.3 p -131.84 153.87 49.73 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.229 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.815 HD13 HG23 ' A' ' 34' ' ' ILE . 2.9 pp -132.75 157.67 43.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.985 0.422 . . . . 0.0 112.122 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.6 t -135.67 138.26 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.227 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.493 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -83.6 158.01 22.07 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.24 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.707 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -153.88 141.97 20.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -131.1 179.57 5.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.044 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.62 -139.83 2.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.864 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.96 142.71 36.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.587 0.232 . . . . 0.0 110.612 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.96 36.32 92.02 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.691 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -121.91 101.16 7.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 111.013 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.26 19.29 5.21 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.248 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.442 ' O ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -139.26 -171.51 3.13 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.4 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.493 HD12 ' HB1' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -136.12 143.55 44.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.108 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.33 117.95 4.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.454 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.815 HG23 HD13 ' A' ' 21' ' ' ILE . 2.0 mp -93.45 87.69 2.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.177 0.513 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HE1' ' HB3' ' A' ' 24' ' ' ALA . 45.6 m-85 -80.61 172.53 13.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.626 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.4 t -103.39 148.15 8.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.644 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.0 -37.23 2.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.709 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 m -153.24 130.93 11.55 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.771 0.32 . . . . 0.0 111.205 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.4 106.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.201 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 t -68.32 135.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.374 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.14 147.56 49.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.966 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.58 -14.61 63.02 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.226 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.634 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.27 -155.07 3.08 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.677 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.56 -41.82 10.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.668 0.27 . . . . 0.0 111.487 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.469 ' HB1' HD12 ' A' ' 51' ' ' LEU . . . -71.26 -33.41 69.77 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.065 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -71.31 -38.45 71.73 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' GLY . 50.0 t -66.31 -54.19 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 111.566 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -63.66 -50.6 68.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.136 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.7 68.43 1.23 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.212 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.556 ' HB3' HG11 ' A' ' 9' ' ' VAL . 21.6 mmt85 -145.06 33.68 1.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.821 0.343 . . . . 0.0 110.648 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.469 HD12 ' HB1' ' A' ' 45' ' ' ALA . 4.0 mt -152.48 176.08 12.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.213 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.32 142.56 4.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.096 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.96 124.0 19.97 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.942 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.82 29.33 6.22 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.405 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.567 ' HB3' HG23 ' A' ' 88' ' ' VAL . 4.0 m-20 -115.81 159.81 20.98 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.521 0.201 . . . . 0.0 110.805 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 48.3 tt0 -96.47 154.8 17.07 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.047 0.451 . . . . 0.0 112.046 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.11 100.23 6.47 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.355 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -69.45 -59.73 2.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.247 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -139.44 159.04 43.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.852 HG13 ' HG ' ' A' ' 86' ' ' LEU . 38.9 t -132.89 124.55 50.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.988 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.1 t70 56.42 31.36 18.65 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.031 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.96 35.44 58.96 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.804 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -101.99 14.2 32.63 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.74 87.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.38 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.895 HD23 HD12 ' A' ' 68' ' ' LEU . 5.5 mt -111.82 61.87 0.62 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.302 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -130.22 98.52 3.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.109 0.48 . . . . 0.0 110.977 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.79 -25.71 4.39 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.747 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.895 HD12 HD23 ' A' ' 65' ' ' LEU . 88.5 mt -66.44 174.76 2.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.15 0.5 . . . . 0.0 111.334 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.0 m -88.73 162.72 16.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.989 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.551 HE21 HG23 ' B' ' 102' ' ' THR . 40.2 tt0 -52.66 -28.48 21.77 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.555 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -77.66 -54.52 6.28 Favored 'General case' 0 C--N 1.335 -0.054 0 CA-C-O 120.575 0.226 . . . . 0.0 111.057 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -56.94 -34.68 68.24 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.29 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.495 ' HB3' HG12 ' A' ' 34' ' ' ILE . . . -70.89 -59.62 2.69 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.366 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.656 ' O ' HG22 ' A' ' 78' ' ' THR . . . -56.57 -48.34 77.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.26 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -57.08 -44.72 83.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.87 -37.62 82.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.621 0.248 . . . . 0.0 111.033 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.781 ' HG2' HG21 ' A' ' 60' ' ' VAL . 56.6 mtp -61.95 -56.52 18.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.437 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 74' ' ' ALA . 1.6 t -61.12 -38.13 85.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.769 0.319 . . . . 0.0 110.506 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -85.5 53.07 2.63 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.454 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.51 179.5 4.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.735 0.302 . . . . 0.0 111.1 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.53 -165.59 1.34 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.749 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.3 m -55.75 -47.51 76.85 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.28 143.74 10.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.881 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.1 t -136.65 111.05 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.054 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.494 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -106.57 83.76 1.91 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.541 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.852 ' HG ' HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -93.62 137.48 32.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.426 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.732 ' HG3' HG23 ' A' ' 8' ' ' THR . 8.4 mt-10 -103.13 140.33 37.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.677 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 55' ' ' ASP . 11.8 p -128.7 138.16 55.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.366 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -109.53 116.65 32.18 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.711 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.216 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.136 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.755 0.312 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.551 HG23 HE21 ' A' ' 70' ' ' GLN . 17.4 p . . . . . 0 C--O 1.233 0.206 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.495 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.06 0.457 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.647 HG21 HD13 ' A' ' 58' ' ' LEU . 4.5 mp -91.2 135.38 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.814 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.568 HD12 HG13 ' A' ' 9' ' ' VAL . 1.5 pp -142.27 138.26 29.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.259 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.918 HG22 HG22 ' A' ' 85' ' ' THR . 3.2 m -104.08 98.54 8.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.568 HG13 HD12 ' A' ' 7' ' ' ILE . 19.2 m -89.17 169.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.44 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -125.18 109.22 12.6 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.755 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 50' ' ' ARG . 2.6 mt -109.52 155.26 21.59 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.768 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -107.52 118.82 37.74 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.725 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -62.45 100.73 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.86 87.48 3.31 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.727 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.12 39.58 28.93 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.208 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.93 153.87 30.53 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.171 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.856 ' O ' HG11 ' A' ' 40' ' ' VAL . 7.5 mtm -80.28 -79.92 0.14 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.648 0.224 . . . . 0.0 111.038 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.75 -0.74 27.45 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.149 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 20' ' ' SER . 3.5 pp -79.86 173.8 12.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 117.071 0.436 . . . . 0.0 110.828 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.467 ' N ' HD12 ' A' ' 19' ' ' LEU . 57.9 m -127.12 151.62 48.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.74 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 34' ' ' ILE . 2.2 pp -139.75 150.83 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.554 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.857 HG23 ' HB2' ' A' ' 37' ' ' LYS . 85.7 t -126.15 145.67 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.274 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . . . -107.2 119.9 40.66 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.748 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.9 151.47 44.29 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.414 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.401 ' HG3' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -118.71 -179.74 3.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.048 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.63 -139.68 2.73 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.35 143.89 38.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.628 0.251 . . . . 0.0 110.801 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.37 41.59 99.56 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.652 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 107.26 7.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.719 0.295 . . . . 0.0 110.973 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.429 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 24.5 t0 -91.93 20.51 5.68 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.316 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.429 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -141.19 -167.87 2.49 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.307 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 25' ' ' LYS . 5.6 tp -136.61 126.2 25.32 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.36 130.39 10.1 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.946 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 21' ' ' ILE . 21.3 mm -95.19 71.13 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.073 0.463 . . . . 0.0 110.835 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 94.4 m-85 -62.16 160.51 12.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 55' ' ' ASP . 23.2 t -96.25 121.22 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.731 0.3 . . . . 0.0 111.277 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.857 ' HB2' HG23 ' A' ' 22' ' ' VAL . 6.3 tttp -80.19 -43.66 21.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.042 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.8 p -156.41 178.23 10.55 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.94 123.05 12.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.673 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.856 HG11 ' O ' ' A' ' 17' ' ' MET . 2.1 p -50.4 132.03 10.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.66 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.84 92.78 8.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.01 -21.64 2.64 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.148 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.64 -167.83 7.26 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.066 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.52 -1.32 53.45 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.45 -43.14 8.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.749 0.309 . . . . 0.0 111.013 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -72.69 -44.97 61.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.524 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.4 t -64.86 -39.53 85.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.541 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.46 -47.92 62.43 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.927 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.22 44.52 6.22 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.665 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.496 ' HB3' HG11 ' A' ' 9' ' ' VAL . 21.9 mmt85 -102.56 -38.63 7.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.547 0.213 . . . . 0.0 110.965 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.437 HD23 HD11 ' A' ' 11' ' ' LEU . 3.9 pp -126.79 158.85 35.49 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.894 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.29 -174.95 4.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.193 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.54 138.94 43.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 39.42 9.98 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.875 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 36' ' ' VAL . 63.5 m-20 -116.16 138.19 51.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.514 0.197 . . . . 0.0 110.742 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.444 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -81.11 147.75 29.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.059 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 2.1 tp -101.02 154.36 18.77 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 111.563 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.647 HD13 HG21 ' A' ' 6' ' ' ILE . 2.3 tt -140.54 -57.53 0.53 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.032 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.53 156.72 48.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.254 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.606 HG11 ' CG ' ' A' ' 77' ' ' MET . 29.3 t -141.49 123.43 13.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.827 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.57 33.05 22.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.313 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.44 27.93 71.94 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.042 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -115.07 165.38 12.96 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.827 0.314 . . . . 0.0 110.825 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.43 106.99 17.66 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.547 HD21 HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -119.99 33.22 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.89 98.86 4.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.24 0.543 . . . . 0.0 110.695 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.34 28.81 3.92 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.64 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 68' ' ' LEU . 17.0 mt -110.42 158.44 18.47 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.764 0.316 . . . . 0.0 110.737 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.67 153.01 42.88 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.391 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 49.3 tt0 -52.01 -34.55 43.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.76 -48.53 71.52 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.313 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -63.51 -44.31 94.65 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.609 0.242 . . . . 0.0 111.335 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -59.67 -56.24 24.4 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.71 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.584 ' O ' HG22 ' A' ' 78' ' ' THR . . . -62.93 -45.97 89.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.075 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -57.79 -26.3 61.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.547 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.3 mt -74.63 -47.87 29.63 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.606 ' CG ' HG11 ' A' ' 60' ' ' VAL . 4.6 mtp -60.43 -48.06 83.38 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.355 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 74' ' ' ALA . 1.4 t -61.12 -36.12 78.87 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.83 0.348 . . . . 0.0 110.304 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.98 52.57 2.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.843 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.456 HG21 HG13 ' A' ' 84' ' ' VAL . 34.9 p -118.01 176.48 5.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 111.072 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -92.54 -163.86 1.1 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.517 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.03 -34.03 58.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.945 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.59 140.8 22.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.904 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.53 HG12 ' CD1' ' A' ' 86' ' ' LEU . 15.0 t -136.76 118.2 18.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.918 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -96.63 100.54 12.1 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.53 ' CD1' HG12 ' A' ' 84' ' ' VAL . 4.8 mp -100.77 116.99 33.95 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.204 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 28.8 tt0 -101.4 101.52 12.16 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.547 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.02 171.32 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.625 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.31 135.94 53.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.096 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt . . . . . 0 C--O 1.232 0.156 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.457 179.885 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 60.2 p . . . . . 0 N--CA 1.466 0.357 0 CA-C-O 120.814 0.34 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.449 HG21 ' CB ' ' A' ' 74' ' ' ALA . 19.7 m . . . . . 0 N--CA 1.465 0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.593 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.256 0.551 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.448 HG12 ' CD1' ' A' ' 58' ' ' LEU . 4.6 mp -80.03 122.33 35.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.176 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.14 138.76 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.337 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.795 HG22 HG22 ' A' ' 85' ' ' THR . 0.2 OUTLIER -100.37 126.58 46.75 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.476 HG13 ' HD2' ' A' ' 50' ' ' ARG . 22.0 t -114.38 131.22 67.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 m -105.31 123.39 47.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.917 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.505 HD21 ' CG ' ' A' ' 48' ' ' ASP . 10.3 mt -140.72 160.18 40.6 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.118 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 mtmm -101.23 163.76 12.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -90.96 98.42 11.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -74.86 -53.14 9.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.2 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -166.46 45.28 0.06 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.347 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.75 150.38 14.31 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.226 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -60.08 3.31 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.688 0.244 . . . . 0.0 110.479 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.93 72.23 1.03 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.324 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 pp -161.14 178.02 9.7 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.446 0.165 . . . . 0.0 110.698 179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -127.54 141.48 51.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.669 0.271 . . . . 0.0 111.615 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 21' ' ' ILE . 2.3 pp -132.59 159.91 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.409 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.491 HG22 ' HA ' ' B' ' 101' ' ' SER . 61.8 t -146.64 148.05 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.356 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -104.35 147.88 27.02 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.056 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.77 149.8 30.21 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.83 0.347 . . . . 0.0 111.762 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -121.79 -179.9 4.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.81 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.2 -144.01 3.82 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.978 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.14 145.15 37.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.603 0.24 . . . . 0.0 110.748 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.81 30.6 63.14 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.587 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.74 108.83 4.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.682 0.277 . . . . 0.0 110.67 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -93.96 27.56 2.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.384 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -116.04 -165.48 1.05 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.421 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.4 tp -144.57 136.87 26.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.632 0.253 . . . . 0.0 111.119 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.35 116.68 5.62 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.625 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.1 mp -85.48 81.54 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.368 0.604 . . . . 0.0 110.496 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 56' ' ' GLN . 93.4 m-85 -79.8 145.59 32.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.106 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.9 t -83.47 123.3 38.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.901 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HB2' HG23 ' A' ' 22' ' ' VAL . 10.3 tptt -82.38 -43.21 17.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.846 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 t -169.01 -179.92 3.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.2 t -132.78 129.94 58.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.706 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.36 129.75 36.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.016 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.8 136.8 58.11 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.62 -26.67 17.27 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.7 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.74 158.73 46.69 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.784 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.3 -39.3 72.5 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.02 -39.62 63.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.196 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -60.35 -38.96 85.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 43' ' ' GLY . 36.7 t -73.35 -38.76 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.335 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.505 ' CG ' HD21 ' A' ' 11' ' ' LEU . 1.1 t0 -59.46 -43.26 93.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.319 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.78 36.48 57.9 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.946 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.476 ' HD2' HG13 ' A' ' 9' ' ' VAL . 19.3 mtt-85 -98.93 -45.9 5.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.781 0.29 . . . . 0.0 110.889 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.4 pp -101.84 171.46 7.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.783 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.75 -173.13 3.8 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.281 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.42 157.75 23.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.47 30.46 71.17 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.696 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.67 -177.02 3.25 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.562 0.22 . . . . 0.0 110.792 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 65.8 tt0 -125.85 152.74 45.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.945 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.754 HD11 HD21 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -112.16 142.84 44.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.126 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -115.17 -54.65 2.54 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.351 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.3 p -140.12 154.36 46.98 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.086 0.47 . . . . 0.0 111.95 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.84 HG23 HD11 ' A' ' 65' ' ' LEU . 59.6 t -132.09 112.84 20.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.518 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.09 35.48 26.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.997 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.07 31.98 45.86 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.041 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -128.9 149.3 50.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.815 0.307 . . . . 0.0 110.655 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t -92.27 132.62 36.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.169 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.84 HD11 HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -107.83 -28.9 9.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.494 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.07 99.24 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.188 0.518 . . . . 0.0 111.017 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 142.87 -35.39 1.7 Allowed Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.882 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.797 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -88.11 166.49 14.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.1 t -72.5 161.07 31.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.757 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.419 ' HG3' ' HB2' ' A' ' 23' ' ' ALA . 3.4 tt0 -53.46 -44.2 68.72 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.067 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -61.4 -39.61 91.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.704 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.37 -35.86 73.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.866 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.797 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . . . -72.04 -61.01 1.94 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.383 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.526 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -54.23 -39.76 67.06 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.313 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HG3' ' CD ' ' A' ' 79' ' ' ARG . 1.7 tt0 -62.55 -50.11 72.62 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.843 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.83 -32.17 65.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.217 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.555 ' CG ' HG21 ' A' ' 60' ' ' VAL . 22.4 mtp -71.22 -58.83 3.17 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.565 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.8 t -59.36 -33.98 71.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.811 0.338 . . . . 0.0 110.709 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.409 ' CD ' ' HG3' ' A' ' 75' ' ' GLU . 66.4 mtp85 -86.43 51.98 2.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.516 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 p -110.09 -178.99 3.66 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.678 0.275 . . . . 0.0 110.95 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.16 -174.03 4.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.83 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.5 p -52.33 -44.11 64.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.22 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.73 140.38 16.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.844 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.28 121.27 65.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.072 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.795 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -113.23 80.87 1.41 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.785 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.754 HD21 HD11 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -90.31 121.8 32.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.938 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.671 ' HB2' HG23 ' A' ' 8' ' ' THR . 24.9 tt0 -104.19 103.8 13.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.5 m -102.32 170.86 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.116 0.484 . . . . 0.0 111.64 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.8 98.11 6.65 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.993 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.233 0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.491 ' HA ' HG22 ' A' ' 22' ' ' VAL . 27.2 t . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 120.802 0.334 . . . . 0.0 111.791 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.526 HG21 ' CB ' ' A' ' 74' ' ' ALA . 31.6 m . . . . . 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.351 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 8.6 tt0 . . . . . 0 C--O 1.233 0.2 0 CA-C-O 121.091 0.472 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.76 125.84 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.629 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.626 HD12 HG13 ' A' ' 9' ' ' VAL . 1.3 pt -141.65 142.79 28.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.262 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.746 HG23 ' HB2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -99.77 116.62 32.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.887 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.626 HG13 HD12 ' A' ' 7' ' ' ILE . 27.2 m -111.2 146.54 16.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.41 HG22 ' CG1' ' A' ' 83' ' ' VAL . 2.1 m -119.95 127.7 52.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.833 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mt -133.38 166.1 23.3 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.407 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -109.83 176.7 4.97 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 mtpt -106.28 92.25 4.05 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.846 0.355 . . . . 0.0 111.361 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -45.41 38.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.439 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -167.05 45.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.209 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.92 145.34 15.32 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.152 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -41.3 98.56 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.643 0.222 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.77 68.3 1.74 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.051 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.487 ' HA ' HG23 ' A' ' 40' ' ' VAL . 2.3 pp -160.75 168.38 24.91 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.553 0.216 . . . . 0.0 111.017 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 m -116.16 153.36 31.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.122 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.089 HD11 HG22 ' B' ' 102' ' ' THR . 2.6 pp -124.17 165.52 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.707 0.289 . . . . 0.0 111.682 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.502 HG23 ' HB2' ' A' ' 37' ' ' LYS . 25.7 t -151.42 140.81 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.465 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.84 158.59 18.69 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.714 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -155.22 132.83 11.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.927 0.394 . . . . 0.0 111.64 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -128.9 179.85 5.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.761 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.72 -140.04 3.02 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.73 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.07 147.79 28.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.629 0.252 . . . . 0.0 110.634 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.25 36.54 92.59 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.693 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.53 106.37 7.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.64 0.257 . . . . 0.0 110.776 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -90.16 20.79 4.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.516 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.595 ' CB ' HG12 ' A' ' 66' ' ' VAL . 21.4 mmtp -144.33 -169.16 3.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.822 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 24' ' ' ALA . 4.7 mt -138.39 131.06 29.32 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.782 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.69 151.05 21.53 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.924 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.675 HG13 ' HB1' ' A' ' 73' ' ' ALA . 23.8 mm -106.39 110.3 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.726 0.298 . . . . 0.0 111.215 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.714 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 6.4 m-85 -103.5 174.1 6.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.207 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.405 HG13 HD13 ' A' ' 19' ' ' LEU . 47.0 t -111.85 112.11 39.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.008 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.502 ' HB2' HG23 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -60.29 -49.64 76.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.592 179.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.4 p -176.61 131.4 0.2 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.0 t -82.74 127.29 39.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.427 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 19' ' ' LEU . 14.8 t -80.06 127.6 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.09 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 128.45 36.38 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.74 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.56 -19.86 11.3 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.967 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.12 -162.27 5.79 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.667 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.06 -34.6 14.33 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.49 -33.8 54.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -67.96 -47.62 68.12 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 43' ' ' GLY . 55.7 t -60.61 -42.18 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.558 0.218 . . . . 0.0 111.336 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.21 -35.67 79.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.148 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.38 45.09 88.55 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.902 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.76 -34.2 10.99 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.577 0.227 . . . . 0.0 110.954 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.7 147.61 50.13 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.006 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.57 -168.59 1.35 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.36 146.81 44.9 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.351 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.45 47.13 23.15 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.245 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.49 129.99 56.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.478 0.18 . . . . 0.0 110.782 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 35' ' ' TYR . 2.1 tm0? -80.62 145.53 31.65 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.02 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.46 HD22 HD23 ' A' ' 86' ' ' LEU . 6.6 mt -117.04 120.92 39.85 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.765 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.41 -58.33 2.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.9 p -130.76 163.92 26.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.579 HG11 ' HG2' ' A' ' 77' ' ' MET . 24.9 t -139.73 114.99 7.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.12 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.34 24.28 12.81 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.508 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.18 28.96 26.58 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.77 160.5 27.17 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 110.636 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -101.96 114.54 28.73 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.698 ' CD2' HD13 ' A' ' 76' ' ' LEU . 51.3 mt -114.63 31.91 6.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.015 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.595 HG12 ' CB ' ' A' ' 31' ' ' LYS . 69.2 t -114.26 100.85 11.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.143 0.497 . . . . 0.0 110.667 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.08 -35.45 1.47 Allowed Glycine 0 CA--C 1.517 0.207 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.627 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.9 168.64 13.22 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 110.459 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 t -64.71 157.57 27.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.181 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.76 ' CD ' HD13 ' A' ' 21' ' ' ILE . 8.6 tp-100 -52.24 -31.08 30.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.928 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.26 -52.23 65.25 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.954 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -43.19 94.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.045 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.675 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -67.45 -61.47 1.89 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.679 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 78' ' ' THR . . . -55.74 -36.12 66.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.631 0.253 . . . . 0.0 111.378 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.408 ' HG2' ' NH2' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -74.72 -34.6 62.61 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.411 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.698 HD13 ' CD2' ' A' ' 65' ' ' LEU . 3.2 mt -68.9 -44.15 73.77 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.482 0.182 . . . . 0.0 110.968 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.579 ' HG2' HG11 ' A' ' 60' ' ' VAL . 36.2 mtp -59.75 -52.46 65.39 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.563 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 74' ' ' ALA . 3.6 t -62.35 -36.75 83.21 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.665 0.269 . . . . 0.0 110.764 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 75' ' ' GLU . 60.0 mtm180 -87.73 53.94 2.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.632 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.2 p -108.76 176.2 5.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 111.005 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.59 -174.55 1.75 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.429 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 m -52.27 -34.26 45.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.628 0.252 . . . . 0.0 111.125 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.41 ' CG1' HG22 ' A' ' 10' ' ' THR . 21.3 t -107.71 151.4 9.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.92 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.8 t -137.65 118.37 16.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.518 HG22 HG22 ' A' ' 8' ' ' THR . 24.0 m -104.58 94.34 5.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.843 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.46 HD23 HD22 ' A' ' 57' ' ' LEU . 3.4 mp -98.95 138.42 36.09 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.411 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.746 ' HB2' HG23 ' A' ' 8' ' ' THR . 48.5 tt0 -114.89 99.74 7.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.714 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.1 m -101.98 173.83 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.041 0.448 . . . . 0.0 111.746 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.87 123.34 39.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.126 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 1.7 mptm? . . . . . 0 C--O 1.233 0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.607 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.804 0.335 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 1.089 HG22 HD11 ' A' ' 21' ' ' ILE . 5.2 t . . . . . 0 CA--C 1.53 0.204 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.907 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 121.052 0.453 . . . . 0.0 110.773 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mt -84.06 113.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.85 141.01 45.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 27.5 m -104.87 141.33 36.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -119.59 127.93 75.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.283 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 m -99.42 103.54 15.33 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.671 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -143.9 149.01 36.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.359 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.18 167.78 14.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.208 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.66 124.89 28.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.62 85.48 2.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.38 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 m120 58.38 34.56 24.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.946 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.11 158.0 31.0 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.669 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.49 -48.57 16.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.534 0.207 . . . . 0.0 110.634 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.48 74.96 0.55 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.555 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 pp -160.74 173.82 14.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.556 0.217 . . . . 0.0 110.776 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -124.35 149.58 46.46 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.804 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' HG22 ' A' ' 34' ' ' ILE . 8.6 pt -137.71 154.48 29.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.8 t -147.12 134.97 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.251 179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.664 ' HB2' ' OE1' ' A' ' 70' ' ' GLN . . . -88.96 144.43 26.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.952 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.41 159.44 35.76 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.837 0.351 . . . . 0.0 111.783 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.45 179.31 4.63 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.052 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.88 -144.06 3.85 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.888 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.07 150.31 28.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.645 0.26 . . . . 0.0 110.865 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.79 28.82 60.84 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.586 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.78 107.98 4.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.651 0.262 . . . . 0.0 110.455 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -97.57 37.42 1.37 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -133.52 -164.62 1.51 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.477 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tp -147.53 125.76 12.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.68 0.276 . . . . 0.0 110.772 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.76 137.57 13.34 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.607 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.601 HG13 ' HB1' ' A' ' 73' ' ' ALA . 18.8 mm -86.6 72.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.107 0.48 . . . . 0.0 110.736 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -60.23 160.18 8.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.348 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 t -100.96 115.09 41.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.964 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.4 -46.78 78.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.791 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -178.94 124.87 0.09 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.902 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.5 m -72.67 142.51 15.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.089 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.91 137.67 21.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.38 153.25 27.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.213 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.05 14.94 76.32 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.884 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -92.18 159.39 25.3 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.296 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.23 69.42 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -83.3 -34.41 25.72 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.291 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.11 -47.09 69.12 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.309 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.2 t -63.81 -46.53 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.4 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -43.95 97.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.168 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.47 64.96 1.77 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.839 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -136.78 23.47 3.1 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.632 0.253 . . . . 0.0 111.374 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.1 pp -179.83 177.97 0.65 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.755 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.77 -170.05 2.07 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.187 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.406 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -72.44 160.23 32.67 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.914 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.91 31.24 80.26 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.244 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.8 124.69 45.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.59 0.234 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.643 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 8.7 tm0? -79.47 117.57 20.55 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.057 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.539 HD11 HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -88.75 136.09 33.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.198 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.451 HD13 ' CG2' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -108.54 -63.01 1.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.837 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 58.8 m -127.91 145.49 50.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.196 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' A' ' 77' ' ' MET . 39.2 t -120.87 118.19 55.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.667 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 60.56 32.01 20.34 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.105 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.73 -6.28 70.66 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.273 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -80.53 154.62 27.41 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 117.186 0.493 . . . . 0.0 111.057 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.35 101.09 12.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.658 HD23 HD12 ' A' ' 68' ' ' LEU . 6.4 mt -110.42 44.2 1.28 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.688 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.451 ' CG2' HD13 ' A' ' 58' ' ' LEU . 60.3 t -101.8 99.97 9.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.719 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.83 -29.25 5.66 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.759 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.658 HD12 HD23 ' A' ' 65' ' ' LEU . 65.7 mt -65.36 168.59 6.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 111.241 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.0 t -87.22 168.16 13.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.449 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.664 ' OE1' ' HB2' ' A' ' 23' ' ' ALA . 5.9 tp60 -58.24 -29.44 65.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.003 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.47 -56.01 27.39 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.786 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -63.21 -45.99 89.11 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.693 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -59.07 -58.39 8.87 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.972 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.893 ' HB1' HG21 ' B' ' 102' ' ' THR . . . -49.07 -48.56 44.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.712 0.291 . . . . 0.0 111.387 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -61.76 2.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.739 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.59 HD12 HD21 ' A' ' 65' ' ' LEU . 16.8 mt -56.22 -30.53 62.44 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.494 ' HA ' HG11 ' A' ' 60' ' ' VAL . 4.3 mmm -66.01 -64.15 0.92 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.8 -0.182 . . . . 0.0 111.175 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 74' ' ' ALA . 3.4 t -62.4 -35.82 80.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.775 0.322 . . . . 0.0 110.729 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -85.33 49.4 1.75 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.333 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.89 169.56 10.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.717 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.14 -169.34 0.93 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.822 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.63 -54.55 21.98 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.697 0.284 . . . . 0.0 110.86 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.73 147.16 5.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.692 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.489 HG12 HD13 ' A' ' 86' ' ' LEU . 33.3 t -121.78 111.63 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.987 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.14 105.85 14.7 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.781 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.539 HD23 HD11 ' A' ' 57' ' ' LEU . 5.4 mp -115.2 131.13 57.03 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.942 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 2.3 mt-10 -102.16 95.55 6.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.3 m -89.66 172.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.256 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -130.48 118.77 21.62 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.52 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.228 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.643 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 53.9 p . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 120.716 0.294 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.893 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.73 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 1.4 tt0 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.984 0.421 . . . . 0.0 111.234 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.63 131.14 43.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.881 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.0 pt -150.74 154.89 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.198 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.72 ' CG2' HG22 ' A' ' 85' ' ' THR . 1.8 m -122.49 132.25 54.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.6 t -115.78 136.8 51.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.183 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -101.68 112.14 24.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.656 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 mt -134.74 168.67 18.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.236 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.1 157.28 19.53 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -86.33 69.75 10.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.488 HE22 ' HB2' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -43.79 -41.27 4.88 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.701 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -172.77 44.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.294 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.46 152.23 25.17 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.178 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.421 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -74.91 -51.42 13.84 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.571 0.224 . . . . 0.0 110.821 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.06 80.77 0.12 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.083 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -160.92 -179.76 7.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.619 0.247 . . . . 0.0 110.88 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 37' ' ' LYS . 15.3 m -125.28 141.69 51.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.067 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.538 HD13 HG23 ' A' ' 34' ' ' ILE . 2.4 pp -136.26 157.47 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.832 0.348 . . . . 0.0 111.796 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -145.32 148.59 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.235 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.09 131.97 46.76 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.235 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.86 146.89 38.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.493 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HG3' HD12 ' A' ' 32' ' ' LEU . 11.5 tttt -122.83 -179.73 4.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.957 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.39 -140.57 2.91 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.751 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.3 147.27 32.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.586 0.231 . . . . 0.0 110.779 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.78 40.89 97.25 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.614 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.53 106.24 7.33 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.715 0.293 . . . . 0.0 110.907 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -90.68 24.43 2.69 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.003 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -144.35 -165.83 2.23 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.647 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.425 HD12 ' HG3' ' A' ' 25' ' ' LYS . 6.9 tp -138.67 135.1 34.48 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.798 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.36 127.42 8.78 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.709 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -95.91 94.72 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 121.129 0.49 . . . . 0.0 110.562 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -78.59 168.56 19.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.375 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.412 ' CG2' HD11 ' A' ' 57' ' ' LEU . 21.2 t -101.48 133.9 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.134 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 20' ' ' SER . 4.7 ttpt -97.53 -40.61 8.56 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.9 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.2 m -160.4 174.29 14.35 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.93 123.47 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.795 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.8 t -79.87 153.19 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.261 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -72.01 153.37 41.81 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.154 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.89 8.92 87.54 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.366 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.675 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -96.16 156.48 21.3 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.377 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' HB2' HE22 ' A' ' 14' ' ' GLN . . . -53.59 -43.35 68.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.622 0.249 . . . . 0.0 111.5 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.38 -34.66 74.87 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.242 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.65 -46.1 48.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.339 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.0 t -61.11 -49.34 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.164 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.69 -44.82 89.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.163 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.95 28.55 66.53 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.081 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.84 -47.52 16.46 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.805 0.303 . . . . 0.0 110.894 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.581 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.1 pp -109.73 170.42 8.08 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.96 177.76 7.58 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.169 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.92 141.72 53.05 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.43 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.48 43.57 4.86 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.675 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -128.22 146.03 50.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.686 0.279 . . . . 0.0 110.887 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -83.5 152.55 24.86 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.676 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.578 ' HB3' HD12 ' A' ' 65' ' ' LEU . 7.0 mp -115.0 148.51 38.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.942 0.401 . . . . 0.0 111.72 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.78 -55.17 2.01 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.782 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.7 p -137.58 152.13 49.09 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.9 0.381 . . . . 0.0 111.778 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.782 HG13 ' HG ' ' A' ' 86' ' ' LEU . 38.4 t -143.38 107.52 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.962 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t0 61.14 41.86 13.07 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.161 0.505 . . . . 0.0 110.823 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.99 37.5 38.14 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.058 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.47 162.0 21.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.766 0.283 . . . . 0.0 110.689 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.22 83.66 1.87 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.591 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.691 HD11 ' CG2' ' A' ' 60' ' ' VAL . 40.7 mt -60.8 -22.68 64.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.298 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.1 t -78.21 97.83 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.186 0.517 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.71 32.95 1.04 Allowed Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.288 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.876 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.2 pp -150.16 165.34 33.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 110.57 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.0 p -79.63 161.79 25.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.946 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -56.55 -32.3 65.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.325 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.84 -34.48 64.56 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.491 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -76.23 -33.22 59.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.978 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.876 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . . . -76.28 -58.64 3.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.334 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.69 ' O ' HG22 ' A' ' 78' ' ' THR . . . -56.55 -42.88 79.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.537 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.77 -39.85 93.1 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-O 120.698 0.285 . . . . 0.0 110.812 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.18 -32.2 68.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.291 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.578 ' HG2' HG11 ' A' ' 60' ' ' VAL . 28.1 mtp -72.24 -53.56 12.18 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.608 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 74' ' ' ALA . 2.0 t -60.7 -38.7 85.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.751 0.31 . . . . 0.0 110.795 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.6 mtp85 -87.87 55.94 3.68 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.644 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.4 p -106.52 178.5 4.54 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.895 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.1 p -88.1 -169.69 2.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.697 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.14 -54.77 43.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.631 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.7 t -84.58 139.27 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' THR . 16.8 t -129.7 151.62 36.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.465 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.72 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -135.11 83.27 2.01 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.781 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.782 ' HG ' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -89.71 122.18 32.57 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.098 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.07 97.46 7.43 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.675 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 51' ' ' LEU . 14.3 m -93.07 173.96 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.332 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.87 101.98 6.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.018 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--O 1.233 0.221 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.75 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 67.1 p . . . . . 0 CA--C 1.531 0.221 0 CA-C-O 120.762 0.315 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.532 HG21 ' CB ' ' A' ' 74' ' ' ALA . 51.8 m . . . . . 0 N--CA 1.463 0.213 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.601 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.065 0.459 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 44.4 mm -99.13 127.33 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.814 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -144.34 148.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.3 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.498 HG22 HG22 ' A' ' 85' ' ' THR . 0.2 OUTLIER -115.22 120.65 40.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 50' ' ' ARG . 15.9 m -94.85 153.34 3.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.144 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.04 106.99 10.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.477 HD21 ' CG ' ' A' ' 48' ' ' ASP . 6.6 mt -138.37 169.08 18.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.141 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -104.77 175.75 5.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -87.15 135.25 33.37 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.17 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.37 84.96 2.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.327 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.45 36.75 28.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.729 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.98 144.23 16.33 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.107 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.426 ' HB3' HD23 ' A' ' 19' ' ' LEU . 5.9 mtm -64.84 -46.84 80.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.553 0.216 . . . . 0.0 110.69 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.53 83.66 0.07 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.944 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 17' ' ' MET . 2.8 pp -160.52 -179.4 7.62 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.65 0.262 . . . . 0.0 110.725 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' B' ' 102' ' ' THR . 46.4 m -131.58 142.63 49.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.309 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 21' ' ' ILE . 2.7 pp -137.68 139.83 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.682 HG23 ' HB2' ' A' ' 37' ' ' LYS . 29.7 t -129.71 132.68 65.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.13 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.09 127.5 43.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.844 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.2 147.05 52.4 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.351 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HG3' HD12 ' A' ' 32' ' ' LEU . 4.4 tttt -119.76 -179.76 4.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.037 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.89 -139.85 2.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.14 143.67 38.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.588 0.233 . . . . 0.0 110.741 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.33 44.75 97.21 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.568 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 108.15 6.91 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.639 0.257 . . . . 0.0 110.916 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -92.61 20.02 6.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.363 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -140.28 -166.09 2.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.458 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 32' ' ' LEU . 5.2 tp -136.43 152.02 50.14 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.672 0.272 . . . . 0.0 110.814 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.13 111.37 2.83 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.703 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -81.43 73.0 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.215 0.531 . . . . 0.0 110.503 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -67.5 155.28 39.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.339 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.62 121.55 44.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.259 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.682 ' HB2' HG23 ' A' ' 22' ' ' VAL . 10.2 tptt -85.28 -36.15 21.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.971 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 5.7 t -170.24 175.32 4.96 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 111.23 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.6 t -138.45 118.15 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.2 t -68.55 125.88 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.019 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 153.16 37.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.472 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.01 -29.92 11.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.773 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.678 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.25 154.8 48.22 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.57 58.54 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.802 ' HB1' HD12 ' A' ' 51' ' ' LEU . . . -58.11 -51.36 70.03 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.26 -34.31 55.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.317 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 43' ' ' GLY . 48.1 t -62.85 -34.22 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.706 0.289 . . . . 0.0 110.698 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.477 ' CG ' HD21 ' A' ' 11' ' ' LEU . 16.2 t70 -71.56 -43.35 66.49 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.048 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.68 40.8 5.55 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.811 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HB3' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -131.05 31.93 4.37 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.677 0.275 . . . . 0.0 110.997 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.802 HD12 ' HB1' ' A' ' 45' ' ' ALA . 8.1 mt -150.63 160.3 43.91 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.295 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.02 143.4 3.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.097 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -62.83 132.86 53.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.836 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.81 29.45 6.18 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.483 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.08 -177.48 3.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.46 0.172 . . . . 0.0 110.714 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -127.57 150.77 49.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.823 0.344 . . . . 0.0 111.375 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.21 150.07 29.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.959 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.84 -57.58 1.43 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.093 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 p -139.12 153.44 47.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.461 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.811 HG11 ' HG2' ' A' ' 77' ' ' MET . 23.2 t -137.94 129.04 38.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.624 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 57.56 34.25 24.32 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.789 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.76 21.91 76.67 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.95 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.432 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -107.38 157.08 18.25 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 111.06 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -101.36 98.88 9.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.614 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.696 HD21 HG23 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -105.95 28.84 7.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.788 179.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.2 t -87.36 100.95 10.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.217 0.532 . . . . 0.0 110.462 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.46 31.74 2.3 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.536 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 mt -119.93 155.57 32.49 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.723 0.297 . . . . 0.0 110.726 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 87.2 p -68.01 157.39 35.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.162 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.87 ' NE2' HG23 ' B' ' 102' ' ' THR . 23.9 tt0 -52.08 -40.31 61.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.049 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -58.45 -53.72 55.18 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.858 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -61.24 -39.07 88.93 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.894 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.07 -62.86 1.38 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.38 -61.25 2.72 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.56 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -40.85 -44.9 2.38 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.511 0.507 . . . . 0.0 111.881 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.432 HD11 ' CZ ' ' A' ' 63' ' ' ARG . 8.8 mt -58.07 -42.19 84.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.779 0.323 . . . . 0.0 110.797 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.811 ' HG2' HG11 ' A' ' 60' ' ' VAL . 3.7 mtp -80.8 -28.67 36.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.384 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -31.54 72.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.66 0.267 . . . . 0.0 110.699 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -101.18 42.82 1.09 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.315 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 77' ' ' MET . 7.8 p -85.38 168.49 14.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.835 0.35 . . . . 0.0 111.196 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.0 p -91.91 -165.73 1.41 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.732 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 p -51.59 -52.34 48.21 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.083 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.45 141.86 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.219 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -128.63 110.97 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.858 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.498 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -101.22 97.58 8.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.919 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.481 HD23 HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -105.18 136.36 44.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.403 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 33.5 tt0 -106.63 107.32 18.27 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.385 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 p -107.64 151.83 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.615 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . . . -100.88 98.74 9.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.194 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.45 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 85.6 p . . . . . 0 C--O 1.233 0.198 0 CA-C-O 120.771 0.319 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' THR . . . . . 0.87 HG23 ' NE2' ' A' ' 70' ' ' GLN . 23.7 p . . . . . 0 N--CA 1.463 0.179 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.344 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ptt? . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.833 0.349 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.49 41.43 0.21 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.047 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 4' ' ' PRO . 7.9 mt-10 62.18 98.97 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.274 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.58 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 3' ' ' GLU . 41.2 Cg_endo -67.31 -173.77 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.755 2.304 . . . . 0.0 112.962 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 16.9 tt0 -116.5 93.31 4.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.174 0.512 . . . . 0.0 110.986 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.1 mt -90.89 133.65 32.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.65 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 pt -148.08 147.23 17.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.172 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -111.91 124.86 53.28 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 m -101.19 135.9 35.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.431 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.2 m -103.16 97.54 7.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.571 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 mt -122.19 163.33 19.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.896 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -108.71 141.3 40.9 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.871 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -77.87 111.01 13.26 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.999 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.08 -42.61 17.22 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -168.41 37.42 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.08 174.51 18.65 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.175 -0.536 . . . . 0.0 112.09 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.484 ' HB3' HD23 ' A' ' 19' ' ' LEU . 28.7 mtm -103.69 -46.94 4.38 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.714 0.257 . . . . 0.0 111.341 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 65.24 81.62 0.12 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.809 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.492 HD11 ' CG1' ' B' ' 104' ' ' VAL . 2.8 pp -160.52 179.54 8.52 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.709 0.29 . . . . 0.0 110.868 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.9 m -132.81 146.59 51.96 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.718 0.294 . . . . 0.0 111.353 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.823 HD11 HG22 ' B' ' 102' ' ' THR . 2.7 pp -142.34 153.43 18.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.819 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' A' ' 37' ' ' LYS . 42.1 t -135.84 136.4 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.425 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.564 ' O ' HD22 ' B' ' 99' ' ' LEU . . . -85.69 130.74 34.48 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.073 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.757 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -135.36 142.6 45.76 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.425 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -122.0 -179.6 4.2 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.924 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -164.03 -141.34 3.1 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.85 143.32 33.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.659 0.266 . . . . 0.0 110.675 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.79 34.02 88.56 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.697 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.75 105.03 7.98 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 120.686 0.279 . . . . 0.0 110.817 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.11 19.96 6.35 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.355 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.467 ' HG3' HG12 ' A' ' 66' ' ' VAL . 1.2 mmtp -138.48 -168.75 2.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.749 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 32' ' ' LEU . 6.7 tp -141.64 130.94 23.56 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.719 0.295 . . . . 0.0 110.927 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.51 136.25 12.71 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.741 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.5 HG13 ' HB1' ' A' ' 73' ' ' ALA . 24.5 mm -90.62 83.76 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 120.991 0.424 . . . . 0.0 110.69 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.757 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 79.9 m-85 -74.14 162.18 29.23 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.359 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.41 134.86 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.264 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' HB2' HG23 ' A' ' 22' ' ' VAL . 2.7 ttpt -105.53 -37.89 6.63 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.156 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 7.0 t -166.05 172.42 11.42 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.691 0.281 . . . . 0.0 110.957 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.0 t -130.89 126.71 60.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.763 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.3 145.17 10.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.009 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -68.14 150.22 48.63 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.323 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.34 20.23 73.2 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.917 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -93.11 157.58 23.41 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.388 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.77 62.03 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.25 -32.67 22.47 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.463 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.09 -44.85 59.89 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.296 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 43' ' ' GLY . 45.8 t -66.4 -44.82 90.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.124 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.34 -37.67 66.02 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.867 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.42 82.61 0.57 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.653 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -133.16 -61.87 0.81 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.625 0.213 . . . . 0.0 111.35 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.29 156.02 16.92 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.336 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.28 173.47 11.68 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.484 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -69.71 140.41 53.52 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.264 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.37 38.95 8.04 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.491 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -121.32 178.59 4.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.498 0.19 . . . . 0.0 110.951 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.2 tm0? -125.04 139.98 53.31 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.414 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.697 HD21 ' CG2' ' A' ' 60' ' ' VAL . 8.3 tp -106.9 147.87 29.27 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.064 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.52 -59.31 1.3 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.385 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.54 144.06 50.73 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.963 0.411 . . . . 0.0 111.759 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.843 HG23 HD21 ' A' ' 65' ' ' LEU . 40.4 t -133.86 123.83 45.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.542 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.01 33.13 22.84 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.798 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.78 23.32 77.98 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.074 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.5 mtm105 -112.96 134.61 54.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 117.018 0.409 . . . . 0.0 110.268 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 m -83.01 86.42 7.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.843 HD21 HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -89.47 54.75 3.01 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.126 0.489 . . . . 0.0 110.869 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.467 HG12 ' HG3' ' A' ' 31' ' ' LYS . 77.6 t -102.27 99.38 8.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.634 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.71 32.89 2.16 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.186 -0.915 . . . . 0.0 112.623 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 22.6 mt -117.66 161.75 19.15 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.4 152.87 24.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.299 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.47 ' NE2' HD13 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -47.07 -42.22 18.35 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.625 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -58.45 -49.99 75.33 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.039 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -69.76 -36.26 75.63 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.941 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -67.63 -58.23 5.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.633 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.516 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -60.96 -46.19 91.71 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.595 0.236 . . . . 0.0 111.276 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -55.42 -50.36 70.0 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.939 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.02 -40.65 96.42 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.393 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.519 ' HG2' HG21 ' A' ' 60' ' ' VAL . 37.9 mtp -58.48 -49.49 77.16 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.221 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.708 ' HB ' HG23 ' B' ' 104' ' ' VAL . 8.9 t -69.9 -27.88 65.16 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -82.96 43.93 0.89 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.801 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 p -101.37 171.26 7.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.856 0.36 . . . . 0.0 111.274 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.9 m -85.27 -166.6 1.55 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.614 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.13 -43.32 74.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.564 0.221 . . . . 0.0 110.928 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 t -93.19 140.2 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.647 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.434 HG12 ' HG ' ' A' ' 86' ' ' LEU . 30.2 t -130.36 134.51 62.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.275 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.48 89.74 3.17 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.646 HD23 HG13 ' A' ' 60' ' ' VAL . 17.1 mt -94.54 120.3 34.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.903 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -98.75 101.92 13.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.323 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.8 p -105.23 150.2 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.353 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.3 148.02 28.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.575 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -101.11 116.13 32.11 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.593 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -165.47 -173.98 2.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.957 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 156.26 139.61 2.79 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.631 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.193 179.832 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.564 HD22 ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.04 172.96 6.61 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.481 0.181 . . . . 0.0 110.574 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 27.8 p -124.21 99.28 6.15 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.765 0.317 . . . . 0.0 111.293 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.823 HG22 HD11 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -92.2 -172.59 3.17 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.744 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.464 ' N ' HG23 ' B' ' 102' ' ' THR . 30.6 tt0 -141.53 118.34 11.11 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.755 0.312 . . . . 0.0 110.408 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.708 HG23 ' HB ' ' A' ' 78' ' ' THR . 12.6 p . . . . . 0 C--O 1.252 1.223 0 CA-C-O 118.706 -0.664 . . . . 0.0 111.401 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 120.604 0.24 . . . . 0.0 111.391 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt 62.55 -174.31 0.15 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.037 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.59 131.01 31.73 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.832 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.66 -164.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.771 2.314 . . . . 0.0 112.692 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 2.6 tt0 -132.44 101.68 5.43 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.153 0.501 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.73 HD12 HD12 ' A' ' 58' ' ' LEU . 34.0 mm -90.49 127.56 42.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pp -145.34 137.89 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.2 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.894 HG23 ' HG3' ' A' ' 87' ' ' GLU . 2.2 m -92.16 139.35 30.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.96 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.63 HG11 ' HB3' ' A' ' 50' ' ' ARG . 21.8 t -119.47 117.9 55.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.912 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.567 HG23 HG23 ' A' ' 85' ' ' THR . 1.5 m -111.06 102.74 11.17 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.863 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.6 mt -131.27 157.67 42.66 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.026 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.5 mmtt -84.19 136.0 34.14 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.489 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.26 96.75 0.67 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.335 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -101.75 100.08 10.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.293 0.568 . . . . 0.0 110.428 179.469 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 55.04 35.2 24.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.921 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.53 -174.51 36.52 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.4 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.1 mtm -102.69 -36.95 8.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.418 0.151 . . . . 0.0 111.095 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.63 79.75 0.13 Allowed Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.599 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 51' ' ' LEU . 3.4 pp -160.71 179.81 8.23 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.669 0.271 . . . . 0.0 111.159 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 36' ' ' VAL . 57.7 m -132.18 156.94 45.53 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.33 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.489 HD12 ' O ' ' A' ' 21' ' ' ILE . 2.8 pp -143.47 146.71 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.681 HG23 ' HB2' ' A' ' 37' ' ' LYS . 40.1 t -133.85 134.83 55.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.261 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.43 122.14 34.58 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.678 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -135.91 149.41 48.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.44 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.61 -179.79 3.76 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.264 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.95 -140.13 2.8 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.746 -0.542 . . . . 0.0 111.746 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.23 146.05 33.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.723 0.296 . . . . 0.0 110.771 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.26 41.05 98.15 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.606 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.34 106.94 7.35 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.671 0.272 . . . . 0.0 110.999 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.36 19.7 5.83 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.256 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.455 ' HG3' HG12 ' A' ' 66' ' ' VAL . 23.2 mmtt -146.97 -171.59 3.8 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.522 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.9 137.19 55.01 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.731 0.3 . . . . 0.0 110.886 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -101.83 125.31 8.5 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.627 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.443 HG13 ' HB1' ' A' ' 73' ' ' ALA . 19.3 mm -84.38 84.68 2.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 121.043 0.449 . . . . 0.0 110.737 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -77.66 168.83 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.512 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 20' ' ' SER . 27.0 t -104.23 129.06 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.403 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.681 ' HB2' HG23 ' A' ' 22' ' ' VAL . 3.0 tttt -83.41 -45.41 13.72 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.603 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -170.4 176.93 4.26 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.058 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.13 127.94 75.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.759 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.92 125.69 40.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.185 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -62.68 143.86 56.93 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.011 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.74 -15.75 60.47 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.115 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.13 -152.23 3.17 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.803 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.25 -60.47 1.67 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.556 0.217 . . . . 0.0 111.576 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' CB ' HD12 ' A' ' 51' ' ' LEU . . . -61.62 -26.45 68.0 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.856 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -72.44 -47.74 46.6 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.2 t -73.38 -37.82 52.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.268 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.96 -44.92 45.65 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.094 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 95.02 65.69 0.99 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.477 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.63 ' HB3' HG11 ' A' ' 9' ' ' VAL . 2.9 mmp_? -141.02 30.79 1.8 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.565 0.221 . . . . 0.0 111.375 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' CD1' HD22 ' A' ' 19' ' ' LEU . 9.3 mt -154.43 171.07 19.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.889 0.376 . . . . 0.0 111.393 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.8 141.76 3.48 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.38 117.09 5.22 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.844 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 107.6 31.41 3.71 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.617 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.24 -178.19 3.57 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.612 0.244 . . . . 0.0 110.999 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.843 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 6.0 tm0? -124.61 159.0 31.72 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.222 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 34' ' ' ILE . 64.2 mt -124.05 107.38 11.23 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.962 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.73 HD12 HD12 ' A' ' 6' ' ' ILE . 0.3 OUTLIER -75.1 -64.44 1.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.179 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.8 m -147.62 159.11 44.14 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.447 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.793 HG21 ' CG ' ' A' ' 77' ' ' MET . 38.9 t -127.87 125.42 64.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.822 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 55.79 33.85 22.29 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.124 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.22 36.61 85.4 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.061 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.4 mtt-85 -119.41 152.75 36.3 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 111.083 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.2 m -79.05 118.2 20.81 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.204 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.737 HD21 HD12 ' A' ' 76' ' ' LEU . 19.2 mt -126.1 31.4 5.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.046 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.455 HG12 ' HG3' ' A' ' 31' ' ' LYS . 62.5 t -115.1 100.34 10.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.128 0.49 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.414 ' CA ' ' HD2' ' A' ' 31' ' ' LYS . . . 132.55 -32.28 2.84 Favored Glycine 0 CA--C 1.518 0.265 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.526 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.415 HD12 HD23 ' A' ' 65' ' ' LEU . 54.7 mt -66.5 172.04 4.46 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.97 0.414 . . . . 0.0 110.984 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.5 m -84.03 160.03 21.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.078 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.719 HE21 HG23 ' B' ' 102' ' ' THR . 36.8 tt0 -51.93 -33.42 37.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.202 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -60.3 -54.87 40.56 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.022 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -60.32 -38.26 83.17 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.828 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -52.71 -62.44 1.65 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.237 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.84 -63.98 1.11 Allowed 'General case' 0 C--N 1.335 -0.055 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -36.07 -41.2 0.24 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.05 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.737 HD12 HD21 ' A' ' 65' ' ' LEU . 7.0 mt -66.31 -47.15 74.47 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.793 ' CG ' HG21 ' A' ' 60' ' ' VAL . 11.9 mtp -75.42 -30.45 60.07 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -32.05 69.1 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.635 0.255 . . . . 0.0 110.575 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -92.42 44.45 1.16 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.895 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.0 160.95 24.45 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.061 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.07 -164.66 1.1 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.038 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 82.5 p -50.27 -42.95 53.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.135 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.5 t -96.03 139.45 19.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.734 0.302 . . . . 0.0 110.807 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.88 96.22 3.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.567 HG23 HG23 ' A' ' 10' ' ' THR . 0.6 OUTLIER -98.02 90.3 4.85 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.72 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.436 ' HG ' HG22 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -115.81 128.8 56.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.955 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.894 ' HG3' HG23 ' A' ' 8' ' ' THR . 12.2 mt-10 -98.93 111.82 24.11 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.48 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.9 t -96.6 142.34 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.561 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.843 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -105.14 108.76 20.45 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.636 179.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 8.1 mtmt -71.01 133.68 46.53 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.162 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -94.08 174.7 7.02 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.22 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -97.38 1.45 60.42 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.812 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.222 179.654 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 mt . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.921 0.391 . . . . 0.0 111.646 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.463 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.3 OUTLIER -121.75 -174.96 2.99 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.31 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.539 ' HB3' ' HD3' ' A' ' 37' ' ' LYS . 35.3 p -138.7 102.85 4.69 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.809 0.338 . . . . 0.0 111.876 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.719 HG23 HE21 ' A' ' 70' ' ' GLN . 39.2 p -94.57 -173.12 2.94 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.317 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.6 pt-20 -141.26 101.6 4.05 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.879 0.371 . . . . 0.0 110.803 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.699 HG21 ' HB2' ' A' ' 77' ' ' MET . 10.2 p . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.421 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.715 0.293 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.17 33.83 4.23 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.918 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -133.51 97.97 15.5 Favored Pre-proline 0 C--O 1.235 0.319 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.729 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -58.36 -178.53 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.071 2.514 . . . . 0.0 112.821 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -116.2 93.12 4.1 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.13 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.677 HG21 HD12 ' A' ' 58' ' ' LEU . 8.5 mt -94.85 113.52 29.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.663 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 pt -127.12 150.66 33.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.321 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.428 ' HB ' ' CG ' ' A' ' 87' ' ' GLU . 7.9 t -109.38 131.92 54.61 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.91 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.58 HG21 ' HG3' ' A' ' 50' ' ' ARG . 14.3 p -106.3 122.79 60.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.004 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -96.27 103.59 15.5 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.599 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' HG ' HG22 ' A' ' 9' ' ' VAL . 7.1 mt -125.45 174.14 8.4 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.093 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.46 142.56 46.55 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.92 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.81 135.52 38.92 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.048 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -92.11 -60.75 1.77 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.307 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.86 36.38 0.26 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.725 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.16 144.79 6.88 Favored Glycine 0 C--N 1.336 0.561 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.024 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.0 mtm -73.03 -61.37 1.84 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.492 0.187 . . . . 0.0 110.788 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.4 81.25 0.2 Allowed Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.569 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.499 HD11 ' CG1' ' B' ' 104' ' ' VAL . 2.2 pp -160.96 179.49 8.42 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.571 0.224 . . . . 0.0 110.807 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.8 m -136.88 149.18 47.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.227 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.475 HD12 HE21 ' A' ' 70' ' ' GLN . 2.8 pp -136.74 157.32 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.603 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.589 HG22 ' O ' ' B' ' 100' ' ' PHE . 14.8 t -127.82 145.43 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.55 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.598 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -101.85 142.0 33.84 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.823 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -142.5 142.43 32.27 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.71 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.89 -179.43 4.7 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.121 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.6 144.93 10.66 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 121.04 -0.6 . . . . 0.0 111.683 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -68.39 141.28 55.77 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.176 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.91 34.66 65.82 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.68 109.8 7.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.226 -0.487 . . . . 0.0 110.298 -178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -88.74 27.51 1.3 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.32 -172.81 3.1 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.712 0.292 . . . . 0.0 110.511 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.598 ' CD2' ' HB1' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -143.24 132.94 23.79 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.939 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.19 119.43 5.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.131 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 24.7 mm -88.41 105.22 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-O 120.899 0.38 . . . . 0.0 110.552 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 55' ' ' ASP . 70.7 m-85 -99.3 169.7 9.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.248 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 36.5 t -96.79 139.49 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.925 0.393 . . . . 0.0 111.001 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HB2' HG23 ' A' ' 22' ' ' VAL . 2.3 tptt -100.79 -45.29 5.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.743 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -161.7 169.89 20.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.982 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.61 115.14 24.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.593 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.86 126.92 32.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.109 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.9 mptt -59.97 149.18 32.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.116 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.85 -24.01 33.98 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.998 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.68 -166.13 6.26 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.576 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -90.3 -52.85 4.72 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 122.705 -0.291 . . . . 0.0 111.617 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.66 -38.08 44.39 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.038 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -69.29 -55.71 9.69 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.629 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -63.79 -31.22 52.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.49 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -65.88 -56.83 9.77 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.084 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.38 57.68 1.84 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.763 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.58 ' HG3' HG21 ' A' ' 9' ' ' VAL . 1.2 mmp_? -119.72 -45.63 2.49 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.552 0.215 . . . . 0.0 110.952 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 pp -128.3 175.81 8.18 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.897 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.42 -173.91 4.54 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.297 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.01 127.57 33.36 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.212 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.9 27.41 6.65 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.617 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.438 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -118.61 138.14 52.78 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.428 ' C ' HD12 ' A' ' 57' ' ' LEU . 35.5 tt0 -82.6 152.02 26.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.844 0.354 . . . . 0.0 111.23 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 56' ' ' GLN . 9.5 mp -119.26 144.04 46.99 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.013 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.677 HD12 HG21 ' A' ' 6' ' ' ILE . 1.1 mt -116.04 -60.6 1.84 Allowed 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.193 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.8 m -123.05 156.73 34.28 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.38 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.664 HG23 HD21 ' A' ' 65' ' ' LEU . 19.5 t -142.1 120.71 9.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.111 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.82 35.59 26.5 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.205 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.63 21.17 79.69 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.945 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.3 mtm-85 -113.7 146.86 39.19 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.863 0.331 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.9 m -102.05 103.58 14.17 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.937 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.664 HD21 HG23 ' A' ' 60' ' ' VAL . 2.1 pp -109.11 42.22 1.48 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.136 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.2 t -87.7 99.57 8.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.189 0.519 . . . . 0.0 110.809 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 114.06 40.87 0.94 Allowed Glycine 0 CA--C 1.52 0.346 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.393 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.449 HD13 ' HB3' ' A' ' 72' ' ' ARG . 13.2 mt -127.97 157.63 40.08 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.712 0.291 . . . . 0.0 110.784 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 85.1 p -70.91 159.46 34.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.126 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.602 ' NE2' HG23 ' B' ' 102' ' ' THR . 37.5 tt0 -54.81 -40.15 69.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.946 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -56.91 -47.27 80.98 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.421 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.449 ' HB3' HD13 ' A' ' 68' ' ' LEU . 1.9 mmm180 -68.51 -38.68 81.14 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.596 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.85 -59.41 4.54 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.3 -67.02 0.42 Allowed 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -35.2 -41.19 0.15 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.29 0.636 . . . . 0.0 112.173 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 76' ' ' LEU . 11.0 mt -63.58 -49.07 74.83 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.599 0.238 . . . . 0.0 111.454 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.866 ' HB2' HG21 ' B' ' 104' ' ' VAL . 7.2 mtm -70.78 -33.47 70.8 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.759 0.314 . . . . 0.0 110.704 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.481 ' OG1' HG23 ' B' ' 104' ' ' VAL . 0.2 OUTLIER -63.25 -29.2 70.58 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.838 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.31 42.67 1.11 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.721 0.296 . . . . 0.0 111.623 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 77' ' ' MET . 22.2 p -98.72 170.18 8.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.775 0.322 . . . . 0.0 111.183 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.6 p -99.9 -161.42 0.87 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.505 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 45.3 m -57.0 -39.71 75.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.518 0.199 . . . . 0.0 110.625 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 t -83.14 145.39 8.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.61 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.55 HG12 HD23 ' A' ' 86' ' ' LEU . 21.2 t -138.82 121.83 18.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.091 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.41 99.19 6.28 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.498 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.55 HD23 HG12 ' A' ' 84' ' ' VAL . 3.2 mm? -106.31 115.04 29.53 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.207 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.428 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 0.1 OUTLIER -81.36 89.48 6.1 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.004 0.43 . . . . 0.0 110.143 179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.438 ' CG2' ' HB3' ' A' ' 55' ' ' ASP . 14.2 p -93.19 150.65 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.472 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.49 143.86 31.67 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.484 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.77 77.11 8.65 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.484 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -125.7 177.53 6.21 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.986 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -107.32 -141.88 10.21 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.414 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.187 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 17.1 mt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.589 ' O ' HG22 ' A' ' 22' ' ' VAL . 64.9 m-85 -60.92 173.12 0.82 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.671 0.272 . . . . 0.0 111.284 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 34.0 t 179.53 100.84 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.406 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.602 HG23 ' NE2' ' A' ' 70' ' ' GLN . 4.0 p -98.37 -163.67 1.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -150.13 111.36 4.4 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.786 0.327 . . . . 0.0 111.113 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.866 HG21 ' HB2' ' A' ' 77' ' ' MET . 9.1 p . . . . . 0 C--O 1.253 1.287 0 CA-C-O 118.648 -0.691 . . . . 0.0 111.213 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttm . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 120.545 0.212 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 tttm 63.54 82.5 0.18 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.805 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.25 89.27 46.48 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.992 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -62.5 -171.47 0.1 Allowed 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.9 2.4 . . . . 0.0 112.802 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 33.1 tt0 -112.83 92.26 3.95 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.193 0.521 . . . . 0.0 110.674 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 41.1 mm -95.59 131.35 42.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.74 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pp -148.14 144.85 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.701 HG22 HG22 ' A' ' 85' ' ' THR . 0.7 OUTLIER -113.69 126.76 55.6 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 m -99.4 113.77 35.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.981 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.462 ' OG1' HG23 ' A' ' 85' ' ' THR . 0.7 OUTLIER -99.86 92.19 5.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.486 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 78.7 mt -116.03 173.87 6.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.17 162.24 13.07 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.022 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.08 113.78 25.51 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.513 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -101.85 -41.47 6.49 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.412 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -163.68 44.82 0.11 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.544 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.09 153.8 28.01 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.374 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.35 -48.54 80.83 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.606 0.203 . . . . 0.0 111.04 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.09 69.53 1.39 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.819 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 3.3 pp -160.72 177.48 10.42 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 122.202 0.201 . . . . 0.0 110.581 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -138.24 134.13 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.688 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.968 HD13 HG23 ' A' ' 34' ' ' ILE . 2.1 pp -120.87 165.73 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.443 HG22 ' CB ' ' B' ' 101' ' ' SER . 47.8 t -149.9 137.14 13.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.501 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.85 123.84 33.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.882 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -139.14 157.79 45.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.848 0.356 . . . . 0.0 111.645 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HG3' HD12 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -122.87 179.69 4.55 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -166.24 -141.21 3.08 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.145 -0.55 . . . . 0.0 111.789 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.88 147.1 31.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.65 0.262 . . . . 0.0 110.787 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.27 37.15 92.57 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.784 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.89 106.29 8.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.65 0.262 . . . . 0.0 110.844 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.8 17.86 6.2 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.384 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HD2' ' CA ' ' A' ' 67' ' ' GLY . 19.4 mmtp -145.15 -171.06 3.57 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.632 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 32' ' ' LEU . 5.2 tp -124.03 139.23 54.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.514 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.21 133.0 11.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.991 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.968 HG23 HD13 ' A' ' 21' ' ' ILE . 29.1 mm -92.12 71.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-O 121.149 0.5 . . . . 0.0 110.512 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 53.1 m-85 -63.4 167.68 5.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.775 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' ILE . 47.9 t -112.1 125.34 69.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.098 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.518 ' HD3' ' HB2' ' B' ' 101' ' ' SER . 2.3 pttt -87.01 -36.51 18.19 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.587 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.5 m -163.42 159.36 22.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.523 0.202 . . . . 0.0 111.039 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 19' ' ' LEU . 16.7 t -118.25 122.91 70.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.778 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.31 133.4 30.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.39 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 154.39 41.87 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.74 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.32 -21.49 45.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.266 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.64 -163.7 4.94 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.59 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.42 -34.32 11.57 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.09 -47.13 38.49 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -59.55 -37.94 79.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.437 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 43' ' ' GLY . 42.8 t -73.79 -32.79 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.248 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.43 -41.68 80.0 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.087 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.71 49.78 10.22 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.787 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -105.5 -36.16 7.23 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.576 0.227 . . . . 0.0 111.349 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.52 173.71 8.29 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.781 0.324 . . . . 0.0 111.277 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.79 165.68 26.84 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.176 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.25 128.44 37.01 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.537 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 104.85 38.77 2.46 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.122 -0.561 . . . . 0.0 113.016 179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 4.1 p30 -116.59 141.53 48.07 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.668 0.271 . . . . 0.0 110.77 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -85.97 143.51 28.12 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.068 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.468 HD11 HD23 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -99.81 143.72 29.71 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.324 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tt -122.41 -58.83 1.67 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.093 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.2 p -140.64 154.24 46.35 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.978 0.418 . . . . 0.0 111.795 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.636 HG22 HD23 ' A' ' 86' ' ' LEU . 22.4 t -135.03 112.83 15.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.438 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 56.83 34.5 24.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.232 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.37 -20.33 49.98 Favored Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.383 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -70.98 151.3 44.79 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 117.27 0.535 . . . . 0.0 111.065 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.1 p -107.14 119.47 39.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.963 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.722 HD22 ' HA ' ' A' ' 73' ' ' ALA . 11.3 mt -110.23 -9.19 14.68 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.736 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.615 ' O ' HG13 ' A' ' 66' ' ' VAL . 8.5 p -68.88 83.62 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-O 121.692 0.758 . . . . 0.0 110.737 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.426 ' CA ' ' HD2' ' A' ' 31' ' ' LYS . . . 140.78 -23.49 2.63 Favored Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.658 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.4 mt -82.47 169.19 16.66 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.917 0.389 . . . . 0.0 111.236 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.6 m -86.1 166.48 15.77 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.759 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -57.85 -28.73 64.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.416 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -64.74 -47.49 78.04 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-O 120.65 0.262 . . . . 0.0 110.765 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -53.78 39.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.871 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.722 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -57.27 -50.58 72.46 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.771 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB1' HG21 ' B' ' 102' ' ' THR . . . -56.41 -63.27 1.25 Allowed 'General case' 0 C--O 1.226 -0.15 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.882 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -46.37 -48.05 18.58 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 123.445 0.466 . . . . 0.0 112.117 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 33.6 mt -68.16 -27.82 66.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.569 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 1.046 ' HE1' HG21 ' B' ' 104' ' ' VAL . 77.6 mtp -86.21 -19.99 29.18 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.68 -43.42 63.11 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.799 0.333 . . . . 0.0 110.61 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 -95.57 65.51 2.67 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.946 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -83.78 147.43 27.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.068 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.51 -167.54 1.83 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.765 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.2 m -56.55 -43.85 80.33 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.921 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.08 144.49 12.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.907 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.1 t -137.69 113.69 11.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.802 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.701 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -111.23 86.77 2.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.649 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.636 HD23 HG22 ' A' ' 60' ' ' VAL . 1.3 mt -94.25 124.41 38.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.294 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 42.7 tt0 -98.9 121.41 40.82 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.289 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.4 m -117.7 168.77 9.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.733 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . . . -128.17 111.43 13.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.987 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 11.8 mmtt -65.18 110.12 2.44 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.521 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.47 -177.62 6.34 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.171 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 166.76 137.26 2.18 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.478 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.142 -0.933 . . . . 0.0 111.108 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 tt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.022 0.439 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -121.19 176.24 5.71 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.477 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.518 ' HB2' ' HD3' ' A' ' 37' ' ' LYS . 97.8 p -118.67 133.36 55.91 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.747 0.308 . . . . 0.0 111.793 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.523 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -98.96 -151.89 0.4 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.523 ' H ' HG22 ' B' ' 102' ' ' THR . 0.3 OUTLIER -174.11 44.89 0.01 OUTLIER 'General case' 0 C--N 1.341 0.22 0 CA-C-O 121.665 0.745 . . . . 0.0 109.404 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.046 HG21 ' HE1' ' A' ' 77' ' ' MET . 34.7 m . . . . . 0 C--O 1.248 1.026 0 CA-C-N 114.807 -1.088 . . . . 0.0 112.035 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 ptt? . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.38 114.34 1.78 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.611 0.243 . . . . 0.0 110.974 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -106.04 92.12 6.18 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.723 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.72 -170.81 0.49 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.432 2.088 . . . . 0.0 112.589 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.416 ' HB3' ' CG ' ' A' ' 90' ' ' LYS . 10.9 tt0 -129.42 103.86 7.15 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.07 0.462 . . . . 0.0 110.79 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.7 mt -97.79 137.15 26.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.598 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.45 150.08 14.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.658 ' CG2' HG22 ' A' ' 85' ' ' THR . 8.3 m -113.88 131.23 56.35 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.879 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 50' ' ' ARG . 6.5 m -102.09 116.29 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.107 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.8 m -105.43 98.43 8.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.544 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 mt -126.87 154.74 44.0 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.24 152.96 21.6 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.788 0.328 . . . . 0.0 110.891 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -70.72 105.15 3.08 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.196 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -94.37 -38.72 10.83 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.087 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -161.58 42.86 0.15 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.01 0.433 . . . . 0.0 110.56 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.94 157.8 6.11 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.118 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.784 ' SD ' HD11 ' A' ' 86' ' ' LEU . 2.7 mtm -65.02 -56.05 15.35 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.696 0.248 . . . . 0.0 110.564 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.13 78.74 0.14 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.264 -0.493 . . . . 0.0 112.894 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 4.0 pp -160.81 177.72 10.14 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.793 0.33 . . . . 0.0 111.154 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.42 ' N ' HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -125.11 153.17 43.37 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.952 179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.922 HD11 HG22 ' B' ' 102' ' ' THR . 2.6 pp -144.75 158.64 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 120.954 0.407 . . . . 0.0 112.088 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' B' ' 100' ' ' PHE . 2.5 p -150.15 141.67 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.17 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.42 149.46 30.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.261 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -146.85 135.04 21.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.335 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -119.73 179.98 4.07 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.914 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.01 -137.85 2.28 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.12 142.78 41.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.665 0.269 . . . . 0.0 110.871 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.92 43.89 98.57 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.917 -0.659 . . . . 0.0 111.914 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.37 107.81 7.82 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.72 0.295 . . . . 0.0 111.025 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -90.96 22.34 3.71 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.435 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -144.13 -171.97 3.67 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.657 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 tp -136.11 136.88 40.49 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.906 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.88 161.88 19.38 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.767 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.617 HG23 HE22 ' A' ' 70' ' ' GLN . 27.0 mm -115.3 103.27 15.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 111.073 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.52 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 6.5 m-85 -90.57 163.78 14.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.83 113.08 40.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.029 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -43.01 69.26 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.97 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 1.9 p -172.18 167.19 5.97 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.777 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.2 m -120.0 127.89 75.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.851 0.357 . . . . 0.0 110.816 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.43 121.7 29.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -64.17 154.18 35.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.19 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.48 -37.01 3.83 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.165 -0.54 . . . . 0.0 112.703 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.534 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.7 -177.8 5.88 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.773 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 14' ' ' GLN . . . -87.1 -2.33 58.55 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.29 -38.32 11.57 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -77.04 -37.38 54.92 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.229 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 43' ' ' GLY . 43.1 t -64.69 -33.27 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.636 0.255 . . . . 0.0 110.95 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.92 -45.18 64.73 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.098 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.74 29.23 43.77 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.784 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.727 ' HB3' HG11 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -89.64 -33.16 16.75 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.515 0.198 . . . . 0.0 111.167 179.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 pp -126.46 171.2 11.24 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.031 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.94 -175.71 5.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.563 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -73.82 162.15 29.43 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.21 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.94 39.82 93.36 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.039 -0.6 . . . . 0.0 112.334 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -127.05 142.79 51.45 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.639 0.257 . . . . 0.0 111.055 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -89.79 160.3 16.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.829 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 34' ' ' ILE . 16.8 mt -124.44 155.41 38.92 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.884 0.373 . . . . 0.0 111.617 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.0 -55.95 1.36 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.072 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.8 m -136.09 142.06 44.27 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.695 0.284 . . . . 0.0 111.429 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.784 HG11 ' HG2' ' A' ' 77' ' ' MET . 18.3 t -135.69 140.89 43.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.998 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 43.65 44.88 5.61 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.534 0.521 . . . . 0.0 111.841 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.5 32.52 81.95 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.663 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -138.69 161.94 35.91 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.855 0.328 . . . . 0.0 110.577 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.9 p -112.77 137.32 51.26 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.767 0.318 . . . . 0.0 111.11 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.62 ' HA ' HD21 ' A' ' 68' ' ' LEU . 19.7 mt -117.38 45.41 1.91 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.0 t -109.36 100.9 11.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 121.187 0.518 . . . . 0.0 110.896 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.77 -37.68 2.85 Favored Glycine 0 C--N 1.328 0.139 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.347 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' A' ' 65' ' ' LEU . 3.8 pp -73.48 147.26 44.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.777 0.322 . . . . 0.0 110.948 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -64.16 156.76 27.54 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.649 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.74 ' CD ' HD13 ' A' ' 21' ' ' ILE . 8.9 tp-100 -52.62 -39.11 61.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.631 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 4.5 tt0 -51.59 -43.99 62.66 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -74.43 -40.79 61.74 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.2 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -56.18 -58.45 7.88 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.651 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -58.75 -64.38 0.95 Allowed 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.06 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 71' ' ' GLU . 4.3 tm-20 -38.04 -46.81 1.04 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.549 0.531 . . . . 0.0 111.764 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.1 mt -60.1 -43.52 95.49 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.007 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.784 ' HG2' HG11 ' A' ' 60' ' ' VAL . 9.1 mtp -76.71 -30.28 56.61 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.258 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -27.88 69.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.544 0.211 . . . . 0.0 110.816 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -96.47 32.82 1.92 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.208 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 77' ' ' MET . 1.2 p -60.21 146.34 43.9 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 111.412 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 m -85.93 -165.94 1.39 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.665 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.3 m -56.51 -31.35 64.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.038 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.9 t -104.45 141.58 19.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.965 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.48 114.65 43.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.619 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.658 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -116.52 88.54 2.92 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.784 HD11 ' SD ' ' A' ' 17' ' ' MET . 5.7 mt -101.77 133.31 46.7 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.317 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -115.72 127.33 55.05 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.926 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.6 m -123.58 170.64 13.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.326 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.35 133.19 51.41 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.903 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.416 ' CG ' ' HB3' ' A' ' 5' ' ' GLU . 48.6 mmtm -70.1 93.02 0.78 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.425 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.28 174.35 15.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.918 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.19 0.33 65.68 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.682 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.487 -0.768 . . . . 0.0 111.369 179.823 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 120.622 0.249 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.489 ' HB2' HG23 ' A' ' 22' ' ' VAL . 2.7 p90 -170.54 31.58 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.689 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 4.6 p 168.98 43.45 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.694 0.283 . . . . 0.0 110.812 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.922 HG22 HD11 ' A' ' 21' ' ' ILE . 1.6 t -84.7 -174.74 5.44 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.788 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 1.2 mp0 -130.36 80.11 1.93 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.649 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 77' ' ' MET . 14.8 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.555 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.679 0.276 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.28 127.06 29.82 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.087 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -133.97 111.38 12.15 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.73 -170.89 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.726 2.284 . . . . 0.0 112.605 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -121.69 98.41 5.95 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.029 0.442 . . . . 0.0 110.674 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.665 HD12 HD12 ' A' ' 58' ' ' LEU . 44.3 mm -95.85 128.98 46.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.2 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.14 141.49 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.129 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.568 ' OG1' HG22 ' A' ' 85' ' ' THR . 10.0 t -112.08 149.71 31.72 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.813 0.339 . . . . 0.0 111.019 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 50' ' ' ARG . 7.0 m -114.22 118.37 58.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.211 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.0 m -94.28 101.13 13.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.463 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.9 mt -131.3 163.07 28.63 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.135 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -92.2 129.92 38.03 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.927 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HB2' ' CG2' ' A' ' 84' ' ' VAL . 8.4 ttpp -83.03 139.39 33.29 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.186 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -93.37 -57.78 2.5 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.509 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -158.99 38.11 0.21 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.723 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.43 -167.99 22.35 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.999 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.708 ' SD ' HD11 ' A' ' 86' ' ' LEU . 6.7 mtm -115.9 -42.73 3.05 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.69 0.245 . . . . 0.0 111.385 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.99 73.96 0.63 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.02 -0.61 . . . . 0.0 113.038 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.445 HD11 ' CG1' ' B' ' 104' ' ' VAL . 4.0 pp -160.8 177.94 9.92 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.646 0.26 . . . . 0.0 111.072 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.423 ' N ' HD12 ' A' ' 19' ' ' LEU . 72.8 m -130.49 150.69 51.59 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.447 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.608 HD11 HG22 ' B' ' 102' ' ' THR . 2.7 pp -142.61 152.53 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.807 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.836 HG23 ' HB2' ' A' ' 37' ' ' LYS . 46.4 t -133.69 135.71 55.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.042 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.66 135.18 33.47 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.167 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.564 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -144.71 152.56 40.6 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.351 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.591 ' HG3' HD12 ' A' ' 32' ' ' LEU . 10.7 tttt -124.2 -179.54 4.48 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.938 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -155.78 -140.42 2.98 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.41 140.96 44.13 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.687 0.28 . . . . 0.0 110.728 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.32 45.79 95.74 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.597 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.4 107.9 7.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.707 0.289 . . . . 0.0 111.127 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -90.1 21.0 3.93 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.962 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -144.02 -168.89 2.98 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.678 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.591 HD12 ' HG3' ' A' ' 25' ' ' LYS . 3.1 tp -136.91 146.76 45.87 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.929 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.12 128.71 9.14 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.845 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.477 HG13 ' HB1' ' A' ' 73' ' ' ALA . 27.6 mm -87.14 87.25 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.994 0.426 . . . . 0.0 110.871 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.564 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 66.0 m-85 -79.17 168.07 20.12 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.603 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.8 t -99.11 135.73 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.606 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.836 ' HB2' HG23 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -100.58 -41.33 7.0 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.286 179.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.1 t -178.0 125.54 0.12 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.055 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.9 m -87.55 136.19 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.247 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 18.2 t -92.29 128.0 44.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.996 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.5 mmtp -62.48 148.5 45.51 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.323 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.55 -30.35 10.42 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.579 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.649 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.97 152.49 51.88 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.428 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -49.75 -36.55 26.16 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.85 -44.26 64.14 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.651 0.263 . . . . 0.0 111.382 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.82 -39.03 92.91 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.45 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 43' ' ' GLY . 42.0 t -57.79 -39.37 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.144 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -78.27 -49.58 13.44 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.058 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.79 76.9 1.06 Allowed Glycine 0 C--N 1.334 0.427 0 C-N-CA 120.957 -0.639 . . . . 0.0 113.171 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.527 ' CB ' HG11 ' A' ' 9' ' ' VAL . 12.9 mmm-85 -139.18 22.48 2.59 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 pp -175.03 153.65 1.67 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.654 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.47 -179.99 6.61 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.487 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.71 139.44 58.38 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.034 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.73 22.06 32.13 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.862 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -103.87 175.68 5.4 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.64 0.22 . . . . 0.0 110.613 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.434 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 3.7 tt0 -125.17 142.36 51.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.053 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.443 HD21 HG22 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -107.94 164.17 12.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.338 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.665 HD12 HD12 ' A' ' 6' ' ' ILE . 1.2 mt -140.21 -55.52 0.54 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.362 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.7 m -127.08 154.62 44.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.916 0.389 . . . . 0.0 111.689 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 77' ' ' MET . 22.6 t -141.91 107.76 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.048 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 57.71 50.71 10.35 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.97 0.414 . . . . 0.0 111.03 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.76 21.4 76.5 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.859 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.424 ' CZ ' HD22 ' A' ' 76' ' ' LEU . 6.2 mtt-85 -113.74 160.8 18.28 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.734 0.267 . . . . 0.0 110.37 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -114.41 110.94 20.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.032 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.533 HD23 HD12 ' A' ' 68' ' ' LEU . 27.1 mt -96.33 43.67 1.08 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.749 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.6 t -105.53 100.09 9.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.186 0.517 . . . . 0.0 110.572 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.87 30.48 5.15 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.553 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD12 HD23 ' A' ' 65' ' ' LEU . 45.5 mt -122.02 158.06 30.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 110.929 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.2 p -79.9 162.11 25.18 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.738 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -54.28 -36.42 63.62 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.768 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.81 -59.69 4.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.091 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -59.71 -36.6 76.86 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.099 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -65.44 -62.02 1.77 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.493 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' B' ' 102' ' ' THR . . . -56.19 -47.07 79.06 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.412 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 79' ' ' ARG . 0.6 OUTLIER -56.3 -54.85 40.47 Favored 'General case' 0 CA--C 1.527 0.083 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.956 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.424 HD22 ' CZ ' ' A' ' 63' ' ' ARG . 14.6 mt -53.69 -33.55 55.8 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.316 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.485 ' HB2' HG21 ' B' ' 104' ' ' VAL . 13.5 mtp -74.78 -51.38 14.27 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.764 ' HB ' HG23 ' B' ' 104' ' ' VAL . 8.6 t -63.2 -33.58 75.8 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.55 0.214 . . . . 0.0 111.161 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -84.2 47.48 1.34 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.878 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -98.2 179.54 4.71 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.868 0.366 . . . . 0.0 111.207 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.5 m -93.83 -165.63 1.36 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.738 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.0 t -55.81 -44.09 77.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.676 0.274 . . . . 0.0 110.925 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.16 145.91 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.852 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 13' ' ' LYS . 22.5 t -128.39 126.76 66.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.532 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.568 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.2 OUTLIER -129.67 83.5 2.14 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.765 -179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.708 HD11 ' SD ' ' A' ' 17' ' ' MET . 7.3 mt -93.67 118.79 31.85 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.495 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' HG3' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -86.34 113.86 22.66 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.547 179.328 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.75 150.56 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.54 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.568 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . . . -106.02 160.4 15.32 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.26 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -114.36 103.84 11.47 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.763 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -83.19 177.75 8.41 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.244 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.69 -0.77 71.86 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.884 -0.598 . . . . 0.0 113.853 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.464 179.697 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.413 ' O ' HG13 ' A' ' 22' ' ' VAL . 13.3 m-85 -132.89 169.92 16.07 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 5.1 p -120.93 90.99 3.43 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.887 0.375 . . . . 0.0 110.774 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.608 HG22 HD11 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -80.49 175.44 10.66 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.681 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.448 ' N ' HG23 ' B' ' 102' ' ' THR . 0.3 OUTLIER -128.54 129.34 45.85 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.804 0.335 . . . . 0.0 110.835 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.764 HG23 ' HB ' ' A' ' 78' ' ' THR . 8.4 p . . . . . 0 C--O 1.251 1.145 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.194 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.677 0.275 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.84 36.61 1.91 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.923 179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.5 tt0 -82.6 123.88 78.1 Favored Pre-proline 0 C--O 1.234 0.253 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 32.2 Cg_exo -62.71 -166.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.861 2.374 . . . . 0.0 112.822 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 34.8 tt0 -108.52 90.75 3.39 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.252 0.548 . . . . 0.0 110.952 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 3.4 mt -93.33 136.68 24.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.844 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 pt -145.5 153.17 13.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.448 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 5.0 m -111.27 141.16 45.16 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.981 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.553 HG11 ' HD2' ' A' ' 50' ' ' ARG . 10.8 m -120.7 133.54 67.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.063 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 m -109.68 95.17 5.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.709 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 66.0 mt -116.49 173.29 6.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -99.57 163.02 12.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.057 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -77.46 100.3 5.96 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.73 80.47 5.31 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.477 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.13 34.55 23.35 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.967 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.96 152.79 29.09 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.239 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.4 -56.41 22.44 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.69 0.281 . . . . 0.0 110.666 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 70.26 72.75 0.84 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.661 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.667 ' CD1' HG23 ' A' ' 21' ' ' ILE . 3.6 pp -160.61 178.12 9.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.732 0.301 . . . . 0.0 110.672 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.464 ' N ' HD12 ' A' ' 19' ' ' LEU . 7.9 m -135.17 126.25 27.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.41 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.669 HD13 ' CG2' ' A' ' 34' ' ' ILE . 2.1 pp -118.09 129.73 74.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.322 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.896 HG22 ' HA ' ' B' ' 101' ' ' SER . 93.7 t -112.5 136.8 47.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 121.099 0.476 . . . . 0.0 111.138 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.796 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -95.27 120.03 34.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.199 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.85 148.65 52.3 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.946 0.403 . . . . 0.0 111.768 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.58 -179.86 4.67 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.667 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.8 -141.53 3.15 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.715 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.34 148.52 27.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.614 0.245 . . . . 0.0 110.66 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.78 33.22 82.05 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.744 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.25 103.46 6.96 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.684 0.278 . . . . 0.0 110.927 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 7.1 t0 -90.64 21.6 3.94 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.227 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -142.01 -168.15 2.63 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.5 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.5 HD21 ' HB1' ' A' ' 23' ' ' ALA . 12.7 tp -142.14 123.91 15.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.747 0.308 . . . . 0.0 110.889 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.78 116.94 5.61 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.411 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.669 ' CG2' HD13 ' A' ' 21' ' ' ILE . 31.3 mm -77.85 87.19 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 CA-C-O 120.957 0.408 . . . . 0.0 110.413 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.94 162.32 28.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.648 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.2 t -104.33 108.01 23.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.835 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.701 ' HB2' HG23 ' A' ' 22' ' ' VAL . 17.9 tttt -62.52 -47.02 85.76 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.859 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 p -175.34 137.83 0.4 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.152 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.28 137.79 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.513 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.0 t -76.07 141.68 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 153.01 35.24 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.236 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.98 19.24 69.65 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.007 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.25 -158.03 33.72 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.442 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.17 -35.18 10.86 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.22 -33.59 20.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.377 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.25 -40.93 94.65 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.539 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.2 t -79.96 -41.85 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.52 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.5 -55.1 34.79 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.361 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.9 49.85 1.72 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.438 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.553 ' HD2' HG11 ' A' ' 9' ' ' VAL . 72.8 mmt-85 -105.77 -58.16 1.94 Allowed 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.653 0.263 . . . . 0.0 110.643 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 pp -117.15 149.72 39.89 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.669 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -123.63 -175.22 3.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.183 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.2 131.1 42.31 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.008 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 95.35 27.6 10.58 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.739 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.18 171.36 7.53 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.589 0.194 . . . . 0.0 110.768 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -120.26 137.9 53.97 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.307 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.607 HD23 HG22 ' A' ' 88' ' ' VAL . 86.6 mt -101.35 162.19 13.08 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.178 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.421 HD23 ' CG2' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -141.48 -53.26 0.45 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.188 179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.0 m -124.04 151.03 44.23 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.979 0.418 . . . . 0.0 111.712 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.64 HG23 HD13 ' A' ' 65' ' ' LEU . 21.7 t -139.34 133.23 38.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.765 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 53.65 38.0 27.33 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.147 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.37 26.98 72.32 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.152 -0.547 . . . . 0.0 113.337 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 mtp-105 -128.89 148.24 50.89 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.897 0.348 . . . . 0.0 110.723 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.5 m -89.66 135.23 33.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.982 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.64 HD13 HG23 ' A' ' 60' ' ' VAL . 4.2 mp -130.0 50.02 2.22 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.974 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.421 ' CG2' HD23 ' A' ' 58' ' ' LEU . 58.0 t -94.14 99.62 9.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.143 0.497 . . . . 0.0 110.876 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 105.54 35.35 3.09 Favored Glycine 0 CA--C 1.519 0.341 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.64 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.7 mt -122.11 153.77 38.25 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.755 0.312 . . . . 0.0 110.768 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 58.8 m -75.33 158.2 33.15 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.796 ' HG3' ' HB2' ' A' ' 23' ' ' ALA . 2.3 tt0 -57.25 -25.52 59.28 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.725 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.15 -49.58 76.51 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 110.692 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -51.89 52.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.022 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.35 -48.47 81.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.584 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.585 ' O ' HG22 ' A' ' 78' ' ' THR . . . -58.79 -56.89 16.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.331 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -53.15 60.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.309 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.52 -32.28 71.31 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.982 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.788 ' SD ' HD21 ' A' ' 86' ' ' LEU . 30.5 mmm -69.58 -64.32 0.9 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.92 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 74' ' ' ALA . 4.7 t -56.01 -36.23 67.71 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.684 0.278 . . . . 0.0 111.024 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -86.86 52.58 2.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.264 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 77' ' ' MET . 1.2 p -94.2 168.47 10.9 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.773 0.32 . . . . 0.0 110.746 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.1 m -97.62 -163.08 1.01 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.591 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 74.3 m -59.04 -26.78 64.88 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.165 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.82 149.21 5.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.952 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.01 87.36 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.79 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.1 m -91.88 80.68 5.2 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.889 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.788 HD21 ' SD ' ' A' ' 77' ' ' MET . 9.1 mt -103.94 133.97 48.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.44 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 27.2 tt0 -107.19 112.11 24.84 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.603 179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.607 HG22 HD23 ' A' ' 57' ' ' LEU . 19.8 t -110.73 147.56 14.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.206 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' ILE . . . -97.37 132.86 42.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.8 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -69.02 91.37 0.48 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.564 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.43 -177.82 4.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.912 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 147.06 140.43 3.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.567 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.153 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.518 179.829 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.569 ' O ' HG13 ' A' ' 22' ' ' VAL . 6.8 m-85 70.05 94.03 0.08 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.794 0.33 . . . . 0.0 110.712 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.896 ' HA ' HG22 ' A' ' 22' ' ' VAL . 8.2 t -154.23 -50.9 0.09 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.931 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.702 HG22 ' H ' ' B' ' 103' ' ' GLU . 0.8 OUTLIER 53.65 -172.74 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.013 0.435 . . . . 0.0 111.841 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.702 ' H ' HG22 ' B' ' 102' ' ' THR . 0.1 OUTLIER 179.35 51.94 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.564 HG21 ' CE ' ' A' ' 77' ' ' MET . 30.8 m . . . . . 0 C--O 1.251 1.153 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.811 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 tpp . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.35 115.22 2.58 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.673 0.273 . . . . 0.0 110.92 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.75 102.39 22.66 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.916 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.98 -172.18 0.57 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.828 2.352 . . . . 0.0 112.679 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -128.21 104.32 7.68 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.026 0.441 . . . . 0.0 111.117 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.0 mt -102.84 141.16 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.737 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.9 pt -146.26 151.84 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 120.791 0.329 . . . . 0.0 111.371 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 87' ' ' GLU . 1.3 m -112.88 140.0 48.04 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.955 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.6 m -123.19 127.92 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.183 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 15.6 m -108.65 112.38 24.68 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.886 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.9 mt -138.97 162.27 35.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.152 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.636 ' HE3' HG22 ' A' ' 83' ' ' VAL . 2.6 mptt -98.08 176.6 5.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.877 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.51 150.42 26.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.83 0.348 . . . . 0.0 111.408 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.98 -58.66 0.96 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.579 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -138.02 35.67 2.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.522 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.61 152.81 28.91 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.106 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.2 mtm -64.41 -48.87 73.74 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.629 0.214 . . . . 0.0 110.723 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.85 82.51 0.07 OUTLIER Glycine 0 C--N 1.336 0.534 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.938 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.524 HD11 HG12 ' B' ' 104' ' ' VAL . 3.6 pp -160.76 179.61 8.39 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.628 0.252 . . . . 0.0 110.781 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.0 m -129.45 144.78 51.39 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.27 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.465 HD13 HG23 ' A' ' 34' ' ' ILE . 2.7 pp -140.55 146.14 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.799 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.58 HG13 ' O ' ' B' ' 100' ' ' PHE . 22.7 t -132.71 137.08 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.544 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.49 158.85 25.73 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.705 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.876 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -159.51 141.53 13.39 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.774 0.321 . . . . 0.0 111.377 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HD2' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -126.31 -179.67 4.85 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.82 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.37 -141.33 3.12 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.8 139.25 40.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.681 0.277 . . . . 0.0 110.597 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 62.43 35.47 91.75 Favored Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.707 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.05 103.76 7.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.672 0.272 . . . . 0.0 110.89 -179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -92.18 28.41 1.91 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.1 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -136.57 -170.16 2.62 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.449 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 32' ' ' LEU . 5.9 tp -151.96 124.47 8.34 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.672 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.22 150.5 20.2 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.025 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.636 HG13 ' HB1' ' A' ' 73' ' ' ALA . 14.7 mm -104.86 81.44 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-O 121.049 0.452 . . . . 0.0 110.786 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.876 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 61.8 m-85 -71.57 166.37 21.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.316 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.3 t -106.43 128.99 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.107 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.54 ' HB2' HG23 ' A' ' 22' ' ' VAL . 8.5 ttpt -91.37 -42.6 10.24 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.519 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -161.3 172.84 15.9 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.726 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -136.05 121.97 30.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.558 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.3 t -72.13 124.96 29.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.721 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 124.12 21.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.79 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.11 -31.6 3.82 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.352 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.57 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -68.66 157.23 53.17 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.621 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.87 -37.16 18.81 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.553 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -63.87 -49.67 71.83 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.683 0.277 . . . . 0.0 111.203 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.48 -41.16 96.64 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.163 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.9 t -61.02 -32.96 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.25 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -68.25 -55.88 10.63 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.238 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.44 51.43 2.92 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.85 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 23.0 mmt85 -128.24 -66.99 0.82 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.729 0.264 . . . . 0.0 110.805 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.553 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.4 pp -70.4 161.59 30.21 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.98 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.93 -174.83 4.37 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.368 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -86.9 120.91 28.68 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.982 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.1 31.26 3.14 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.023 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -116.78 139.2 50.86 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.705 0.252 . . . . 0.0 110.955 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.426 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.9 tt0 -81.9 145.33 30.4 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -97.53 168.94 10.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.012 0.434 . . . . 0.0 111.321 179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.43 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -148.18 -59.02 0.24 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.035 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 83.5 p -128.3 150.6 49.99 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.963 0.411 . . . . 0.0 111.713 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.622 HG11 ' CG ' ' A' ' 77' ' ' MET . 39.9 t -141.97 96.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.854 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.46 41.99 31.63 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.962 0.41 . . . . 0.0 111.0 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.36 25.86 49.66 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.952 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -120.64 129.78 53.86 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.19 111.14 21.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.967 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 60' ' ' VAL . 41.5 mt -99.72 26.84 5.84 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.056 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.2 p -107.39 73.43 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.661 0.743 . . . . 0.0 110.638 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.66 -22.4 1.49 Allowed Glycine 0 CA--C 1.519 0.286 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.199 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.4 mt -81.32 159.26 24.47 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.966 0.412 . . . . 0.0 111.188 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.5 m -74.73 147.17 41.6 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.024 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.455 ' HG2' ' CG2' ' B' ' 102' ' ' THR . 0.0 OUTLIER -42.45 -41.25 2.86 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 123.178 0.299 . . . . 0.0 111.412 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.94 -56.94 12.24 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.306 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -60.44 -40.83 92.53 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.739 -0.21 . . . . 0.0 110.875 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.636 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -58.73 -60.84 3.19 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.702 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.509 ' O ' HG22 ' A' ' 78' ' ' THR . . . -63.49 -36.86 85.17 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.353 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -35.82 76.93 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.433 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.1 mt -73.45 -44.18 58.7 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.622 ' CG ' HG11 ' A' ' 60' ' ' VAL . 11.1 mtp -59.53 -48.17 82.7 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.433 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.708 ' HB ' HG23 ' B' ' 104' ' ' VAL . 7.8 t -64.51 -33.46 75.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.63 0.252 . . . . 0.0 110.611 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.72 50.19 1.92 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.892 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.0 p -103.79 172.72 6.65 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.646 0.26 . . . . 0.0 110.865 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.9 t -79.73 -169.93 2.17 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.49 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -53.4 -40.59 65.19 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.254 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.636 HG22 ' HE3' ' A' ' 12' ' ' LYS . 21.1 t -97.35 143.63 12.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.121 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 10' ' ' THR . 23.9 t -119.74 149.13 22.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.14 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.9 m -143.54 85.56 1.85 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.436 HD23 HG22 ' A' ' 60' ' ' VAL . 3.8 mt -98.27 140.45 32.54 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.365 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.472 ' HB2' HG23 ' A' ' 8' ' ' THR . 41.9 tt0 -121.78 110.07 15.46 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.735 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.7 m -106.84 169.19 2.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.204 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.17 137.67 53.59 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.17 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.62 121.44 36.18 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.548 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -159.46 -171.83 3.48 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.871 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 164.5 138.99 2.53 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.489 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.428 -0.796 . . . . 0.0 111.244 179.935 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 120.479 0.181 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.58 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.9 OUTLIER 73.65 144.25 0.07 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.991 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.476 ' HB2' HG22 ' A' ' 22' ' ' VAL . 21.5 t -121.75 134.92 54.94 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.975 0.417 . . . . 0.0 111.507 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.455 ' CG2' ' HG2' ' A' ' 70' ' ' GLN . 0.9 OUTLIER -120.55 -176.23 3.19 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.155 179.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 6.1 mt-10 -135.94 116.86 14.2 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.783 0.325 . . . . 0.0 110.783 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.708 HG23 ' HB ' ' A' ' 78' ' ' THR . 14.2 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.157 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ttp . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.664 0.269 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 tptm -174.45 116.54 0.2 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.695 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 66.57 108.35 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.541 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.85 -174.84 0.51 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.592 2.195 . . . . 0.0 112.64 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.5 100.95 5.97 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.875 0.369 . . . . 0.0 111.025 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 mt -100.49 139.14 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.318 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.02 139.19 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.145 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.433 ' HB ' ' CG ' ' A' ' 87' ' ' GLU . 7.3 t -109.41 159.25 17.17 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.801 0.334 . . . . 0.0 110.98 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -140.61 132.7 31.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.326 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 m -90.99 97.0 10.92 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.471 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.21 169.12 8.94 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.357 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -113.54 153.84 28.11 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.752 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -82.61 102.8 11.68 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.212 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -100.46 78.55 2.03 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.279 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 57.74 36.97 27.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.905 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.73 148.04 16.22 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.091 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 6.4 mtm -65.64 -68.8 0.34 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.733 0.266 . . . . 0.0 111.007 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 94.53 70.09 1.09 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.045 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 20' ' ' SER . 3.9 pp -160.65 176.82 11.12 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.401 0.143 . . . . 0.0 110.633 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.466 ' N ' HD12 ' A' ' 19' ' ' LEU . 49.0 m -134.21 142.14 47.28 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.631 ' CD1' HG22 ' B' ' 102' ' ' THR . 0.0 OUTLIER -131.96 163.19 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-O 121.036 0.446 . . . . 0.0 112.069 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.923 HG13 ' HB2' ' B' ' 100' ' ' PHE . 21.2 t -142.06 131.83 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.974 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.445 ' CB ' ' HB2' ' A' ' 70' ' ' GLN . . . -99.31 118.58 36.28 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.641 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -120.49 132.62 55.29 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.569 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.442 ' HG3' ' CD1' ' A' ' 32' ' ' LEU . 4.6 tttt -114.51 -179.69 3.7 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.889 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -170.16 -140.52 3.01 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.69 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.46 152.63 23.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.56 0.219 . . . . 0.0 110.766 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.18 37.46 86.56 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.501 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.27 107.74 7.36 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.609 0.242 . . . . 0.0 110.801 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.472 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 7.8 p-10 -90.7 15.11 11.69 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.835 0.35 . . . . 0.0 111.47 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.472 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -144.36 -171.38 3.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.383 179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.442 ' CD1' ' HG3' ' A' ' 25' ' ' LYS . 0.6 OUTLIER -145.1 135.34 24.02 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.757 0.313 . . . . 0.0 111.002 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.03 127.85 9.32 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.822 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.73 78.78 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-O 121.031 0.443 . . . . 0.0 110.513 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.439 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 73.0 m-85 -68.79 157.8 35.68 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.623 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -95.12 135.19 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.308 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.2 tttp -92.77 -47.77 6.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.622 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.17 130.57 0.17 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.03 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -82.13 132.22 31.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.667 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -81.74 139.41 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.19 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.72 145.17 55.4 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.206 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.57 -26.25 23.88 Favored Glycine 0 CA--C 1.521 0.431 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.869 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -67.2 150.12 51.58 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.024 -0.608 . . . . 0.0 113.149 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.59 -36.69 67.17 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.53 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -61.22 -40.93 95.84 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.689 0.281 . . . . 0.0 110.86 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.68 -40.64 63.5 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 43' ' ' GLY . 40.6 t -63.83 -36.38 76.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.397 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.28 -38.21 60.53 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.051 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.26 64.27 2.69 Favored Glycine 0 C--N 1.335 0.524 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.494 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -49.04 1.86 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.583 0.23 . . . . 0.0 111.383 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.53 HD21 ' HB1' ' A' ' 45' ' ' ALA . 0.5 OUTLIER -103.84 165.72 10.87 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.261 -179.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.8 177.77 7.95 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.519 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.77 140.31 42.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.047 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.61 27.94 28.27 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.871 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' HB3' ' CG2' ' A' ' 88' ' ' VAL . 1.4 m-20 -110.67 155.22 22.73 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 116.635 0.218 . . . . 0.0 110.536 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.439 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 4.8 tt0 -96.67 144.56 26.58 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.091 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.96 169.24 8.62 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.002 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.65 -57.61 0.22 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.241 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 t -126.52 144.23 50.94 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.112 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.752 HG21 ' SD ' ' A' ' 77' ' ' MET . 23.4 t -135.47 112.22 13.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.576 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 t70 59.09 39.04 23.64 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.333 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.48 4.64 84.88 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.321 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -98.96 142.33 30.6 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 117.42 0.61 . . . . 0.0 110.808 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.05 108.78 21.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.828 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 68.8 mt -100.33 32.42 3.03 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.866 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.472 HG12 ' HG2' ' A' ' 31' ' ' LYS . 62.5 t -90.09 99.96 10.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 121.189 0.519 . . . . 0.0 110.826 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 110.93 32.35 2.66 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.521 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 68' ' ' LEU . 23.3 mt -129.18 161.5 29.97 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.695 0.284 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.81 154.23 30.06 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.445 ' HB2' ' CB ' ' A' ' 23' ' ' ALA . 1.2 tm0? -52.29 -36.24 52.43 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.885 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -54.66 -53.1 59.27 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.715 0.293 . . . . 0.0 110.384 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -63.2 -41.33 99.16 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.738 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 77' ' ' MET . . . -60.4 -59.92 4.64 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.229 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.535 ' O ' HG22 ' A' ' 78' ' ' THR . . . -56.07 -33.96 65.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.626 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -45.08 57.82 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.602 0.239 . . . . 0.0 111.327 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.9 mt -67.69 -32.46 73.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.464 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.752 ' SD ' HG21 ' A' ' 60' ' ' VAL . 6.6 mtm -73.83 -48.2 32.98 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.491 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.777 ' HB ' HG23 ' B' ' 104' ' ' VAL . 9.9 t -64.1 -34.2 77.5 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.615 0.245 . . . . 0.0 110.793 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 56.7 mtm180 -83.8 49.04 1.53 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.669 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.7 -175.9 3.58 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.545 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.4 m -104.3 -164.59 1.07 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.3 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 12' ' ' LYS . 13.7 p -56.77 -31.71 64.9 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.753 0.311 . . . . 0.0 110.714 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.48 148.34 13.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.629 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.41 139.46 21.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.125 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.28 95.2 4.45 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.736 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.73 104.69 17.25 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.078 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' CG ' ' HB ' ' A' ' 8' ' ' THR . 1.8 mt-10 -80.23 83.14 6.14 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.227 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 55' ' ' ASP . 14.8 p -84.41 142.85 12.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.434 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.61 117.98 31.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.186 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -71.21 148.29 47.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -139.13 169.02 18.54 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.859 0.361 . . . . 0.0 111.572 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.22 -4.25 62.92 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.544 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.989 179.812 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.923 ' HB2' HG13 ' A' ' 22' ' ' VAL . 55.6 p90 -62.85 170.73 2.48 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.734 0.302 . . . . 0.0 111.645 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 59.8 p 53.84 70.17 0.63 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.582 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.631 HG22 ' CD1' ' A' ' 21' ' ' ILE . 1.5 t -111.34 -164.59 0.93 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.284 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.451 ' N ' HG23 ' B' ' 102' ' ' THR . 1.3 pt-20 -131.32 127.52 37.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.906 0.384 . . . . 0.0 111.11 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.777 HG23 ' HB ' ' A' ' 78' ' ' THR . 10.8 p . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.142 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 120.66 0.267 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -102.67 25.66 8.91 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.209 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -153.3 88.7 3.7 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.026 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_exo -62.71 -171.57 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.982 2.454 . . . . 0.0 112.834 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 40.0 tt0 -116.41 87.26 2.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.222 0.534 . . . . 0.0 111.119 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.763 HD12 HD12 ' A' ' 58' ' ' LEU . 42.6 mm -84.52 125.69 40.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.608 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.48 HD12 HG13 ' A' ' 9' ' ' VAL . 1.2 pp -140.49 137.67 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.848 0.356 . . . . 0.0 111.119 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.683 HG23 ' HB2' ' A' ' 87' ' ' GLU . 1.0 OUTLIER -105.08 113.03 26.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.887 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.48 HG13 HD12 ' A' ' 7' ' ' ILE . 26.9 m -100.51 151.91 5.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.166 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.22 119.69 25.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.771 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 mt -132.97 162.54 31.41 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.41 ' HG2' HG22 ' A' ' 83' ' ' VAL . 9.6 mtmt -110.03 138.06 46.94 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.727 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 mttt -64.85 121.47 14.68 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.216 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -93.34 -50.89 5.25 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.663 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -164.95 41.38 0.08 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.795 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.43 147.28 16.72 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.151 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 2.7 mmm -68.38 -68.06 0.42 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.453 0.168 . . . . 0.0 110.832 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.96 78.57 0.53 Allowed Glycine 0 C--N 1.335 0.527 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.855 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.515 HD11 ' CG1' ' B' ' 104' ' ' VAL . 3.7 pp -160.46 179.47 8.59 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.52 0.2 . . . . 0.0 110.857 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.6 m -129.04 141.56 51.19 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.716 0.293 . . . . 0.0 111.665 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.718 HD11 HG22 ' B' ' 102' ' ' THR . 2.9 pp -137.68 154.77 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.806 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.648 HG13 ' O ' ' B' ' 100' ' ' PHE . 49.1 t -142.57 135.13 26.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.989 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.71 146.62 23.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.777 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.63 158.03 43.8 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.864 0.364 . . . . 0.0 111.935 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.31 179.16 4.19 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.856 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.89 -143.61 3.75 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.07 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.66 150.54 28.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.551 0.215 . . . . 0.0 110.878 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.83 28.57 63.41 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.502 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.55 106.93 4.04 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.799 0.333 . . . . 0.0 110.565 -178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -97.44 39.27 1.21 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.936 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -137.29 -159.83 1.0 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.256 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 32' ' ' LEU . 2.7 tp -146.54 126.81 13.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.507 0.194 . . . . 0.0 110.747 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.15 142.69 15.64 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.822 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.666 HG12 ' HB1' ' A' ' 73' ' ' ALA . 1.6 mp -86.69 135.16 25.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.774 0.321 . . . . 0.0 110.502 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -125.66 143.93 50.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.011 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.456 HG12 ' HA ' ' A' ' 53' ' ' ALA . 39.3 t -81.37 130.01 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.005 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -100.54 -40.74 7.27 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.327 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -179.48 128.13 0.09 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.633 0.254 . . . . 0.0 110.993 -179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 m -90.64 133.38 32.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.124 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.9 t -73.56 131.21 35.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.7 mmmt -61.56 115.48 3.96 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.065 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.27 -30.03 3.38 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.786 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.494 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.58 151.19 50.85 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.689 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.76 -36.66 65.07 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.72 -36.64 84.94 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -76.22 -45.91 30.73 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.243 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 43' ' ' GLY . 25.3 t -60.26 -38.52 77.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.365 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.74 -41.57 62.31 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.145 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.24 33.09 18.37 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.984 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -83.83 -54.3 4.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.806 0.336 . . . . 0.0 110.689 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 pp -115.19 152.64 32.27 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.818 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.99 175.12 10.08 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.138 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.456 ' HA ' HG12 ' A' ' 36' ' ' VAL . . . -61.01 122.81 15.87 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.315 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 106.4 38.77 2.2 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.926 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 36' ' ' VAL . 29.4 m-20 -135.24 142.31 45.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.517 0.199 . . . . 0.0 110.796 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -93.55 152.97 18.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.933 0.397 . . . . 0.0 110.774 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.427 HD21 HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -101.53 172.12 7.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.023 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.763 HD12 HD12 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -149.87 -54.25 0.16 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.329 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 11.8 t -133.87 140.73 47.04 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.66 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.958 HG23 HD11 ' A' ' 65' ' ' LEU . 37.5 t -129.1 120.24 51.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.594 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.59 34.92 25.27 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.184 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.74 35.65 39.64 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.106 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 175.22 8.69 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.655 0.264 . . . . 0.0 110.851 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -121.34 121.59 37.98 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.139 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.958 HD11 HG23 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -106.18 29.18 6.99 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.263 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 77.7 t -87.27 100.27 9.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.231 0.538 . . . . 0.0 110.878 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.97 27.58 5.07 Favored Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.593 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.0 mt -118.84 164.68 15.06 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.87 0.367 . . . . 0.0 110.82 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -83.97 152.29 24.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.275 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -51.39 -30.89 20.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.337 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -65.37 -51.16 62.31 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.771 0.319 . . . . 0.0 110.498 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -62.97 -40.43 97.69 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.666 ' HB1' HG12 ' A' ' 34' ' ' ILE . . . -58.32 -60.31 3.97 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.45 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.567 ' O ' HG22 ' A' ' 78' ' ' THR . . . -61.3 -44.68 96.82 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.848 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -39.09 81.32 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.048 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.4 mt -68.88 -34.89 76.18 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.027 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.666 ' HB2' HG21 ' B' ' 104' ' ' VAL . 11.3 mtp -76.31 -41.6 48.01 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.738 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.641 ' HB ' HG23 ' B' ' 104' ' ' VAL . 5.3 t -70.85 -37.36 73.13 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 121.135 -0.226 . . . . 0.0 110.648 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 47.9 mtp85 -89.95 56.08 3.35 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.444 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.9 p -110.52 178.84 4.25 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.877 0.37 . . . . 0.0 111.246 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.65 -175.75 4.02 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.714 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.7 m -52.63 -39.29 61.59 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.137 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.41 HG22 ' HG2' ' A' ' 12' ' ' LYS . 24.4 t -97.84 147.84 6.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.925 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.41 134.18 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.64 85.0 2.35 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.01 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.427 HD23 HD21 ' A' ' 57' ' ' LEU . 4.1 mt -92.23 139.08 30.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.258 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.683 ' HB2' HG23 ' A' ' 8' ' ' THR . 27.8 tt0 -124.86 98.9 5.9 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.583 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.3 m -105.07 172.33 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.803 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.43 107.15 17.57 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.942 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.408 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 1.7 mmtt -63.97 104.15 0.67 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -135.84 158.68 43.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.317 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -99.83 1.16 56.59 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.715 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.593 -0.718 . . . . 0.0 111.471 179.773 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.648 ' O ' HG13 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -138.91 160.38 39.86 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.602 0.239 . . . . 0.0 110.859 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 80.6 p -128.99 118.62 22.9 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.698 179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.718 HG22 HD11 ' A' ' 21' ' ' ILE . 1.7 t -111.58 -164.25 0.9 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.685 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.462 ' N ' HG23 ' B' ' 102' ' ' THR . 0.0 OUTLIER -143.06 114.03 7.68 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.85 0.357 . . . . 0.0 110.748 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.666 HG21 ' HB2' ' A' ' 77' ' ' MET . 9.0 p . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.083 -0.961 . . . . 0.0 111.032 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtm . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.684 0.278 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt 62.91 89.11 0.09 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.126 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -69.59 117.19 50.69 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.987 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -64.09 -163.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.939 2.426 . . . . 0.0 112.634 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -100.43 86.44 3.17 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.239 0.542 . . . . 0.0 111.019 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mp -96.43 128.08 47.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.666 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.6 pt -142.66 155.98 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.025 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.568 ' OG1' HG22 ' A' ' 85' ' ' THR . 14.5 t -118.6 128.83 54.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.199 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.1 t -87.85 91.62 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.634 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 32.4 m -81.51 105.16 12.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.934 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 77.8 mt -139.4 177.58 7.82 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.086 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.27 153.06 20.8 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.684 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.79 100.75 0.21 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.879 0.371 . . . . 0.0 111.12 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.38 80.35 2.4 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.406 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 m120 56.55 35.62 26.32 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.079 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.05 160.72 28.48 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.614 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.473 ' HB3' HD23 ' A' ' 19' ' ' LEU . 42.1 mtm -77.62 -38.91 46.96 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.497 0.189 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.85 70.4 1.06 Allowed Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.903 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' CD1' HG23 ' A' ' 21' ' ' ILE . 3.4 pp -160.62 176.76 11.21 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.793 0.33 . . . . 0.0 111.009 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -134.89 129.23 34.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.668 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 21' ' ' ILE . 2.8 pp -121.83 153.43 25.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-O 120.891 0.377 . . . . 0.0 111.535 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' B' ' 101' ' ' SER . 43.2 t -142.33 146.92 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.231 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' B' ' 99' ' ' LEU . . . -107.08 147.32 30.14 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.196 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.74 155.09 39.56 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.64 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -120.1 179.47 4.27 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.772 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -163.13 -143.31 3.65 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.908 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.91 146.08 31.44 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.8 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.12 27.89 63.22 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.693 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.57 105.6 3.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.673 0.273 . . . . 0.0 110.486 -179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -96.3 28.16 3.4 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.412 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.8 OUTLIER -120.19 -165.53 1.2 Allowed 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.358 179.423 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.519 ' HG ' ' HB1' ' A' ' 23' ' ' ALA . 1.4 tp -145.03 124.5 13.13 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.628 0.252 . . . . 0.0 110.828 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.23 119.48 5.47 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.478 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.605 HG23 HE22 ' A' ' 70' ' ' GLN . 18.6 mm -80.09 74.62 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 120.938 0.399 . . . . 0.0 110.893 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -71.2 168.19 17.79 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.426 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.7 t -107.52 108.7 25.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.057 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.49 ' HB2' HG23 ' A' ' 22' ' ' VAL . 6.5 tttt -64.33 -45.94 85.66 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.903 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 60.4 p -176.62 155.85 1.39 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.885 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.503 HG12 ' HB2' ' A' ' 46' ' ' ASP . 11.0 t -103.49 131.79 51.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.881 0.372 . . . . 0.0 110.797 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 29.9 t -79.61 132.32 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.974 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.05 127.98 34.2 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.008 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.59 -21.43 30.37 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.877 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.582 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -64.57 157.19 45.17 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.962 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.08 -38.37 76.26 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.25 -35.65 58.85 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.536 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.503 ' HB2' HG12 ' A' ' 39' ' ' VAL . 16.7 t70 -64.47 -45.11 88.78 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.141 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 43' ' ' GLY . 39.5 t -61.77 -34.75 63.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.5 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -68.06 -53.95 21.87 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.687 0.28 . . . . 0.0 111.442 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.73 30.58 23.48 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.923 -0.655 . . . . 0.0 113.085 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -44.14 16.59 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.863 0.363 . . . . 0.0 110.724 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.82 178.77 4.16 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.95 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.22 175.99 11.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.366 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -69.68 132.76 46.65 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.676 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.77 28.89 8.5 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.5 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -110.33 174.57 5.8 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.459 0.171 . . . . 0.0 110.687 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -118.3 144.78 45.58 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.35 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.588 HD21 HG23 ' A' ' 60' ' ' VAL . 6.6 tt -113.28 140.84 47.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.192 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.47 -58.74 1.83 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.98 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 27.0 m -136.63 156.77 48.1 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.935 0.398 . . . . 0.0 111.459 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.751 HG21 ' SD ' ' A' ' 77' ' ' MET . 40.4 t -128.9 122.88 57.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.516 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 t70 67.35 11.68 8.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.445 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.3 18.74 30.11 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.557 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -125.46 142.63 51.4 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.376 0.588 . . . . 0.0 111.164 179.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.3 m -74.58 128.67 36.11 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.391 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.808 HD22 ' HA ' ' A' ' 73' ' ' ALA . 1.4 mt -132.66 31.57 3.96 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.16 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.618 ' O ' HG13 ' A' ' 66' ' ' VAL . 8.0 p -104.35 83.54 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 121.596 0.713 . . . . 0.0 110.467 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 157.62 -28.92 0.49 Allowed Glycine 0 CA--C 1.518 0.253 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.523 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.9 167.91 12.84 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.856 0.36 . . . . 0.0 110.84 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -71.07 158.77 35.91 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.145 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.609 ' CD ' HD13 ' A' ' 21' ' ' ILE . 5.6 tp-100 -54.83 -28.73 51.79 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.301 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -60.53 -36.48 78.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.348 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.22 -42.39 31.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.645 0.259 . . . . 0.0 110.883 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.808 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -72.47 -51.76 18.78 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.617 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.682 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -59.47 -46.35 89.05 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.415 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 79' ' ' ARG . 2.9 tp10 -57.37 -45.26 84.62 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 120.685 0.278 . . . . 0.0 110.569 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.5 mt -66.71 -33.49 75.75 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.32 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.751 ' SD ' HG21 ' A' ' 60' ' ' VAL . 0.7 OUTLIER -60.69 -57.14 13.95 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.138 -179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.4 t -62.38 -39.3 92.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.785 0.326 . . . . 0.0 110.391 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -84.08 51.92 2.19 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.779 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.37 176.8 5.57 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.839 0.352 . . . . 0.0 111.048 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.43 -173.46 4.73 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.233 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 4.5 t -54.91 -33.4 62.04 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.626 0.25 . . . . 0.0 111.135 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.5 144.35 15.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.063 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 10' ' ' THR . 19.9 t -112.64 145.97 17.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.568 HG22 ' OG1' ' A' ' 8' ' ' THR . 0.6 OUTLIER -143.75 81.14 1.68 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.084 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.92 113.16 24.85 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.172 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.08 91.81 6.16 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.615 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.3 p -97.64 136.13 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.245 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.88 145.56 26.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.423 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.07 122.62 41.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -163.76 -174.9 3.86 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 158.53 139.8 2.77 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.625 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.475 -0.774 . . . . 0.0 111.409 179.68 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . 0.528 ' HA ' ' HB3' ' A' ' 23' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.997 0.427 . . . . 0.0 111.301 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -139.59 177.7 7.75 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.535 ' HA ' HG22 ' A' ' 22' ' ' VAL . 40.2 t -103.03 104.51 14.69 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.462 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.682 HG21 ' CB ' ' A' ' 74' ' ' ALA . 18.7 p -85.18 -149.8 0.12 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.733 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 14.1 pt-20 -170.78 48.13 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.905 0.86 . . . . 0.0 109.297 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.679 HG21 ' CE ' ' A' ' 77' ' ' MET . 20.1 m . . . . . 0 C--O 1.248 1.004 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.135 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.9 ttm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.874 0.369 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.47 129.04 34.96 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.65 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -125.27 150.0 65.86 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.941 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -68.27 172.03 11.8 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.739 2.293 . . . . 0.0 112.596 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 19.4 tt0 -132.84 100.62 4.97 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.731 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.4 mp -88.14 135.97 24.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.655 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.55 145.9 22.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.634 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.2 m -106.62 126.61 52.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.839 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.01 163.77 15.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.176 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -126.44 113.19 16.52 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.597 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 mt -124.83 143.33 50.88 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.852 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -95.1 155.35 16.77 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.04 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -80.11 126.96 31.74 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.043 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' A' ' 44' ' ' ALA . 8.3 mm-40 -95.12 -52.85 4.03 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.503 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -164.62 44.24 0.09 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.532 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.97 151.01 17.69 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.226 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 8.1 mmm -74.28 -70.89 0.37 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.481 0.181 . . . . 0.0 110.683 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.31 77.09 0.58 Allowed Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.82 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.716 ' HB3' HG23 ' A' ' 39' ' ' VAL . 3.4 pp -161.21 177.68 9.99 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.671 0.272 . . . . 0.0 110.992 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.0 m -130.17 155.76 45.7 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.477 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.939 HD11 ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -144.12 164.33 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.778 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' B' ' 100' ' ' PHE . 64.8 t -140.79 138.75 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.701 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.603 ' HB1' ' CD2' ' A' ' 32' ' ' LEU . . . -88.26 94.97 10.0 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.804 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.75 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -93.57 146.04 24.09 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.041 0.448 . . . . 0.0 112.109 -178.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -132.65 -179.89 5.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.492 -0.777 . . . . 0.0 110.67 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -177.3 -142.63 4.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.775 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.83 149.34 25.75 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.615 0.245 . . . . 0.0 110.718 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.92 31.32 75.81 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.779 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.13 103.9 7.24 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.627 0.251 . . . . 0.0 110.731 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -91.1 23.06 3.41 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.222 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.4 mmtm -140.77 -164.11 1.67 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.541 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.603 ' CD2' ' HB1' ' A' ' 23' ' ' ALA . 7.0 tp -140.55 116.62 10.49 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.477 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.26 133.25 11.8 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.471 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.8 mp -92.45 88.74 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-O 121.054 0.454 . . . . 0.0 110.498 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.75 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 47.0 m-85 -82.28 173.03 12.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.918 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.8 t -103.16 136.34 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.748 0.309 . . . . 0.0 111.356 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.408 ' HB2' HG23 ' A' ' 22' ' ' VAL . 11.6 tttp -98.37 -43.99 6.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.815 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.97 107.9 0.07 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.012 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.716 HG23 ' HB3' ' A' ' 19' ' ' LEU . 14.8 p -81.65 137.41 21.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.1 132.44 32.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.051 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.84 151.51 47.39 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.94 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.05 -28.79 12.96 Favored Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.679 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -68.85 157.65 53.23 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.27 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.478 ' HB2' ' HG2' ' A' ' 14' ' ' GLN . . . -49.33 -40.32 34.85 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.82 -36.82 70.38 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.398 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -86.09 -39.99 16.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.247 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 43' ' ' GLY . 21.9 t -67.36 -37.68 79.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.87 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -68.7 -43.55 75.8 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.511 0.196 . . . . 0.0 111.202 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.06 75.5 1.09 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.762 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.19 -50.88 0.76 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.538 0.209 . . . . 0.0 110.819 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -123.78 177.57 5.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.099 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.54 -174.31 4.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.413 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.1 152.07 44.75 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.392 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.57 26.16 63.79 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.365 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.452 ' HA ' ' NE2' ' A' ' 91' ' ' GLN . 0.8 OUTLIER -107.03 169.12 8.74 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.629 0.252 . . . . 0.0 110.766 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.437 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 1.3 tt0 -100.25 166.55 10.93 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.59 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.788 HD21 HD12 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -156.05 130.8 9.07 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.953 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.99 -44.65 1.04 Allowed 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.877 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' A' ' 87' ' ' GLU . 22.8 t -95.65 143.34 27.01 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 111.583 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.734 HG21 HD12 ' A' ' 65' ' ' LEU . 39.4 t -144.47 121.75 5.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.805 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 56.12 35.09 25.05 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.268 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.5 24.04 68.9 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.873 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.4 mtp85 -125.13 -176.55 3.6 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.3 p -123.65 116.24 22.76 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.689 0.28 . . . . 0.0 110.979 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.734 HD12 HG21 ' A' ' 60' ' ' VAL . 37.4 mt -110.68 31.29 6.09 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.004 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.1 t -89.87 101.21 11.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 121.123 0.487 . . . . 0.0 110.415 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 118.93 42.85 0.55 Allowed Glycine 0 CA--C 1.518 0.233 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.444 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 65' ' ' LEU . 84.0 mt -117.82 -178.81 3.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.773 0.321 . . . . 0.0 110.764 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.21 19.45 10.61 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.844 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 40.3 tt0 78.49 -54.87 0.48 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.098 0.559 . . . . 0.0 111.581 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -53.37 -43.69 68.01 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.621 0.248 . . . . 0.0 110.773 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -33.31 75.5 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.657 ' HA ' HD13 ' A' ' 65' ' ' LEU . . . -66.92 -62.8 1.25 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.288 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.939 ' HB2' HD11 ' A' ' 21' ' ' ILE . . . -56.53 -42.1 77.88 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.867 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -60.72 -33.1 72.38 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.122 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 76' ' ' LEU . 7.4 mt -77.82 -46.2 22.21 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-O 120.61 0.243 . . . . 0.0 110.898 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.734 ' HG3' HG11 ' A' ' 60' ' ' VAL . 4.6 mtp -57.58 -41.24 80.74 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.187 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.868 ' HB ' HG23 ' B' ' 104' ' ' VAL . 8.9 t -73.42 -32.33 64.35 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.574 0.226 . . . . 0.0 110.563 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -87.38 49.63 1.85 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.34 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 26.9 p -115.13 170.32 8.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.656 0.265 . . . . 0.0 111.081 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.5 t -81.58 -170.88 3.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.685 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.51 -48.68 68.79 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.9 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.3 p -85.47 127.81 39.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.979 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.521 HG12 HD22 ' A' ' 86' ' ' LEU . 6.5 t -122.43 141.72 41.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 m -119.93 106.4 12.0 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.095 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.788 HD12 HD21 ' A' ' 57' ' ' LEU . 3.3 mm? -109.69 133.14 53.47 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.121 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 45.8 tt0 -115.39 106.02 13.52 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.756 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.538 HG12 HD12 ' A' ' 57' ' ' LEU . 34.2 m -105.24 174.27 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.595 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -123.2 143.39 50.06 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.895 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -84.8 97.84 9.94 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.345 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.452 ' NE2' ' HA ' ' A' ' 55' ' ' ASP . 1.6 pm0 -143.35 -172.95 3.81 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.171 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 152.04 140.01 3.05 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.459 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.824 -179.856 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 21.9 tp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 120.829 0.347 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 23' ' ' ALA . 10.2 m-85 -100.76 163.03 12.51 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.806 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 94.2 p -167.83 144.04 4.04 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.839 0.352 . . . . 0.0 111.543 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.91 173.61 15.72 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.49 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -146.97 128.95 15.46 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.639 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.868 HG23 ' HB ' ' A' ' 78' ' ' THR . 8.2 p . . . . . 0 C--O 1.251 1.173 0 CA-C-O 118.644 -0.693 . . . . 0.0 111.035 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttt . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.502 0.191 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.46 134.45 9.11 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.264 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -59.48 113.08 6.21 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.965 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.3 -168.02 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 123.059 2.506 . . . . 0.0 112.739 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 19.9 tt0 -114.99 99.1 7.21 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.627 HG21 HD12 ' A' ' 58' ' ' LEU . 33.7 mt -103.81 116.78 48.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.879 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 pt -142.88 149.55 18.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.804 0.335 . . . . 0.0 111.488 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.722 HG22 HG22 ' A' ' 85' ' ' THR . 1.3 m -111.3 120.34 41.89 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.055 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' THR . 12.6 m -96.03 169.56 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.154 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.96 114.44 8.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.801 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' A' ' 48' ' ' ASP . 0.9 OUTLIER -135.16 164.09 28.46 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.248 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.8 mttm -96.16 144.12 26.67 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.976 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -87.86 105.33 17.35 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.083 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -58.56 3.89 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.588 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.86 36.55 0.4 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.774 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.65 147.37 8.0 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.352 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.09 -52.27 64.58 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.603 0.239 . . . . 0.0 110.929 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.93 64.33 2.35 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.718 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 20' ' ' SER . 4.0 pp -160.54 179.33 8.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.46 0.171 . . . . 0.0 110.727 179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.529 ' N ' HD12 ' A' ' 19' ' ' LEU . 75.3 m -138.36 151.69 47.75 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.439 0.162 . . . . 0.0 111.183 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.048 HD13 HG23 ' A' ' 34' ' ' ILE . 2.2 pp -133.72 156.53 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.68 HG23 ' HB2' ' A' ' 37' ' ' LYS . 30.5 t -137.78 133.85 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.119 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -86.91 128.5 35.06 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.887 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.786 ' HB3' ' CE2' ' A' ' 35' ' ' TYR . . . -135.4 143.69 46.14 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.79 0.328 . . . . 0.0 111.471 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -120.33 -179.71 4.04 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.12 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -165.92 -139.82 2.74 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.093 -0.575 . . . . 0.0 111.734 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.32 150.95 27.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.67 0.271 . . . . 0.0 110.789 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.37 38.23 93.11 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.63 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.43 107.5 8.1 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.711 0.291 . . . . 0.0 110.855 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -90.29 19.0 5.43 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.545 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.8 mmtt -144.77 -169.73 3.24 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.486 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 32' ' ' LEU . 10.6 tp -129.19 142.81 50.75 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.66 0.267 . . . . 0.0 110.962 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.17 128.28 8.93 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.754 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.048 HG23 HD13 ' A' ' 21' ' ' ILE . 1.9 mp -92.15 91.63 3.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-O 121.155 0.503 . . . . 0.0 110.274 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.786 ' CE2' ' HB3' ' A' ' 24' ' ' ALA . 75.8 m-85 -80.16 167.81 19.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.593 -179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.402 HG11 HG13 ' A' ' 39' ' ' VAL . 43.4 t -94.93 127.48 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 111.094 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.68 ' HB2' HG23 ' A' ' 22' ' ' VAL . 7.8 tptt -80.36 -49.11 11.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.691 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.473 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 52.3 p -178.96 111.08 0.05 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.114 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.402 HG13 HG11 ' A' ' 36' ' ' VAL . 9.2 m -73.58 129.34 36.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.793 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.2 t -78.54 141.46 15.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.202 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 151.82 42.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.066 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.81 -37.68 3.38 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.742 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.612 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -62.43 151.81 45.58 Favored Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.428 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.29 -36.69 43.6 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.3 -36.87 84.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.738 0.304 . . . . 0.0 111.137 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -78.0 -39.77 41.21 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.501 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.2 t -58.88 -34.03 51.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.576 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.445 ' HB2' HD21 ' A' ' 11' ' ' LEU . 32.4 t0 -68.53 -55.84 10.36 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.886 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.15 32.09 11.08 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.708 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -88.23 -43.38 11.64 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.687 0.279 . . . . 0.0 110.896 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.596 ' HB3' HG21 ' A' ' 88' ' ' VAL . 0.7 OUTLIER -116.86 -178.77 3.51 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.886 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.89 -177.33 6.49 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.377 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.473 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -72.9 156.98 38.31 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.069 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.97 27.11 71.07 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.751 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -109.53 172.75 6.67 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.631 0.215 . . . . 0.0 110.579 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.632 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 8.5 tm0? -110.05 147.42 33.6 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.6 0.238 . . . . 0.0 110.814 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.895 HD11 HD23 ' A' ' 86' ' ' LEU . 1.7 tp -115.84 142.17 47.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.873 0.368 . . . . 0.0 111.314 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.627 HD12 HG21 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -106.6 -56.27 2.21 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.4 -179.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.4 t -147.28 156.35 42.85 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.055 0.455 . . . . 0.0 111.96 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.888 HG21 ' HG2' ' A' ' 77' ' ' MET . 41.8 t -133.0 121.35 43.79 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.524 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 t70 60.09 35.23 21.28 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.287 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.3 26.29 73.8 Favored Glycine 0 CA--C 1.522 0.497 0 C-N-CA 120.937 -0.649 . . . . 0.0 113.263 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.576 ' HD3' HD22 ' A' ' 76' ' ' LEU . 10.0 mtt-85 -96.91 -178.31 4.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.988 0.394 . . . . 0.0 110.799 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.2 m -120.67 103.47 9.15 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.899 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.66 HD22 ' HA ' ' A' ' 73' ' ' ALA . 36.9 mt -108.39 29.57 7.25 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.175 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.8 t -111.35 100.75 11.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-O 121.207 0.527 . . . . 0.0 110.875 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 109.35 30.7 3.5 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.642 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.612 HD22 ' HG2' ' A' ' 72' ' ' ARG . 10.6 mt -133.47 179.43 6.22 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.77 0.319 . . . . 0.0 110.307 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.07 168.5 10.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.524 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -61.43 -21.58 64.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.837 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -77.75 -38.09 47.68 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.756 0.312 . . . . 0.0 111.158 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HG2' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -68.09 -56.66 8.03 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.32 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.66 ' HA ' HD22 ' A' ' 65' ' ' LEU . . . -61.49 -45.58 93.63 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.616 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.727 ' HB1' HG21 ' B' ' 102' ' ' THR . . . -56.55 -55.15 37.47 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.395 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -54.53 -36.19 64.0 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.045 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.576 HD22 ' HD3' ' A' ' 63' ' ' ARG . 56.7 mt -72.01 -39.91 68.85 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.254 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.888 ' HG2' HG21 ' A' ' 60' ' ' VAL . 81.9 mtp -64.61 -55.35 20.85 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.093 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 74' ' ' ALA . 1.8 t -57.38 -36.28 71.05 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.851 0.357 . . . . 0.0 110.429 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -83.35 52.04 2.12 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.656 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.08 168.75 9.63 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.686 0.279 . . . . 0.0 111.109 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.98 -164.64 1.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.624 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.4 m -57.19 -34.99 69.05 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.3 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.4 t -95.99 150.66 4.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.922 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.432 HG12 ' CD1' ' A' ' 86' ' ' LEU . 21.4 t -132.61 120.58 42.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.268 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.722 HG22 HG22 ' A' ' 8' ' ' THR . 5.4 m -123.58 95.99 4.8 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.01 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.895 HD23 HD11 ' A' ' 57' ' ' LEU . 5.3 mp -108.74 141.89 40.08 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.409 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -107.35 106.93 17.6 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.535 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 51' ' ' LEU . 20.9 t -96.61 149.1 4.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.675 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -121.25 104.36 9.68 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.835 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 7.0 mttm -68.93 133.16 47.82 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.928 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.79 -165.4 1.51 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.241 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.16 135.72 2.64 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.326 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.404 179.869 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.451 0.167 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.667 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.7 t80 -114.55 164.94 13.3 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.648 0.261 . . . . 0.0 110.779 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 2.4 p -121.19 124.85 45.69 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.934 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.727 HG21 ' HB1' ' A' ' 74' ' ' ALA . 1.2 m -82.54 -147.98 0.08 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.763 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.582 ' H ' HG22 ' B' ' 102' ' ' THR . 1.8 pt-20 -178.55 54.44 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.518 HG21 ' HE1' ' A' ' 77' ' ' MET . 25.2 m . . . . . 0 C--O 1.252 1.202 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.04 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 120.606 0.241 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.45 69.93 0.71 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 60.74 85.04 0.19 Allowed Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.419 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.89 -179.62 4.43 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.777 2.318 . . . . 0.0 112.78 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 30.0 tt0 -107.27 94.37 5.06 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.136 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.3 mt -115.86 125.33 72.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.767 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.63 138.04 46.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.34 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.732 HG23 ' HG3' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -94.49 145.77 24.56 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.823 179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.556 HG11 ' HB3' ' A' ' 50' ' ' ARG . 28.1 m -124.08 125.56 70.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.047 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.75 111.71 23.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.76 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.1 mt -131.9 154.49 49.17 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 mtmt -91.4 130.48 37.24 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.764 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.42 122.46 21.28 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.227 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.64 -40.16 5.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.83 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -160.12 43.42 0.2 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.902 0.382 . . . . 0.0 111.214 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.42 -165.22 49.95 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.122 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.0 mtm -127.13 90.73 3.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.768 0.284 . . . . 0.0 110.684 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.77 84.32 0.02 OUTLIER Glycine 0 C--O 1.225 -0.43 0 C-N-CA 121.394 -0.431 . . . . 0.0 113.104 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 20' ' ' SER . 4.1 pp -160.84 178.57 9.29 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.748 0.309 . . . . 0.0 110.942 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.454 ' N ' HD12 ' A' ' 19' ' ' LEU . 2.3 p -131.84 153.87 49.73 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.229 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.815 HD13 HG23 ' A' ' 34' ' ' ILE . 2.9 pp -132.75 157.67 43.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 120.985 0.422 . . . . 0.0 112.122 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG22 ' O ' ' B' ' 100' ' ' PHE . 59.6 t -135.67 138.26 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.227 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.493 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -83.6 158.01 22.07 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.24 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.707 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -153.88 141.97 20.34 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -131.1 179.57 5.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.044 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -168.62 -139.83 2.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.994 -0.622 . . . . 0.0 111.864 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.96 142.71 36.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.587 0.232 . . . . 0.0 110.612 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.96 36.32 92.02 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.691 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -121.91 101.16 7.39 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.762 0.315 . . . . 0.0 111.013 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -90.26 19.29 5.21 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.248 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' O ' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -139.26 -171.51 3.13 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.4 179.667 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.493 HD12 ' HB1' ' A' ' 23' ' ' ALA . 0.4 OUTLIER -136.12 143.55 44.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.108 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.33 117.95 4.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.454 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.815 HG23 HD13 ' A' ' 21' ' ' ILE . 2.0 mp -93.45 87.69 2.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.177 0.513 . . . . 0.0 110.219 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.707 ' HE1' ' HB3' ' A' ' 24' ' ' ALA . 45.6 m-85 -80.61 172.53 13.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.626 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 37.4 t -103.39 148.15 8.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.644 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.0 -37.23 2.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.709 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.4 m -153.24 130.93 11.55 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.771 0.32 . . . . 0.0 111.205 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.4 106.47 20.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.201 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.1 t -68.32 135.31 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.374 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.14 147.56 49.76 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.966 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.58 -14.61 63.02 Favored Glycine 0 CA--C 1.521 0.453 0 C-N-CA 120.744 -0.741 . . . . 0.0 113.226 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.634 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -73.27 -155.07 3.08 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.677 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.56 -41.82 10.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.668 0.27 . . . . 0.0 111.487 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.469 ' HB1' HD12 ' A' ' 51' ' ' LEU . . . -71.26 -33.41 69.77 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.065 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -71.31 -38.45 71.73 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' GLY . 50.0 t -66.31 -54.19 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 111.566 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -63.66 -50.6 68.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.136 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.7 68.43 1.23 Allowed Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.212 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.556 ' HB3' HG11 ' A' ' 9' ' ' VAL . 21.6 mmt85 -145.06 33.68 1.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.821 0.343 . . . . 0.0 110.648 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.469 HD12 ' HB1' ' A' ' 45' ' ' ALA . 4.0 mt -152.48 176.08 12.05 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.213 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.32 142.56 4.86 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.096 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.96 124.0 19.97 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.942 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.82 29.33 6.22 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.405 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.567 ' HB3' HG23 ' A' ' 88' ' ' VAL . 4.0 m-20 -115.81 159.81 20.98 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.521 0.201 . . . . 0.0 110.805 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 48.3 tt0 -96.47 154.8 17.07 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.047 0.451 . . . . 0.0 112.046 -179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mp -125.11 100.23 6.47 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.355 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -69.45 -59.73 2.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.247 -179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -139.44 159.04 43.08 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.065 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.852 HG13 ' HG ' ' A' ' 86' ' ' LEU . 38.9 t -132.89 124.55 50.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.988 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.1 t70 56.42 31.36 18.65 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.031 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 54.96 35.44 58.96 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.804 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.4 mtt-85 -101.99 14.2 32.63 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.74 87.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.38 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.895 HD23 HD12 ' A' ' 68' ' ' LEU . 5.5 mt -111.82 61.87 0.62 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.302 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -130.22 98.52 3.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.109 0.48 . . . . 0.0 110.977 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 129.79 -25.71 4.39 Favored Glycine 0 CA--C 1.519 0.3 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.747 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.895 HD12 HD23 ' A' ' 65' ' ' LEU . 88.5 mt -66.44 174.76 2.56 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.15 0.5 . . . . 0.0 111.334 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.0 m -88.73 162.72 16.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.989 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.551 HE21 HG23 ' B' ' 102' ' ' THR . 40.2 tt0 -52.66 -28.48 21.77 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.555 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -77.66 -54.52 6.28 Favored 'General case' 0 C--N 1.335 -0.054 0 CA-C-O 120.575 0.226 . . . . 0.0 111.057 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -56.94 -34.68 68.24 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.29 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.495 ' HB3' HG12 ' A' ' 34' ' ' ILE . . . -70.89 -59.62 2.69 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.366 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.656 ' O ' HG22 ' A' ' 78' ' ' THR . . . -56.57 -48.34 77.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.26 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -57.08 -44.72 83.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.22 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.87 -37.62 82.05 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.621 0.248 . . . . 0.0 111.033 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.781 ' HG2' HG21 ' A' ' 60' ' ' VAL . 56.6 mtp -61.95 -56.52 18.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.437 -179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 74' ' ' ALA . 1.6 t -61.12 -38.13 85.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.769 0.319 . . . . 0.0 110.506 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -85.5 53.07 2.63 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.454 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.51 179.5 4.68 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.735 0.302 . . . . 0.0 111.1 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.53 -165.59 1.34 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.749 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.3 m -55.75 -47.51 76.85 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.879 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.8 t -89.28 143.74 10.56 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.881 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.1 t -136.65 111.05 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.054 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.494 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -106.57 83.76 1.91 Allowed 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.541 179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.852 ' HG ' HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -93.62 137.48 32.85 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.426 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.732 ' HG3' HG23 ' A' ' 8' ' ' THR . 8.4 mt-10 -103.13 140.33 37.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.677 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.567 HG23 ' HB3' ' A' ' 55' ' ' ASP . 11.8 p -128.7 138.16 55.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.366 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -109.53 116.65 32.18 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.711 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -61.3 120.38 10.29 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.136 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.15 -172.41 2.02 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.133 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -83.29 3.02 86.1 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.8 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.215 179.491 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.1 tp . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.989 0.424 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.486 ' O ' HG22 ' A' ' 22' ' ' VAL . 32.1 m-85 -141.56 -170.65 3.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.382 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 2.4 p -132.29 110.91 10.93 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.755 0.312 . . . . 0.0 111.44 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.551 HG23 HE21 ' A' ' 70' ' ' GLN . 17.4 p -98.18 -164.57 1.15 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.495 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.76 94.04 2.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.326 0.584 . . . . 0.0 110.737 178.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.461 HG21 ' CB ' ' A' ' 77' ' ' MET . 5.3 p . . . . . 0 C--O 1.252 1.232 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.038 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ttt . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.544 0.211 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.37 80.33 0.23 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.912 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -88.22 118.75 69.9 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.913 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.48 -179.0 2.49 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.678 2.252 . . . . 0.0 112.521 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -124.67 94.83 4.31 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.06 0.457 . . . . 0.0 110.813 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.647 HG21 HD13 ' A' ' 58' ' ' LEU . 4.5 mp -91.2 135.38 27.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.814 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.568 HD12 HG13 ' A' ' 9' ' ' VAL . 1.5 pp -142.27 138.26 29.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.259 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.918 HG22 HG22 ' A' ' 85' ' ' THR . 3.2 m -104.08 98.54 8.34 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.568 HG13 HD12 ' A' ' 7' ' ' ILE . 19.2 m -89.17 169.79 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.44 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -125.18 109.22 12.6 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.755 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 50' ' ' ARG . 2.6 mt -109.52 155.26 21.59 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.768 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -107.52 118.82 37.74 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.725 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -62.45 100.73 0.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.134 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.86 87.48 3.31 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.727 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.12 39.58 28.93 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.208 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.93 153.87 30.53 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.171 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.856 ' O ' HG11 ' A' ' 40' ' ' VAL . 7.5 mtm -80.28 -79.92 0.14 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.648 0.224 . . . . 0.0 111.038 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 111.75 -0.74 27.45 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 120.98 -0.629 . . . . 0.0 113.149 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 20' ' ' SER . 3.5 pp -79.86 173.8 12.22 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 117.071 0.436 . . . . 0.0 110.828 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.467 ' N ' HD12 ' A' ' 19' ' ' LEU . 57.9 m -127.12 151.62 48.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.74 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.598 HD13 HG23 ' A' ' 34' ' ' ILE . 2.2 pp -139.75 150.83 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.554 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.857 HG23 ' HB2' ' A' ' 37' ' ' LYS . 85.7 t -126.15 145.67 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.274 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HB2' ' HB2' ' A' ' 70' ' ' GLN . . . -107.2 119.9 40.66 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.748 179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.9 151.47 44.29 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.414 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.401 ' HG3' ' CD1' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -118.71 -179.74 3.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.048 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.63 -139.68 2.73 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.35 143.89 38.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.628 0.251 . . . . 0.0 110.801 179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.37 41.59 99.56 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.652 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.48 107.26 7.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.719 0.295 . . . . 0.0 110.973 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.429 ' C ' ' HG3' ' A' ' 31' ' ' LYS . 24.5 t0 -91.93 20.51 5.68 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.316 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.429 ' HG3' ' C ' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -141.19 -167.87 2.49 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.307 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.401 ' CD1' ' HG3' ' A' ' 25' ' ' LYS . 5.6 tp -136.61 126.2 25.32 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 110.801 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.36 130.39 10.1 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.946 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.598 HG23 HD13 ' A' ' 21' ' ' ILE . 21.3 mm -95.19 71.13 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.073 0.463 . . . . 0.0 110.835 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE1' ' HG3' ' A' ' 56' ' ' GLN . 94.4 m-85 -62.16 160.51 12.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.21 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 55' ' ' ASP . 23.2 t -96.25 121.22 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.731 0.3 . . . . 0.0 111.277 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.857 ' HB2' HG23 ' A' ' 22' ' ' VAL . 6.3 tttp -80.19 -43.66 21.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.042 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 90.8 p -156.41 178.23 10.55 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.6 m -141.94 123.05 12.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.673 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.856 HG11 ' O ' ' A' ' 17' ' ' MET . 2.1 p -50.4 132.03 10.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.66 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -91.84 92.78 8.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.506 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 141.01 -21.64 2.64 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.148 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -70.64 -167.83 7.26 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.066 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.52 -1.32 53.45 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.45 -43.14 8.12 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.749 0.309 . . . . 0.0 111.013 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -72.69 -44.97 61.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.524 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.4 t -64.86 -39.53 85.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.541 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.46 -47.92 62.43 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.927 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.22 44.52 6.22 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.665 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.496 ' HB3' HG11 ' A' ' 9' ' ' VAL . 21.9 mmt85 -102.56 -38.63 7.45 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.547 0.213 . . . . 0.0 110.965 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.437 HD23 HD11 ' A' ' 11' ' ' LEU . 3.9 pp -126.79 158.85 35.49 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.894 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.29 -174.95 4.44 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.193 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.54 138.94 43.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.078 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 83.22 39.42 9.98 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.875 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 36' ' ' VAL . 63.5 m-20 -116.16 138.19 51.48 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.514 0.197 . . . . 0.0 110.742 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.444 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 0.9 OUTLIER -81.11 147.75 29.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.059 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 2.1 tp -101.02 154.36 18.77 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 111.563 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.647 HD13 HG21 ' A' ' 6' ' ' ILE . 2.3 tt -140.54 -57.53 0.53 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.032 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.53 156.72 48.44 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.883 0.373 . . . . 0.0 111.254 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.606 HG11 ' CG ' ' A' ' 77' ' ' MET . 29.3 t -141.49 123.43 13.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.827 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.57 33.05 22.76 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.313 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.44 27.93 71.94 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.872 -0.68 . . . . 0.0 113.042 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.1 mtt180 -115.07 165.38 12.96 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.827 0.314 . . . . 0.0 110.825 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.43 106.99 17.66 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.831 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.547 HD21 HG23 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -119.99 33.22 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.9 t -80.89 98.86 4.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.24 0.543 . . . . 0.0 110.695 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.34 28.81 3.92 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.64 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 68' ' ' LEU . 17.0 mt -110.42 158.44 18.47 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.764 0.316 . . . . 0.0 110.737 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.67 153.01 42.88 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.391 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 49.3 tt0 -52.01 -34.55 43.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.967 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -65.76 -48.53 71.52 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.313 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -63.51 -44.31 94.65 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.609 0.242 . . . . 0.0 111.335 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.434 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -59.67 -56.24 24.4 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.71 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.584 ' O ' HG22 ' A' ' 78' ' ' THR . . . -62.93 -45.97 89.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.075 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -57.79 -26.3 61.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.547 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.3 mt -74.63 -47.87 29.63 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.795 ' HB2' HG21 ' B' ' 104' ' ' VAL . 4.6 mtp -60.43 -48.06 83.38 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.811 -0.177 . . . . 0.0 111.355 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 74' ' ' ALA . 1.4 t -61.12 -36.12 78.87 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.83 0.348 . . . . 0.0 110.304 179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -83.98 52.57 2.33 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.843 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.456 HG21 HG13 ' A' ' 84' ' ' VAL . 34.9 p -118.01 176.48 5.19 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.796 0.332 . . . . 0.0 111.072 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -92.54 -163.86 1.1 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.517 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.03 -34.03 58.88 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.576 -0.283 . . . . 0.0 110.945 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.59 140.8 22.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.904 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.53 HG12 ' CD1' ' A' ' 86' ' ' LEU . 15.0 t -136.76 118.2 18.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.137 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.918 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -96.63 100.54 12.1 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.86 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.53 ' CD1' HG12 ' A' ' 84' ' ' VAL . 4.8 mp -100.77 116.99 33.95 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.204 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 28.8 tt0 -101.4 101.52 12.16 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.547 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.02 171.32 3.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.625 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.31 135.94 53.44 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.096 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -93.98 117.04 29.55 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.457 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -160.72 167.04 27.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.52 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 150.37 -119.74 1.05 Allowed Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.406 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.283 -0.865 . . . . 0.0 111.69 179.911 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -127.4 -176.46 3.75 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.579 0.228 . . . . 0.0 111.443 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 60.2 p -168.95 146.72 3.8 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.814 0.34 . . . . 0.0 111.843 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.449 HG21 ' CB ' ' A' ' 74' ' ' ALA . 19.7 m -157.9 158.68 35.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.593 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -135.0 88.38 2.42 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.959 0.409 . . . . 0.0 110.144 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.795 HG21 ' HB2' ' A' ' 77' ' ' MET . 8.0 p . . . . . 0 C--O 1.252 1.212 0 CA-C-O 118.707 -0.664 . . . . 0.0 112.005 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 120.711 0.291 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -102.99 95.09 5.91 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.626 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -107.64 128.97 24.87 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 34.0 Cg_exo -58.97 175.27 0.65 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.812 2.341 . . . . 0.0 112.719 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.24 97.37 3.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.256 0.551 . . . . 0.0 110.842 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.448 HG12 ' CD1' ' A' ' 58' ' ' LEU . 4.6 mp -80.03 122.33 35.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.176 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.14 138.76 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.337 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.795 HG22 HG22 ' A' ' 85' ' ' THR . 0.2 OUTLIER -100.37 126.58 46.75 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.476 HG13 ' HD2' ' A' ' 50' ' ' ARG . 22.0 t -114.38 131.22 67.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.9 m -105.31 123.39 47.78 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.917 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.505 HD21 ' CG ' ' A' ' 48' ' ' ASP . 10.3 mt -140.72 160.18 40.6 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.118 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.9 mtmm -101.23 163.76 12.12 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.892 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.1 mtpt -90.96 98.42 11.77 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -74.86 -53.14 9.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.2 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -166.46 45.28 0.06 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.347 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.75 150.38 14.31 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.226 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -60.08 3.31 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.688 0.244 . . . . 0.0 110.479 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.93 72.23 1.03 Allowed Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.324 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.487 HD11 ' CG1' ' B' ' 104' ' ' VAL . 3.3 pp -161.14 178.02 9.7 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.446 0.165 . . . . 0.0 110.698 179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 67.4 m -127.54 141.48 51.63 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.669 0.271 . . . . 0.0 111.615 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 21' ' ' ILE . 2.3 pp -132.59 159.91 42.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.409 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.496 HG13 ' O ' ' B' ' 100' ' ' PHE . 61.8 t -146.64 148.05 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.356 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.419 ' HB2' ' HG3' ' A' ' 70' ' ' GLN . . . -104.35 147.88 27.02 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.056 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.77 149.8 30.21 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.83 0.347 . . . . 0.0 111.762 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 tttt -121.79 -179.9 4.27 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.81 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -158.2 -144.01 3.82 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.978 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.14 145.15 37.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.603 0.24 . . . . 0.0 110.748 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.81 30.6 63.14 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.587 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.74 108.83 4.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.682 0.277 . . . . 0.0 110.67 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -93.96 27.56 2.74 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.384 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.497 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.4 OUTLIER -116.04 -165.48 1.05 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.421 179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 32' ' ' LEU . 1.4 tp -144.57 136.87 26.35 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.632 0.253 . . . . 0.0 111.119 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.35 116.68 5.62 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.625 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.1 mp -85.48 81.54 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.368 0.604 . . . . 0.0 110.496 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 56' ' ' GLN . 93.4 m-85 -79.8 145.59 32.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.106 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.9 t -83.47 123.3 38.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.901 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.486 ' HB2' HG23 ' A' ' 22' ' ' VAL . 10.3 tptt -82.38 -43.21 17.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.846 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 t -169.01 -179.92 3.82 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.118 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.2 t -132.78 129.94 58.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.706 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.36 129.75 36.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.016 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.8 136.8 58.11 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.117 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.62 -26.67 17.27 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.7 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.565 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -65.74 158.73 46.69 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.784 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.3 -39.3 72.5 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.02 -39.62 63.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.196 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -60.35 -38.96 85.47 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 43' ' ' GLY . 36.7 t -73.35 -38.76 54.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.335 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.505 ' CG ' HD21 ' A' ' 11' ' ' LEU . 1.1 t0 -59.46 -43.26 93.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.319 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.78 36.48 57.9 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.946 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.476 ' HD2' HG13 ' A' ' 9' ' ' VAL . 19.3 mtt-85 -98.93 -45.9 5.81 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.781 0.29 . . . . 0.0 110.889 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.4 pp -101.84 171.46 7.52 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.783 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.75 -173.13 3.8 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.281 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -82.42 157.75 23.56 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.014 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.47 30.46 71.17 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.921 -0.656 . . . . 0.0 112.696 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -103.67 -177.02 3.25 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.562 0.22 . . . . 0.0 110.792 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 35' ' ' TYR . 65.8 tt0 -125.85 152.74 45.1 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.945 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.754 HD11 HD21 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -112.16 142.84 44.13 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.126 179.74 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.491 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -115.17 -54.65 2.54 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.351 -179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.3 p -140.12 154.36 46.98 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.086 0.47 . . . . 0.0 111.95 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.84 HG23 HD11 ' A' ' 65' ' ' LEU . 59.6 t -132.09 112.84 20.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.518 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.09 35.48 26.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.997 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.07 31.98 45.86 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.041 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -128.9 149.3 50.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.815 0.307 . . . . 0.0 110.655 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 t -92.27 132.62 36.54 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.169 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.84 HD11 HG23 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -107.83 -28.9 9.37 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.494 179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.07 99.24 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-O 121.188 0.518 . . . . 0.0 111.017 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 31' ' ' LYS . . . 142.87 -35.39 1.7 Allowed Glycine 0 CA--C 1.521 0.431 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.882 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.797 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 0.7 OUTLIER -88.11 166.49 14.38 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.008 0.432 . . . . 0.0 111.109 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.1 t -72.5 161.07 31.28 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.757 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' B' ' 100' ' ' PHE . 3.4 tt0 -53.46 -44.2 68.72 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.067 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -61.4 -39.61 91.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.704 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.37 -35.86 73.8 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.866 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.797 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . . . -72.04 -61.01 1.94 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.383 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.526 ' CB ' HG21 ' B' ' 102' ' ' THR . . . -54.23 -39.76 67.06 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.313 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.409 ' HG3' ' CD ' ' A' ' 79' ' ' ARG . 1.7 tt0 -62.55 -50.11 72.62 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.843 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.83 -32.17 65.47 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.217 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.582 ' HE1' HG11 ' B' ' 104' ' ' VAL . 22.4 mtp -71.22 -58.83 3.17 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.565 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.535 ' HB ' HG23 ' B' ' 104' ' ' VAL . 4.8 t -59.36 -33.98 71.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.811 0.338 . . . . 0.0 110.709 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.409 ' CD ' ' HG3' ' A' ' 75' ' ' GLU . 66.4 mtp85 -86.43 51.98 2.37 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.516 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 p -110.09 -178.99 3.66 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.678 0.275 . . . . 0.0 110.95 179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.16 -174.03 4.65 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.83 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.5 p -52.33 -44.11 64.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.22 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.73 140.38 16.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.844 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.28 121.27 65.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.072 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.795 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -113.23 80.87 1.41 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.785 179.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.754 HD21 HD11 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -90.31 121.8 32.64 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.938 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.671 ' HB2' HG23 ' A' ' 8' ' ' THR . 24.9 tt0 -104.19 103.8 13.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.579 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.5 m -102.32 170.86 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.116 0.484 . . . . 0.0 111.64 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.8 98.11 6.65 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.993 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.89 126.67 28.09 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.972 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -148.86 170.42 18.31 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.327 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -86.39 -7.01 80.21 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.657 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.211 0 CA-C-O 118.47 -0.776 . . . . 0.0 111.679 -179.76 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 120.757 0.313 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.496 ' O ' HG13 ' A' ' 22' ' ' VAL . 52.1 m-85 -103.56 117.76 35.17 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.082 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.491 ' HA ' HG22 ' A' ' 22' ' ' VAL . 27.2 t -175.68 119.33 0.17 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.791 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.526 HG21 ' CB ' ' A' ' 74' ' ' ALA . 31.6 m -122.24 159.02 28.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.351 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -121.92 88.4 2.93 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.117 0.484 . . . . 0.0 110.319 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.582 HG11 ' HE1' ' A' ' 77' ' ' MET . 8.0 p . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.071 -0.966 . . . . 0.0 111.688 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 79.77 0.86 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.905 0.383 . . . . 0.0 110.676 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -135.42 146.11 56.42 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.704 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.9 -178.26 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.942 2.428 . . . . 0.0 112.91 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 8.6 tt0 -129.27 97.2 4.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.091 0.472 . . . . 0.0 110.922 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mp -88.76 125.84 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.629 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.626 HD12 HG13 ' A' ' 9' ' ' VAL . 1.3 pt -141.65 142.79 28.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.262 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.746 HG23 ' HB2' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -99.77 116.62 32.29 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.887 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.626 HG13 HD12 ' A' ' 7' ' ' ILE . 27.2 m -111.2 146.54 16.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.41 HG22 ' CG1' ' A' ' 83' ' ' VAL . 2.1 m -119.95 127.7 52.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.833 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mt -133.38 166.1 23.3 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.407 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 mttp -109.83 176.7 4.97 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.7 mtpt -106.28 92.25 4.05 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.846 0.355 . . . . 0.0 111.361 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -45.41 38.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.439 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -167.05 45.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.209 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.92 145.34 15.32 Favored Glycine 0 C--N 1.335 0.519 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.152 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -41.3 98.56 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.643 0.222 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.77 68.3 1.74 Allowed Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.131 -0.557 . . . . 0.0 113.051 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.487 ' HA ' HG23 ' A' ' 40' ' ' VAL . 2.3 pp -160.75 168.38 24.91 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.553 0.216 . . . . 0.0 111.017 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' B' ' 103' ' ' GLU . 7.5 m -116.16 153.36 31.95 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.122 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.089 HD11 HG22 ' B' ' 102' ' ' THR . 2.6 pp -124.17 165.52 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-O 120.707 0.289 . . . . 0.0 111.682 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.747 HG13 ' HB2' ' B' ' 100' ' ' PHE . 25.7 t -151.42 140.81 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.465 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -87.84 158.59 18.69 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.714 ' HB3' ' CE1' ' A' ' 35' ' ' TYR . . . -155.22 132.83 11.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.927 0.394 . . . . 0.0 111.64 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -128.9 179.85 5.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.761 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -172.72 -140.04 3.02 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.06 -0.59 . . . . 0.0 111.73 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.07 147.79 28.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.629 0.252 . . . . 0.0 110.634 179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 61.25 36.54 92.59 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.693 -179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.53 106.37 7.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.64 0.257 . . . . 0.0 110.776 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -90.16 20.79 4.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.516 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.595 ' CB ' HG12 ' A' ' 66' ' ' VAL . 21.4 mmtp -144.33 -169.16 3.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.822 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 24' ' ' ALA . 4.7 mt -138.39 131.06 29.32 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.782 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.69 151.05 21.53 Favored Glycine 0 CA--C 1.521 0.446 0 C-N-CA 120.821 -0.705 . . . . 0.0 112.924 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.675 HG13 ' HB1' ' A' ' 73' ' ' ALA . 23.8 mm -106.39 110.3 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-O 120.726 0.298 . . . . 0.0 111.215 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.714 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 6.4 m-85 -103.5 174.1 6.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.207 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.405 HG13 HD13 ' A' ' 19' ' ' LEU . 47.0 t -111.85 112.11 39.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.008 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.502 ' HB2' HG23 ' A' ' 22' ' ' VAL . 0.6 OUTLIER -60.29 -49.64 76.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.592 179.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.4 p -176.61 131.4 0.2 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.898 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.0 t -82.74 127.29 39.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.427 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 19' ' ' LEU . 14.8 t -80.06 127.6 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.09 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 128.45 36.38 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.74 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.56 -19.86 11.3 Favored Glycine 0 CA--C 1.519 0.337 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.967 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.408 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -72.12 -162.27 5.79 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.667 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.06 -34.6 14.33 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.49 -33.8 54.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -67.96 -47.62 68.12 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 43' ' ' GLY . 55.7 t -60.61 -42.18 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.558 0.218 . . . . 0.0 111.336 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.21 -35.67 79.58 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.148 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.38 45.09 88.55 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.902 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.76 -34.2 10.99 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.577 0.227 . . . . 0.0 110.954 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.7 147.61 50.13 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.006 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -109.57 -168.59 1.35 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.043 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.36 146.81 44.9 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.351 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.45 47.13 23.15 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.245 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.49 129.99 56.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.478 0.18 . . . . 0.0 110.782 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 35' ' ' TYR . 2.1 tm0? -80.62 145.53 31.65 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.02 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.46 HD22 HD23 ' A' ' 86' ' ' LEU . 6.6 mt -117.04 120.92 39.85 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.765 179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.41 -58.33 2.66 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.042 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.9 p -130.76 163.92 26.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.247 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.579 HG11 ' HG2' ' A' ' 77' ' ' MET . 24.9 t -139.73 114.99 7.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.12 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 59.34 24.28 12.81 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.508 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.18 28.96 26.58 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.527 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.77 160.5 27.17 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.72 0.295 . . . . 0.0 110.636 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.4 m -101.96 114.54 28.73 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.698 ' CD2' HD13 ' A' ' 76' ' ' LEU . 51.3 mt -114.63 31.91 6.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.015 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.595 HG12 ' CB ' ' A' ' 31' ' ' LYS . 69.2 t -114.26 100.85 11.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 121.143 0.497 . . . . 0.0 110.667 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.08 -35.45 1.47 Allowed Glycine 0 CA--C 1.517 0.207 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.627 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.9 168.64 13.22 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 110.459 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.3 t -64.71 157.57 27.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.181 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.76 ' CD ' HD13 ' A' ' 21' ' ' ILE . 8.6 tp-100 -52.24 -31.08 30.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.928 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.26 -52.23 65.25 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.954 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.81 -43.19 94.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.045 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.675 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -67.45 -61.47 1.89 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.679 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 78' ' ' THR . . . -55.74 -36.12 66.92 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.631 0.253 . . . . 0.0 111.378 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.408 ' HG2' ' NH2' ' A' ' 79' ' ' ARG . 0.9 OUTLIER -74.72 -34.6 62.61 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.411 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.698 HD13 ' CD2' ' A' ' 65' ' ' LEU . 3.2 mt -68.9 -44.15 73.77 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.482 0.182 . . . . 0.0 110.968 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.579 ' HG2' HG11 ' A' ' 60' ' ' VAL . 36.2 mtp -59.75 -52.46 65.39 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.563 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 74' ' ' ALA . 3.6 t -62.35 -36.75 83.21 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.665 0.269 . . . . 0.0 110.764 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.408 ' NH2' ' HG2' ' A' ' 75' ' ' GLU . 60.0 mtm180 -87.73 53.94 2.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.632 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 11.2 p -108.76 176.2 5.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 111.005 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.59 -174.55 1.75 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.429 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.5 m -52.27 -34.26 45.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.628 0.252 . . . . 0.0 111.125 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.41 ' CG1' HG22 ' A' ' 10' ' ' THR . 21.3 t -107.71 151.4 9.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.92 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.8 t -137.65 118.37 16.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.518 HG22 HG22 ' A' ' 8' ' ' THR . 24.0 m -104.58 94.34 5.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.843 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.46 HD23 HD22 ' A' ' 57' ' ' LEU . 3.4 mp -98.95 138.42 36.09 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.411 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.746 ' HB2' HG23 ' A' ' 8' ' ' THR . 48.5 tt0 -114.89 99.74 7.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.714 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.1 m -101.98 173.83 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 121.041 0.448 . . . . 0.0 111.746 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.87 123.34 39.73 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.126 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 1.7 mptm? -79.42 96.46 6.05 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.607 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 pm0 -135.19 -173.89 3.46 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.927 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 133.42 140.39 4.36 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.536 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.464 -0.779 . . . . 0.0 111.514 -179.868 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.66 0.267 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.747 ' HB2' HG13 ' A' ' 22' ' ' VAL . 33.5 p90 -112.98 164.24 13.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.915 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 4.4 t 64.21 86.17 0.13 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 1.089 HG22 HD11 ' A' ' 21' ' ' ILE . 5.2 t -137.38 17.44 2.94 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.907 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 0.6 OUTLIER 59.66 174.87 0.08 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.226 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 74' ' ' ALA . 8.0 p . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.405 -0.807 . . . . 0.0 111.401 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.868 0.366 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.448 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 1.7 mtmp? -66.8 168.37 9.75 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.657 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.82 86.95 11.59 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.942 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 2' ' ' LYS . 26.9 Cg_exo -63.11 179.52 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.768 2.312 . . . . 0.0 112.59 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -127.61 94.3 3.93 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.773 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mt -84.06 113.67 23.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.971 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.85 141.01 45.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 27.5 m -104.87 141.33 36.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.106 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -119.59 127.93 75.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.283 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.1 m -99.42 103.54 15.33 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.671 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 23.9 mt -143.9 149.01 36.23 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.359 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.18 167.78 14.59 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.208 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.66 124.89 28.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.62 85.48 2.4 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.38 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 m120 58.38 34.56 24.11 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.946 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.11 158.0 31.0 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.669 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.49 -48.57 16.75 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.534 0.207 . . . . 0.0 110.634 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 68.48 74.96 0.55 Allowed Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.555 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' B' ' 103' ' ' GLU . 2.8 pp -160.74 173.82 14.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.556 0.217 . . . . 0.0 110.776 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -124.35 149.58 46.46 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.804 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.408 ' HB ' HG22 ' A' ' 34' ' ' ILE . 8.6 pt -137.71 154.48 29.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.627 HG13 ' O ' ' B' ' 100' ' ' PHE . 61.8 t -147.12 134.97 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.251 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.664 ' HB2' ' OE1' ' A' ' 70' ' ' GLN . . . -88.96 144.43 26.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.952 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -158.41 159.44 35.76 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.837 0.351 . . . . 0.0 111.783 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -122.45 179.31 4.63 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.052 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.88 -144.06 3.85 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.888 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.07 150.31 28.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.645 0.26 . . . . 0.0 110.865 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.79 28.82 60.84 Favored Glycine 0 C--N 1.335 0.517 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.586 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.78 107.98 4.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.651 0.262 . . . . 0.0 110.455 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -97.57 37.42 1.37 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.175 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -133.52 -164.62 1.51 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.477 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 tp -147.53 125.76 12.24 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.68 0.276 . . . . 0.0 110.772 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.76 137.57 13.34 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.607 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.601 HG13 ' HB1' ' A' ' 73' ' ' ALA . 18.8 mm -86.6 72.63 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.107 0.48 . . . . 0.0 110.736 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -60.23 160.18 8.77 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.348 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.0 t -100.96 115.09 41.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.964 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.4 -46.78 78.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.791 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -178.94 124.87 0.09 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.902 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.5 m -72.67 142.51 15.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.089 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 t -91.91 137.67 21.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.127 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.38 153.25 27.36 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.213 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.05 14.94 76.32 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.839 -0.695 . . . . 0.0 112.884 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -92.18 159.39 25.3 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.296 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.7 -36.23 69.42 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 51' ' ' LEU . . . -83.3 -34.41 25.72 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.291 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -68.11 -47.09 69.12 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.309 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 43' ' ' GLY . 44.2 t -63.81 -46.53 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.4 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -43.95 97.56 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.168 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.47 64.96 1.77 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.839 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -136.78 23.47 3.1 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.632 0.253 . . . . 0.0 111.374 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 45' ' ' ALA . 3.1 pp -179.83 177.97 0.65 Allowed 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.755 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.77 -170.05 2.07 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.187 -179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.406 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -72.44 160.23 32.67 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.914 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 91' ' ' GLN . . . 64.91 31.24 80.26 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.244 -179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.8 124.69 45.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.59 0.234 . . . . 0.0 110.5 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.643 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . 8.7 tm0? -79.47 117.57 20.55 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.057 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.539 HD11 HD23 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -88.75 136.09 33.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.198 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.451 HD13 ' CG2' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -108.54 -63.01 1.38 Allowed 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.837 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 58.8 m -127.91 145.49 50.94 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.196 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' A' ' 77' ' ' MET . 39.2 t -120.87 118.19 55.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.667 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 60.56 32.01 20.34 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.105 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.73 -6.28 70.66 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 120.89 -0.672 . . . . 0.0 113.273 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -80.53 154.62 27.41 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 117.186 0.493 . . . . 0.0 111.057 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.35 101.09 12.55 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.946 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.658 HD23 HD12 ' A' ' 68' ' ' LEU . 6.4 mt -110.42 44.2 1.28 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.688 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.451 ' CG2' HD13 ' A' ' 58' ' ' LEU . 60.3 t -101.8 99.97 9.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.719 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.83 -29.25 5.66 Favored Glycine 0 CA--C 1.52 0.356 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.759 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.658 HD12 HD23 ' A' ' 65' ' ' LEU . 65.7 mt -65.36 168.59 6.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 111.241 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.0 t -87.22 168.16 13.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.449 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.664 ' OE1' ' HB2' ' A' ' 23' ' ' ALA . 5.9 tp60 -58.24 -29.44 65.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.003 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.47 -56.01 27.39 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.676 -0.238 . . . . 0.0 110.786 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -63.21 -45.99 89.11 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.693 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.601 ' HB1' HG13 ' A' ' 34' ' ' ILE . . . -59.07 -58.39 8.87 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.972 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.893 ' HB1' HG21 ' B' ' 102' ' ' THR . . . -49.07 -48.56 44.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.712 0.291 . . . . 0.0 111.387 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.37 -61.76 2.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.739 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.59 HD12 HD21 ' A' ' 65' ' ' LEU . 16.8 mt -56.22 -30.53 62.44 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.703 ' CE ' HG21 ' B' ' 104' ' ' VAL . 4.3 mmm -66.01 -64.15 0.92 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.8 -0.182 . . . . 0.0 111.175 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 74' ' ' ALA . 3.4 t -62.4 -35.82 80.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.775 0.322 . . . . 0.0 110.729 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 68.2 mtm180 -85.33 49.4 1.75 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.333 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.89 169.56 10.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.717 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.14 -169.34 0.93 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.822 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.63 -54.55 21.98 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.697 0.284 . . . . 0.0 110.86 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.73 147.16 5.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.692 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.489 HG12 HD13 ' A' ' 86' ' ' LEU . 33.3 t -121.78 111.63 31.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.987 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.14 105.85 14.7 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.781 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.539 HD23 HD11 ' A' ' 57' ' ' LEU . 5.4 mp -115.2 131.13 57.03 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.942 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 2.3 mt-10 -102.16 95.55 6.4 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.461 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.3 m -89.66 172.68 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.256 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.643 ' HB3' ' HB3' ' A' ' 56' ' ' GLN . . . -130.48 118.77 21.62 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.52 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 106.78 0.27 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.643 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 91' ' ' GLN . 1.0 OUTLIER -70.47 -178.87 1.88 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.187 -179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 130.97 145.21 5.61 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.368 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.393 -0.813 . . . . 0.0 111.183 179.736 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.0 mt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.693 0.282 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.627 ' O ' HG13 ' A' ' 22' ' ' VAL . 22.7 p90 -171.41 36.52 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.42 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 53.9 p -162.94 78.02 0.45 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.986 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.893 HG21 ' HB1' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -96.58 -152.51 0.38 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.73 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.561 ' H ' HG22 ' B' ' 102' ' ' THR . 0.2 OUTLIER -176.34 48.28 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.703 HG21 ' CE ' ' A' ' 77' ' ' MET . 26.0 m . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.165 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptp . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -75.29 158.84 32.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.018 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -118.92 104.53 46.58 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.206 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.62 -170.2 0.37 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.808 2.339 . . . . 0.0 112.556 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 1.4 tt0 -132.71 102.58 5.73 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.984 0.421 . . . . 0.0 111.234 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 mt -95.63 131.14 43.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.881 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.0 pt -150.74 154.89 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.198 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.72 ' CG2' HG22 ' A' ' 85' ' ' THR . 1.8 m -122.49 132.25 54.24 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.882 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 19.6 t -115.78 136.8 51.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.183 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -101.68 112.14 24.62 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.656 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 mt -134.74 168.67 18.6 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.236 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.1 157.28 19.53 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -86.33 69.75 10.46 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.488 HE22 ' HB2' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -43.79 -41.27 4.88 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.701 -179.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -172.77 44.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.294 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.46 152.23 25.17 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.178 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.421 ' O ' ' HA3' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -74.91 -51.42 13.84 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.571 0.224 . . . . 0.0 110.821 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 64.06 80.77 0.12 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.083 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.446 HD11 ' CG1' ' B' ' 104' ' ' VAL . 3.0 pp -160.92 -179.76 7.82 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.619 0.247 . . . . 0.0 110.88 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 37' ' ' LYS . 15.3 m -125.28 141.69 51.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.067 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.538 HD13 HG23 ' A' ' 34' ' ' ILE . 2.4 pp -136.26 157.47 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 120.832 0.348 . . . . 0.0 111.796 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 90.9 t -145.32 148.59 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.235 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -101.09 131.97 46.76 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.235 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -140.86 146.89 38.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.493 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HG3' HD12 ' A' ' 32' ' ' LEU . 11.5 tttt -122.83 -179.73 4.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.957 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.39 -140.57 2.91 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.751 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.3 147.27 32.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.586 0.231 . . . . 0.0 110.779 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 59.78 40.89 97.25 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.614 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.53 106.24 7.33 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.715 0.293 . . . . 0.0 110.907 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -90.68 24.43 2.69 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.003 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -144.35 -165.83 2.23 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.647 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.425 HD12 ' HG3' ' A' ' 25' ' ' LYS . 6.9 tp -138.67 135.1 34.48 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.798 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.36 127.42 8.78 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.709 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.582 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -95.91 94.72 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 CA-C-O 121.129 0.49 . . . . 0.0 110.562 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -78.59 168.56 19.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.375 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.412 ' CG2' HD11 ' A' ' 57' ' ' LEU . 21.2 t -101.48 133.9 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.134 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 20' ' ' SER . 4.7 ttpt -97.53 -40.61 8.56 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.9 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.2 m -160.4 174.29 14.35 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.93 123.47 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.795 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.8 t -79.87 153.19 4.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.261 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -72.01 153.37 41.81 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.154 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.89 8.92 87.54 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.366 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.675 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -96.16 156.48 21.3 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.377 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' HB2' HE22 ' A' ' 14' ' ' GLN . . . -53.59 -43.35 68.5 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.622 0.249 . . . . 0.0 111.5 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.38 -34.66 74.87 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.242 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.65 -46.1 48.72 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.339 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 43' ' ' GLY . 41.0 t -61.11 -49.34 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.164 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.69 -44.82 89.08 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.163 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.95 28.55 66.53 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.081 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.84 -47.52 16.46 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.805 0.303 . . . . 0.0 110.894 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.581 ' HB3' HG21 ' A' ' 88' ' ' VAL . 3.1 pp -109.73 170.42 8.08 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.1 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.96 177.76 7.58 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.169 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.92 141.72 53.05 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.43 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.48 43.57 4.86 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.675 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -128.22 146.03 50.86 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.686 0.279 . . . . 0.0 110.887 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -83.5 152.55 24.86 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.676 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.578 ' HB3' HD12 ' A' ' 65' ' ' LEU . 7.0 mp -115.0 148.51 38.73 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.942 0.401 . . . . 0.0 111.72 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.78 -55.17 2.01 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.782 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.7 p -137.58 152.13 49.09 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.9 0.381 . . . . 0.0 111.778 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.782 HG13 ' HG ' ' A' ' 86' ' ' LEU . 38.4 t -143.38 107.52 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.962 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.9 t0 61.14 41.86 13.07 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.161 0.505 . . . . 0.0 110.823 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.99 37.5 38.14 Favored Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.887 -0.597 . . . . 0.0 113.058 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.47 162.0 21.26 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.766 0.283 . . . . 0.0 110.689 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.22 83.66 1.87 Allowed 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.591 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.691 HD11 ' CG2' ' A' ' 60' ' ' VAL . 40.7 mt -60.8 -22.68 64.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.298 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 63.1 t -78.21 97.83 2.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 121.186 0.517 . . . . 0.0 111.113 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.71 32.95 1.04 Allowed Glycine 0 CA--C 1.521 0.446 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.288 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.876 ' CD1' ' HB2' ' A' ' 73' ' ' ALA . 1.2 pp -150.16 165.34 33.18 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 110.57 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 83.0 p -79.63 161.79 25.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.946 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -56.55 -32.3 65.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.325 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -73.84 -34.48 64.56 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.491 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -76.23 -33.22 59.22 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.978 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.876 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . . . -76.28 -58.64 3.16 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.334 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.69 ' O ' HG22 ' A' ' 78' ' ' THR . . . -56.55 -42.88 79.27 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.537 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.77 -39.85 93.1 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-O 120.698 0.285 . . . . 0.0 110.812 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 mt -71.18 -32.2 68.59 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.291 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.578 ' HG2' HG11 ' A' ' 60' ' ' VAL . 28.1 mtp -72.24 -53.56 12.18 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.608 -179.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 74' ' ' ALA . 2.0 t -60.7 -38.7 85.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.751 0.31 . . . . 0.0 110.795 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 40.6 mtp85 -87.87 55.94 3.68 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.644 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.4 p -106.52 178.5 4.54 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.895 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 56.1 p -88.1 -169.69 2.67 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.697 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.14 -54.77 43.04 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.631 179.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.7 t -84.58 139.27 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.152 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.036 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 10' ' ' THR . 16.8 t -129.7 151.62 36.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.465 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.72 HG22 ' CG2' ' A' ' 8' ' ' THR . 0.2 OUTLIER -135.11 83.27 2.01 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.781 -179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.782 ' HG ' HG13 ' A' ' 60' ' ' VAL . 0.2 OUTLIER -89.71 122.18 32.57 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.098 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.07 97.46 7.43 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.675 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 51' ' ' LEU . 14.3 m -93.07 173.96 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.332 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -126.87 101.98 6.82 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.018 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -55.88 103.62 0.11 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.75 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -119.79 -167.48 1.44 Allowed 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.886 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.47 134.73 2.08 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.487 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.316 -0.849 . . . . 0.0 110.988 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.639 0.257 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -143.7 -167.61 2.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.68 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 67.1 p -113.27 130.33 56.27 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.762 0.315 . . . . 0.0 111.284 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.532 HG21 ' CB ' ' A' ' 74' ' ' ALA . 51.8 m -124.4 159.45 30.4 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.601 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.2 mt-10 -124.78 79.75 1.8 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.002 0.43 . . . . 0.0 110.358 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.551 HG11 ' HE1' ' A' ' 77' ' ' MET . 11.5 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.677 -0.678 . . . . 0.0 111.668 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 ptm . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.648 0.261 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -81.3 93.31 6.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.823 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.7 tt0 -73.91 117.22 59.46 Favored Pre-proline 0 C--O 1.234 0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.058 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 27.7 Cg_exo -63.49 -165.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.997 2.465 . . . . 0.0 112.859 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -113.56 95.79 5.53 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.065 0.459 . . . . 0.0 111.047 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 89' ' ' ALA . 44.4 mm -99.13 127.33 51.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.814 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -144.34 148.99 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.3 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.498 HG22 HG22 ' A' ' 85' ' ' THR . 0.2 OUTLIER -115.22 120.65 40.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.984 -179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 50' ' ' ARG . 15.9 m -94.85 153.34 3.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.144 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.04 106.99 10.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.477 HD21 ' CG ' ' A' ' 48' ' ' ASP . 6.6 mt -138.37 169.08 18.42 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.141 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -104.77 175.75 5.39 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -87.15 135.25 33.37 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.17 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.37 84.96 2.28 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.327 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.45 36.75 28.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.729 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.98 144.23 16.33 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.107 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.426 ' HB3' HD23 ' A' ' 19' ' ' LEU . 5.9 mtm -64.84 -46.84 80.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.553 0.216 . . . . 0.0 110.69 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.53 83.66 0.07 OUTLIER Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.944 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.634 HD11 HG12 ' B' ' 104' ' ' VAL . 2.8 pp -160.52 -179.4 7.62 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.65 0.262 . . . . 0.0 110.725 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' B' ' 102' ' ' THR . 46.4 m -131.58 142.63 49.94 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.309 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 21' ' ' ILE . 2.7 pp -137.68 139.83 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.682 HG23 ' HB2' ' A' ' 37' ' ' LYS . 29.7 t -129.71 132.68 65.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.13 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -97.09 127.5 43.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.844 179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.2 147.05 52.4 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.351 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.408 ' HG3' HD12 ' A' ' 32' ' ' LEU . 4.4 tttt -119.76 -179.76 4.0 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.037 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -162.89 -139.85 2.73 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.14 143.67 38.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.588 0.233 . . . . 0.0 110.741 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.33 44.75 97.21 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.568 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.71 108.15 6.91 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.639 0.257 . . . . 0.0 110.916 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -92.61 20.02 6.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.363 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -140.28 -166.09 2.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.458 179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 32' ' ' LEU . 5.2 tp -136.43 152.02 50.14 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.672 0.272 . . . . 0.0 110.814 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.13 111.37 2.83 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.703 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mm -81.43 73.0 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.215 0.531 . . . . 0.0 110.503 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -67.5 155.28 39.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.339 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 t -93.62 121.55 44.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.259 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.682 ' HB2' HG23 ' A' ' 22' ' ' VAL . 10.2 tptt -85.28 -36.15 21.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.971 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 53' ' ' ALA . 5.7 t -170.24 175.32 4.96 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 111.23 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 20.6 t -138.45 118.15 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.626 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.2 t -68.55 125.88 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.019 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 153.16 37.94 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.472 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.01 -29.92 11.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.773 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.678 ' O ' HG23 ' A' ' 47' ' ' VAL . . . -74.25 154.8 48.22 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.516 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.57 58.54 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.802 ' HB1' HD12 ' A' ' 51' ' ' LEU . . . -58.11 -51.36 70.03 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -77.26 -34.31 55.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.317 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 43' ' ' GLY . 48.1 t -62.85 -34.22 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.706 0.289 . . . . 0.0 110.698 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.477 ' CG ' HD21 ' A' ' 11' ' ' LEU . 16.2 t70 -71.56 -43.35 66.49 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.048 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 90.68 40.8 5.55 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.811 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.421 ' HB3' HG11 ' A' ' 9' ' ' VAL . 1.0 OUTLIER -131.05 31.93 4.37 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.677 0.275 . . . . 0.0 110.997 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.802 HD12 ' HB1' ' A' ' 45' ' ' ALA . 8.1 mt -150.63 160.3 43.91 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.295 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.02 143.4 3.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.097 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.465 ' HB2' ' HA ' ' A' ' 38' ' ' SER . . . -62.83 132.86 53.59 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.836 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 101.81 29.45 6.18 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.483 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -113.08 -177.48 3.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.46 0.172 . . . . 0.0 110.714 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -127.57 150.77 49.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.823 0.344 . . . . 0.0 111.375 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -110.21 150.07 29.2 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.959 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.84 -57.58 1.43 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.093 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 p -139.12 153.44 47.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.461 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.811 HG11 ' HG2' ' A' ' 77' ' ' MET . 23.2 t -137.94 129.04 38.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.624 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 t0 57.56 34.25 24.32 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.789 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 69.76 21.91 76.67 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.95 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.432 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -107.38 157.08 18.25 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.885 0.374 . . . . 0.0 111.06 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -101.36 98.88 9.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.614 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.696 HD21 HG23 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -105.95 28.84 7.21 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.788 179.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.2 t -87.36 100.95 10.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.217 0.532 . . . . 0.0 110.462 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.46 31.74 2.3 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.217 -0.902 . . . . 0.0 112.536 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 24.4 mt -119.93 155.57 32.49 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.723 0.297 . . . . 0.0 110.726 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 87.2 p -68.01 157.39 35.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.162 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.87 ' NE2' HG23 ' B' ' 102' ' ' THR . 23.9 tt0 -52.08 -40.31 61.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.049 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -58.45 -53.72 55.18 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.858 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -61.24 -39.07 88.93 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.894 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.07 -62.86 1.38 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.942 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.38 -61.25 2.72 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.56 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -40.85 -44.9 2.38 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.511 0.507 . . . . 0.0 111.881 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.432 HD11 ' CZ ' ' A' ' 63' ' ' ARG . 8.8 mt -58.07 -42.19 84.98 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.779 0.323 . . . . 0.0 110.797 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.811 ' HG2' HG11 ' A' ' 60' ' ' VAL . 3.7 mtp -80.8 -28.67 36.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.384 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -31.54 72.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.66 0.267 . . . . 0.0 110.699 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -101.18 42.82 1.09 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.315 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 77' ' ' MET . 7.8 p -85.38 168.49 14.58 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.835 0.35 . . . . 0.0 111.196 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 85.0 p -91.91 -165.73 1.41 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.732 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 2.1 p -51.59 -52.34 48.21 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.083 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.45 141.86 13.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.219 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -128.63 110.97 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.858 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.498 HG22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -101.22 97.58 8.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.919 -179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.481 HD23 HG22 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -105.18 136.36 44.83 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.403 -179.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 8' ' ' THR . 33.5 tt0 -106.63 107.32 18.27 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.385 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.0 p -107.64 151.83 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.615 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 6' ' ' ILE . . . -100.88 98.74 9.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.1 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.36 109.07 3.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.45 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.22 163.09 25.48 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.024 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -81.97 -6.83 88.6 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.814 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.988 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.991 179.997 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 11.3 tp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.668 0.27 . . . . 0.0 111.61 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.479 ' O ' HG13 ' A' ' 22' ' ' VAL . 1.0 OUTLIER -159.8 152.3 21.15 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.468 179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 85.6 p -127.03 113.1 16.01 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.771 0.319 . . . . 0.0 111.143 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.87 HG23 ' NE2' ' A' ' 70' ' ' GLN . 23.7 p -91.54 -166.99 1.68 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.344 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -146.81 112.11 5.51 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.875 0.369 . . . . 0.0 110.932 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 77' ' ' MET . 12.5 p . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.8 179.849 . . . . . . . . 1 1 . 1 stop_ save_